Sentence,class,file
http://www.fda.gov/downloads/biologicsblood vaccines/guidancecomplianceregulatoryinformation/ guidances/vaccines/ucm175909.pdf.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
The American journal of tropical medicine and hygiene 2013; 89:3-12; PMID:23629939; http://dx.doi.org/10.4269/ajtmh.12-0749 56.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
The Americanjournal of tropical medicine and hygiene 2013; 89:56- 61; PMID:23629936; http://dx.doi.org/10.4269/ ajtmh.12-0756 57.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Human vaccines & immunotherapeutics 2014; 10; PMID:24861668; http://dx.doi.org/ 10.4161/hv.29241 58.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
The Lancet infectious diseases 2012; 12:93-4; PMID:22071250; http://dx.doi.org/10.1016/S1473-3099(11)70312-7 59.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Expert review of vaccines 2014; 13:221-34; PMID:24308581; http://dx.doi.org/10.1586/ 14760584.2014.864563 60.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
PloS one2013; 8:e83374; PMID:24349497; http://dx.doi.org/ 10.1371/journal.pone.0083374 61.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2007; 25:2811-6; PMID:17291636; http://dx.doi.org/ 10.1016/j.vaccine.2006.12.013 63.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2008; 26:1913- 21; PMID:18336960; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2014; 32:1147-52; PMID:24440207;http://dx.doi.org/10.1016/j.vaccine.2014.01.002 66.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
JAMA : the journal of the AmericanMedical Association 1971; 218:57-61; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Diphtheria-tetanus-acellular pertussis ( D T a P )v a c c i n e .J A M A:t h ej o u r n a lo ft h eA m e r i - can Medical Association 1996; 276:1803-4; PMID:8946898; http://dx.doi.org/10.1001/jama.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
ClinIinfect Dis 2012; 55:1434-5; author reply 5-6; PMID:22871826; http://dx.doi.org/10.1093/cid/cis672 73.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2003; 21:3593-600; PMID:12922087; http://dx.doi.org/10.1016/ S0264-410X(03)00420-1 76.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 1999; 18:947-54; PMID:10580209; http://dx.doi.org/10.1016/S0264-410X(99)00331-X77.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Pediatr Infect Dis J 1998; 17:1026-33; PMID:9849987; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Lancet 1999;354:2063-8; PMID:10636384; http://dx.doi.org/ 10.1016/S0140-6736(99)04377-9 79.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
"Guerra FA, Blatter MM, Greenberg DP, Pichi- chero M, Noriega FR, Pentacel Study G. Safety and immunogenicity of a pentavalent vaccine com-pared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies b efore a preschool booster d o s e :ar a n d o m i z e d ,c l i n i c a lt r i a l .P e d i a t r i c s2 0 0 9 ; 123:301-12; PMID:19117896; http://dx.doi.org/ 10.1542/peds.2007-3317 80.",Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Pediatr Infecti Dis J 2000; 19:417-23; PMID:10819337; http://dx.doi.org/10.1097/00006454-200005000-00006 82.,OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2006; 24:1776-85;PMID:16303216; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Drugs 2010; 70:1021-58; PMID:20481658; http://dx.doi.org/10.2165/ 11204830-000000000-00000 84.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Ann Pharmacother 2010; 44:515-23; PMID: 20197476; http://dx.doi.org/10.1345/aph.1M468 85.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Human Vaccin 2011; 7:258-64; PMID:21307655; http://dx.doi.org/10.4161/ hv.7.2.14170 87.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Pediatr Infect Dis J 2006; 25:713- 20; PMID:16874171; http://dx.doi.org/10.1097/01.,OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
"Pediatr Infect Dis J 2006; 25:943-5; PMID:17006294; http://dx.doi.org/ 10.1097/01.inf.0000237917.60734.05 8 9 .K n u fM ,H a b e r m e h lP ,C i m i n oC ,P e t e r s e nG , Schmitt HJ.",OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2006; 24:4727-36; PMID:16616973; http://dx.doi.org/10.1016/j.vaccine.2006.03.032 90.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
The Pediatr Infect Dis J 2009; 28:S109-18; PMID:19325447; http://dx.doi.org/10.1097/ INF.0b013e318199f62d 91.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2011; 29:6042-8; PMID:21704105; http://dx.doi.org/10.1016/j.vaccine.2011.06.026 92.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Clin Vaccin Immunol 2010; 17:1055- 65; PMID:20463105; http://dx.doi.org/10.1128/ CVI.00131-10 93.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Expert Rev Vaccines 2009; 8:831-40; PMID:19538110;http://dx.doi.org/10.1586/erv.09.59 94.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
J Global Infect Dis 2011; 3:63-72; PMID:21572611; http://dx.doi.org/ 10.4103/0974-777X.77298 95.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2014; 32:1055-60; PMID:24440210; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Lancet Infect Dis 2014; 14:119-29;PMID:24290843; http://dx.doi.org/10.1016/ S1473-3099(13)70241-X 98.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2011; 29:5094-106; PMID:21616112; http://dx.doi.org/ 10.1016/j.vaccine.2011.05.022 99.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD909 induce opsonophagocytic functional antibod- ies in humans that cross-react with S. Paratyphi A and S. Paratyphi B. Clin Vaccine Immunol 2014; 21:427-34; PMID:24429069; http://dx.doi.org/ 10.1128/CVI.00786-13 101.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
N Engl J Med 2014; 370:568-70; PMID:24422677; http://dx.doi.org/10.1056/NEJMe1315836 102.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Pediatrics2008; 122:e1062-6; PMID:18977955; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Pediatrics 2014; 134:15-23; PMID:24913793;http://dx.doi.org/10.1542/ peds.2013-3849 1 0 5 .,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Expert Rev Vaccines 2014; 13:365- 76; PMID:24392657; http://dx.doi.org/10.1586/14760584.2014.877846 106.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Expert Rev Vaccines 2006; 5:483-94; PMID:16989629; http://dx.doi.org/ 10.1586/14760584.5.4.483 108.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2011;29:8285-92; PMID:21907255; http://dx.doi.org/ 10.1016/j.vaccine.2011.08.108 110.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Clin Vaccine Immunol 2014; 21:66- 73; PMID:24173028; http://dx.doi.org/10.1128/CVI.00601-13 111.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Clin Infect Dis 2014; 59:933-41;PMID:24958238; http://dx.doi.org/10.1093/cid/ ciu468 112.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2013; 31:2667-72; PMID:23602665; http://dx.doi.org/10.1016/j.vaccine.2013.04.012 113.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Infect Immun 2009; 77:1128-36; PMID:19114545; http://dx.doi.org/ 10.1128/IAI.01056-08 115.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Infect Immun2013; 81:665-72; PMID:23250948; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccines against Campylobacter jejuni .J Infect Dis 1997; 176 Suppl 2:S183-8; PMID:9396708; http://dx.doi.org/10.1086/513791 117.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Clin Vaccine Immunol 2014; 21:366-82; PMID:24403527; http://dx.doi.org/ 10.1128/CVI.00683-13 118.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Expert Rev Vaccines 2006; 5:669- 86; PMID:17181440; http://dx.doi.org/10.1586/ 14760584.5.5.669 119.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2011; 29:7009-19; PMID:21787825; http://dx.doi.org/10.1016/j.vaccine.2011.07.033 120.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Clin Vaccine Immunol 2011; 18:2118-27; PMID:21994354; http://dx.doi.org/ 10.1128/CVI.05342-11 121.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2010; 28:2231-5; PMID:20056180; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Clin Vaccine Immunol 2012; 19:1921-31; PMID:23035175; http://dx.doi.org/ 10.1128/CVI.00364-12 123.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Lancet Infecti Dis 2014; 14:174-5; PMID:24291167; http://dx.doi.org/10.1016/S1473-3099(13)70355-4 124.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Lancet Infect Dis 2014; 14:197-204; PMID:24291168; http://dx.doi.org/10.1016/S1473- 3099(13)70297-4 125.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Expert Rev Vaccines2009; 8:1693-704; PMID:19943764; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2008; 26:1353-64; PMID:18276045; http://dx.doi.org/ 10.1016/j.vaccine.2007.12.040 127.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Int J Med Microbiol 2013; 303:105-13; PMID:23474241; http://dx.doi.org/ 10.1016/j.ijmm.2013.01.001 131.,OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Microbial Cell Factories 2010; 9:61; PMID:20701771; http://dx.doi.org/10.1186/1475-2859-9-61 133.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
J Immunol 2009; 182:2241-7; PMID:19201878; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Expert Rrev Vaccines 2012; 11:677-94; PMID:22873126; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Proc Natl Acad Sci U S A 2010; 107:8794-9; PMID:20421480; http://dx.doi.org/ 10.1073/pnas.0914121107 137.,OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Methods 2013; 60:264-8; PMID:23046911; http://dx.doi.org/10.1016/j.ymeth.2012.09.008 138.,OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Infect Immun 2013; 81: 4470-7; PMID:24060976; http://dx.doi.org/ 10.1128/IAI.00859-13 140.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Nat Rev Gastroenterol Hepatol 2013;10:245-55; PMID:23419287; http://dx.doi.org/ 10.1038/nrgastro.2013.12 141.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2013; 31:1163- 70; PMID:23306362; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
"Therap Adv Vaccines 2013; 1:113-23; PMID:24757519; http://dx.doi.org/ 10.1177/2051013613500428 143. de la Cabada Bauche J, Dupont HL.",Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Am J Trop Med Hyg 2011; 84:59-64; PMID:21212203; http://dx.doi.org/10.4269/ ajtmh.2011.10-0093145.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2013; 31:2457-64; PMID:23541621; http://dx.doi.org/ 10.1016/j.vaccine.2013.03.027 148.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Pediatrics 2002; 109:124-9; PMID:11773551; http://dx.doi.org/ 10.1542/peds.109.1.124 151.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Paediatric drugs 2008; 10:337-47;PMID:18754700; http://dx.doi.org/10.2165/ 00148581-200810050-00007 152.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Clin Exp Vaccine Res 2014; 3:91-9; PMID:24427766; http://dx.doi.org/10.7774/cevr.2014.3.1.91 153.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2012; 30:6731-3;PMID:22975026; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Inter J Parasitol 2008; 38:913-22; PMID:18158154; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Hum Vaccin Immunother 2014; 10; PMID:24804797; http://dx.doi.org/10.4161/ hv.29054 156.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
J Infect Dis 2012; 205:431-44; PMID:22184729; http://dx.doi.org/10.1093/infdis/jir757 157.,OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Vaccine 2006;24:3505-12; PMID:16524648; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
J Immunol 2012; 188:2189-97; PMID:22291184; http://dx.doi.org/10.4049/jimmunol.1102696 161.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Expert Rev Vaccines 2013;12:13-30; PMID:23256736; http://dx.doi.org/ 10.1586/erv.12.140 162.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
http://www.fda.gov/BiologicsBloodVaccines/ Vaccines/ApprovedProducts/ucm172495.htm.,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
Clin Infect Dis 2001; 33 Suppl 4:S340-5; PMID:11709770; http://dx.doi.org/10.1086/322571 1448 Volume 11 Issue 6 Human Vaccines & Immunotherapeutics,Non-OADS,/arxiv_data1/oa_pdf/72/25/khvi-11-06-986984.PMC4517455.pdf
"© Silvia P /C19erez-Vilar, Javier Díez-Domingo, Joan Puig-Barber /C18a, Ruth Gil-Prieto, and Silvana Romio *Correspondence to: Silvia P /C19erez-Vilar; Email: perez_silvil@gva.es Submitted: 02/24/2015; Revised: 04/19/2015; Accepted: 05/06/2015 http://dx.doi.org/10.1080/21645515.2015.1049787 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/ae/khvi-11-07-1049787.PMC4517458.pdf
N Eng J Med 2001; 344:564-72; PMID:11207352; http://dx.doi.org/ 10.1056/NEJM200102223440804 4.,OADS,/arxiv_data1/oa_pdf/d1/ae/khvi-11-07-1049787.PMC4517458.pdf
Pediat Infect DisJ 2001; 20:410-6; PMID:11332666; http://dx.doi.org/ 10.1097/00006454-200104000-00008 5.,OADS,/arxiv_data1/oa_pdf/d1/ae/khvi-11-07-1049787.PMC4517458.pdf
N Eng J Med 2006; 354:11-22; PMID:16394298;http://dx.doi.org/10.1056/NEJMoa052434 7.,OADS,/arxiv_data1/oa_pdf/d1/ae/khvi-11-07-1049787.PMC4517458.pdf
Vaccine 2011; 29:3061-6; PMID:21316503; http://dx.doi.org/ 10.1016/j.vaccine.2011.01.0888.,Non-OADS,/arxiv_data1/oa_pdf/d1/ae/khvi-11-07-1049787.PMC4517458.pdf
Intussusception risk and disease prevention associated with rotavirus vac- cines in Australia’s National Immunization Program.Clin Infect Dis 2013; 57:1427-34; PMID:23964090; http://dx.doi.org/10.1093/cid/cit520 9.,Non-OADS,/arxiv_data1/oa_pdf/d1/ae/khvi-11-07-1049787.PMC4517458.pdf
N Eng J Med 2011; 364:2283-92; PMID:21675888; http://dx.doi.org/10.1056/NEJMoa1012952 10.,Non-OADS,/arxiv_data1/oa_pdf/d1/ae/khvi-11-07-1049787.PMC4517458.pdf
Hum Vaccin 2011; 7:798-9; PMID:21715979; http://dx.doi.org/ 10.4161/hv.7.7.15683 12.,Non-OADS,/arxiv_data1/oa_pdf/d1/ae/khvi-11-07-1049787.PMC4517458.pdf
Stat Med 2006; 25:1768-97; PMID:16220518; http://dx.doi.org/10.1002/sim.2302 16.,OADS,/arxiv_data1/oa_pdf/d1/ae/khvi-11-07-1049787.PMC4517458.pdf
Phar-macoepidemiol Drug Safety 2012; 21 Suppl 1:50-61; PMID:22262593; http://dx.doi.org/10.1002/pds.2330 17.,Non-OADS,/arxiv_data1/oa_pdf/d1/ae/khvi-11-07-1049787.PMC4517458.pdf
Vaccine 2004; 22:569-74;PMID:14741146; http://dx.doi.org/10.1016/j.vaccine.,Non-OADS,/arxiv_data1/oa_pdf/d1/ae/khvi-11-07-1049787.PMC4517458.pdf
"SUPPLEMENTARY MATERIAL  is linked to the online version of the paper at  http://www.nature.com/ajg       Am J Gastroenterol   2015; 110:1022–1034; doi: 10.1038/ajg.2015.65; published online 31 March 2015     1   Inﬂ  ammatory Bowel Disease Unit, St Mark’s Hospital ,  London ,  UK   ;     2   Tumour Biology, Barts Cancer Institute, Queen Mary University of London ,  London ,  UK   ;      3   University Hospital of North Tees ,  Teesside ,  UK   ;     4   Department of Colorectal Surgery, St Mark’s Hospital ,  London ,  UK   ;     5   Department of Pathology, St Mark’s  Hospital ,  London ,  UK   ;     6   Wolfson Unit for Endoscopy, St Mark’s Hospital ,  London ,  UK   ;     7   Co-senior authors   .",Non-OADS,/arxiv_data1/oa_pdf/db/14/ajg201565a.PMC4517513.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-sa/4.0/",Non-OADS,/arxiv_data1/oa_pdf/db/14/ajg201565a.PMC4517513.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/94/d8/dddt-9-3877.PMC4517514.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3877–3884Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3877Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8760 9Aterofisiol® in carotid plaque evolution Bruno amato1,2,* rita compagna1,2,* Maurizio amato2 luca gallelli3 stefano de Franciscis1,4,* raffaele serra1–4,* 1interuniversity center  of Phlebolymphology (ciFl),   international research and  educational Program in clinical  and experimental Biotechnology,   University Magna graecia of  catanzaro, catanzaro, 2Department  of clinical Medicine and surgery,   University Federico ii of naples,   naples, 3Department of health  sciences, University of catanzaro,   catanzaro, 4Department of Medical  and surgical sciences, University  Magna graecia of catanzaro,   catanzaro, italy *These authors contributed equally  to this workBackground:  In patients with carotid stenosis, the risk of plaque rupture is related to the  composition of the atherosclerotic plaque rather than to its magnitude.",Non-OADS,/arxiv_data1/oa_pdf/94/d8/dddt-9-3877.PMC4517514.pdf
"Keywords:  Aterofisiol®, carotid stenosis, endarterectomy, carotid plaque, neurological  symptoms, cholesterol Introduction The World Health Organization ranks cardiovascular diseases (CVD) as the leading  cause of death worldwide, and showed that CVD constitute 48.6% of the ten main  causes of death.1 It has also been estimated that of the 83.6 million American adults  with CVD, about 18% have atherosclerosis2 and the presence of atherosclerotic plaque  into the carotid artery is a risk factor for transient ischemic attack (TIA) and stroke.3 Usually, atherosclerotic plaque contains a coating of soft material formed by mac - rophages and lipids and a core of harder fibrous tissue; the size of the nucleus atheroma,  the thinness of the cap, and the density of macrophages are the main determinants of  the risk of plaque rupture.4,5 This risk is related to the composition of the atherosclerotic  plaque rather than to its magnitude; plaques with high concentration of lipids are more  susceptible to rupture with subsequent formation of blood clots.6,7 The plaque rupture  often occurs on the surface during growth and is related to changes within the plaque  as well as to an increase in the circumferential pressure outside the plaque.correspondence: raffaele serra Department of Medical and surgical  sciences, University Magna graecia  of catanzaro – catanzaro, Viale  europa – germaneto 88100,  catanzaro, italy Tel +39 0961 364 7380 cell +39 338 707 8043 Fax +39 0961 364 7175 email rserra@unicz.i t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Amato et al Running head recto: Aterofisiol® and plaques DOI: http://dx.doi.org/10.2147/DDDT.S87609",Non-OADS,/arxiv_data1/oa_pdf/94/d8/dddt-9-3877.PMC4517514.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs310/en /.,Non-OADS,/arxiv_data1/oa_pdf/94/d8/dddt-9-3877.PMC4517514.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/94/d8/dddt-9-3877.PMC4517514.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/d8/dddt-9-3877.PMC4517514.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/aa/jaa-8-075.PMC4517515.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Asthma and Allergy 2015:8 75–86Journal of Asthma and Allergy Dove press submit your manuscript | www.dovepress.co m Dove press  75Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S6228 8Stinging insect allergy: current perspectives   on venom immunotherapy Sian w Ludman1 Robert J Boyle2 1Paediatric Allergy Department,    St Mary’s Hospital, imperial  Healthcare NHS Trust, London, UK;   2Department of Paediatrics, imperial  College London, London, UK Correspondence: Robert J Boyle   Paediatric Research Unit, Department  of Paediatrics, imperial College London,  Norfolk Place, London w2  1PG, UK   Tel +44 20 7594 3990   Fax +44 20 7594 3984   email r.boyle@imperial.ac.u kAbstract:  Systemic allergic reactions to insect stings affect up to  5% of the population during  their lifetime, and up to  32% of beekeepers.",Non-OADS,/arxiv_data1/oa_pdf/ff/aa/jaa-8-075.PMC4517515.pdf
Available from: http://www.phadia.,Non-OADS,/arxiv_data1/oa_pdf/ff/aa/jaa-8-075.PMC4517515.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/ff/aa/jaa-8-075.PMC4517515.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/aa/jaa-8-075.PMC4517515.pdf
Available from: https://www.nice.org.uk/guidance/ ta246.,Non-OADS,/arxiv_data1/oa_pdf/ff/aa/jaa-8-075.PMC4517515.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7c/18/dddt-9-3817.PMC4517516.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 3817–3819Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3817LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S85608A new recombinant factor VIII: from genetics  to clinical use Christoph Kannicht1 Guido Kohla1 Maya Tiemeyer2 Olaf Walter3 Helena Sandberg4 1Octapharma Biopharmaceuticals  GmbH, Molecular Biochemistry,   Berlin, Germany; 2Octapharma  Biopharmaceuticals GmbH,   Heidelberg, Germany; 3Octapharma  AG, Lachen, Switzerland; 4CoaBio AB,   Bromma, SwedenDear editor The December 2014 issue of Drug Design, Development and Therapy included a review  article by Santagostino entitled “A new recombinant factor VIII: from genetics to clini - cal use”.1 The article provided a timely review of recent advances and developments in  the treatment of hemophilia A with recombinant factor VIII (rFVIII).1 However, when  reviewing licensed rFVIII products, Santagostino1 did not include Human-cl rhFVIII  (simoctocog alfa, Nuwiq®).2–4 Nuwiq® is a new-generation rFVIII protein produced in  HEK 293 F cells that was approved by the European Medicines Agency in July 2014  for the prevention and treatment of bleeds in hemophilia A patients of all ages.5 Santagostino1 described the gradual improvements made to rFVIII production/ formulation and how these have coincided with the introduction of first-, second-, and  third-generation rFVIII products, particularly in relation to the elimination of production- related additives from animal/human sources and viral removal/inactivation.",Non-OADS,/arxiv_data1/oa_pdf/7c/18/dddt-9-3817.PMC4517516.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/7c/18/dddt-9-3817.PMC4517516.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/18/dddt-9-3817.PMC4517516.pdf
Avail - able from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/ medicines/human/medicines/002813/human_med_001781.,Non-OADS,/arxiv_data1/oa_pdf/7c/18/dddt-9-3817.PMC4517516.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/54/dc/dddt-9-3863.PMC4517517.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3863–3865Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3863EDiT orialopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8303 8Functional magnetic resonance imaging is a  powerful approach to probing the mechanism of  action of therapeutic drugs that act on the central  nervous system Shu-Feng Zhou Department of Pharmaceutical  Science, College of Pharmacy,   University of South Florida, Tampa,   Fl, USaIn the paper by Pickering et al1 published in this issue of Drug Design, Development and  Therapy , the authors explore the brain areas actively involved in the mechanism of action  of acetaminophen as an analgesic in healthy subjects using functional magnetic resonance  imaging (fMRI).",Non-OADS,/arxiv_data1/oa_pdf/54/dc/dddt-9-3863.PMC4517517.pdf
"The reduction of perceived pain intensity scores Correspondence: Shu-Feng Zhou Department of Pharmaceutical Sciences,  Colleges of Pharmacy and Medicine,  University of South Florida, 12901 Bruce B  Downs Boulevard, Tampa, Fl 33612, USa Tel +1 813 974 6276 Fax +1 813 974 9885 Email szhou@health.usf.ed u Journal name: Drug Design, Development and Therapy Article Designation: Editorial Y ear: 2015 Volume: 9 Running head verso: Zhou Running head recto: fMRI and study of CNS drugs DOI: http://dx.doi.org/10.2147/DDDT.S83038",Non-OADS,/arxiv_data1/oa_pdf/54/dc/dddt-9-3863.PMC4517517.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/54/dc/dddt-9-3863.PMC4517517.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/54/dc/dddt-9-3863.PMC4517517.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/23/dddt-9-3853.PMC4517518.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 3853–3862Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3853Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8100 4The brain signature of paracetamol in healthy  volunteers: a double-blind randomized trial gisèle Pickering1–3 adrian Kastler4 nicolas Macian1,2 Bruno Pereira5 romain Valabrègue6 stéphane lehericy6 louis Boyer4,7 claude Dubray1–3 Betty Jean4 1chU clermont-Ferrand, centre  de Pharmacologie clinique, 2centre  d’investigation clinique – inserm  1405, 3clermont Université,   laboratoire de Pharmacologie,   Faculté de médecine, 4chU gabriel  Montpied, clermont-Ferrand,   service d’ imagerie Ostéo-articulaire  thoracique et neurologique, 5chU  clermont-Ferrand, Délégation  recherche clinique et à l’innovation,   clermont-Ferrand, France; 6institut  du cerveau et de la Moelle epiniere  – icM, centre de neuroimagerie  de recherche cenir, inserm  U1127, cnrs  UMr 7225, sorbonne  Universités, UPM c University  Paris, Paris, France, Department of  neuroradiology, groupe hospitalier  Pitié-salpêtrière, Paris, France; 7UMr  cnrs Ud a 6284, clemont-Ferrand,   FranceBackground:  Paracetamol’s (APAP) mechanism of action suggests the implication of  supraspinal structures but no neuroimaging study has been performed in humans.",Non-OADS,/arxiv_data1/oa_pdf/1c/23/dddt-9-3853.PMC4517518.pdf
"Clinical studies in healthy volunteers have confirmed the central  serotonergic activation4 and the reinforcement by APAP of descending inhibitory pain correspondence: gisèle Pickering clinical Pharmacology centre,  Bâtiment 3c, chU of clermont-Ferrand,  58 Montalembert road, 63001 clermont- Ferrand cedex, France Tel +33 4 7317 8416 Fax +33 4 7317 8412 email gisele.pickering@udamail.f r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Pickering et al Running head recto: The brain signature of paracetamol in healthy volunteers DOI: http://dx.doi.org/10.2147/DDDT.S81004",Non-OADS,/arxiv_data1/oa_pdf/1c/23/dddt-9-3853.PMC4517518.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1c/23/dddt-9-3853.PMC4517518.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/23/dddt-9-3853.PMC4517518.pdf
"Available from:  http://www.ncbi.nlm.nih.gov/pubmed/2776031  47. de Freitas RL, de Oliveira RC, de Oliveira R, Paschoalin-Maurin T,   de Aguiar Corrêa FM, Coimbra NC.",Non-OADS,/arxiv_data1/oa_pdf/1c/23/dddt-9-3853.PMC4517518.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/81/68/ccid-8-355.PMC4517519.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 355–360Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  355OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S8601 5Highly efficient and compatible shampoo for use  after hair transplant Dorothea schweiger1 andrea M schoelermann1 Alexander Filbry1 Tina hamann1 Claudia Moser2 Frank rippke1 1research and Development,   Beiersdorf AG, Hamburg, Germany;   2Moser Medical, Clinics for aesthetic  Plastic surgery, Vienna, austria Correspondence: Dorothea schweiger   research and Development,  Beiersdorf ag, Bf.",Non-OADS,/arxiv_data1/oa_pdf/81/68/ccid-8-355.PMC4517519.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/81/68/ccid-8-355.PMC4517519.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/81/68/ccid-8-355.PMC4517519.pdf
"Available  from: http://www.skin-care-forum.basf.com/de/artikel/home/ new-concepts-in-acne-pathogenesis/2013/12/christos.zouboulis@ klinikum-dessau.de/sensitive-skin/2013/03/21?id =c5507340-a11c- 4146-a79 a-dba915b09c18&mode =Detai l. Accessed February 16,  2015.",Non-OADS,/arxiv_data1/oa_pdf/81/68/ccid-8-355.PMC4517519.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/86/a6/dddt-9-3837.PMC4517520.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3837–3851Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3837Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8535 7navigating into the binding pockets of the her  family protein kinases: discovery of novel egFr  inhibitor as antitumor agent Wei liu1,* Jin-Feng ning2,* Qing-Wei Meng1 Jing hu1 Yan-Bin Zhao1 chao liu3 li cai1 1The Fourth Department of Medical  Oncology, harbin Medical University  cancer hospital, 2The Thoracic  surgery Department, harbin Medical  University cancer hospital, harbin,   People’s republic of china; 3general  surgery Department, Mudanjiang  guanliju central hospital, Mishan,   heilongjiang Province, People’s  republic of china *These authors contributed equally  to this workAbstract:  The epidermal growth factor receptor (EGFR) family has been validated as a  successful antitumor drug target for decades.",Non-OADS,/arxiv_data1/oa_pdf/86/a6/dddt-9-3837.PMC4517520.pdf
"To date, there are dozens of gene mutations reported,8 which correspondence: li cai The Fourth Department of  Medical Oncology, harbin Medical  University cancer hospital,  haping road 150, harbin 150040,  People’s republic of china Tel +86 451 8629 8735 Fax +86 451 8629 8735 email caiwenxin76@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Liu et al Running head recto: Binding pockets of the HER family protein kinases DOI: http://dx.doi.org/10.2147/DDDT.S85357",Non-OADS,/arxiv_data1/oa_pdf/86/a6/dddt-9-3837.PMC4517520.pdf
The crystal structures of two HER proteins complex  were retrieved from the RCSB PDB ( http://www.rcsb.org/ pdb/home/home.d o).,OADS,/arxiv_data1/oa_pdf/86/a6/dddt-9-3837.PMC4517520.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/86/a6/dddt-9-3837.PMC4517520.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/a6/dddt-9-3837.PMC4517520.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/bb/ndt-11-1805.PMC4517522.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1805–1815Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1805OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8733 2altered blood oxygen level-dependent signal  variability in chronic post-traumatic stress  disorder during symptom provocation Jun Ke1,* li Zhang2,* rongfeng Qi1,* Qiang Xu1 Weihui li2 cailan hou3 Yuan Zhong1 Zhiqiang Zhang1 Zhong he4 lingjiang li2,5 guangming lu1 1Department of Medical imaging, Jinling  hospital, Medical school of Nanjing  University, Nanjing, 2Mental health  institute, the second Xiangya hospital,   National T echnology institute of Psychiatry,   Key laboratory of Psychiatry and Mental  health of hunan Province, central south  University, changsha, 3guangdong academy  of Medical science, guangdong general  hospital, guangdong Mental health center,   guangzhou, 4Department of radiology of  the second Xiangya hospital, central south  University, changsha, 5shenzhen Kangning  hospital of guangdong Province, shenzhen,   People’s republic of china *These authors contributed equally   to this workBackground:  Recent research suggests that variability in brain signal provides important information  about brain function in health and disease.",Non-OADS,/arxiv_data1/oa_pdf/bb/bb/ndt-11-1805.PMC4517522.pdf
The fMRI data were pre - processed and analyzed using SPM8 ( http://www.fil.ion.,OADS,/arxiv_data1/oa_pdf/bb/bb/ndt-11-1805.PMC4517522.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/bb/bb/ndt-11-1805.PMC4517522.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/bb/ndt-11-1805.PMC4517522.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/33/eb/ndt-11-1817.PMC4517523.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1817–1834Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1817OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8483 3Paliperidone extended-release tablets in chinese  patients with schizophrenia: meta-analysis  of randomized controlled trials shangli cai1,2 huafei lu2 Zhihua Bai2 renrong Wu1 Jingping Zhao1 1Mental health institute of the second  Xiangya hospital, National T echnology  institute of Psychiatry, Key laboratory  of Psychiatry and Mental health  of hunan Province, central south  University, hunan, 2Janssen research  and Development, Beijing, People’s  republic of china Background:  Previous meta-analyses have compared paliperidone extended-release (ER)  tablets with other antipsychotics, but none have involved Chinese patients or studies from  People’s Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/33/eb/ndt-11-1817.PMC4517523.pdf
Tel +86 731 8555 4052 Fax +86 731 8555 4052 email jpzhao@outlook.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Cai et al Running head recto: Paliperidone ER tablets in Chinese patients with schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S84833,Non-OADS,/arxiv_data1/oa_pdf/33/eb/ndt-11-1817.PMC4517523.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/33/eb/ndt-11-1817.PMC4517523.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/eb/ndt-11-1817.PMC4517523.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ba/c9/dddt-9-3867.PMC4517524.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3867–3876Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3867Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7570 2Dendrimer-coupled sonophoresis-mediated  transdermal drug-delivery system for diclofenac Bin huang1 Wei-Jiang Dong2 gao-Yi Yang3 Wei Wang1 cong-hua Ji1 Fei-n i Zhou4 1Department of Ultrasound, First  affiliated hospital of Zhejiang  chinese Medical University, hangzhou,   2Department of Ultrasonography,   Tongxiang chinese Medicine  hospital, Jiaxing, 3Department of  Ultrasound, hangzhou red cross  hospital, 4Department of Medical  records and  statistics, First affiliated  hospital of Zhejiang chinese Medical  University, hangzhou, People’s  republic of chinaAbstract:  The purpose of the present study was to develop a novel transdermal drug-delivery  system comprising a polyamidoamine dendrimer coupled with sonophoresis to enhance the  permeation of diclofenac (DF) through the skin.",Non-OADS,/arxiv_data1/oa_pdf/ba/c9/dddt-9-3867.PMC4517524.pdf
"These barriers are  hurdles for the penetration of drugs.correspondence: gao-Yi Yang Department of Ultrasound, hangzhou  red cross hospital, 208 east huancheng  road, hangzhou, Zhejiang 310003,  People’s republic of china Tel/fax +86 571 5610 9999 email gaoyiyang23@gmail.co mJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Huang et al Running head recto: Sonophoresis-mediated TDDS for diclofenac DOI: http://dx.doi.org/10.2147/DDDT.S75702",Non-OADS,/arxiv_data1/oa_pdf/ba/c9/dddt-9-3867.PMC4517524.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2011/021005s013lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ba/c9/dddt-9-3867.PMC4517524.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ba/c9/dddt-9-3867.PMC4517524.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/c9/dddt-9-3867.PMC4517524.pdf
Graphical abstract This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/f7/nihms710295.PMC4517581.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four figures, one table, and five movies and can be found  with this article online at http://dx.doi.org/10.1016/j.celrep.2015.06.026 .",OADS,/arxiv_data1/oa_pdf/44/f7/nihms710295.PMC4517581.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/content/ full/1/4/e1500169/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/0e/e4/1500169.PMC4517844.pdf
"MLST analysis was performed using the scheme at the Uni- versity College of Cork (UCC) E. coli MLST Web site (http://mlst.ucc.ie), which is based on the housekeeping genes adk,fumC ,gyrB,icd,mdh, purA ,a n d recA (19).",OADS,/arxiv_data1/oa_pdf/7b/e0/1500183.PMC4517851.pdf
Polymerase chain reaction (PCR) was performed according to protocol (http://mlst.ucc.ie/mlst/dbs/Ecoli/documents/primersColi_html).,OADS,/arxiv_data1/oa_pdf/7b/e0/1500183.PMC4517851.pdf
Allele and ST assignments were made and deposited at the publicly accessible E. coli UCC MLST data- base (http://mlst.ucc.ie/mlst/dbs/Ecoli) ( 19).,OADS,/arxiv_data1/oa_pdf/7b/e0/1500183.PMC4517851.pdf
"Alignment of functionally selected AR genes to the HMP and MetaHITAR genes were compared to the HMP ( 65)a n dM e t a H I T( 66)s h o t g u n assemblies (HMP: 749 assemblies, h ttp://www.hmpdacc.org/HMASM/; MetaHIT: 124 assemblies, NCBI/European Bioinformatics Institute acces-sion ERA000116, http://www.bork.embl .de/~arumugam/Qin_et_al_2010/) via blastn.",OADS,/arxiv_data1/oa_pdf/7b/e0/1500183.PMC4517851.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/content/ full/1/3/e1500183/DC1 Text Table S1.,Non-OADS,/arxiv_data1/oa_pdf/7b/e0/1500183.PMC4517851.pdf
"12.American Gut , http://github.com/biocore/American-Gut 13.",Non-OADS,/arxiv_data1/oa_pdf/7b/e0/1500183.PMC4517851.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/content/ full/1/5/e1500358/DC1 Fig.,Non-OADS,/arxiv_data1/oa_pdf/a6/93/1500358.PMC4517858.pdf
"102pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.2.102 Annals of Surgical Treatment and ResearchCASE REPORT Necrotizing fasciitis of the breast in a pregnant woman  successfully treated using negative-pressure wound therapy Jina Lee, Kwan Ju Lee, Woo Young Sun Department of Surgery, Daejeon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Daejeon, Korea INTRODUCTION Necrotising fasciitis (NF) is the most aggressive form of soft  tissue infection which involves necrosis of subcutaneous fat  and spreads along the fascial planes.",Non-OADS,/arxiv_data1/oa_pdf/50/7c/astr-89-102.PMC4518028.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/7c/astr-89-102.PMC4518028.pdf
" Annals of Surgical Treatment and Research 107pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.2.107 Annals of Surgical Treatment and ResearchCASE REPORT Endovascular aortic aneurysm repair using a bifurcated  stent graft in a patient with femoro-femoral bypass Su Hwan Kang, Jung Min Bae, Woo-Sung Yun Division of Transplantation and Vascular Surgery, Department of Surgery, Yeungnam University Medical Center,   Yeungnam University College of Medicine, Daegu, Korea INTRODUCTION Iliofemoral access-related difficulties are among the main  problems encountered during endovascular aortic aneurysm  repair (EVAR).",Non-OADS,/arxiv_data1/oa_pdf/b5/12/astr-89-107.PMC4518029.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/12/astr-89-107.PMC4518029.pdf
" Annals of Surgical Treatment and Research 55pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.2.55 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Clinical significance of single-port laparoscopic  splenectomy: comparison of single-port and multiport laparoscopic procedure Eui Soo Han, Young Kyoung You, Dong Goo Kim, Jun Suh Lee, Eun Young Kim, Soo Ho Lee,   Tae Ho Hong, Gun Hyung Na Department of Hepato-Biliary and Pancreas Surgery, Seoul St. Mary’s Hospital, The Catholic University of Korea College of  Medicine, Seoul, Korea INTRODUCTION After Delaitre and Maignien [1] reported the first splenectomy  case using laparoscopic approach in 1991, laparoscopic  splenectomy (LS) has been performed by many surgeons for hematologic diseases such as idiopathic thrombocytopenic purpura and hereditary spherocytosis, and malignancies of spleen that are either primary or metastatic lesion [2-6].",Non-OADS,/arxiv_data1/oa_pdf/ee/af/astr-89-55.PMC4518030.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/af/astr-89-55.PMC4518030.pdf
" Annals of Surgical Treatment and Research 61pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.2.61 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE The effects of the end-to-side inverted mattress  pancreaticojejunostomy on postoperative pancreatic fistula: a single surgeon’s experience  Hyung Jun Kwon, Heon Tak Ha, Young Yeun Choi1, Sang Geol Kim Department of Surgery, Kyungpook National University Medical Center, Daegu, 1Department of Surgery, Kyungpook National  University School of Medicine, Daegu, Korea INTRODUCTION Pancreatoduodenectomy (PD) is the standard surgery  for malignant diseases and severe injuries involving the  periampullary region.",Non-OADS,/arxiv_data1/oa_pdf/cd/87/astr-89-61.PMC4518031.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/87/astr-89-61.PMC4518031.pdf
"68pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.2.68 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE The safety and efficacy of percutaneous transhepatic  gallbladder drainage in elderly patients with acute cholecystitis before laparoscopic cholecystectomy Byung-Gon Na, Young-Sun Yoo, Seong-Pyo Mun, Seong-Hwan Kim, Hyun-Young Lee1, Nam-Kyu Choi Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery and 1Department of Anesthesiology and Pain  Medicine, Chosun University Hospital, Gwangju, Korea INTRODUCTION Open cholecystectomy was the standard treatment for  symptomatic cholecystitis until the advent of laparoscopic  cholecystectomy (LC) in the late 1980s and early 1990s.",Non-OADS,/arxiv_data1/oa_pdf/1b/db/astr-89-68.PMC4518032.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/db/astr-89-68.PMC4518032.pdf
"74pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.2.74 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Association between genetic polymorphisms in   cortactin and susceptibility to gastric cancer Dae Yong Kim, Joo Hyun Lee, Keun Young Kim, Dong Baek Kang, Won Cheol Park, Soo Cheon Chae1,   Jeong Kyun Lee Departments of Surgery and 1Pathology, Institute of Medical Science, Wonkwang University School of Medicine, Iksan, Korea INTRODUCTION Gastric cancer is the most prevalent cancer in Korea, and it  ranks as one of the leading causes of cancer death, followed by  lung cancer [1,2].",Non-OADS,/arxiv_data1/oa_pdf/0d/d4/astr-89-74.PMC4518033.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/d4/astr-89-74.PMC4518033.pdf
" Annals of Surgical Treatment and Research 81pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.2.81 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Preoperative neutrophil-to-lymphocyte ratio is a  prognostic factor for overall survival in patients  with gastric cancer Jeong Hwan Kim, Dong-Seok Han, Ho Yoon Bang, Pyeong Su Kim, Kyung-Yung Lee Department of Surgery, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea INTRODUCTION Gastric cancer is the second most common malignancy  and the third leading cause of cancer death in Korea [1].",Non-OADS,/arxiv_data1/oa_pdf/7f/e5/astr-89-81.PMC4518034.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/e5/astr-89-81.PMC4518034.pdf
" Annals of Surgical Treatment and Research 87pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.2.87 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE The repair of umbilical hernia in cirrhotic patients:   18 consecutive case series in a single institute Byung Chul Yu, Min Chung, Giljae Lee Department of Surgery, Gachon University Gil Medical Center, Incheon, Korea INTRODUCTION The prevalence of umbilical hernia in cirrhotic patients with  ascites is up to 20% [1].",Non-OADS,/arxiv_data1/oa_pdf/bf/70/astr-89-87.PMC4518035.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/70/astr-89-87.PMC4518035.pdf
"92pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.2.92 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE YouTube as a potential training method for laparoscopic  cholecystectomy Jun Suh Lee, Ho Seok Seo1, Tae Ho Hong Department of Surgery, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul,   1Department of Surgery, Armed Forces Capital Hospital, Seongnam, Korea INTRODUCTION In 1999, Darcy DiNucci coined the term ‘Web 2.0’, which  describes websites that allow users to interact with each other  as creators of user-generated contents, in contrast to web sites where people are limited to the passive viewing of contents [1].",Non-OADS,/arxiv_data1/oa_pdf/ee/ef/astr-89-92.PMC4518036.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/ef/astr-89-92.PMC4518036.pdf
Health Informatics J  2014 Mar 25 [Epub] http://dx.doi.org/  10.1177/1460458213512220.,Non-OADS,/arxiv_data1/oa_pdf/ee/ef/astr-89-92.PMC4518036.pdf
"98pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2015.89.2.98 Annals of Surgical Treatment and ResearchCASE REPORT Primary hepatic tuberculosis mimicking intrahepatic  cholangiocarcinoma: report of two cases Jeong-Ik Park Department of Surgery, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea INTRODUCTION Tuberculosis (TB) is known to involve the liver in different  ways.",Non-OADS,/arxiv_data1/oa_pdf/8a/b2/astr-89-98.PMC4518037.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/b2/astr-89-98.PMC4518037.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/37/main.PMC4518041.pdf
http://dx.doi.org/10.1016/j.ypmed.2015.05.025 0091-7435/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/37/main.PMC4518041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/37/main.PMC4518041.pdf
[Internet] [cited 2013 Oct 9];Available from http://www.ats.ucla.edu/stat/stata/faq/binary_mediation.htm .,OADS,/arxiv_data1/oa_pdf/0d/37/main.PMC4518041.pdf
[Internet] [cited 2013 Oct 9];Available from http://www.ats.ucla.edu/stat/stata/faq/sgmediation.htm .,OADS,/arxiv_data1/oa_pdf/0d/37/main.PMC4518041.pdf
"Mason was initially described as behaving appropriately: she ‘‘flattered’’ Rochester and ‘‘had lavishly displayed for [his] pleasure her charms and accomplishments.’’ Rochester and Mason were quickly betrothed for financial reasonsand it was only after the wedding that Rochester learned of Mason’s family history of ‘‘idiots and maniacs through three generations.’’ During the first 4 years of his marriage to Mason, Rochester describes the emergence of ‘‘vile discoveries’’ in her ‘‘cast of mind.’’ By the time that Mason was in her early thirties, Rochester describes an escalating illness: ‘‘her character ripened and developed with frightful rapidity.’’ This depiction of aprogressive familial disorder with behavioral and cognitive decline with violent movements is similar to Huntington’s original essay describing Huntington disease.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/57/86/tre-05-323-6978-2.PMC4518130.pdf
"Bronte ¨ described Mason as having ‘‘movements of the wild beast.’’ While thiscomplies with Huntington’s original description of ‘‘violence,’’ it is opposed to classic choreiform movements in Huntington disease.Coon EA, Hassan A Huntington Disease in Fiction Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/57/86/tre-05-323-6978-2.PMC4518130.pdf
"Neurologist 2003;9:175–179.Huntington Disease in Fiction Coon EA, Hassan A Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/57/86/tre-05-323-6978-2.PMC4518130.pdf
"J Neurol Neurosurg Psychiatry 2008;79:874–880, doi: http://dx.doi.org/10.1136/jnnp.2007.128728.",Non-OADS,/arxiv_data1/oa_pdf/57/86/tre-05-323-6978-2.PMC4518130.pdf
"Am J Psychiatry 2005;162:725–731, doi: http://dx.doi.org/10.1176/appi.ajp.162.4.725.",Non-OADS,/arxiv_data1/oa_pdf/57/86/tre-05-323-6978-2.PMC4518130.pdf
"Nat Clin Pract Neurol 2007;3:517–525, doi: http://dx.doi.org/10.1038/ ncpneuro0606.",Non-OADS,/arxiv_data1/oa_pdf/57/86/tre-05-323-6978-2.PMC4518130.pdf
"Schizophr Res 2013;150:3–10, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/57/86/tre-05-323-6978-2.PMC4518130.pdf
"Victorian Web, 2003, http://www.victorianweb.org/authors/bronte/cbronte/iwama8.",Non-OADS,/arxiv_data1/oa_pdf/57/86/tre-05-323-6978-2.PMC4518130.pdf
"J Neurol Neurosurg Psychiatry 2012;83:994–999.Coon EA, Hassan A Huntington Disease in Fiction Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/57/86/tre-05-323-6978-2.PMC4518130.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/41/gav026.PMC4518136.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/7b/rjv073.PMC4518209.pdf
Available from: http://www.who.int/docstore/wer/pdf/2000/wer7501.pdf [Last accessed on 2014 Oct 3].,OADS,/arxiv_data1/oa_pdf/ba/f1/NMJ-56-161.PMC4518330.pdf
Available from: http://cheld.org/wp-content/uploads/2012/04/National-Policy-on-Integrated-Disease-Surveillance-and-Response.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ba/f1/NMJ-56-161.PMC4518330.pdf
Available from: http://www.cdc.gov/niosh/ershdb/EmergencyResponseCard_29750029.html.,OADS,/arxiv_data1/oa_pdf/aa/7c/NMJ-56-169.PMC4518331.pdf
Prepared by the National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NTP-NICEATM) Available from: http://iccvam.niehs.nih.gov/methods/acutetox/invidocs/phIIIprot/nhkphIII.pdf.,OADS,/arxiv_data1/oa_pdf/aa/7c/NMJ-56-169.PMC4518331.pdf
"Available from: http://www.webmedcentral.com/article [Last accessed on 2012 Sept 18].How to cite this article: Ogunrinde TJ, Opeodu OI.",Non-OADS,/arxiv_data1/oa_pdf/6b/75/NMJ-56-199.PMC4518337.pdf
Available from: http://www.academicjournals.org/ijmms [Last accessed on 2014 Nov 30].,Non-OADS,/arxiv_data1/oa_pdf/e6/c4/NMJ-56-213.PMC4518340.pdf
Available from:  http://www.zsbeike.com/yuer/24009.html [Last accessed on  2013 Oct 9].,Non-OADS,/arxiv_data1/oa_pdf/46/45/ATM-10-151.PMC4518344.pdf
Available  from: http://www.medscape.com/Medscape Family Medicine/ Assessing the Geriatric Patient [Last accessed on 2009 Nov 25].,Non-OADS,/arxiv_data1/oa_pdf/de/cf/ATM-10-158.PMC4518345.pdf
Available from: http://apps.who.int/iris/ bitstream/10665/137094/1/9789241564809_eng.pdf?ua=1 [Last  accessed on 2015 Jan 27].,OADS,/arxiv_data1/oa_pdf/92/66/ATM-10-185.PMC4518349.pdf
"Cited 21st February, 2015. https://extranet.who.int/sree/ Reports?op=Replet&name=/WHO_HQ_Reports/G2/PROD/ EXT/TBCountryProfile&ISO2=NG&outtype=PDF.",OADS,/arxiv_data1/oa_pdf/92/66/ATM-10-185.PMC4518349.pdf
Available from: http://www.nigeria-aids.org/ documents/2010_National%20HIV%20Sero %20Prevalence%20 Sentinel%20Survey.pdf [Last accessed on 2015 Jan 27].,Non-OADS,/arxiv_data1/oa_pdf/92/66/ATM-10-185.PMC4518349.pdf
"Middle East Respiratory Syndrome Coronavirus (MERS-CoV):  Summary of Current Situation, Literature Update and Risk  Assessment — As of 5 February 2015. WHO Available from:  http://www.who.int/csr/disease/coronavirus_infections/ mers-5-february-2015.pdf.",Non-OADS,/arxiv_data1/oa_pdf/25/5f/ATM-10-218.PMC4518356.pdf
Available from: http://www.who.int/csr/don/26-march-2015- mers-saudi-arabia/en/.,Non-OADS,/arxiv_data1/oa_pdf/25/5f/ATM-10-218.PMC4518356.pdf
"Middle East Respiratory Syndrome Coronavirus (MERS-CoV):  Summary of Current Situation, Literature Update and Risk  Assessment — As of 5 February 2015. WHO Available from:  http://www.who.int/csr/disease/coronavirus_infections/ mers-5-february-2015.pdf.",Non-OADS,/arxiv_data1/oa_pdf/0f/83/ATM-10-219.PMC4518357.pdf
Available from: http://www.who.int/csr/don/26-march-2015- mers-saudi-arabia/en/.,Non-OADS,/arxiv_data1/oa_pdf/0f/83/ATM-10-219.PMC4518357.pdf
Available from:  http://www.cebm.net/index.aspx?o=1025.,Non-OADS,/arxiv_data1/oa_pdf/76/4f/UA-7-289.PMC4518361.pdf
Available from:  http://www.uptodate.com/contents/renal‑disease‑in‑tuberculosis.,Non-OADS,/arxiv_data1/oa_pdf/f0/eb/UA-7-375.PMC4518379.pdf
Available from: http://www.who.int/tb/ publications/global_report/2011/gtbr11_full.pdf.,OADS,/arxiv_data1/oa_pdf/03/37/JNSBM-6-314.PMC4518400.pdf
"MATERIALS AND METHODS A detailed review of  published literature from http://www.google.com, http://www.pubmed.com, British medical http://www.journal.com, Medline, ERIC, http://www.frontiersin.org and other online journals was performed and analyzed.",Non-OADS,/arxiv_data1/oa_pdf/52/83/JNSBM-6-321.PMC4518401.pdf
Available from: http://www.worlddiabetesfoundation.org/composite-1220.htm.,OADS,/arxiv_data1/oa_pdf/9a/ee/JNSBM-6-356.PMC4518409.pdf
Available from: http://www.cdc.gov/nchs/data/nhanes/growthcharts/zscore/bmiagerev.xls.,OADS,/arxiv_data1/oa_pdf/9a/ee/JNSBM-6-356.PMC4518409.pdf
Av ailable	from:	http://www.dabur .com/Products- Health%20Care-Meswakage.,Non-OADS,/arxiv_data1/oa_pdf/3c/a5/JNSBM-6-364.PMC4518411.pdf
Available from: http://www.acr.org/secondarymainmenucategories/quality_safety/app_criteria.aspx.,Non-OADS,/arxiv_data1/oa_pdf/76/fa/JNSBM-6-398.PMC4518418.pdf
Available from: http://www.imagingpathways.health.wa.gov.au/includes/index.html.,Non-OADS,/arxiv_data1/oa_pdf/76/fa/JNSBM-6-398.PMC4518418.pdf
Available from: http://www.stralsakerhetsmyndigheten.se/Global/Publikationer/Rapport/Stralskydd/2009/SSM-Rapport-2009-03.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/fa/JNSBM-6-398.PMC4518418.pdf
Available 	from:	http://www.who.int/immunization_financing/data/ about/terminology/en.,Non-OADS,/arxiv_data1/oa_pdf/0d/b1/JNSBM-6-411.PMC4518421.pdf
Av ailable	from:	http://nmpb.nic.in/ WriteReadData/links/3733877856shatavari.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b0/b1/JNSBM-6-415.PMC4518422.pdf
Available from: http://www.radsource.us.,Non-OADS,/arxiv_data1/oa_pdf/5e/56/JNSBM-6-439.PMC4518427.pdf
Available from: http://www.radsource.us.,Non-OADS,/arxiv_data1/oa_pdf/5b/90/JNSBM-6-442.PMC4518428.pdf
"Accession Numbers GSE68219 Topham et al., 2015, Cancer Cell 28, 129–140 July 13, 2015 ª2015 The Authors http://dx.doi.org/10.1016/j.ccell.2015.06.001",Non-OADS,/arxiv_data1/oa_pdf/4a/56/main.PMC4518499.pdf
"Cancer Cell Article MYC Is a Major Determinant of Mitotic Cell Fate Caroline Topham,1,5Anthony Tighe,1,5Peter Ly,2Ailsa Bennett,1Olivia Sloss,1Louisa Nelson,1Rachel A. Ridgway,3 David Huels,3Samantha Littler,1Claudia Schandl,1Ying Sun,2Beatrice Bechi,4David J. Procter,4Owen J. Sansom,3 Don W. Cleveland,2and Stephen S. Taylor1,* 1Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK 2Ludwig Institute for Cancer Research and Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093, USA 3Cancer Research UK Beatson Institute, Garscube Estate, Glasgow G61BD, UK 4School of Chemistry, University of Manchester, Oxford Road, Manchester M13 9PL, UK 5Co-ﬁrst author *Correspondence: stephen.taylor@manchester.ac.uk http://dx.doi.org/10.1016/j.ccell.2015.06.001This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/4a/56/main.PMC4518499.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven ﬁgures, and seven tables and can be found with this article online athttp://dx.doi.org/10.1016/j.ccell.2015.06.001 .",OADS,/arxiv_data1/oa_pdf/4a/56/main.PMC4518499.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Making serotonergic neurons from human ﬁbroblasts ZX u et al 70 Molecular Psychiatry (2016), 62 –70 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/e1/4f/mp2015101a.PMC4518549.pdf
systematic review 167 http://dx.doi.org/10.1590/bjpt-rbf.2014.0089  Braz J Phys Ther.,OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
"2015 May-June; 19(3):167-176. http://dx.doi.org/10.1590/bjpt-rbf.2014.0089 1Departamento de Fisioterapia , Escola de Educação Física, Fisioterapia e Terapia Ocupacional  (EEFFTO), Universidade Federal de Minas Gerais   (UFMG), Belo Horizonte , MG, Brazil   2Department of Physical Therapy and Athletic Training , Sargent College of Health and Rehabilitation Sciences , Boston University , MA, United States   Received: May 17, 2014 Revised: Nov. 03, 2014 Accepted: Dec. 08, 2014Introduction Patellofemoral pain syndrome (PFPS) is characterized  by retro or peripatellar pain, mainly during weight- bearing activities, such as ascending and descending  stairs1.",Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
1999 ;14(10):722-8. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
2003;33(11):639-46.  http://dx.doi.org/10.2519/jospt.2003.33.11.639 .,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
http://dx.doi.org/10.2519/ jospt.2010.0302 .,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
2010 ;14(6):477-82. http://dx.doi.org/10.1590/ S1413-35552010000600005.,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
2003;33(11):671-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
2007;37(5):232-8.  http://dx.doi.org/10.2519/jospt.2007.2439 .,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
2008;38(1):12-8. http://dx.doi.org/10.2519/ jospt.2008.2462 .,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
2013 ;47(4):207-14. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
2012;42(1):22-9. http://dx.doi.org/10.2519/jospt.2012.3704 .,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
2010;40(11):736-42. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
2008;22(12):1051-60. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
1998;317(7167):1185-90. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
1994 ;309(6954 ):597-9. http://dx.doi.org/10.1136/ bmj.309.6954.597 .,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
2011;24(3):523-33. http://dx.doi.org/10.1590/ S0103-51502011000300017 .,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
2010;40(5):277-85. http://dx.doi.org/10.2519/ jospt.2010.3215 .,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
1997 ;30(5):447-55. http://dx.doi.org/10.1016/ S0021-9290(96)00170-4 .,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
http://dx.doi.org/10.2519/jospt.2012.0301 .,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
2010;40(5):377-95. http://dx.doi.org/10.2165/11530780- 000000000-00000 .,Non-OADS,/arxiv_data1/oa_pdf/a9/f2/rbfis-19-03-0167.PMC4518569.pdf
http://dx.doi.org/10.1590/bjpt-rbf.2014.0088original article 177   Braz J Phys Ther.,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
"2015 May-June; 19(3):177-185. http://dx.doi.org/10.1590/bjpt-rbf.2014.0088 1 Departamento de Farmacologia , Instituto de Biociências , Universidade Estadual Paulista  (UNESP), Botucatu , SP, Brazil 2 Departamento de Proteção Vegetal , Faculdade de Ciências Agronômicas , UNESP , Botucatu , SP, Brazil 3 Faculdade de Ciências Médicas , Universidade Estadual de Campinas  (UNICAMP), Campinas , SP, Brazil Received: May.",Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2011;44(4):337-44. http://dx.doi.org/10.1590/S0100- 879X2011007500043 .,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2008 ;22(10):678-86. http://dx.doi.org/10.1038/ jhh.2008.36 .,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2004;97(2):683- 8. http://dx.doi.org/10.1152/japplphysiol.00923.2003 .,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2004 ;36(4):606-12. http://dx.doi.org/10.1249/01.,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2013;305(9):H1321 -31.  http://dx.doi.org/10.1152/ajpheart.00531.2013 .,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2011;53(6):464-70. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2012;74(9):896- 903. http://dx.doi.org/10.1097/PSY .0b013e31827457f4 .,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2013 ;4:314. http://dx.doi.org/10.3389/fphys.2013.00314 .,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2014 ;5:105. http://dx.doi.org/10.3389/ fphys.2014.00105 .,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2014 ;18(1):38-46. http://dx.doi.org/10.1590/S1413- 35552012005000135 .,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2010 ;36(5):357-65. http://dx.doi.org/10.5271/sjweh.2913 .,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
1936;20(5):667-72. http://dx.doi.org/10.1210/endo-20-5-667 .,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2004 ;37(12):1909 -17. http://dx.doi.org/10.1590/ S0100-879X2004001200018 .,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2014 ;56(4):441-7.  http://dx.doi.org/10.1016/j.pcad.2013.09.012 .,OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
1993 ;58(1):57-64. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2002 ;51(7):925-31.  http://dx.doi.org/10.1053/meta.2002.33353 .,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2005;85(3):191-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
1997 ;30(3 Pt 2 ):714-9.  http://dx.doi.org/10.1161/01.HYP.30.3.714 .,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
http://dx.doi.org/10.1161/ JAHA.112.004473 .,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2011;97(1):40- 5. http://dx.doi.org/10.1590/S0066-782X2011005000063 .,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
1995;115(4):587-94. http://dx.doi.org/10.1111/j.1476-5381.1995.,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2006 ;291(5):H2075 -81. http://dx.doi.org/10.1152/ ajpheart.01109.2005 .,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
1997 ;29(11):1454 -61. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
2004 ;101(12):4280 -5. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/d6/rbfis-19-03-0177.PMC4518570.pdf
http://dx.doi.org/10.1590/bjpt-rbf.2014.0086original article  186  Braz J Phys Ther.,Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
"2015 May-June; 19(3):186-193. http://dx.doi.org/10.1590/bjpt-rbf.2014.0086 1Curso de Fisioterapia, Departamento de Biomecânica, Medicina e Reabilitação do Aparelho Locomotor , Faculdade de Medicina de Ribeirão Preto ,  Universidade de São Paulo  (USP), Ribeirão Preto , SP, Brazil   2Núcleo de Apoio à Pesquisa em Doenças Crônico-Degenerativas , Escola de Educação Física e Esporte de Ribeirão Preto , Universidade de São Paulo   (USP), Ribeirão Preto , SP, Brazil Received: May 11, 2014 Revised: Aug. 07, 2014 Accepted: Nov. 18, 2014Introduction The risk of falls increases with age1 and it has been  predicted that one-third of the community-dwelling  elderly will fall over the course of one year2.",Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2012 ;17(3):723-30. http://dx.doi.org/10.1590/ S1413-81232012000300019 .,Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2002 ;36(6):709-16. http://dx.doi.org/10.1590/S0034- 89102002000700008 .,Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2011;14(2):381-93. http://dx.doi.org/10.1590/ S1809-98232011000200017 .,Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2009;13(3):223-9.  http://dx.doi.org/10.1590/S1413-35552009005000026 .,Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
1998;119(1):89- 92. http://dx.doi.org/10.1016/S0194-5998(98)70177-9 .,Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2012 ;22(1):131-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2006 ;25(3):435-46. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2010 ;14(3):183-92. http://dx.doi.org/10.1590/S1413- 35552010000300003 .,Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
1984 ;107(Pt 4):1143 -63. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2008;441(3):257-60.  http://dx.doi.org/10.1016/j.neulet.2008.06.039 .,OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2013 ;35(3):883-90. http://dx.doi.org/10.1007/s11357-012- 9386-x .,Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2012 ;36(3):586-90. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2011 ;111(7):1485 -95. http://dx.doi.org/10.1007/ s00421-010-1770-6 .,Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2012;108(4):1138-48. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2008;114(12):719-27.  http://dx.doi.org/10.1042/CS20070301 .,Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2006 ;52(1):1-16. http://dx.doi.org/10.1159/000089820 .,Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2012;36(4):662-6. http://dx.doi.org/10.1016/j.gaitpost.2012.06.016 .,OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2000;81(5):587- 91. http://dx.doi.org/10.1016/S0003-9993(00)90039-X .,OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
2014;232(10):3269-76. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/8e/rbfis-19-03-0186.PMC4518571.pdf
http://dx.doi.org/10.1590/bjpt-rbf.2014.0091original article  194  Braz J Phys Ther.,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
"2015 May-June; 19(3):194-200.   http://dx.doi.org/10.1590/bjpt-rbf.2014.0091 1Programa de Mestrado e Doutorado em Fisioterapia , Universidade Cidade de São Paulo  (UNICID), São Paulo , SP, Brazil   2Faculdade de Ciências Humanas e da Saúde , Pontifícia Universidade Católica de São Paulo  (PUC-SP), São Paulo , SP, Brazil   3Departamento de Clínica Médica , Faculdade de Medicina de Ribeirão Preto  (FMRP), Universidade de São Paulo  (USP), Ribeirão Preto , SP, Brazil   4Departamento de Fisioterapia , Programa de Ciências da Reabilitação , Universidade Federal de Minas Gerais  (UFMG), Belo Horizonte , MG, Brazil Received: May 27, 2014 Revised: Sept. 12, 2014 Accepted: Dec. 08, 2014Introduction Reports of fatigue are common in the older  adult population1,2 and affect about 15-75% of  community-dwelling older persons3-8, depending  on the studied population.",Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2007 ;10(5):729- 33. http://dx.doi.org/10.1375/twin.10.5.729 .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2009;64(1):76-82. http://dx.doi.org/10.1093/gerona/ gln017 .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2010;65(8):887-95. http://dx.doi.org/10.1093/gerona/glq064 .,OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2010 ;127(1-3):248-56. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2010 ;58(5):967-75. http://dx.doi.org/10.1111/j.1532- 5415.2010.02811.x .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2010 ;22(2):100-15.  http://dx.doi.org/10.1007/BF03324782 .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2008 ;63(12):1389 -92. http://dx.doi.org/10.1093/ gerona/63.12.1389 .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2010 ;39(6):1033 -42. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2009;64(1):76-82. http://dx.doi.org/10.1093/gerona/ gln017 .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2004 ;2(1):4. http://dx.doi.org/10.1186/1478- 7547-2-4 .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2011;15(3):241-8. http://dx.doi.org/10.1590/S1413- 35552011000300011 .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2010 ;5:319-26. http://dx.doi.org/10.2147/COPD.S12321 .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2006 ;32(2):118-28. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2010;65(8):887-95. http://dx.doi.org/10.1093/gerona/glq064 .,OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
1994;52(1):1- 7. http://dx.doi.org/10.1590/S0004-282X1994000100001 .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2007;41(4):598-605.  http://dx.doi.org/10.1590/S0034-89102007000400014 .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2005;39(6):918-23. http://dx.doi.org/10.1590/ S0034-89102005000600008 .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2009;35(9):877-83. http://dx.doi.org/10.1590/ S1806-37132009000900009 .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
1978;31(12):741-55.  http://dx.doi.org/10.1016/0021-9681(78)90058-9 .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
1993 ;25(1):71-80. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
1969 ;9(3):179-86. http://dx.doi.org/10.1093/ geront/9.3_Part_1.179 .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2005;53(10):1675-80. http://dx.doi.org/10.1111/j.1532- 5415.2005.53501.x .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2009;64(2):223-9. http://dx.doi.org/10.1093/gerona/ gln022 .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2007 ;55(5):780- 91. http://dx.doi.org/10.1111/j.1532-5415.2007.01156.x .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2002 ;50(3):461-7. http://dx.doi.org/10.1046/j.1532- 5415.2002.50111.x .,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
2009;13(10):878-80. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/c4/rbfis-19-03-0194.PMC4518572.pdf
http://dx.doi.org/10.1590/bjpt-rbf.2014.0087original article 201 Braz J Phys Ther.,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
"2015 May-June; 19(3):201-210.  http://dx.doi.org/10.1590/bjpt-rbf.2014.0087 1Departamento de Educação Integrada em Saúde , Universidade Federal do Espírito Santo  (UFES), Vitória , ES, Brazil 2Departamento de Ciências Fisiológicas , UFES , Vitória , ES, Brazil   Received: May 28, 2014 Revised: Sept. 03, 2014 Accepted: Dec. 08, 2014Introduction During mouth breathing (MB), accessory muscle  overuse leads to a predominance of chest wall motion  during inspiration1,2, and forward head posture (FHP)  is the most commonly adopted postural compensation  among MB individuals3.",Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
2008;78(1):77-82. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
2011;37(4):471- 9. http://dx.doi.org/10.1590/S1806-37132011000400009 .,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
2014 ;19(1):32-6. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
2004 ;70(5):665-70. http://dx.doi.org/10.1590/ S0034-72992004000500014 .,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
2008;84(6):529-35. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
2013 ;79(5):620-4. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
2001 ;22(4):248-56. http://dx.doi.org/10.1097/00004703- 200108000-00007 .,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
2007;11(2):139- 45. http://dx.doi.org/10.1590/S1413-35552007000200009 .,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
2011;75(8):999-1004.  http://dx.doi.org/10.1016/j.ijporl.2011.04.018 .,OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
http://sapo.incubadora.fapesp.br .,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
2011;87(4):357-63.  http://dx.doi.org/10.2223/JPED.2102 .,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
1997 ;78(11):1215 -23. http://dx.doi.org/10.1016/ S0003-9993(97)90335-X .,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
2011 ;77(5):656-62. http://dx.doi.org/10.1590/S1808- 86942011000500020 .,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
2011;54(2):179-86. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
1986;29(12):1539-52. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
2008;5(2):253-62.  http://dx.doi.org/10.1513/pats.200707-111MG .,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
2012;16(3):887-94. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
2008;12(6):495- 501. http://dx.doi.org/10.1590/S1413-35552008005000010 .,Non-OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
2013 ;89:361-5.  http://dx.doi.org/10.1016/j.jped.2012.12.007 .,OADS,/arxiv_data1/oa_pdf/77/bf/rbfis-19-03-0201.PMC4518573.pdf
http://dx.doi.org/10.1590/bjpt-rbf.2014.0090original article 211 Braz J Phys Ther.,Non-OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
"2015 May-June; 19(3):211-217. http://dx.doi.org/10.1590/bjpt-rbf.2014.0090 1Programa de Pós-graduação em Educação Física , Centro de Educação Física e Desportos , Universidade Federal de Santa Maria  (UFSM), Santa Maria ,  RS, Brazil   2Departamento de Métodos e Técnicas Desportivas , Centro de Educação Física e Desportos , UFSM , Santa Maria , RS, Brazil Received: Jun.",OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
2009;28(3):387-93.  http://dx.doi.org/10.1016/j.humov.2009.04.001 .,OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
2011;135(4):271-6. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
2010 ;68(6):908-13. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
2014;26(2):309-11. http://dx.doi.org/10.1589/ jpts.26.309 .,Non-OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
2013 ;20(1):43-9. http://dx.doi.org/10.1590/ S1809-29502013000100008 .,Non-OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
2007 ;11(6):503-7. http://dx.doi.org/10.1590/ S1413-35552007000600013 .,Non-OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
2011;92(5):774-9. http://dx.doi.org/10.1016/j.apmr.2010.11.031 .,OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
2013 ;56(3):478-81. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
2011;65(2):211-6. http://dx.doi.org/10.5014/ ajot.2011.000851 .,Non-OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
2014;26(1):25- 7. http://dx.doi.org/10.1589/jpts.26.25 .,Non-OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
2010;42(38):488-95. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
1999;158(2):113-9.  http://dx.doi.org/10.1053/tvjl.1998.0334 .,Non-OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
2004 ;36(8):754-7.  http://dx.doi.org/10.2746/0425164044848235 .,Non-OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
2009;41(3):285-91. http://dx.doi.org/10.2746/042516409X397136 .,Non-OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
2010 ;184(1):56-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
2004;1(3):193- 8. http://dx.doi.org/10.1079/ECP200420 .,Non-OADS,/arxiv_data1/oa_pdf/16/e7/rbfis-19-03-0211.PMC4518574.pdf
http://dx.doi.org/10.1590/bjpt-rbf.2014.0095original article  218  Braz J Phys Ther.,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
"2015 May-June; 19(3):218-226.   http://dx.doi.org/10.1590/bjpt-rbf.2014.0095 1 Colegiado de Fisioterapia , Universidade de Brasília  (UnB), Brasília , DF, Brasil 2 Programa de Pós-graduação em Ciências da Reabilitação , Escola de Educação Física, Fisioterapia e Terapia Ocupacional,  Universidade Federal de  Minas Gerais  (UFMG), Belo Horizonte , MG, Brasil 3 Universidade Federal de Alfenas  (UNIFAL), Alfenas , MG, Brasil Received: June 20, 2014 Revised: Sept. 09, 2014 Accepted: Feb. 04, 2015Introduction Falls are events with a high prevalence among the  elderly population, even among those who are active  and healthy, and constitute one of the major preventable  geriatric syndromes1.",Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2007 ;297(1):77-86. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2012;46(1):138-46. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2009 ;31(10):496-502. http://dx.doi.org/10.1590/ S0100-72032009001000005 .,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2010;31(3):317-21. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2000 ;32(3):371-2. http://dx.doi.org/10.1016/ S0001-4575(99)00066-4 .,OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2009 ;55(6):660-5.  http://dx.doi.org/10.1159/000235652 .,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2011;40(2):277-80. http://dx.doi.org/10.1093/ageing/afq177 .,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2012;16(5):381- 8. http://dx.doi.org/10.1590/S1413-35552012005000041 .,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2012;16(2):166-72. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2006;35(1):5-10. http://dx.doi.org/10.1093/ ageing/afi218 .,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2005 ;53(12):2190 - 4. http://dx.doi.org/10.1111/j.1532-5415.2005.00509.x .,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2006;20(4):331-9.  http://dx.doi.org/10.1191/0269215506cr947oa .,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2003;61(3B):777-81. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2011;23(6):941-9. http://dx.doi.org/10.1017/ S1041610211000627 .,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2012;16(1):55-61. http://dx.doi.org/10.1007/s12603- 012-0003-6 .,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2006 ;22(12):2623 -36. http://dx.doi.org/10.1590/ S0102-311X2006001200012 .,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2005 ;16(8):1004 -10. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
2005 ;35(7):452-60. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/f0/rbfis-19-03-0218.PMC4518575.pdf
http://dx.doi.org/10.1590/bjpt-rbf.2014.0096original article 227 Braz J Phys Ther.,Non-OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
"2015 May-June; 19(3):227-234. http://dx.doi.org/10.1590/bjpt-rbf.2014.0096 1Department of Rehabilitation Science , Graduate School , INJE University , Gimhae , South Korea   2Department of Physical Therapy , Dong-Eui Institute of Technology , Busan , South Korea   3Department of Physical Therapy , College of Biomedical Science and Engineering , INJE University , Gimhae , South Korea Received: July 18, 2014 Revised: Nov. 21, 2014 Accepted: Feb. 19, 2015Introduction In older adults, high levels of lower limb strength  and balance are important prerequisites for the  independent and successful performance of activities  of daily living.",Non-OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
http://dx.doi.org/10.1093/geronj/45.3.M82 .,Non-OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
2013 ;27(6):1503 - 10. http://dx.doi.org/10.1519/JSC.0b013e318269f83d .,Non-OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
2006 ;60(2):268-73. http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
1994 ;23(6):452-60. http://dx.doi.org/10.1093/ ageing/23.6.452 .,Non-OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
1994;4(1):82-7. http://dx.doi.org/10.1111/j.1600-0838.1994.,Non-OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
2011;3(5):466-9. http://dx.doi.org/10.1177/1941738111414127 .,Non-OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
2008 ;88(4):449-59. http://dx.doi.org/10.2522/ ptj.20070251 .,Non-OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
2004;85(4):589-92.  http://dx.doi.org/10.1016/j.apmr.2003.06.031 .,OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
2008 ;89(2):364-70. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
2010;24(3):815-24. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
2003;95(4):1717-27. http://dx.doi.org/10.1152/ japplphysiol.00347.2003 .,Non-OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
2010;39(4):412-23.  http://dx.doi.org/10.1093/ageing/afq034 .,Non-OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
http://dx.doi.org/10.1093/geronb/51B.4.S173 .,Non-OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
2004 ;59(7):730-54. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
2000 ;55(8):M469 -76. http://dx.doi.org/10.1093/ gerona/55.8.M469 .,OADS,/arxiv_data1/oa_pdf/d3/ab/rbfis-19-03-0227.PMC4518576.pdf
http://dx.doi.org/10.1590/bjpt-rbf.2014.0092original article 235 Braz J Phys Ther.,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
"2015 May-June; 19(3):235-242. http://dx.doi.org/10.1590/bjpt-rbf.2014.0092 1Programa de Pós Graduação em Ciências da Reabilitação , Universidade Nove de Julho , São Paulo , SP, Brazil Received: July 22, 2014 Revised: Nov. 08, 2014 Accepted: Dec. 16, 2014Introduction Clinical field tests are used to assess the functional  capacity (FC) and exercise tolerance of patients with  pulmonary diseases.",Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
2007;29(1):185-209.  http://dx.doi.org/10.1183/09031936.00046906 .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
2002;166(1):111-7. http://dx.doi.org/10.1164/ajrccm.166.1.at1102 .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
2010 ;104(6):849-57. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
2008;32(3):637-43. http://dx.doi.org/10.1183/09031936.00140507 .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
2004 ;23(1):28-33. http://dx.doi.org/10.1183/09031936.03.0 0034603 .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
2003;167(11):1522-7. http://dx.doi.org/10.1164/rccm.200203- 166OC .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
2010 ;79(2):121-7. http://dx.doi.org/10.1159/000220343 .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
2010 ;15(8):1192 -6. http://dx.doi.org/10.1111/j.1440- 1843.2010.01841.x .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
2005;171(10):1150-7.  http://dx.doi.org/10.1164/rccm.200405-578OC .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
2006 ;100(2):316-23.  http://dx.doi.org/10.1016/j.rmed.2005.04.022 .,OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
2003;123(5):1401- 7. http://dx.doi.org/10.1378/chest.123.5.1401 .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
2013;17(4):351-8. http://dx.doi.org/10.1590/ S1413-35552013005000098 .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
2008 ;34(12):1008 -18. http://dx.doi.org/10.1590/S1806- 37132008001200005 .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
1998 ;158(5 Pt 1 ):1384 -7. http://dx.doi.org/10.1164/ ajrccm.158.5.9710086 .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
1999 ;14(2):270-4. http://dx.doi.org/10.1034/j.1399- 3003.1999.14b06.x .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
1986 ;1(8476 ):307-10. http://dx.doi.org/10.1016/ S0140-6736(86)90837-8 .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
2014;46(1):88-94. http://dx.doi.org/10.2340/16501977-1217 .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
2011 ;17(5):310-4. http://dx.doi.org/10.1590/ S1517-86922011000500003 .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
2011;15(6):467-73. http://dx.doi.org/10.1590/S1413- 35552011005000034 .,Non-OADS,/arxiv_data1/oa_pdf/c4/ad/rbfis-19-03-0235.PMC4518577.pdf
http://dx.doi.org/10.1590/bjpt-rbf.2014.0093original article 243 Braz J Phys Ther.,Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
"2015 May-June; 19(3):243-250.  http://dx.doi.org/10.1590/bjpt-rbf.2014.0093 1Programa de Pós-graduação em Neuropsiquiatria e Ciências do Comportamento , Universidade Federal de Pernambuco  (UFPE), Recife , PE, Brazil 2Departamento de Fisioterapia , UFPE , Recife , PE, Brazil   Received: Aug. 26, 2014 Revised: Nov. 16, 2014 Accepted: Dec. 16, 2014Introduction Migraine and tension-type headache are the most  common source of pain in young workers and they  have also been characterized as significant public health  issues, with great socioeconomic impact1-4.",Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2007 ;11(4):285-9. http://dx.doi.org/10.1590/ S1413-35552007000400013 .,Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2012 ;32(2):159-70. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2008 ;7(1):70- 83. http://dx.doi.org/10.1016/S1474-4422(07)70325-3 .,Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
1994 ;93(5):335-44. http://dx.doi.org/10.1016/0168- 5597(94)90121-X .,Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2005;9(3):191-6. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2003;126(Pt 8):1801-13. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2014;18(1):19-29. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2004 ;29(19):2108 -14.  http://dx.doi.org/10.1097/01.brs.0000141170.89317.0e .,Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2011;90(4):293-301. http://dx.doi.org/10.1097/ PHM.0b013e31820173e5 .,Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2011;34(8):514-24. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2007 ;11(7):764-72. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
1996 ;77(7):680-7. http://dx.doi.org/10.1016/ S0003-9993(96)90008-8 .,OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2008 ;28(7):744-51. http://dx.doi.org/10.1111/ j.1468-2982.2008.01584.x .,Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
1994;16(4):367-71.  http://dx.doi.org/10.1007/BF01627655 .,Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2001;71(6):747-51.  http://dx.doi.org/10.1136/jnnp.71.6.747 .,Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2006;31(14):1621- 7. http://dx.doi.org/10.1097/01.brs.0000221989.53069.16 .,Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2000 ;10(5):361-74. http://dx.doi.org/10.1016/S1050- 6411(00)00027-4 .,OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2008;18(6):955-64. http://dx.doi.org/10.1016/j.jelekin.2007.05.001 .,OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2013 ;17(1):64-8. http://dx.doi.org/10.1590/ S1413-35552012005000054 .,Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
2014 ;54(7):1203 -10. http://dx.doi.org/10.1111/ head.12393 .,Non-OADS,/arxiv_data1/oa_pdf/8c/9c/rbfis-19-03-0243.PMC4518578.pdf
August 2013. http://www.medicines.org.uk/emc/medicine/ 25084#COMPOSITION (accessed 28 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/b1/b7/archdischild-2013-305511.PMC4518659.pdf
http://www.cdc.gov/ mmwr/preview/mmwrhtml/rr6207a1.htm (accessed 28 Oct 2013).,OADS,/arxiv_data1/oa_pdf/b1/b7/archdischild-2013-305511.PMC4518659.pdf
"These  resources can vary from generalized support and in - formation, as can be found at Stupid Cancer (www.stu - pidcancer.org) and the Ulman Cancer Fund for Young  Adults (http://ulmanfund.org), to Web sites focused on  specific issues such as fertility, financial needs, and fam - ily concerns.",Non-OADS,/arxiv_data1/oa_pdf/26/57/DialoguesClinNeurosci-17-171.PMC4518700.pdf
"Both formal and informal online  communities, ranging from large organizations such as  Planet Cancer (http://myplanet.planetcancer.org) to  individual blogs and personal Web sites, provide peer- based support for A YA patients with cancer.",Non-OADS,/arxiv_data1/oa_pdf/26/57/DialoguesClinNeurosci-17-171.PMC4518700.pdf
Available at: http://www.who.int/entity/healthinfo/global_burden_ disease/GBD_report_2004update_full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/26/57/DialoguesClinNeurosci-17-171.PMC4518700.pdf
Available at: http://www.jointcommission.org/assets/1/18/ sea_46.pdf.,OADS,/arxiv_data1/oa_pdf/26/57/DialoguesClinNeurosci-17-171.PMC4518700.pdf
Available at:  http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/4d/5c/DialoguesClinNeurosci-17-207.PMC4518703.pdf
Available at:  http://www.unicef.org.uk/BabyFriendly/About-Baby-Friendly/Breastfeed - ing-in-the-UK/UK-Breastfeeding-rates/ .,Non-OADS,/arxiv_data1/oa_pdf/4d/5c/DialoguesClinNeurosci-17-207.PMC4518703.pdf
Avail - able at: http://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm.,Non-OADS,/arxiv_data1/oa_pdf/4d/5c/DialoguesClinNeurosci-17-207.PMC4518703.pdf
Available at: http://www.urmc.rochester.edu/childrens-hospi - tal/neonatology/lactation.aspx.,Non-OADS,/arxiv_data1/oa_pdf/4d/5c/DialoguesClinNeurosci-17-207.PMC4518703.pdf
Available at: http://www.motherisk.org/index.jsp.,Non-OADS,/arxiv_data1/oa_pdf/4d/5c/DialoguesClinNeurosci-17-207.PMC4518703.pdf
Avail - able at: http://www.breastfeedingnetwork.org.uk/detailed-information/ drugs-in-breastmilk/.,Non-OADS,/arxiv_data1/oa_pdf/4d/5c/DialoguesClinNeurosci-17-207.PMC4518703.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/1f/rjv076.PMC4518717.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/15/rjv093.PMC4518719.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 SMARTRISK.,Non-OADS,/arxiv_data1/oa_pdf/9e/22/injuryprev-2014-041437.PMC4518736.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ sextrans-2014-051708).,Non-OADS,/arxiv_data1/oa_pdf/71/28/sextrans-2014-051708.PMC4518737.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Ray K, Bala M, Gupta SM, et al.",Non-OADS,/arxiv_data1/oa_pdf/71/28/sextrans-2014-051708.PMC4518737.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Muley TR, Herth FJ, Schnabel PA, et al.",Non-OADS,/arxiv_data1/oa_pdf/f0/a9/jclinpath-2015-202888.PMC4518739.pdf
"ORIGINAL ARTICLE Association between diastolic dysfunction and future atrial ﬁbrillation in the Tromsø Study from 1994 to 2010 Sweta Tiwari,1Henrik Schirmer,2,3Bjarne K Jacobsen,1Laila A Hopstock,1 Audhild Nyrnes,1Geir Heggelund,2Inger Njølstad,1Ellisiv B Mathiesen,2,4 Maja-Lisa Løchen1 1Department of Community Medicine, UiT The ArcticUniversity of Norway, Tromsø, Norway 2Department of Clinical Medicine, UiT The ArcticUniversity of Norway, Tromsø, Norway 3Department of Cardiology, The University Hospital ofNorth Norway, Tromsø, Norway 4Department of Neurology and Neurophysiology, TheUniversity Hospital of NorthNorway, Tromsø, Norway Correspondence to Sweta Tiwari, Department of Community Medicine, UiT TheArctic University of Norway,N-9037 Tromsø, Norway; sweta.tiwari@uit.no Received 2 January 2015 Revised 8 April 2015Accepted 13 April 2015 Published Online First 13 May 2015 ▸http://dx.doi.org/10.1136/ heartjnl-2015-307885 To cite: Tiwari S, Schirmer H, Jacobsen BK, et al.Heart 2015; 101:1302 –1308.ABSTRACT Objective To investigate the association between echocardiographic measurements with emphasis ondiastolic dysfunction and risk of atrial ﬁbrillation (AF) in a population-based cohort study.Methods We followed 2406 participants from the Tromsø Study from 1994 to 2010.",Non-OADS,/arxiv_data1/oa_pdf/e2/df/heartjnl-2015-307438.PMC4518740.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Benjamin EJ, Wolf PA, D ’Agostino RB, et al.",Non-OADS,/arxiv_data1/oa_pdf/e2/df/heartjnl-2015-307438.PMC4518740.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 United Nations International Children ’s Fund (UNICEF).,Non-OADS,/arxiv_data1/oa_pdf/09/cf/sextrans-2014-051797.PMC4518741.pdf
"Nairobi, Kenya: NACC and NASCOP, 2012. http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_KE_Narrative_Report.pdf (accessed 25 Jun 2014).",Non-OADS,/arxiv_data1/oa_pdf/09/cf/sextrans-2014-051797.PMC4518741.pdf
Pan Afr Med J 2011;10:23. http://www.panafrican-med-journal.com/content/article/10/ 23/full/ (accessed 28 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/09/cf/sextrans-2014-051797.PMC4518741.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ emermed-2014-203962).,OADS,/arxiv_data1/oa_pdf/1a/58/emermed-2014-203962.PMC4518743.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Grote G. Safety management in different high-risk domains –All the same?,Non-OADS,/arxiv_data1/oa_pdf/1a/58/emermed-2014-203962.PMC4518743.pdf
http://www.luftambulanse.no/ årsrapport-2013-er-klar (accessed 13 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/1a/58/emermed-2014-203962.PMC4518743.pdf
http://www.luftfartstilsynet.no/regelverk/Europeisk_regelverk/article1325.ece (accessed 30 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/1a/58/emermed-2014-203962.PMC4518743.pdf
Thestudy was registered (NCT02173873 http://www.clinicaltrials.gov).,Non-OADS,/arxiv_data1/oa_pdf/0b/33/bjophthalmol-2014-306319.PMC4518747.pdf
†http://www.pmlive.com/pharma_news/novartis_nhs_price_lucentis_wet_amd_roche_avastin_402440 (accessed Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/0b/33/bjophthalmol-2014-306319.PMC4518747.pdf
‡National Institute for Health and Care Excellence (NICE) technology appraisal guidance 242 (http://www.nice.org.uk/guidance/ta242/chapter/t he-technologies) (accessed Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/0b/33/bjophthalmol-2014-306319.PMC4518747.pdf
§NICE technology appraisal guidance 305 issued February 2014 (http://guidance.nice.org.uk/ta305).¶NICE technology appraisal guidance 617 iss ued March 2014 (http://guidance.nice.,Non-OADS,/arxiv_data1/oa_pdf/0b/33/bjophthalmol-2014-306319.PMC4518747.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Schmid MK, Bachmann LM, Fäs L, et al.E fﬁcacy and adverse events of a ﬂibercept, ranibizumab and bevacizumab in age-related macular degeneration: a trade-offanalysis.",Non-OADS,/arxiv_data1/oa_pdf/0b/33/bjophthalmol-2014-306319.PMC4518747.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Gillespie LD, Robertson MC, Gillespie WJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/1c/a5/injuryprev-2014-041351.PMC4518748.pdf
"Canberra: Australian Institute of Healthand Welfare, 2012. http://www.aihw.gov.au/publication-detail/?id=10737421923 (accessed 9 Sep 2013).",Non-OADS,/arxiv_data1/oa_pdf/1c/a5/injuryprev-2014-041351.PMC4518748.pdf
http://www.kdd.org/ (accessed 25 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/1c/a5/injuryprev-2014-041351.PMC4518748.pdf
HARP Hospital Admissions Risk Program Victoria: Department of Health; 2013. http://www.health.vic.gov.au/harp/about.htm (accessed 1 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/1c/a5/injuryprev-2014-041351.PMC4518748.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Dooley IJ, O ’Brien PD.",Non-OADS,/arxiv_data1/oa_pdf/c2/27/bjophthalmol-2014-306065.PMC4518749.pdf
Cataract and Refractive Surgery Today January 2008. http://bmctoday.net/crstodayeurope/ 2008/01/article.asp?f=0108_19.php (accessed 13 Aug 2014).,Non-OADS,/arxiv_data1/oa_pdf/c2/27/bjophthalmol-2014-306065.PMC4518749.pdf
"9 The Irish Longitudinal Study on Ageing (TILDA, http://www.tilda.ie)10is a prospective cohort study aimed at providing representative and comprehen-sive data relating to older people and the ageingpopulation in ROI, by collecting data on the social,economic and health status of participants aged50 years and over.",Non-OADS,/arxiv_data1/oa_pdf/4e/1f/bjophthalmol-2014-305768.PMC4518752.pdf
"The photographs were anonymised using a unique iden-tiﬁer and transferred to the Moor ﬁelds Eye Hospital (MEH) Reading Centre, London, UK (http://www.readingcentre.org) andthe Macular Pigment Research Group (MPRG, http://www .mprg.ie), Vision Research Centre, W aterford, Ireland.",Non-OADS,/arxiv_data1/oa_pdf/4e/1f/bjophthalmol-2014-305768.PMC4518752.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/Table 7 Prevalence of age-related macular degeneration (AMD) in comparable population-based studies Study name Country Age group (year) Early AMD (%) Late AMD (%) Atrophic AMD (%) Neovascular AMD (%) Baltimore Eye Survey* USA 40 –49 0.0 0.0 0.0 1985–19881750–59 0.5 0.2 0.4 60–69 0.7 0.7 0.0 70–79 2.9 1.8 1.6 80+ 7.0 4.0 5.6 Beaver Dam Eye Study USA 43 –54 8.4 0.1 1988–19901855–64 13.8 0.6 65–74 18.0 1.4 75+ 29.7 7.1 Blue Mountains Eye Study Australia 49 –54 1.3 0.0 1992–19931955–64 2.6 0.2 65–74 8.5 0.7 75–84 15.5 5.4 85+ 28.0 18.5 Reykjavik Eye Study Iceland 50 –59 8.9 0.3 0.3 0.0 19962060–69 16.4 1.2 1.2 0.0 70–79 27.5 5.8 5.3 0.5 >80 37.1 30.8 25.0 9.8 MESA* USA 45 –54 1.8 0.0 2000–20022155–64 2.8 0.1 65–74 5.5 0.3 75–84 13.3 2.9 TILDA Study ROI 50 –64 4.9 0.1 0.1 0.1 2009–2011 65 –74 7.3 0.5 0.2 0.2 ≥75 11.0 2.2 1.3 1.0 *Data on only white participants.,Non-OADS,/arxiv_data1/oa_pdf/4e/1f/bjophthalmol-2014-305768.PMC4518752.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Nyman SR, Dibb B, Victor CR, et al.",Non-OADS,/arxiv_data1/oa_pdf/52/80/bjophthalmol-2014-305986.PMC4518753.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/archdischild-2014-307401).,Non-OADS,/arxiv_data1/oa_pdf/5f/07/archdischild-2014-307401.PMC4518754.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Australasian College for Emergency Medicine.,Non-OADS,/arxiv_data1/oa_pdf/5f/07/archdischild-2014-307401.PMC4518754.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Cook JL, Purdam CR.",Non-OADS,/arxiv_data1/oa_pdf/ea/52/bjsports-2014-093989.PMC4518755.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ References AGRIA INSURANCE COMPANY (2013) Ny SCB-statistik: Hundarna blir ﬂer och katterna färre.,OADS,/arxiv_data1/oa_pdf/f5/fe/vetrec-2014-102960.PMC4518756.pdf
"http://www.R-project.org/ REDMAN, J.",Non-OADS,/arxiv_data1/oa_pdf/f5/fe/vetrec-2014-102960.PMC4518756.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ injuryprev-2014-041444).,OADS,/arxiv_data1/oa_pdf/61/df/injuryprev-2014-041444.PMC4518757.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Braddock M, Lapidus G, Gregorio D, et al.",Non-OADS,/arxiv_data1/oa_pdf/61/df/injuryprev-2014-041444.PMC4518757.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Bazarian JJ, Cernak I, Noble-Haeusslein Linda, et al.",Non-OADS,/arxiv_data1/oa_pdf/a9/55/bjsports-2014-093877.PMC4518758.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Lusk AC, et al.Inj Prev 2015; 21:221–230.",Non-OADS,/arxiv_data1/oa_pdf/94/f3/injuryprev-2014-041317.PMC4518761.pdf
Environ Health Perspect 2010. http://ehsehplp03.niehs.nih.gov/ article/info%3Adoi%2F10.1289%2Fehp.0901747 (accessed 26 Aug 2010).,Non-OADS,/arxiv_data1/oa_pdf/94/f3/injuryprev-2014-041317.PMC4518761.pdf
http://www.nhtsa-tsis.net/statecatalog/stateData.html (accessed 12 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/94/f3/injuryprev-2014-041317.PMC4518761.pdf
2008. http://www.actar.org/reports.html (accessed 12 Apr 2014).,OADS,/arxiv_data1/oa_pdf/94/f3/injuryprev-2014-041317.PMC4518761.pdf
Accepted 28 May 2015 Published Online First 18 June 2015 ▸http://dx.doi.org/10.1136/bjsports-2015-094911 Br J Sports Med 2015; 49:969 –970.,Non-OADS,/arxiv_data1/oa_pdf/05/26/bjsports-2015-094592.PMC4518762.pdf
4 http://www.who.int/mediacentre/factsheets/fs311/en/ (accessed 28 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/05/26/bjsports-2015-094592.PMC4518762.pdf
5 http://www.nice.org.uk/guidance/cg43/resources/ guidance-obesity-pdf (accessed 28 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/05/26/bjsports-2015-094592.PMC4518762.pdf
6 http://www.aomrc.org.uk/general-news/exercise-the- miracle-cure.html (accessed 28 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/05/26/bjsports-2015-094592.PMC4518762.pdf
"See: http://creativecommons.org/licenses/ by-nc/4.0/ To cite Blair SN, Hand GA, Hill JO.",Non-OADS,/arxiv_data1/oa_pdf/05/26/bjsports-2015-094592.PMC4518762.pdf
"Accepted 20 November 2014 Published Online First 19 December 2014 ▸http://dx.doi.org/10.1136/bjsports-2014-094441 Br J Sports Med 2015; 49:1025. doi:10.1136/bjsports-2014-094363 REFERENCES 1 Elliott AD, La Gerche A.",Non-OADS,/arxiv_data1/oa_pdf/c2/44/bjsports-2014-094363.PMC4518763.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Brinkert R. A literature review of con ﬂict communication causes, costs, bene ﬁts and interventions in nursing.",Non-OADS,/arxiv_data1/oa_pdf/d3/2f/archdischild-2014-307780.PMC4518764.pdf
2010. http://www.gmc-uk.org/Treatment_and_care_towards_the_end_of_life___English_0914.pdf_48902105.pdf (accessed 10/4/2015).,Non-OADS,/arxiv_data1/oa_pdf/d3/2f/archdischild-2014-307780.PMC4518764.pdf
"DOI: 10.6061/clinics/2015(08)06Copyright &2015 CLINICS –This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2009;27(47):6550-7, http://dx.doi.org/ 10.1016/j.vaccine.2009.08.048.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2013;87(3):147-59, http://dx.doi.org/10.1159/000346743.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2010;41(3):425-30, http://dx.doi.org/ 10.1016/j.humpath.2009.06.021.",OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2010;45(1):86-94, http://dx.doi.org/10.1007/s00535-009-0128-5.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2008;371(9615):838-51, http://dx.doi.org/10.1016/S0140-6736(08)60383-9.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2006;45(4):529-38,http://dx.doi.org/10.1016/j.jhep.2006.05.013.",OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2011;21(6):401-16, http://dx.doi.org/10.2188/jea.JE20100190.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2009;200(1):39-47, http://dx.doi.org/10.1086/599173.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2013;10(11):656-65, http://dx.doi.org/ 10.1038/nrgastro.2013.183.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2011; 34(3):274-85, http://dx.doi.org/10.1111/apt.2011.34.issue-3.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2009;50(1):204-10, http://dx.doi.org/10.1016/j.jhep.2008.10.010.",OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2004;127(5):S97-S103, http://dx.doi.org/10.1053/j.gastro.2004.09.021.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2014;29(1):173-8, http://dx.doi.org/10.1111/jgh.2014.29.issue-1.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2014;18(1):1-18, http://dx.doi.org/ 10.1016/j.cld.2013.09.019.",OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2010;51(6):1972-8, http://dx.doi.org/10.1002/hep.23527.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2013;29(8):451-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2009;44(12):1190-4, http://dx.doi.org/10.1007/s00535-009-0112-0.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2012;42(8):767-73, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"J Hepatol.2014;60(2):325-30, http://dx.doi.org/10.1016/j.jhep.2013.09.015.",OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2014;60:110-7, http://dx.doi.org/10.1016/j.jhep.2013.08.011.",OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2014;30(5):325-9, http://dx.doi.org/10.3109/ 09513590.2013.875992.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2012;18(3):237-43, http://dx.doi.org/10.3748/wjg.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"2007;37(4):239-47, http://dx.doi.org/10.1111/ hep.2007.37.issue-4.",Non-OADS,/arxiv_data1/oa_pdf/b9/13/cln-70-08-563.PMC4518765.pdf
"DOI: 10.6061/clinics/2015(08)02Copyright &2015 CLINICS –This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/d9/cln-70-08-541.PMC4518766.pdf
"2013;27(1):107 –12, http://dx.doi.org/10.1038/leu.2012.181.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2012;119(8):1838 –43, http://dx.doi.org/10.1182/blood-2011-10-383000.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2009;27(25):4204 –10, http://dx.doi.org/10.1200/JCO.2009.21.8230.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2007;110(12):4005 –11, http://dx.doi.org/10.1182/blood-2007-03-080838.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2006;108(6):1809 –20, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2009;27 (35):6041 –51, http://dx.doi.org/10.1200/JCO.2009.25.0779.9.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2006: 106(6):1306-15, http://dx.doi.org/10.1002/(ISSN)1097-0142.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2009;114(24):4939 –43, http://dx.doi.org/10.1182/blood- 2009-07-229864.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2011;33(3):211 –5, http://dx.doi.org/10.5581/1516-8484.20110056.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2006;108(1):28 –37, http://dx.doi.org/ 10.1182/blood-2006-01-0092.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2003;102(1):276 –83, http://dx.doi.org/ 10.1182/blood-2002-09-2896.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2007;109(2):497 –9, http://dx.doi.org/ 10.1182/blood-2006-07-035493.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2010;24 (7):1299 –301, http://dx.doi.org/10.1038/leu.2010.110.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2012;30(3):232 –8, http://dx.doi.org/10.1200/JCO.2011.38.6565.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2010;116(19):3758 –65, http://dx.doi.org/10.1182/blood-2010-03-273979.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2012;26(9):2096 –102, http://dx.doi.org/10.1038/leu.2012.85.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2012;30 (35):4323 –9, http://dx.doi.org/10.1200/JCO.2011.40.5217.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"Blood.2014;123(15):2317-24, http://dx.doi.org/10.1182/blood-2013-10-532341.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2009;113(25):6315 –21, http://dx.doi.org/ 10.1182/blood-2008-07-166694.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2010;116(25):5497 –500, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"2009;114(20): 4361 –8, http://dx.doi.org/10.1182/blood-2009-05-221531.",Non-OADS,/arxiv_data1/oa_pdf/79/e9/cln-70-08-550.PMC4518767.pdf
"Results of an in vitro study showed that elemene increased the radiosensitivity of renal carcinoma cells, tongue squamous cancer cells, and non-small cell lung DOI: 10.6061/clinics/2015(08)05Copyright &2015 CLINICS –This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"2014;19(6):353-60, http://dx.doi.org/10.1016/j.rpor.2014.04.012.",OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"2002;78(12):1139-47, http://dx.doi.org/10.1080/09553000210166606.",Non-OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"2002;23(5):687-96, http://dx.doi.org/10.1093/carcin/23.5.687.",Non-OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"1999; 17(1):56-72, http://dx.doi.org/10.3109/07357909909011718.",Non-OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"2009;8(1):12-5, http://dx.doi.org/10.1007/s10330-008-0139-3.",Non-OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"2014;35(10):9735-41, http://dx.doi.org/10.1007/s13277-014-2226-0.",Non-OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"2006;4(4):392-6, http://dx.doi.org/10.3736/jcim20060415.",Non-OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"2011; 25(7):1095-7, http://dx.doi.org/10.1002/ptr.v25.7.",Non-OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"2014;53(8):1035-40, http://dx.doi.org/10.3109/0284186X.2014.925582.",Non-OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"2010;25(2):113-23, http://dx.doi.org/10.1093/mutage/gep048.",Non-OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"2008;47(5):1495-503, http://dx.doi.org/10.1002/(ISSN)1527-3350.",Non-OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"2012;27(1):56-64, http://dx.doi.org/10.1089/cbr.2011.1003.",Non-OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"2014;86(2):144-50, http://dx.doi.org/10.1016/j.lungcan.2014.08.015.",OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"2003;326(1):93-103, http://dx.doi.org/10.1016/S0022-2836(02)01328-1.",Non-OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"Cancer Res.2005;65(10):4368-75, http://dx.doi.org/10.1158/0008-5472.CAN-04-4202.",Non-OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"2010;29(10):1431-50, http://dx.doi.org/10.1038/onc.2009.438.",Non-OADS,/arxiv_data1/oa_pdf/94/71/cln-70-08-556.PMC4518768.pdf
"In particular, the diameter of the gracilis artery is only 1.0 m m to 2.5 mm (17-19), which DOI: 10.6061/clinics/2015(08)03Copyright &2015 CLINICS –This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"1997;40(6):1182-9, http://dx.doi.org/10.1097/ 00006123-199706000-00014 2.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2002;27 (2):159-60, http://dx.doi.org/10.1054/jhsb.2001.0665 4.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2012;20(8):506-17, http://dx.doi.org/10.5435/JAAOS-20-08-506 5.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2007;119(4):73e-92e, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2009;124(4):1225-36, http://dx.doi.org/10.1097/PRS.0b013e3181b5a322 9.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2010;24(1):57-66, http://dx.doi.org/10.1055/s-0030-1253242 10.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2004;20(3):227-35, http://dx.doi.org/10.1055/s-2004-823110 14.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"1996;98(6):1023-31, http://dx.doi.org/10.1097/00006534-199611000-00015 15.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2010;63(9):e665-73, http://dx.doi.org/10.1016/j.bjps.2010.06.011 17.",OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2008;21(7):696-704, http://dx.doi.org/10.1002/ca.v21:7 18.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"1993;15 (3):163-8, http://dx.doi.org/10.1007/BF01627695 19.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"1990;43(3):266-72, http://dx.doi.org/10.1016/0007-1226(90)90071-7 20.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"1984;37(2):139-48, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"1991;44(7): 533-7, http://dx.doi.org/10.1016/0007-1226(91)90012-9 22.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2011;27(2):109-14, http://dx.doi.org/10.1055/s-0030-1268209 24.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"1999;47(2):416-9, http://dx.doi.org/ 10.1097/00005373-199908000-00042 25.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2014;16(2):147-50, http://dx.doi.org/10.1001/jamafacial.2013.2263 26.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2014;72(6): 1197-202, http://dx.doi.org/10.1016/j.joms.2013.12.011 27.",OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2005;116(4):1082-9, http://dx.doi.org/10.1097/01.prs.0000178791.85118.ca 28.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2005;21(6):355-7, http://dx.doi.org/10.1055/s-2005-915201 30.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2012;130(1):229e-31e, http://dx.doi.org/ 10.1097/PRS.0b013e3182550260 31.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"1995;16(9):598-600, http://dx.doi.org/10.1002/(ISSN)1098-2752 32.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"1981;67(2): 177-87, http://dx.doi.org/10.1097/00006534-198167020-00007 33.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"1999;42(6):630-3, http://dx.doi.org/10.1097/ 00000637-199906000-00008 34.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2005;58(4):445-8, http://dx.doi.org/10.1016/j.bjps.2004.11.021 35.",OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2008;122(2):449-55, http://dx.doi.org/ 10.1097/PRS.0b013e31817d62c5 36.",Non-OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2004;52(1):61-3, http://dx.doi.org/10.1097/01.sap.0000096425.18223.60 549CLINICS 2015;70(8):544-549  Flow-through anastomosis for FFMT Hou Y et al.",OADS,/arxiv_data1/oa_pdf/59/97/cln-70-08-544.PMC4518818.pdf
"2012;21(3):423-9, http://dx.doi.org/10.1016/j.jse.2011.08.053.",OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"1975; 7(2):101-6, http://dx.doi.org/10.1016/0020-1383(75)90006-6.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"1987; 58(1):71-4, http://dx.doi.org/10.3109/17453678709146346.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"1986;105(6):337-8, http://dx.doi.org/10.1007/BF00449938.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"1998;2(8):572-6, http://dx.doi.org/10.1097/00005131-199811000-00008.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"1997;79(4):537-9, http://dx.doi.org/10.1302/0301-620X.79B4.7529.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2006;88(1):35-40, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2012; 94(8):675-84, http://dx.doi.org/10.2106/JBJS.J.01364.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2009;62(10):1006-12, http://dx.doi.org/ 10.1016/j.jclinepi.2009.06.005.",OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"1996;17(1):1-12, http://dx.doi.org/10.1016/0197-2456(95)00134-4.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2009;23(2):106-12, http://dx.doi.org/10.1097/ BOT.0b013e318190cf88.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"Acta Orthop Traumatol Turc.2011;45(1):34-40, http://dx.doi.org/ 10.3944/AOTT.2011.2431.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2012;94(17):1546-53, http://dx.doi.org/10.2106/JBJS.J.01999.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2013; 95(17):1576-84, http://dx.doi.org/10.2106/JBJS.L.00307.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2008;43(10):419-25, http://dx.doi.org/10.1590/S0102-36162008001000001.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2011;25(1):31-8, http://dx.doi.org/10.1097/BOT.0b013e3181d8290e.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2005;108(9):707-14, http://dx.doi.org/10.1007/s00113-005-0970-8.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2012;132(5):617-25, http://dx.doi.org/10.1007/s00402-011-1456-5.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2011;25(1):39-43, http://dx.doi.org/10.1097/ BOT.0b013e3181d8893a.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2011;131(6):841-7, http://dx.doi.org/10.1007/s00402-010-1240-y.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2009;21(2):170-9, http://dx.doi.org/10.1007/s00064-009-1705-8.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2013;27(3):121-5, http://dx.doi.org/10.1097/BOT.0b013e3182693f32.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2014;9:55, http://dx.doi.org/10.1186/s13018-014-0055-x.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2008;16(3):28, http://dx.doi.org/10.1186/1749-799X-3-28.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2010;19(6):783-9, http://dx.doi.org/10.1016/j.jse.2010.05.002.",OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2014;15(3):165-71, http://dx.doi.org/10.1007/s10195-014-0298-7.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2011;12(4):185-92, http://dx.doi.org/10.1007/ s10195-011-0158-7.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2014;15:55-9, http://dx.doi.org/10.1097/ BTE.0000000000000007.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2011;20(6):1008-15, http://dx.doi.org/10.1016/j.jse.2011.01.018.",OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2012;83(1):65-73, http://dx.doi.org/10.3109/17453674.2011.652884.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2014; 23(2):173-81, http://dx.doi.org/10.1016/j.jse.2013.06.025.",OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"2013;37(8):1495-500, http://dx.doi.org/10.1007/s00264-013-1871-z.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/cln-70-08-584.PMC4518819.pdf
"The ALI model used in the current study involves the intratracheal instillation of hydrochloric acid (HCl) and attempts to mimic the clinical scenario of gastric content aspiration, wherein a pulmonary lesion is caused by the action DOI: 10.6061/clinics/2015(08)08Copyright &2015 CLINICS –This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2007;369(9572):1553-64, http://dx.doi.org/10.1016/S0140-6736(07)60604-7.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2002;30(11):2450-6, http://dx.doi.org/10.1097/00003246-200211000-00008.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2001;344(9):665-71, http://dx.doi.org/10.1056/NEJM200103013440908.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2011;166(2):e195-204, http://dx.doi.org/10.1016/j.jss.2010.10.015.",OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2008;8:9, http://dx.doi.org/ 10.1186/1471-2466-8-9.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"1996;60(1):176-80,http://dx.doi.org/10.1006/jsre.1996.0028.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2005;172(8):1002-7, http://dx.doi.org/10.1164/rccm.200501-005OC.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2008;36(9):2569-75, http://dx.doi.org/10.1097/CCM.0b013e3181841a91.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2006;290(4):C1051-9, http://dx.doi.org/10.1152/ ajpcell.00216.2005.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2011;27(3):735-52, http://dx.doi.org/10.1016/j.ccc.2011.05.013.",OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2008;295(3):L379-99,http://dx.doi.org/10.1152/ajplung.00010.2008.14.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"1998;26(5):912-6, http://dx.doi.org/10.1097/00003246-199805000-00027.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"1989;117(1):53-8, http://dx.doi.org/10.1016/0022-1759(89)90118-X.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2003;138(1):9-14, http://dx.doi.org/10.1001/archsurg.138.1.9.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2013;8(9):e74369, http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"1998;45(1):7-12; discussion -3, http://dx.doi.org/10.1097/00005373-199807000-00002.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2011;35(2):178-83, http://dx.doi.org/10.1097/SHK.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2002;236(5):634-42, http://dx.doi.org/10.1097/ 00000658-200211000-00014.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2003;54(1):121-30; discussion 30-2, http://dx.doi.org/10.1097/00005373-200301000-00015.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2003;112(10):1541-9, http://dx.doi.org/10.1172/JCI18370.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"1997;42(4):602-6; discussion 6-7, http://dx.doi.org/10.1097/00005373-199704000-00004.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2011;39(7):1721-30, http://dx.doi.org/ 10.1097/CCM.0b013e3182186d09.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2001;164(10 Pt 1):1896-903, http://dx.doi.org/10.1164/ajrccm.164.10.2104013.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2008;27(11):1229-36, http://dx.doi.org/10.1016/ j.healun.2008.07.027.",OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"2007;33(12):2199-206, http://dx.doi.org/10.1007/s00134-007-0782-0.",Non-OADS,/arxiv_data1/oa_pdf/9b/e7/cln-70-08-577.PMC4518820.pdf
"1993;329(14):977-86, http://dx.doi.org/10.1056/NEJM199309303291401.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2014;2014:801269, http://dx.doi.org/10.1155/2014/801269.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2014;7:29, http://dx.doi.org/10.1186/1755-8794-7-29.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2001;345(19):1359-67, http://dx.doi.org/10.1056/NEJMoa011300.",OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2014;15 (1):e23941, http://dx.doi.org/10.5812/hepatmon.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2000;80(4):513-27, http://dx.doi.org/10.1038/ labinvest.3780057.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2000;87(12):1123-32, http://dx.doi.org/10.1161/01.RES.87.12.1123.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2001; 47:463-532, http://dx.doi.org/10.1067/mda.2001.119745.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2007;27(4):339-50, http://dx.doi.org/ 10.1055/s-2007-991511.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"1997;336(15):1066-71,http://dx.doi.org/10.1056/NEJM199704103361506.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2003;60(1):49-57, http://dx.doi.org/10.1016/S0008-6363(03)00397-3.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"1998;24(2):101-9, http://dx.doi.org/10.1006/mpat.1997.0178.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2009;13(4):173, http://dx.doi.org/10.1186/cc7966.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"1997;112(1):235-43, http://dx.doi.org/ 10.1378/chest.112.1.235.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2012;205(3):392-400,http://dx.doi.org/10.1093/infdis/jir764.21.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2005;288(3):L530-5, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2008;73(7):751-62, http://dx.doi.org/10.1134/S0006297908070031.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2011;16 (3):2583-98, http://dx.doi.org/10.3390/molecules16032583.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2001;98(5):1542-8, http://dx.doi.org/10.1182/ blood.V98.5.1542.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2007;100(4):460-73, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2002;16(13):1738-48, http://dx.doi.org/10.1096/fj.01-1027com.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2008;42(8):689 –706, http://dx.doi.org/10.1080/10715760802317663.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2005;5(2):94-111, http://dx.doi.org/10.1124/mi.5.2.7.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2005;37(4):822-34, http://dx.doi.org/10.1016/j.biocel.2004.09.010.",OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2003;60(1):49-57, http://dx.doi.org/10.1016/S0008-6363(03)00397-3.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2007;11(2):R49, http://dx.doi.org/10.1186/cc5783.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"1996;77(1):110-7, http://dx.doi.org/10.1093/bja/77.1.110.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"1996;125(3):191-6, http://dx.doi.org/10.7326/0003-4819-125-3-199608010-00005.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2008;39(1): 77-85, http://dx.doi.org/10.1165/rcmb.2007-0248OC.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"1998;16(5-6):457-99, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2005;11(12):1742-6, http://dx.doi.org/10.3748/wjg.v11.i12.1742.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2003;6(2):217-22, http://dx.doi.org/10.1097/00075197-200303000-00011.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"2009;296(3):L288-95,http://dx.doi.org/10.1152/ajplung.90479.2008.",Non-OADS,/arxiv_data1/oa_pdf/09/31/cln-70-08-569.PMC4518821.pdf
"DOI: 10.6061/clinics/2015(08)01Copyright &2015 CLINICS –This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/e4/cln-70-08-535.PMC4518841.pdf
"1987;55(1):61-6, http://dx.doi.org/10.1038/ bjc.1987.13 2.",Non-OADS,/arxiv_data1/oa_pdf/dd/e4/cln-70-08-535.PMC4518841.pdf
"2004;350 (16):1655-64, http://dx.doi.org/10.1056/NEJMra030831 3.",Non-OADS,/arxiv_data1/oa_pdf/dd/e4/cln-70-08-535.PMC4518841.pdf
"2002;2(8):584-93, http://dx.doi.org/ 10.1038/nrc8674.",Non-OADS,/arxiv_data1/oa_pdf/dd/e4/cln-70-08-535.PMC4518841.pdf
"2003;97(3Suppl):834-9, http://dx.doi.org/ 10.1002/(ISSN)1097-0142 5.",Non-OADS,/arxiv_data1/oa_pdf/dd/e4/cln-70-08-535.PMC4518841.pdf
"2005;87(5):698-703, http://dx.doi.org/10.1302/ 0301-620X.87B5.15185 7.",Non-OADS,/arxiv_data1/oa_pdf/dd/e4/cln-70-08-535.PMC4518841.pdf
"Prediction of survival in patients with metastases in the spinal column.Cancer.2005;103(2):320-8, http://dx.doi.org/10.1002/(ISSN)1097-0142 8.",Non-OADS,/arxiv_data1/oa_pdf/dd/e4/cln-70-08-535.PMC4518841.pdf
"1982:5(6):649-55, http://dx.doi.org/10.1097/ 00000421-198212000-00014 9.",Non-OADS,/arxiv_data1/oa_pdf/dd/e4/cln-70-08-535.PMC4518841.pdf
"1981;17(1):45-56, http://dx.doi.org/10.1016/0304-3959(83)90126-4 10.",Non-OADS,/arxiv_data1/oa_pdf/dd/e4/cln-70-08-535.PMC4518841.pdf
"2006;16(2):120-30, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/dd/e4/cln-70-08-535.PMC4518841.pdf
"2006;66(12):6243-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/dd/e4/cln-70-08-535.PMC4518841.pdf
"2013;54(5):1168-77, http://dx.doi.org/10.3349/ymj.2013.54.5.1168 13.",Non-OADS,/arxiv_data1/oa_pdf/dd/e4/cln-70-08-535.PMC4518841.pdf
"2008;466(3):729-36, http://dx.doi.org/10.1007/s11999-007-0051-0 15.",Non-OADS,/arxiv_data1/oa_pdf/dd/e4/cln-70-08-535.PMC4518841.pdf
"2013;18(1):164-9, http://dx.doi.org/10.1007/s10147-011-0359-3 16.",Non-OADS,/arxiv_data1/oa_pdf/dd/e4/cln-70-08-535.PMC4518841.pdf
"2003;14(8):1234-40, http://dx.doi.org/10.1093/annonc/mdg348 17.",Non-OADS,/arxiv_data1/oa_pdf/dd/e4/cln-70-08-535.PMC4518841.pdf
"DOI: 10.6061/clinics/2015(08)10Copyright &2015 CLINICS –This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2005;7(1):122-35, http://dx.doi.org/ 10.1111/dom.2005.7.issue-2.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2000;88(3-4):264-5, http://dx.doi.org/10.1159/000015534.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2005;280(2):1457-64, http://dx.doi.org/10.1074/jbc.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2006;38(3):320-3, http://dx.doi.org/ 10.1038/ng1732.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2006;55(9):2640-4, http://dx.doi.org/10.2337/db06-0355.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2007;117(8):2155-63, http://dx.doi.org/10.1172/JCI30706.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2006;55(10):2890-5, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2012;50(3-4):159-79, http://dx.doi.org/10.1007/s10528-011-9456-2.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2007;15(3):342-6, http://dx.doi.org/10.1038/ sj.ejhg.5201773.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2007;56(2): 389-93, http://dx.doi.org/10.2337/ db06-0860.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2007;50(1):63-7, http://dx.doi.org/10.1007/s00125-006-0502-2.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2007;50(5):980-4, http://dx.doi.org/ 10.1007/s00125-007-0618-z.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2007;92(9):3733-7, http://dx.doi.org/ 10.1210/jc.2007-0849.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2010;11:97, http://dx.doi.org/10.1186/ 1471-2350-11-97.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"Meta Gene.2014;2:332-41, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2005;24(9):1291-306, http://dx.doi.org/10.1002/(ISSN)1097-0258.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2010;8(5):336-41, http://dx.doi.org/10.1016/j.ijsu.2010.02.007.",OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
http://www.ohri.ca/pro- grams/clinical_epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"1997;127(9):820-6, http://dx.doi.org/10.7326/ 0003-4819-127-9-199711010-00008.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"1986;7(3):177-88, http://dx.doi.org/10.1016/0197-2456(86)90046-2.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2003;327(7414):557-60, http://dx.doi.org/10.1136/ bmj.327.7414.557.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2010;59(3):747-50, http://dx.doi.org/10.2337/db09-1050.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2009;58(4):800-2, http://dx.doi.org/10.2337/db09-0099.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2009;58(4):894-5, http://dx.doi.org/10.2337/db08-1187.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"Mol Biol Rep. 2012; 39(1): 17-23, http://dx.doi.org/10.1007/s11033-011-0705-6.",OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2009; 85: 139-46, http://dx.doi.org/10.1016/j.diabres.2009.04.024.",OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2010;5(2):e9153, http://dx.doi.org/10.1371/journal.pone.0009153.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2012;495(2):115-9, http://dx.doi.org/10.1016/ j.gene.2011.12.055.",OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2008;53(2):174-80, http://dx.doi.org/10.1007/s10038-007-0231-5.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2012;12(2):115-9, http://dx.doi.org/10.1007/ s10238-011-0144-7.",Non-OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
"2009;85(6):762-74, http://dx.doi.org/10.1016/ j.ajhg.2009.10.015.",OADS,/arxiv_data1/oa_pdf/2c/59/cln-70-08-593.PMC4518842.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/1c/nihms-709062.PMC4519231.pdf
2013 http://dx.doi.org/10.1007/ s00167-013-2680-z .,Non-OADS,/arxiv_data1/oa_pdf/90/1c/nihms-709062.PMC4519231.pdf
2014 http://dx.doi.org/10.1002/jcp.24707 .,Non-OADS,/arxiv_data1/oa_pdf/90/1c/nihms-709062.PMC4519231.pdf
Available at:  http://publications.cpa-apc.org/cjp/2014/supple - ment/index.html#/20/ (accessed 31 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/1d/d1/10.1177_0004867415584643.PMC4519522.pdf
http://dx.doi.org/10.1016/j.rboe.2014.12.004 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/d3/81/main.PMC4519558.pdf
http://dx.doi.org/10.1016/j.rboe.2014.12.003 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/b2/1f/main.PMC4519559.pdf
http://dx.doi.org/10.1016/j.rboe.2015.01.007 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/15/b6/main.PMC4519560.pdf
Available  in:  http://bvsms.saude.gov.,Non-OADS,/arxiv_data1/oa_pdf/15/b6/main.PMC4519560.pdf
Available  in: http://www.cedeplar.ufmg.br/component/content/article/191-textos-para-discussao/1546-estimacao-dos-parametros-de-valorizacao-dos-estados-de-saude-em-minas-gerais-a-partir-do-eq-5d.html [accessed  20.01.13].,OADS,/arxiv_data1/oa_pdf/15/b6/main.PMC4519560.pdf
http://dx.doi.org/10.1016/j.rboe.2015.03.001 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/a1/fd/main.PMC4519561.pdf
http://dx.doi.org/10.1016/j.rboe.2015.02.003 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/9e/e0/main.PMC4519562.pdf
http://dx.doi.org/10.1016/j.rboe.2015.03.004 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/0a/a9/main.PMC4519563.pdf
"In  fact,  there  is  a  waiting list of  more  than  one  year  for  publication,  which  is  being resolved  through  publication  on  the  web,  in  Science  Direct (http://www.sciencedirect.com/Science/journal/aip/01023616 ), for all  studies  that  have  been  approved  by  the  editorial  board, independent  of  the  date.",Non-OADS,/arxiv_data1/oa_pdf/61/cf/main.PMC4519564.pdf
Gilberto  Luis  Camanho Revista Brasileira de  Ortopedia E-mail:  gilbertocamanho@uol.com.br 22  March  2015 23 March  2015 Available online  24  April  2015 http://dx.doi.org/10.1016/j.rboe.2015.03.011 2255-4971/© 2015  Sociedade  Brasileira  de  Ortopedia  e Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/61/cf/main.PMC4519564.pdf
http://dx.doi.org/10.1016/j.rboe.2015.01.003 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/ab/42/main.PMC4519565.pdf
http://dx.doi.org/10.1016/j.rboe.2015.01.001 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/71/19/main.PMC4519566.pdf
http://dx.doi.org/10.1016/j.rboe.2015.02.012 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/31/7b/main.PMC4519567.pdf
http://dx.doi.org/10.1016/j.rboe.2014.12.005 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/67/05/main.PMC4519568.pdf
http://dx.doi.org/10.1016/j.rboe.2014.04.024,OADS,/arxiv_data1/oa_pdf/d5/07/main.PMC4519569.pdf
http://dx.doi.org/10.1016/j.rboe.2015.03.006 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/1c/27/main.PMC4519570.pdf
http://dx.doi.org/10.1016/j.rboe.2015.01.004 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/2d/e3/main.PMC4519571.pdf
http://dx.doi.org/10.1016/j.rboe.2015.02.002 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/59/b6/main.PMC4519572.pdf
http://dx.doi.org/10.1016/j.rboe.2015.03.002 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/37/16/main.PMC4519573.pdf
Available from:  http://bvsms.saude.gov.br/bvs/publicacoes/ formulario terapeutico  nacional  2008.pdf 29.,Non-OADS,/arxiv_data1/oa_pdf/37/16/main.PMC4519573.pdf
http://dx.doi.org/10.1016/j.rboe.2015.04.001 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/e9/49/main.PMC4519574.pdf
http://dx.doi.org/10.1016/j.rboe.2015.02.008 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/e3/b3/main.PMC4519575.pdf
http://dx.doi.org/10.1016/j.rboe.2015.02.009 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/d3/23/main.PMC4519576.pdf
The results were incorporated in a web-based nomogram ( http://www.utwente.nl/mira/inﬂuence ).,OADS,/arxiv_data1/oa_pdf/dc/23/10549_2015_Article_3490.PMC4519578.pdf
Analyses were performed using STATA version 13 and R3.1.1 software ( http://www.r-project.org ).,OADS,/arxiv_data1/oa_pdf/dc/23/10549_2015_Article_3490.PMC4519578.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/dc/23/10549_2015_Article_3490.PMC4519578.pdf
https://www.adjuvantonline.com .,Non-OADS,/arxiv_data1/oa_pdf/dc/23/10549_2015_Article_3490.PMC4519578.pdf
http://nomograms.mskcc.org/Breast/ .,Non-OADS,/arxiv_data1/oa_pdf/dc/23/10549_2015_Article_3490.PMC4519578.pdf
https://www.tuftsmedicalcenter.org/ ibtr/.,Non-OADS,/arxiv_data1/oa_pdf/dc/23/10549_2015_Article_3490.PMC4519578.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/95/8b/40273_2015_Article_292.PMC4519579.pdf
http://www.cijfersoverkanker.nl/kerncijfers-over-kanker-49.,Non-OADS,/arxiv_data1/oa_pdf/9e/42/520_2015_Article_2605.PMC4519580.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e0/7f/40261_2015_Article_306.PMC4519582.pdf
Sociedad Española de Oncología Médica (SEOM) y Sociedad Española de Enfermería Oncológica (SEEO) 2008. http://seom.org/seomcms/images/ stories/recursos/sociosyprofs/documentacion/boletinseom/2010/ 69/14publicaciones.seom.bol69.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/33/f8/520_2015_Article_2809.PMC4519584.pdf
http://dx.doi.org/10.1016/j.rboe.2015.01.002 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/33/49/main.PMC4519588.pdf
http://dx.doi.org/10.1016/j.rboe.2015.02.007 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/ae/03/main.PMC4519590.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c6/c4/10549_2015_Article_3513.PMC4519591.pdf
http://www.R-project.org/ 14.,Non-OADS,/arxiv_data1/oa_pdf/c6/c4/10549_2015_Article_3513.PMC4519591.pdf
http://dx.doi.org/10.1016/j.rboe.2015.02.001 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/e4/17/main.PMC4519592.pdf
"2 Report of  Shanghai Renal  Registry, 2013  .http://sh.cnrds.org .",Non-OADS,/arxiv_data1/oa_pdf/2c/6c/cnd-0005-0140.PMC4519610.pdf
"de  Almeida  Monteiro).results.1More  than  100,000  new  cases  are  performed  in  the United States  every  year.2However,  this  procedure  is  not  free from  complications,3with  an  incidence  rate  of  between  1.8% and  24%.4 http://dx.doi.org/10.1016/j.rboe.2015.04.009 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.",Non-OADS,/arxiv_data1/oa_pdf/2a/c2/main.PMC4519612.pdf
http://dx.doi.org/10.1016/j.rboe.2015.01.006 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/0c/fc/main.PMC4519614.pdf
Available  at: http://www.mjaﬁ.net/article/S0377-1237%2812%2900254-7/fulltext 9.,Non-OADS,/arxiv_data1/oa_pdf/0c/fc/main.PMC4519614.pdf
http://dx.doi.org/10.1016/j.rboe.2015.03.003 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/ad/fd/main.PMC4519615.pdf
http://dx.doi.org/10.1016/j.rboe.2014.12.006 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/1d/44/main.PMC4519616.pdf
http://dx.doi.org/10.1016/j.rboe.2015.04.007 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/28/37/main.PMC4519617.pdf
http://dx.doi.org/10.1016/j.rboe.2014.12.007 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/e3/aa/main.PMC4519618.pdf
http://dx.doi.org/10.1016/j.rboe.2015.02.016 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/6a/99/main.PMC4519619.pdf
Available  in:  http://www.projetodiretrizes.org.br/7 volume/29-hernia.sc.lom.adul.pdf  [accessed  on  15.12.12].,Non-OADS,/arxiv_data1/oa_pdf/6a/99/main.PMC4519619.pdf
Available  from:  http://journals.lww.com/ spinejournalabstracts/Fulltext/2011/10001/The Effect  of  L2 Spinal  Nerve  Root  Inﬁltration.165.aspx  [accessed  on  15.12.12].,Non-OADS,/arxiv_data1/oa_pdf/6a/99/main.PMC4519619.pdf
http://dx.doi.org/10.1016/j.rboe.2015.02.014 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/98/c6/main.PMC4519620.pdf
Available  from: http://www.biblioteca.epm.br/ 20.,Non-OADS,/arxiv_data1/oa_pdf/98/c6/main.PMC4519620.pdf
http://dx.doi.org/10.1016/j.rboe.2015.02.010 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/a3/a4/main.PMC4519621.pdf
http://dx.doi.org/10.1016/j.rboe.2015.05.006 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/99/cf/main.PMC4519622.pdf
http://dx.doi.org/10.1016/j.rboe.2015.02.011 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/68/11/main.PMC4519623.pdf
http://dx.doi.org/10.1016/j.rboe.2015.03.009 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/4f/c4/main.PMC4519625.pdf
Available from:  http://ojs.sagepub.com/content/1/7/ 2325967113513546.abstract?patientinform-links=yes&legid=spojs;1/7/2325967113513546 6.,Non-OADS,/arxiv_data1/oa_pdf/4f/c4/main.PMC4519625.pdf
http://dx.doi.org/10.1016/j.rboe.2015.03.010 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/ff/f7/main.PMC4519626.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/16/51/40273_2015_Article_278.PMC4519630.pdf
http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx .,Non-OADS,/arxiv_data1/oa_pdf/60/9a/520_2015_Article_2622.PMC4519631.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/64/9e/40258_2015_Article_181.PMC4519632.pdf
National Institute for Health and CareExcellence; 2014. http://www.nice.org.uk/guidance/mtg22 .,Non-OADS,/arxiv_data1/oa_pdf/64/9e/40258_2015_Article_181.PMC4519632.pdf
2015. http://www.gpcontract.co.uk/browse/UK/Diabetes% 20Mellitus/14 .,Non-OADS,/arxiv_data1/oa_pdf/64/9e/40258_2015_Article_181.PMC4519632.pdf
2010 Feb 2. http://www.vibratip.com/pdf/ 20100202_vibratip_on_western_daily_press.pdf .,Non-OADS,/arxiv_data1/oa_pdf/64/9e/40258_2015_Article_181.PMC4519632.pdf
2015. http://my.supplychain.nhs.uk/Catalogue/product/ erp1862 .,Non-OADS,/arxiv_data1/oa_pdf/64/9e/40258_2015_Article_181.PMC4519632.pdf
"If no exchange rate wasprovided in the study itself, we used the average exchange rate (midpoint exchange rate according to OANDA his- torical exchange rates [ http://www.oanda.com/currency/ historical-rates/ ]) for the reported year.",Non-OADS,/arxiv_data1/oa_pdf/33/ec/40273_2015_Article_268.PMC4519633.pdf
http://dx.doi.org/10.1016/j.rboe.2014.12.002 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/3e/52/main.PMC4519636.pdf
http://dx.doi.org/10.1016/j.rboe.2015.03.005 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/91/90/main.PMC4519639.pdf
http://dx.doi.org/10.1016/j.rboe.2015.01.008 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/67/87/main.PMC4519640.pdf
http://dx.doi.org/10.1016/j.rboe.2015.02.013 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/4e/63/main.PMC4519641.pdf
http://dx.doi.org/10.1016/j.rboe.2015.05.002 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/91/4f/main.PMC4519642.pdf
http://dx.doi.org/10.1016/j.rboe.2015.02.015 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/6f/d3/main.PMC4519643.pdf
http://dx.doi.org/10.1016/j.rboe.2015.01.005 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/b3/80/main.PMC4519644.pdf
http://dx.doi.org/10.1016/j.rboe.2015.02.005 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/cc/b6/main.PMC4519645.pdf
Gilberto Luis  Camanho Revista Brasileira de  Ortopedia E-mail:  gilbertocamanho@uol.com.br Available online  21  February  2015 http://dx.doi.org/10.1016/j.rboe.2015.02.006 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/09/35/main.PMC4519646.pdf
http://dx.doi.org/10.1016/j.rboe.2015.03.008 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/8b/0c/main.PMC4519647.pdf
http://dx.doi.org/10.1016/j.rboe.2015.02.004 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/a8/8f/main.PMC4519648.pdf
http://dx.doi.org/10.1016/j.rboe.2015.03.007 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/0e/ba/main.PMC4519649.pdf
http://dx.doi.org/10.1016/j.rboe.2015.04.006 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/22/2d/main.PMC4519650.pdf
http://dx.doi.org/10.1016/j.rboe.2015.04.002 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/bf/2a/main.PMC4519651.pdf
http://dx.doi.org/10.1016/j.rboe.2015.04.005 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/17/65/main.PMC4519653.pdf
http://dx.doi.org/10.1016/j.rboe.2015.05.007 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/ed/6d/main.PMC4519659.pdf
http://dx.doi.org/10.1016/j.rboe.2015.06.001 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/24/ad/main.PMC4519660.pdf
http://dx.doi.org/10.1016/j.rboe.2015.05.003 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/a5/c1/main.PMC4519661.pdf
http://dx.doi.org/10.1016/j.rboe.2015.06.002 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/12/ff/main.PMC4519662.pdf
http://dx.doi.org/10.1016/j.rboe.2015.04.003 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/8b/d7/main.PMC4519663.pdf
http://dx.doi.org/10.1016/j.rboe.2015.05.004 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/4a/d6/main.PMC4519664.pdf
http://dx.doi.org/10.1016/j.rboe.2015.06.003 2255-4971/©  2015  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/cc/f0/main.PMC4519665.pdf
http://dx.doi.org/10.1016/j.rboe.2015.04.004 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/3c/ce/main.PMC4519666.pdf
http://dx.doi.org/10.1016/j.rboe.2015.04.008 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/e0/1a/main.PMC4519667.pdf
http://dx.doi.org/10.1016/j.rboe.2015.06.004 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/ea/6f/main.PMC4519668.pdf
http://dx.doi.org/10.1016/j.rboe.2015.05.001 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/9d/c2/main.PMC4519669.pdf
http://dx.doi.org/10.1016/j.rboe.2015.06.005 2255-4971/©  2014  Sociedade  Brasileira  de  Ortopedia  e  Traumatologia.,Non-OADS,/arxiv_data1/oa_pdf/1e/85/main.PMC4519670.pdf
"Access  to  the  electronic journal is  available  through  ScienceDirect,  on  the  website http://www.sciencedirect.com/Science/journal/aip/01023616 .",Non-OADS,/arxiv_data1/oa_pdf/73/07/main.PMC4519679.pdf
http://dx.doi.org/10.1016/j.rboe.2015.05.005,OADS,/arxiv_data1/oa_pdf/73/07/main.PMC4519679.pdf
"Brief  considerations  about  performance  status and functional  status Performance  status  –  assessed  by  KPS  and/or  by  ECOG  (Table  2) – is  the  traditional  method  applied  by  hematologists  to http://dx.doi.org/10.1016/j.bjhh.2015.03.007 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/33/45/main.PMC4519698.pdf
http://dx.doi.org/10.1016/j.bjhh.2015.02.009,OADS,/arxiv_data1/oa_pdf/d1/38/main.PMC4519699.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.03.002 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/96/77/main.PMC4519700.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.03.005 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/58/1b/main.PMC4519701.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.05.003 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/0a/b9/main.PMC4519702.pdf
"Strategies  to  reduce  the  risk  of  platelet-associated HTRs  include  volume  reduction  of  platelets  and  screening donor plasma  for  high  titers  of  antibodies  by  performing  anti- A  and/or  anti-B  titration  or  assays  for  in  vitro  hemolysis.1 Methods currently employed  to  identify  high  titers  of  anti- A  and/or  anti-B  antibodies  include  titration  by  the  saline agglutination  test,  with  and  without  incubation,  gel  test, DOI  of  original  article:  http://dx.doi.org/10.1016/j.bjhh.2015.05.001 .",Non-OADS,/arxiv_data1/oa_pdf/8f/47/main.PMC4519703.pdf
"Regulatory agencies  require  that  blood  banks  have  a  policy to  prevent  HTRs  due  to  plasma-incompatible  platelet  trans- fusions  but  the  choice  of  the  best  approach  to  predict  HTRs http://dx.doi.org/10.1016/j.bjhh.2015.04.002 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/8f/47/main.PMC4519703.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.03.017 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/82/9b/main.PMC4519704.pdf
"The  corticoid  dose  was  reduced  after  monitoring http://dx.doi.org/10.1016/j.bjhh.2015.05.002 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/86/c9/main.PMC4519705.pdf
"PHC http://dx.doi.org/10.1016/j.bjhh.2015.03.016 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/bb/9f/main.PMC4519706.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.05.004 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/16/78/main.PMC4519707.pdf
"However,  these  cultures  may take four  to  six  weeks  to  grow  and  their  sensitivity  depends on  the  disease  load.5 http://dx.doi.org/10.1016/j.bjhh.2015.03.006 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/3a/68/main.PMC4519708.pdf
Available  from: http://www.uptodate.com  [10.06.13].,Non-OADS,/arxiv_data1/oa_pdf/3a/68/main.PMC4519708.pdf
"These  patients  are  commonly  examined http://dx.doi.org/10.1016/j.bjhh.2015.04.003 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/26/9e/main.PMC4519709.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.03.009 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/9a/17/main.PMC4519710.pdf
Available  from: http://web.mit.edu/r  v3.0.1/fullrefman.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/9a/17/main.PMC4519710.pdf
"MDS  is  relatively  common  with  a  reported incidence  of  3.5–4.9  per  100,000  people.1The  incidence increases  to  28–36  per  100,000  in  over  80-year-old  individuals, making it  as  common  as  myeloma  in  this  age  group.2Red blood cell  (RBC)  transfusions  comprise  the  most  effective http://dx.doi.org/10.1016/j.bjhh.2015.03.014 1516-8484/©  2014  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/e6/5f/main.PMC4519711.pdf
http://dx.doi.org/10.1371/journal .pone.0012474 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6c/zcd957.PMC4519725.pdf
http://dx.doi.org/10.1371/journal.pone .0095612 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6c/zcd957.PMC4519725.pdf
http://dx.doi.org/10.1128/JCM.00229-11 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6c/zcd957.PMC4519725.pdf
Inﬂuenza Other Respir Viruses http://dx.doi.org/10.1111/j.1750 -2659.2012.0370a.x .,Non-OADS,/arxiv_data1/oa_pdf/4a/6c/zcd957.PMC4519725.pdf
InﬂuenzaOther Respir Viruses http://dx.doi.org/10.1111/irv.12068 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6c/zcd957.PMC4519725.pdf
Future Medicine Ltd http://dx.doi.org /10.2217/ebo.13.504 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6c/zcd957.PMC4519725.pdf
http://www.who.int/inﬂuenza/gisrs_laboratory/manual_diagnosis_surveillance_inﬂuenza/en/ .,Non-OADS,/arxiv_data1/oa_pdf/4a/6c/zcd957.PMC4519725.pdf
Vaccine 25:4056 – 4063. http://dx.doi.org/10.1016/j.vaccine.2007.02.039 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6c/zcd957.PMC4519725.pdf
Emerg Infect Dis 15:1250 – 1259. http://dx.doi.org/10.3201/eid1508.081754 .,Non-OADS,/arxiv_data1/oa_pdf/4a/6c/zcd957.PMC4519725.pdf
http://dx.doi.org/10.1016/0264-410X(94)90056-6 .,OADS,/arxiv_data1/oa_pdf/4a/6c/zcd957.PMC4519725.pdf
"http://dx.doi.org/10 .1016/j.vaccine.2011.11.019 .16.Tannock GA, Paul JA, Herd R, Barry RD, Reid AL, Hensley MJ, Gillett RS, Gillett SM, Lawrance P, Henry RL, Saunders NA.",OADS,/arxiv_data1/oa_pdf/4a/6c/zcd957.PMC4519725.pdf
contributed equally to this article.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /EC.00064-15 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Separation between WGD and small-scale duplications pre-WGD (SSD*) and post-WGD (SSD) was based on the information in the Yeast Gene Order Browser(YGOB; http://ygob.ucd.ie/ )(119).,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
The sequence data generated in this study are searchable at NCBI–Entrez ( http://www.ncbi.nlm.nih .gov/ ) under Bioproject PRJNA269221.,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Nat Rev Genet 11:97– 108. http://dx.doi.org/10.1038/nrg2689 .2.Ohno S. 1970.,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1016/S0169-5347(03)000 33-8 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org /10.1038/42711 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Na- ture428:617– 624. http://dx.doi.org/10.1038/nature02424 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1371/journal.pgen.1000113 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Nat Genet 40:676 – 681. http://dx.doi.org/10.1038/ng.123 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1101 /gr.076174.108 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi .org/10.1038/nrg2482 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Res Microbiol 147:448 – 455. http://dx.doi.org/10.1016 /0923-2508(96)83998-2 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1016/0079 -6107(93)90001-Z .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1042/0264-6021:3430115 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
BMC Biol 4:16. http://dx.doi.org/10.1186/1741 -7007-4-16 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
FEMS Yeast Res 14:826 – 832. http://dx.doi.org/10.1111/1567-1364.12161 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1007/BF00871229 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Nature421:63– 66. http://dx.doi.org/10.1038/nature01198 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1371/journal.pgen.1000485 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1111/j.1742-4658.2007.05645.x .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Mol Syst Biol 3:129. http://dx.doi .org/10.1038/msb4100170 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Proc Biol Sci 271:89 – 96. http://dx.doi.org/10.1098/rspb.2003.2560 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1016/j.pbi.2012.01.003 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org /10.1371/journal.pgen.1000014 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1016/j.cell.2009.01 .027.,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1038 /40618 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1371 /journal.pbio.1000347 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Nature 477:471– 476. http://dx.doi.org/10 .1038/nature10403 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1046/j.1432-1327 .2000.01527.x .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
FEBS Lett 587:2832– 2841. http://dx.doi.org/10.1016/j.febslet.2013.06.043 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
J Bacteriol 186: 595– 600. http://dx.doi .org/10.1128/JB.186.3.595-600.2004 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Mi- crob Cell Fact 11:36. http://dx.doi.org/10.1186/1475-2859-11-36 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1016/S0141-0229(00)00162-9 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org /10.1093/nar/30.6.e23 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Nucleic Acids Res 15:8573– 8573. http://dx.doi.org/10 .1093/nar/15.20.8573 .Solis-Escalante et al.,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1002/yea .320101310 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1093/nar/24.13 .2519 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1016/j.ymben.2011.06.001 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1016/0378-1119(83)90223-8 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1534 /genetics.112.541.test .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Yeast 23:399 – 405. http://dx.doi.org/10.1002/yea.1365 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1111/1567-1364.12024 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Yeast 8:501– 517. http://dx.doi.org/10.1002/yea.320080703 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10 .1128/AEM.68.5.2095-2100.2002 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
BMC Syst Biol 6:151. http://dx.doi.org/10.1186/1752-0509-6 -151 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1002/bit.10054 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1007/s11306-008 -0116-4 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1016/j.ab.2004.09.001 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1016/j.jchromb .2009.07.019 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1016/S0003-2670(02)00240-4 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1016/j.ymben.2013 .11.005 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1074/jbc.M204490200 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi .org/10.1093/bioinformatics/btp698 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1128/MMBR.00036-07 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
BMC Genomics 10:53. http://dx.doi.org/10.1186/1471-2164-10-53 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1074/jbc.M600911200 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1042 /BJ20100663 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1111/j .1432-1033.1977.tb11954.x .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Mol Gen Genet 195:530 – 535. http://dx.doi.org/10.1007/BF00341458 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1021/bi0 0537a037 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
J Bacteriol 182:4730 – 4737. http://dx.doi.org/10.1128/JB.182.17.4730-4737.2000 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1111/j .1567-1364.2011.00775.x .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Mol Cell52:485– 494. http://dx.doi.org/10.1016/j.molcel.2013.09.026 .Yeast Minimal Glycolysis August 2015 Volume 14 Number 8 ec.asm.org 815 Eukaryotic Cell,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1074/jbc.M610845200 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
FEMS Yeast Res 12:33– 47. http://dx.doi.org/10.1111 /j.1567-1364.2011.00760.x .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Cell Metab 14:415– 427. http://dx.doi.org/10.1016/j .cmet.2011.06.017 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1016/j.yexcr .2012.03.019 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org /10.1111/j.1567-1364.2009.00530.x .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1016/j.tibs.2005 .01.005 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1128/MMBR.70.1.177-191.2006 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1074 /jbc.M209759200 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1093/nar/gkq257 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1016/S1097-2765(02)00500-2 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Maintenance of duplicate genes and their functional redundancy by reduced expression.Trends Genet 26:425– 430. http://dx.doi.org/10.1016/j.tig.2010.07.002 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
J Gen Microbiol 136:395– 403. http://dx.doi.org/10.1099 /00221287-136-3-395 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1007/s00018-012-0945-1 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Microbiol Mol Biol Rev 72:379 – 412. http://dx.doi.org/10 .1128/MMBR.00025-07 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1093 /femsyr/fov009 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1016/j.ymben.2010.08 .003.104.,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Eur J Biochem 188:615– 621. http://dx.doi.org/10.1111/j.1432 -1033.1990.tb15442.x .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Nucleic Acids Res 41:4336 – 4343. http://dx.doi.org/10.1093/nar /gkt135 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1016/S0014-5793(99)01698-1 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1371 /journal.pgen.1003587 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1007/s00253 -013-5225-y .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
Plant Physiol 133:182– 190. http://dx.doi.org/10.1104/pp.103.026674 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1038/nature05364 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10 .1128/EC.00028-08 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi .org/10.1128/AEM.02651-10 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
FEMS Yeast Res5:419 – 430. http://dx.doi.org/10.1016/j.femsyr.2004.11.008 .,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10 .1101/gr.3672305 .,Non-OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
http://dx.doi.org/10.1093/femsyr/fou004 .Solis-Escalante et al.,OADS,/arxiv_data1/oa_pdf/43/8e/zek804.PMC4519752.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contents  lists  available  at  ScienceDirect Photoacoustics jo  ur  n  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/pac  s http://dx.doi.org/10.1016/j.pacs.2015.02.003 2213-5979/ /C223  2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/9b/main.PMC4519804.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6c/9b/main.PMC4519804.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/31/main.PMC4519806.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/71/31/main.PMC4519806.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/9f/main.PMC4519807.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/57/9f/main.PMC4519807.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/b0/main.PMC4519808.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/9f/b0/main.PMC4519808.pdf
"http://dx.doi.org/10.1016/j.bjhh.2015.05.001 1516-8484/©  2015  Associac ¸ã o  Brasileira  de  Hematologia,  Hemoterapia  e  Terapia  Celular.",Non-OADS,/arxiv_data1/oa_pdf/12/5a/main.PMC4519819.pdf
"For TACC1 cloning, the above primers were designed based upon the TACC1 annotated sequence from the laevis genome v6.0 gene model (http://www.xen- base.org).",OADS,/arxiv_data1/oa_pdf/be/db/CM-72-225.PMC4520305.pdf
MJP Online Early; available at: http://www.mjpsychiatry.org/index.php/mjp/article/ view/143 (access: 2013.10.20).,Non-OADS,/arxiv_data1/oa_pdf/cb/8b/MR-13-22410.PMC4520331.pdf
"Relacja z Europejskiego Kongresu Osteoporozy i Osteoartrozy, Rzym 17–20 kwiecień 2013; http://www.naukawpolsce.pap.pl (access: 10.06.2013).",Non-OADS,/arxiv_data1/oa_pdf/da/de/MR-13-22417.PMC4520338.pdf
2013; http://dx.doi.org/10.1155/2013/851815.,Non-OADS,/arxiv_data1/oa_pdf/f2/06/MR-13-22418.PMC4520339.pdf
American Brachytherapy Society  Breast Brachytherapy Task Group; http://www.americanbrachytherapy.,Non-OADS,/arxiv_data1/oa_pdf/4f/1b/MR-13-22420.PMC4520341.pdf
http://www.onkologia.org.pl.,Non-OADS,/arxiv_data1/oa_pdf/6c/5e/MR-13-22739.PMC4520346.pdf
"IARC,  Lyon 2008; http://globocan.iarc.fr/ 4.",Non-OADS,/arxiv_data1/oa_pdf/cd/40/MR-13-22743.PMC4520350.pdf
70. http://www.mitomap.org/pub/MITOMAP/MitomapFigures/mitomapge- nome.pdf 71.,OADS,/arxiv_data1/oa_pdf/65/a1/MR-13-22746.PMC4520353.pdf
We determined IC50 parameter using a computer  program ED50plus v1.0 (http://www.free-downloads-center.com/download/ed50plus-v1-0-2434.html).,OADS,/arxiv_data1/oa_pdf/aa/6a/MR-13-23056.PMC4520357.pdf
Założenia i cele operacyjne 2006-2015; available at: http://www.mz.gov.pl/wwwfiles/ma_ struktura/docs/zalozenia_ustawy_o_npzchn.pdf (access: 2013.11.30).,Non-OADS,/arxiv_data1/oa_pdf/a6/64/MR-13-23060.PMC4520360.pdf
Zakład Epidemiologii i  Prewencji Nowotworów;  http://epoid.coi.waw.pl/krn 2.,Non-OADS,/arxiv_data1/oa_pdf/59/46/MR-13-23061.PMC4520361.pdf
References 1. http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Causes_ of_death_statistics/pl (dostęp 05.11.2014 r.)2.,Non-OADS,/arxiv_data1/oa_pdf/c7/ed/KITP-12-24931.PMC4520503.pdf
"This is an Open Access articledistributed under the terms of theCreative Commons Attribution-NonCommercial-NoDerivs licence(http://creativecommons.org/licenses/by-nc-nd/4.0/), whichpermits non-commercialreproduction and distribution ofthe work, in any medium, providedthe original work is not altered ortransformed in any way, and thatthe work is properly cited.DOI: 10.1093/asj/sjv035 www.aestheticsurgeryjournal.com",Non-OADS,/arxiv_data1/oa_pdf/47/b0/sjv035.PMC4520583.pdf
"Tel: +44 1304 648044; E-mail: Katrina.Gore@Pﬁzer.com Received: 11 June 2015; Accepted: 12 June 2015 Pharma Res Per, 3(4), 2015, e00162, doi: 10.1002/prp2.162 doi: 10.1002/prp2.162 The article originated from discussions emanating from the Pharmacology 2014 meeting on London (December 2014) at which Pharmacology Research and Perspectives hosted a symposium on replication in research http://www.bps.ac.uk/ SpringboardWebApp/userﬁles/bps/ﬁle/ Meetings/meetings%202014/Pharmacology% 202014/Pharmacology% 202014_Reduced.pdf.Abstract Numerous articles in Nature, Science, Pharmacology Research and Perspectives, and other biomedical research journals over the past decade have highlighted that research is plagued by ﬁndings that are not reliable and cannot be repro- duced.",Non-OADS,/arxiv_data1/oa_pdf/56/8b/prp20003-e00162.PMC4520620.pdf
That paper contained acase study of its use and was a highlighted publication onthe National Centre for the 3Rs September e-newsletter(http://www.nc3rs.org.uk/nc3rs-e-newsletter-september-2014).,Non-OADS,/arxiv_data1/oa_pdf/56/8b/prp20003-e00162.PMC4520620.pdf
"Received: 10 June 2015; Accepted: 12 June 2015 Pharma Res Per, 3(4), 2015, e00163, doi: 10.1002/prp2.163 doi: 10.1002/prp2.163 The article originated from discussions emanating from the Pharmacology 2014 meeting in London (December 2014) at which Pharmacology Research and Perspectives hosted a symposium on replication in research http://www.bps.ac.uk/ SpringboardWebApp/userﬁles/bps/ﬁle/ Meetings/meetings%202014/Pharmacology% 202014/Pharmacology% 202014_Reduced.pdfAbstract Drug discovery productivity has failed to improve markedly in recent years and a key issue is high attrition due to efﬁcacy failures in initial proof-of concept clinical studies.",Non-OADS,/arxiv_data1/oa_pdf/2e/ef/prp20003-e00163.PMC4520621.pdf
"They have published on their web-site (http://www.mpip-initiative.org/) ten recommenda- tions of which the second was ‘Make public all results, including negative or unfavorable ones , in a timely fashion, while avoiding redundancy’.",Non-OADS,/arxiv_data1/oa_pdf/2e/ef/prp20003-e00163.PMC4520621.pdf
"Tel: +44 (0) 20 71991085; Fax: +44(0)2071883902; E-mail: michael.curtis@kcl.ac.uk Received: 10 June 2015; Accepted: 12 June 2015 Pharma Res Per, 3(4), 2015, e00164, doi: 10.1002/prp2.164 doi: 10.1002/prp2.164 The article originated from discussions emanating from the Pharmacology 2014 meeting on London (December 2014) at which Pharmacology Research and Perspectives hosted a symposium on replication in research http://www.bps.ac.uk/ SpringboardWebApp/userﬁles/bps/ﬁle/ Meetings/meetings%202014/Pharmacology% 202014/Pharmacology% 202014_Reduced.pdf.Abstract The pharmacology research sector is changing to accommodate a need for greater transparency and better standards.",Non-OADS,/arxiv_data1/oa_pdf/99/68/prp20003-e00164.PMC4520622.pdf
"As we argued recently (https://youtu.be/IS8NY6Hx- hAQ), data that falsify a hypothesis may be of greatervalue than data that supports a hypothesis, and this needsto be recognized and embraced.",Non-OADS,/arxiv_data1/oa_pdf/99/68/prp20003-e00164.PMC4520622.pdf
doi: 10.1038/news041004-19 Available at http://www.nature.com/news/2004/041004/full/ news041004-19.html.,Non-OADS,/arxiv_data1/oa_pdf/99/68/prp20003-e00164.PMC4520622.pdf
Available from URL: http://ganjoho.ncc.go.jp/professional/statistics/index.html 2 Oshima A.,OADS,/arxiv_data1/oa_pdf/27/7a/cas0106-0812.PMC4520631.pdf
"rithm (http://www.abgent.com.cn/doc/sumoplot/login.asp) for the presence of consensus SUMOylation motifs revealed thatthree lysine residues (K167, K483 and K498) had a high prob- ability of being sites for SUMOylation (Fig.",OADS,/arxiv_data1/oa_pdf/3f/d6/cas0106-0848.PMC4520636.pdf
"2013/07/01 [cited 2013 September 19]; Available from URL: http://ganjoho.jp/pro/statis-tics/en/table_download.html 2 Siegel R, Naishadham D, Jemal A.",OADS,/arxiv_data1/oa_pdf/6f/4d/cas0106-0883.PMC4520640.pdf
"Available from URL: http://ganjoho.jp/pro/statistics/en/table_down- load.html 4 Berlin JD, Catalano P, Thomas JP, Kugler JW, Haller DG, Benson AB 3rd.",OADS,/arxiv_data1/oa_pdf/6f/4d/cas0106-0883.PMC4520640.pdf
Tumor Biol 2014; http://dx.doi.org/10.1007/s13277-014-2996-4.,Non-OADS,/arxiv_data1/oa_pdf/cd/cb/cas0106-0902.PMC4520643.pdf
These results indicate that comprehensive transcriptomic analysis with our data- base (http://scads.jfcr.or.jp/db/cs/) is a powerful strategy to validate and re-evalu- ate the target pathways of anticancer compounds.,OADS,/arxiv_data1/oa_pdf/6d/f0/cas0106-0909.PMC4520644.pdf
(10)The signature data will be released on our website (http://scads.jfcr.or.jp/db/cs/).,Non-OADS,/arxiv_data1/oa_pdf/6d/f0/cas0106-0909.PMC4520644.pdf
All analyses were carried out using the statistical programming language R version 2.15.0 (http:// www.r-project.org/) and Bioconductor version 2.10 (http://bio-conductor.org/).,OADS,/arxiv_data1/oa_pdf/6d/f0/cas0106-0909.PMC4520644.pdf
"To estimate the effect of cell type differ- ence on the gene expression analysis, we treated the cell lineswith SN38 and doxorubicin, and obtained gene expression data as reference data (the gene expression data will be released on our website, http://scads.jfcr.or.jp/db/cs/).",OADS,/arxiv_data1/oa_pdf/6d/f0/cas0106-0909.PMC4520644.pdf
Connectivity map (C-map)(https://www.broadinstitute.org/cmap/) is a pioneering database that contains genome-wide transcriptome data for more than 1000 compounds.,OADS,/arxiv_data1/oa_pdf/6d/f0/cas0106-0909.PMC4520644.pdf
"(9)In addition, several other databases con- taining drug-related gene expression data have recently beenestablished, such as the Library of Integrated Cellular Signa- tures (http://www.lincsproject.org/) and the Cancer Cell Line Encyclopedia (https://www.broadinstitute.org/ccle/home).",Non-OADS,/arxiv_data1/oa_pdf/6d/f0/cas0106-0909.PMC4520644.pdf
Ourwebsite (http://scads.jfcr.or.jp/db/cs/) also provides an onlineanalysis tool for users to easily compare the gene signature of query compounds to those in our database.,OADS,/arxiv_data1/oa_pdf/6d/f0/cas0106-0909.PMC4520644.pdf
(14)The BACs were selected based on their homology to locations in the human genome according tothe database provided by the University of California SantaCruz (http://genome.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/25/46/cas0106-0929.PMC4520646.pdf
"To determine if EVI1 expression might be associated with alterations in genes of the TGF- bsignaling pathway in the HCC cell lines that we used, we searched the Catalogue Of Somatic Mutations In Cancer database (http://cancer.san- ger.ac.uk/cancergenome/projects/cosmic/) for mutations in suchgenes.",OADS,/arxiv_data1/oa_pdf/25/46/cas0106-0929.PMC4520646.pdf
"The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/ .Non- commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is  properly attributed.",Non-OADS,/arxiv_data1/oa_pdf/1f/d5/nihms709018.PMC4520704.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.php Correspondence: Christine A Pellegrini, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine,  680 N Lakeshore Drive, Suite 1400, Chicago, IL, 60611, USA, Tel +1 312 503 1395, Fax +1 312 908 9588, c- pellegrini@northwestern.edu.",Non-OADS,/arxiv_data1/oa_pdf/1f/d5/nihms709018.PMC4520704.pdf
"Acknowledgments This work was supported by NIDDK R01 DK097364, NHLBI R01 HL075451, and by grant U54EB020404  awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) through funds provided by  the trans-NIH Big Data to Knowledge (BD2K) initiative ( http://www.bd2k.nih.gov ).",Non-OADS,/arxiv_data1/oa_pdf/1f/d5/nihms709018.PMC4520704.pdf
"[homepage on the Internet]Available from: http://www.pewinternet.org/2015/04/01/us- smartphone-use-in-2015/  [Accessed June 11, 2015] 12.",Non-OADS,/arxiv_data1/oa_pdf/1f/d5/nihms709018.PMC4520704.pdf
"Available from: https://www.citrix.com/ content/dam/citrix/en_us/documents/products-solutions/citrix-mobile-analytics-report- february-2015.pdf  [Accessed June 11, 2015] 13.",OADS,/arxiv_data1/oa_pdf/1f/d5/nihms709018.PMC4520704.pdf
"[homepage on the Internet]Available from: http://www.pewinternet.org/2012/11/08/mobile- health-2012/  [Accessed June 11, 2015] 20.",Non-OADS,/arxiv_data1/oa_pdf/1f/d5/nihms709018.PMC4520704.pdf
Available from:  http://www.usrds.org/adr.aspx.,Non-OADS,/arxiv_data1/oa_pdf/20/00/pdi_35_4_006.PMC4520723.pdf
Available from: https://secure.cihi.ca/free_products/2011_ CORR_Annua_Report_EN.pdf.,OADS,/arxiv_data1/oa_pdf/20/00/pdi_35_4_006.PMC4520723.pdf
Available from:  http://orp.renalnetwork.on.ca/common/pages/UserFile.,OADS,/arxiv_data1/oa_pdf/20/00/pdi_35_4_006.PMC4520723.pdf
Available from:  http://www.jstz.lss.gov.cn.,Non-OADS,/arxiv_data1/oa_pdf/20/00/pdi_35_4_006.PMC4520723.pdf
Available from: http://www.chinabiotoday.,Non-OADS,/arxiv_data1/oa_pdf/20/00/pdi_35_4_006.PMC4520723.pdf
Available from: http://www.gov.cn/ gzdt/2011-06/13/content_1882823.htm.,Non-OADS,/arxiv_data1/oa_pdf/20/00/pdi_35_4_006.PMC4520723.pdf
Available from: http://www3.inegi.org.mx/ sistemas/mexicocifras.,Non-OADS,/arxiv_data1/oa_pdf/20/00/pdi_35_4_006.PMC4520723.pdf
Available from: http://pandora.nla.,Non-OADS,/arxiv_data1/oa_pdf/20/00/pdi_35_4_006.PMC4520723.pdf
Available from: http://pandora.nla.gov.au/ pan/108521/20091015-1137/www.health.qld.gov.au/ publications/qh_plans/QS_renal_plan_part1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/20/00/pdi_35_4_006.PMC4520723.pdf
Available from:  http://www.federalfinancialrelations.gov.au/content/ npa/healthcare/national-agreement-superseded-Jul12.,Non-OADS,/arxiv_data1/oa_pdf/20/00/pdi_35_4_006.PMC4520723.pdf
Available from: http://www.aci.health.,Non-OADS,/arxiv_data1/oa_pdf/20/00/pdi_35_4_006.PMC4520723.pdf
Available from:  http://www.who.int/whr/2010/en/index.html.,OADS,/arxiv_data1/oa_pdf/20/00/pdi_35_4_006.PMC4520723.pdf
Available from:   http://guidance.nice.org.uk/CG125/NICEGuidance/pdf/ English.,Non-OADS,/arxiv_data1/oa_pdf/20/00/pdi_35_4_006.PMC4520723.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/20/00/pdi_35_4_006.PMC4520723.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/gutjnl-2014-308653).,Non-OADS,/arxiv_data1/oa_pdf/fd/85/gutjnl-2014-308653.PMC4520782.pdf
"Correspondence to Dr Michael Goggins, JohnsHopkins Medical Institutions, Department of Pathology, 1550 Orleans Street,Baltimore, MD 21231, USA;mgoggins@jhmi.edu Received 16 October 2014 Revised 26 November 2014Accepted 19 December 2014Published Online First 30 January 2015 ▸http://dx.doi.org/10.1136/ gutjnl-2014-309066 To cite: Yu J, Blackford AL, dal Molin M, et al.Gut 2015; 64:1783–1789.ABSTRACT Objective Although pancreatic ductal adenocarcinoma is considered a rapidly progressive disease, mathematicalmodels estimate that it takes many years for an initiatingpancreatic cancer cell to grow into an advanced stagecancer.",Non-OADS,/arxiv_data1/oa_pdf/fd/85/gutjnl-2014-308653.PMC4520782.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Canto MI, Hruban RH, Fishman EK, et al.",Non-OADS,/arxiv_data1/oa_pdf/fd/85/gutjnl-2014-308653.PMC4520782.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(4):213-219   http://dx.doi.org/10.3341/kjo.2015.29.4.213 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.213 Original ArticleClinical Association of Thyroid Stimulating Hormone Receptor  Antibody Levels with Disease Severity in the Chronic Inactive Stage  of Graves’ Orbitopathy Young Jae Woo1, Sun Young Jang2, Tyler Hyung Taek Lim1, Jin Sook Yoon1 1Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea 2Department of Ophthalmology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea Purpose : To investigate associations between serum thyroid stimulating hormone (TSH) receptor antibody  (TRAb) levels and Graves’ orbitopathy (GO) activity/severity in chronic-stage GO and compare the perfor - mance of two newly-developed TRAb assays (third-generation TSH-binding inhibition immunoglobulin [TBII]  assay versus Mc4 thyroid-stimulating immunoglobulin [TSI] bioassay).",Non-OADS,/arxiv_data1/oa_pdf/f1/52/kjo-29-213.PMC4520863.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(4):220-225 http://dx.doi.org/10.3341/kjo.2015.29.4.220 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.220 Original ArticleEvaluation of Anterior Segment Parameters in Obesity Alime Gunes1, Feyzahan Uzun2, Emine Esra Karaca³, Mustafa Kalaycı4 1Department of Ophthalmology, Süleyman Demirel University Medical School, Isparta, Turkey 2Department of Ophthalmology, Recep Tayyip Erdoğan University Medical School, Rize, Turkey 3Department of Ophthalmology, Sorgun State Hospital, Yozgat, Turkey 4Department of Ophthalmology, Gazipasa State Hospital, Antalya, Turkey Purpose:  To investigate anterior segment parameters in obese patients in comparison to healthy individuals.",Non-OADS,/arxiv_data1/oa_pdf/0e/db/kjo-29-220.PMC4520864.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(4):226-232   http://dx.doi.org/10.3341/kjo.2015.29.4.226 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.226 Original ArticleAflibercept Treatment for Neovascular Age-related Macular  Degeneration and Polypoidal Choroidal Vasculopathy Refractory to  Anti-vascular Endothelial Growth Factor Da Ru Chi Moon, Dong Kyu Lee, Soon Hyun Kim, Yong Sung You, Oh Woong Kwon Retina Center, Nune Eye Hospital, Seoul, Korea Purpose:  To report the results of switching treatment to vascular endothelial growth factor (VEGF) Trap-Eye  (aflibercept) in neovascular age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy  (PCV) refractory to anti-VEGF (ranibizumab and bevacizumab).",Non-OADS,/arxiv_data1/oa_pdf/24/e8/kjo-29-226.PMC4520865.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(4):233-240 http://dx.doi.org/10.3341/kjo.2015.29.4.233 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.233 Original ArticleIatrogenic Central Retinal Artery Occlusion Following Retrobulbar  Anesthesia for Intraocular Surgery Eun Hye Jung1, Kyu Hyung Park2, Se Joon Woo2 1Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea 2Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea Purpose : To present clinical features of central retinal artery occlusion (CRAO) following retrobulbar anesthesia  for intraocular surgery.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/kjo-29-233.PMC4520866.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(4):241-248 http://dx.doi.org/10.3341/kjo.2015.29.4.241 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.241 Original ArticleOcular Manifestations of Acquired Immunodeficiency Syndrome Young Shin Kim1, Hae Jung Sun1, Tae Hyong Kim2, Kui Dong Kang3, Sung Jin Lee1 1Department of Ophthalmology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea 2Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea 3Department of Ophthalmology, Incheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Incheon, Korea Purpose:  To investigate the patterns and risk factors of the ocular manifestations of acquired immunodeficiency  syndrome (AIDS) and their correlation with CD4+ count in the era of highly active antiretroviral therapy (HAART).",Non-OADS,/arxiv_data1/oa_pdf/6d/ef/kjo-29-241.PMC4520867.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(4):249-255 http://dx.doi.org/10.3341/kjo.2015.29.4.249 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.249 Original ArticleA Family with Axenfeld-Rieger Syndrome: Report of the Clinical and  Genetic Findings Hee Jung Yang1, You Kyung Lee1, Choun-Ki Joo1, Jung Il Moon1, Jee Won Mok2, Myoung Hee Park1 1Department of Ophthalmology, The Catholic University of Korea College of Medicine,  Seoul, Korea 2Catholic Institute for Visual Science, Department of Ophthalmology and Visual Science, Seoul St. Mary’s Hospital, The Catholic  University of Korea College of Medicine, Seoul, Korea Purpose:  To describe clinical findings in a Korean family with Axenfeld-Rieger syndrome.",Non-OADS,/arxiv_data1/oa_pdf/a8/d9/kjo-29-249.PMC4520868.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(4):256-262 http://dx.doi.org/10.3341/kjo.2015.29.4.256 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.256 Original ArticleOcular Manifestations of Venomous Snake Bite over a One-year  Period in a Tertiary Care Hospital Praveen Kumar K V, Praveen Kumar S, Nirupama Kasturi, Shashi Ahuja Department of Ophthalmology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India Purpose:  Ocular manifestations in snake-bite injuries are quite rare.",Non-OADS,/arxiv_data1/oa_pdf/be/f8/kjo-29-256.PMC4520869.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(4):263-269 http://dx.doi.org/10.3341/kjo.2015.29.4.263 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.263 Original ArticleRelationship between Peripapillary Retinal Nerve Fiber Layer  Thickness Measured by Optical Coherence Tomography and Visual  Field Severity Indices Eun Min Kang, Samin Hong, Chan Yun Kim, Gong Je Seong Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea Purpose : Though there are many reports regarding the structure-function relationship in glaucoma, they are too  complicated to apply to the routine clinical setting.",Non-OADS,/arxiv_data1/oa_pdf/a0/08/kjo-29-263.PMC4520870.pdf
Stei - ger’s Z-test was computed using the FZT Computator  (http://psych.unl.edu/psycrs/statpage/regression.html) and  the corrected Akaike’s information criteria (AIC) was cal - culated using QuickCalcs (http://www.graphpad.com/ quickcalcs/AIC1.cfm).,OADS,/arxiv_data1/oa_pdf/a0/08/kjo-29-263.PMC4520870.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(4):270-279 http://dx.doi.org/10.3341/kjo.2015.29.4.270 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.270 Original ArticleIn Vivo  Effects of Preservative-free and Preserved Prostaglandin  Analogs: Mouse Ocular Surface Study Jee Hyun Kim1, Eun Joo Kim1, Yeoun-Hee Kim1, Yong Il Kim1, Se-Hyung Lee2, Jae-Chang Jung2, Kyoo Won Lee1,  Young Jeung Park1 1Cheil Eye Research Institute, Cheil Eye Hospital, Daegu, Korea 2Developmental Biology Laboratory, Department of Biology, College of Natural Sciences, Kyungpook National University, Daegu, Korea Purpose:  Chronic use of topical hypotensive agents induces several side effects caused by preservatives.",Non-OADS,/arxiv_data1/oa_pdf/e1/b2/kjo-29-270.PMC4520871.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.280Uveal Melanoma with Massive Ex - traocular Extension through the  Sclerocorneal Limbus Dear Editor,  A 52-year-old male was referred to our institution be - cause of an intraocular mass in his right eye.",Non-OADS,/arxiv_data1/oa_pdf/d7/22/kjo-29-280.PMC4520872.pdf
"The 5-year  survival rate was 22%, which is significantly lower than Korean J Ophthalmol 2015;29(4):280-281 http://dx.doi.org/10.3341/kjo.2015.29.4.280Correspondence  A CB D Fig.",Non-OADS,/arxiv_data1/oa_pdf/d7/22/kjo-29-280.PMC4520872.pdf
OCT showed bright reflectivity of the anterior Korean J Ophthalmol 2015;29(4):282-283 http://dx.doi.org/10.3341/kjo.2015.29.4.282 Fig.,OADS,/arxiv_data1/oa_pdf/14/83/kjo-29-282.PMC4520873.pdf
"ReviewISSN 1738-5997(Print) • ISSN 2092-9935(Online) Electrolyte Blood Press 13:1-6, 2015  http://dx.doi.org/10.5049/EBP.2015.13.1.1 Copyright © 2015 The Korean Society of Electrolyte MetabolismA Minireview on Vasopressin-regulated Aquaporin-2 in Kidney Collecting Duct Cells Eui-Jung Park, MSc.",Non-OADS,/arxiv_data1/oa_pdf/dc/13/ebp-13-1.PMC4520882.pdf
"Electrolyte Blood Press 13:1-6, 2015 • http://Dx.Doi.Org/10.5049/Ebp.2015.13.1.1 3 Copyright © 2015 The Korean Society of Electrolyte MetabolismTable 1.",Non-OADS,/arxiv_data1/oa_pdf/dc/13/ebp-13-1.PMC4520882.pdf
"Electrolyte Blood Press 13:1-6, 2015 • http://Dx.Doi.Org/10.5049/Ebp.2015.13.1.1 5 Copyright © 2015 The Korean Society of Electrolyte Metabolismwater channel localization and regulation in rat kidney.",Non-OADS,/arxiv_data1/oa_pdf/dc/13/ebp-13-1.PMC4520882.pdf
"ReviewISSN 1738-5997(Print) • ISSN 2092-9935(Online) Electrolyte Blood Press 13:17-21, 2015  http://dx.doi.org/10.5049/EBP.2015.13.1.17 Copyright © 2015 The Korean Society of Electrolyte MetabolismLoop Diuretics in Clinical Practice Se Won Oh, M.D.",Non-OADS,/arxiv_data1/oa_pdf/35/09/ebp-13-17.PMC4520883.pdf
"Electrolyte Blood Press 13:17-21, 2015 • http://Dx.Doi.Org/10.5049/Ebp.2015.13.1.17 19 Copyright © 2015 The Korean Society of Electrolyte MetabolismmL/min/1.73 m2 because other diuretics, including thia- zide, are less effective in advanced CKD15).",Non-OADS,/arxiv_data1/oa_pdf/35/09/ebp-13-17.PMC4520883.pdf
"Electrolyte Blood Press 13:17-21, 2015 • http://Dx.Doi.Org/10.5049/Ebp.2015.13.1.17 21 Copyright © 2015 The Korean Society of Electrolyte Metabolismment of hypertension.",Non-OADS,/arxiv_data1/oa_pdf/35/09/ebp-13-17.PMC4520883.pdf
"Clinical ArticleISSN 1738-5997(Print) • ISSN 2092-9935(Online) Electrolyte Blood Press 13:22-29, 2015  http://dx.doi.org/10.5049/EBP.2015.13.1.22 Copyright © 2015 The Korean Society of Electrolyte MetabolismAbdominal Obesity and Mortality in Continuous  Ambulatory Peritoneal Dialysis Patients Haifeng Jin, M.D.1,  Jun Young Shin, M.D.2, Seung Ho Lee, M.D.2, Joon Ho Song, M.D.2, Moon-Jae Kim, M.D.2  and Seoung Woo Lee, M.D.2 1Division of Nephrology, Department of Internal  Medicine, Yanbian University Hospital, Yanji, Jilin Province, China,  2D i v i s i o n  o f  N e p h r o l o g y  a n d  H y p e r t e n s i o n ,   D e pa rtm e n t o f In te rn a l M e d icin e , In h a  Un ive rsity College of Medicine, Incheon, KoreaBackground:  The relationship between abdominal obesity (AO) and mortality in  peritoneal dialysis (PD) patients is controversial.",Non-OADS,/arxiv_data1/oa_pdf/58/b5/ebp-13-22.PMC4520884.pdf
"Electrolyte Blood Press 13:22-29, 2015 • http://Dx.Doi.Org/10.5049/Ebp.2015.13.1.22 23 Copyright © 2015 The Korean Society of Electrolyte Metabolismpatient PD clinic, Inha University Hospital in Incheon,  Korea.",Non-OADS,/arxiv_data1/oa_pdf/58/b5/ebp-13-22.PMC4520884.pdf
"Electrolyte Blood Press 13:22-29, 2015 • http://Dx.Doi.Org/10.5049/Ebp.2015.13.1.22 25 Copyright © 2015 The Korean Society of Electrolyte MetabolismTable 2.",Non-OADS,/arxiv_data1/oa_pdf/58/b5/ebp-13-22.PMC4520884.pdf
"Electrolyte Blood Press 13:22-29, 2015 • http://Dx.Doi.Org/10.5049/Ebp.2015.13.1.22 27 Copyright © 2015 The Korean Society of Electrolyte Metabolismthis, the subjects were cared for by the same nephrologists  for the follow-up period.",Non-OADS,/arxiv_data1/oa_pdf/58/b5/ebp-13-22.PMC4520884.pdf
"Electrolyte Blood Press 13:22-29, 2015 • http://Dx.Doi.Org/10.5049/Ebp.2015.13.1.22 29 Copyright © 2015 The Korean Society of Electrolyte MetabolismOreopoulos DG, Page D: Increased peritoneal membrane  transport is associated with decreased patient and techni-que survival for continuous peritoneal dialysis patients.",Non-OADS,/arxiv_data1/oa_pdf/58/b5/ebp-13-22.PMC4520884.pdf
"Case ReportISSN 1738-5997(Print) • ISSN 2092-9935(Online) Electrolyte Blood Press 13:30-36, 2015  http://dx.doi.org/10.5049/EBP.2015.13.1.30 Copyright © 2015 The Korean Society of Electrolyte MetabolismA Case of Osmotic Demyelination Presenting with  Severe Hypernatremia Min Jee Han, M.D.1, Do Hyoung Kim, M.D.2, Young Hwa Kim, M.D.2, In Mo Yang, M.D.2, Joon Hyung Park, M.D.2 and Moon Ki Hong, M.D.3 1Department of Internal Medicine, Chung-Ang  University Hospital, Chung-Ang University  College of Medicine, Seoul, 2D e p a r t m e n t  o f  I n t e r n a l  M e d i c i n e ,  I n c h e o n   Christian Hospital, Incheon, 3D e p a r t m e n t  o f  I n t e r n a l  M e d i c i n e ,  N a t i o n a l Rehabilitation Center, Seoul, KoreaOsmotic demyelination syndrome is a demyelinating disorder associated with  rapid correction of hyponatremia.",Non-OADS,/arxiv_data1/oa_pdf/0b/d8/ebp-13-30.PMC4520885.pdf
"Electrolyte Blood Press 13:30-34, 2015 • http://Dx.Doi.Org/10.5049/Ebp.2015.13.1.30 31 Copyright © 2015 The Korean Society of Electrolyte Metabolism Fig.",Non-OADS,/arxiv_data1/oa_pdf/0b/d8/ebp-13-30.PMC4520885.pdf
"Electrolyte Blood Press 13:30-34, 2015 • http://Dx.Doi.Org/10.5049/Ebp.2015.13.1.30 33 Copyright © 2015 The Korean Society of Electrolyte Metabolismpus callosum lesion had resolved on FLAIR and DW ima-  ges.",Non-OADS,/arxiv_data1/oa_pdf/0b/d8/ebp-13-30.PMC4520885.pdf
"ReviewISSN 1738-5997(Print) • ISSN 2092-9935(Online) Electrolyte Blood Press 13:7-16, 2015  http://dx.doi.org/10.5049/EBP.2015.13.1.7 Copyright © 2015 The Korean Society of Electrolyte MetabolismSalt Sensitivity and Hypertension: A Paradigm Shift  from Kidney Malfunction to Vascular Endothelial Dysfunction Hoon Young Choi, M.D., Hyeong Cheon Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/b3/10/ebp-13-7.PMC4520886.pdf
"Electrolyte Blood Press 13:7-16, 2015 • http://Dx.Doi.Org/10.5049/Ebp.2015.13.1.7 9 Copyright © 2015 The Korean Society of Electrolyte Metabolismthe amount of sodium and water retained with such  an increase of sodium intake leads to a body weight in-crease 30).",Non-OADS,/arxiv_data1/oa_pdf/b3/10/ebp-13-7.PMC4520886.pdf
"Electrolyte Blood Press 13:7-16, 2015 • http://Dx.Doi.Org/10.5049/Ebp.2015.13.1.7 11 Copyright © 2015 The Korean Society of Electrolyte MetabolismGenSalt study, retested BP responses to dietary sodium  and potassium interventions among previous 487 partici- pants 39).",Non-OADS,/arxiv_data1/oa_pdf/b3/10/ebp-13-7.PMC4520886.pdf
"Electrolyte Blood Press 13:7-16, 2015 • http://Dx.Doi.Org/10.5049/Ebp.2015.13.1.7 13 Copyright © 2015 The Korean Society of Electrolyte Metabolismof the endothelial glycocalyx is severely damaged by ex- cessive sodium intake over time, leading to a signifi- cant reduction of the negatively charged heparan sulphate resi-dues in the endothelial glycocalyx 56).",Non-OADS,/arxiv_data1/oa_pdf/b3/10/ebp-13-7.PMC4520886.pdf
"Electrolyte Blood Press 13:7-16, 2015 • http://Dx.Doi.Org/10.5049/Ebp.2015.13.1.7 15 Copyright © 2015 The Korean Society of Electrolyte Metabolism31.",Non-OADS,/arxiv_data1/oa_pdf/b3/10/ebp-13-7.PMC4520886.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Treatment of Helicobacter pylori  Infection in Korea: A Systematic  Review and Meta-analysis The efficacy of seven-day clarithromycin-based standard triple therapy (STT) for  Helicobacter pylori  has decreased in Korea over the past decade.",Non-OADS,/arxiv_data1/oa_pdf/ec/85/jkms-30-1001.PMC4520928.pdf
"Received: 11 November 2014 Accepted: 27 April 2015 Address for Correspondence: Jae Gyu Kim, MD Division of Gastroenterology, Department of Internal Medicine,  Chung-Ang University College of Medicine, 102 Heukseok-ro,  Dongjak-gu, Seoul 156-755, Korea  Tel: +82.2-6299-3147, Fax: +82.2-6299-1137  E-mail: jgkimd@cau.ac.kr http://dx.doi.org/10.3346/jkms.2015.30.8.1001  • J Korean Med Sci 2015; 30: 1001-1009 INTRODUCTION Seven-day standard triple therapy (STT) has been the most rec - ommended and used first-line therapy for the eradication of H.  pylori  in many countries, including Korea.",Non-OADS,/arxiv_data1/oa_pdf/ec/85/jkms-30-1001.PMC4520928.pdf
"• Treatment of Helicobacter pylori  Infection 1002  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1001following terms: Helicobacter pylori  and Korea or Korean and  regimen, therapy, treatment, concomitant, quadruple, dual, se - quential, triple, standard, clarithromycin, moxifloxacin, levo - floxacin, tetracycline, amoxicillin, metronidazole or rifabutin.",Non-OADS,/arxiv_data1/oa_pdf/ec/85/jkms-30-1001.PMC4520928.pdf
• Treatment of Helicobacter pylori  Infection http://jkms.org   1003 http://dx.doi.org/10.3346/jkms.2015.30.8.1001PPI (b.i.d.,Non-OADS,/arxiv_data1/oa_pdf/ec/85/jkms-30-1001.PMC4520928.pdf
"• Treatment of Helicobacter pylori  Infection 1004  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1001respectively, and 80.8% and 81.3% in the CT group.",Non-OADS,/arxiv_data1/oa_pdf/ec/85/jkms-30-1001.PMC4520928.pdf
"• Treatment of Helicobacter pylori  Infection http://jkms.org   1005 http://dx.doi.org/10.3346/jkms.2015.30.8.1001 In our systematic review, three RCTs comparing 14-day with  seven-day BCQT for H. pylori  eradication met the inclusion cri - teria (23-25).",Non-OADS,/arxiv_data1/oa_pdf/ec/85/jkms-30-1001.PMC4520928.pdf
"• Treatment of Helicobacter pylori  Infection 1006  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1001Third-line therapies In Korea, there was no RCT for third-line therapies.",Non-OADS,/arxiv_data1/oa_pdf/ec/85/jkms-30-1001.PMC4520928.pdf
"• Treatment of Helicobacter pylori  Infection http://jkms.org   1007 http://dx.doi.org/10.3346/jkms.2015.30.8.1001for seven days, and the most common regimen of the studies in  the meta-analysis is the seven-day STT.",Non-OADS,/arxiv_data1/oa_pdf/ec/85/jkms-30-1001.PMC4520928.pdf
• Treatment of Helicobacter pylori  Infection 1008  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1001ORCID Sang Wook Lee http://orcid.org/0000-0001-9762-6998 Hyun Jung Kim http://orcid.org/0000-0003-2018-2385 Jae Gyu Kim http://orcid.org/0000-0002-4841-9404   REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/ec/85/jkms-30-1001.PMC4520928.pdf
• Treatment of Helicobacter pylori  Infection http://jkms.org   1009 http://dx.doi.org/10.3346/jkms.2015.30.8.1001parison of 1-week or 2-week bismuth-containing quadruple therapy.,Non-OADS,/arxiv_data1/oa_pdf/ec/85/jkms-30-1001.PMC4520928.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Publishing Ethics and Predatory Practices: A Dilemma for All  Stakeholders of Science Communication Publishing scholarly articles in traditional and newly-launched journals is a responsible  task, requiring diligence from authors, reviewers, editors, and publishers.",Non-OADS,/arxiv_data1/oa_pdf/bd/8b/jkms-30-1010.PMC4520929.pdf
"Keywords:  Publishing Ethics; Science Communication; Quality Control; Periodicals as  Topic; Research ManagementArmen Yuri Gasparyan,1   Marlen Yessirkepov,2   Svetlana N. Diyanova,3   and George D. Kitas1,4 1Departments of Rheumatology and Research and  Development, Dudley Group NHS Foundation Trust  (Teaching Trust of the University of Birmingham,  UK), Russells Hall Hospital, Dudley, West Midlands,  UK; 2Department of Biochemistry, Biology and  Microbiology, South Kazakhstan State  Pharmaceutical Academy, Shymkent, Kazakhstan;  3Department of Technologies of Trade and Public  Catering, Plekhanov Russian University of  Economics, Krasnodar Branch, Krasnodar, Russian  Federation; 4Arthritis Research UK Epidemiology  Unit, University of Manchester, Manchester, United  Kingdom Received: 24 March 2015 Accepted: 15 April 2015 Address for Correspondence: Armen Yuri Gasparyan, MD Departments of Rheumatology and Research & Development,  Dudley Group NHS Foundation Trust (Teaching Trust of  University of Birmingham, UK), Russells Hall Hospital, Dudley  DY1 2HQ, West Midlands, UK Tel: +44.1384-244842, Fax: +44.1384-244808 E-mail: a.gasparyan@gmail.comhttp://dx.doi.org/10.3346/jkms.2015.30.8.1010  • J Korean Med Sci 2015; 30: 1010-1016 INTRODUCTION Adhering to ethical standards of publishing is critically impor - tant if science editors and publishers are to reach out to the  global scientific community.",Non-OADS,/arxiv_data1/oa_pdf/bd/8b/jkms-30-1010.PMC4520929.pdf
• Publishing Ethics and Predatory Practices http://jkms.org   1011 http://dx.doi.org/10.3346/jkms.2015.30.8.1010where in the world (8).,Non-OADS,/arxiv_data1/oa_pdf/bd/8b/jkms-30-1010.PMC4520929.pdf
"• Publishing Ethics and Predatory Practices 1012  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1010honorable invitations, authors should be aware of a trend in  email communications by unethical publishers, whose sole aim  is to redirect flows of papers to their substandard journals.",Non-OADS,/arxiv_data1/oa_pdf/bd/8b/jkms-30-1010.PMC4520929.pdf
"• Publishing Ethics and Predatory Practices http://jkms.org   1013 http://dx.doi.org/10.3346/jkms.2015.30.8.1010associations can help them acquire credentials in research re - porting, ethical conduct, and publishing quality journals.",Non-OADS,/arxiv_data1/oa_pdf/bd/8b/jkms-30-1010.PMC4520929.pdf
"• Publishing Ethics and Predatory Practices 1014  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1010EMERGING CHALLENGES AND A CALL FOR  CONCERTED ACTION TO TACKLE UNETHICAL  PUBLISHING PRACTICES   The ease of launching online journals in the Internet age cre - ates short-cuts for illegitimate publishers and standalone jour - nals, pursuing financial gain at the expense of the quality and  validity of the publications.",Non-OADS,/arxiv_data1/oa_pdf/bd/8b/jkms-30-1010.PMC4520929.pdf
• Publishing Ethics and Predatory Practices http://jkms.org   1015 http://dx.doi.org/10.3346/jkms.2015.30.8.1010sure against predatory publishing practices.,Non-OADS,/arxiv_data1/oa_pdf/bd/8b/jkms-30-1010.PMC4520929.pdf
ORCID Armen Yuri Gasparyan http://orcid.org/0000-0001-8749-6018 Marlen Yessirkepov http://orcid.org/0000-0003-2511-6918 Svetlana N. Diyanova http://orcid.org/0000-0003-1386-3342 George D. Kitas http://orcid.org/0000-0002-0828-6176 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bd/8b/jkms-30-1010.PMC4520929.pdf
Available at http://scholarlyoa.com/2014/05/13/idosi-journals- no-longer-to-be-indexed-in-scopus/ [accessed on 3 March 2015].,Non-OADS,/arxiv_data1/oa_pdf/bd/8b/jkms-30-1010.PMC4520929.pdf
Available at https://scholarlyoa.files.wordpress.com/2015/01/criteria-  2015.pdf [accessed on 3 March 2015].,Non-OADS,/arxiv_data1/oa_pdf/bd/8b/jkms-30-1010.PMC4520929.pdf
Available at http://m.tengrinews.kz/en/ science/Publications-in-pseudoscientific-journals-damage-reputation- of-Kazakhstani-255439 [accessed on 3 March 2015].,Non-OADS,/arxiv_data1/oa_pdf/bd/8b/jkms-30-1010.PMC4520929.pdf
Available at http://blog.rubriq.com/2014/03/  04/welcome-journalguide/ [accessed on 3 March 2015].,Non-OADS,/arxiv_data1/oa_pdf/bd/8b/jkms-30-1010.PMC4520929.pdf
• Publishing Ethics and Predatory Practices 1016  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1010Med 2014; 107: 384-5.,Non-OADS,/arxiv_data1/oa_pdf/bd/8b/jkms-30-1010.PMC4520929.pdf
Available at http://nursingeditors.com/journals-directory/ [accessed on 3 March 2015].,Non-OADS,/arxiv_data1/oa_pdf/bd/8b/jkms-30-1010.PMC4520929.pdf
Available at http://oaspa.org/ principles-of-transparency-and-best-practice-in-scholarly-publishing/  [accessed on 3 March 2015].,Non-OADS,/arxiv_data1/oa_pdf/bd/8b/jkms-30-1010.PMC4520929.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Interaction Effect between Weight Perception and Comorbidities  on Weight Control Behavior in Overweight and Obese Adults: Is  There a Sex Difference?",Non-OADS,/arxiv_data1/oa_pdf/01/f5/jkms-30-1017.PMC4520930.pdf
"Keywords:  Comorbidity; Body Image; Weight Perception; Obesity Jun Hyun Hwang,1 Dong Hee Ryu,2   and Soon-Woo Park1 1Department of Preventive Medicine, Catholic  University of Daegu School of Medicine, Daegu;  2Department of Preventive Medicine, School of  Medicine, Kyungpook National University, Daegu,  Korea Received: 27 January 2015 Accepted: 27 April 2015 Address for Correspondence: Soon-Woo Park, MD Department of Preventive Medicine, Catholic University of  Daegu School of Medicine, 33 Duryugongwon-ro 17-gil,   Nam-gu, Daegu 705-718, Korea  Tel: +82.53-650-4493, Fax: +82.53-654-3881  E-mail: parksw@cu.ac.kr Funding:  This work was supported by a research grant from the  Catholic University of Daegu in 2014 (20145001).http://dx.doi.org/10.3346/jkms.2015.30.8.1017  • J Korean Med Sci 2015; 30: 1017-1024 INTRODUCTION Obesity is an important risk factor for various diseases, includ - ing hypertension, type 2 diabetes, cardiovascular diseases, can - cers, and premature death (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/01/f5/jkms-30-1017.PMC4520930.pdf
"• Weight Perception and Weight Control Behavior 1018  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1017disease tend to control their weight better than those without a  chronic disease (13, 26).",Non-OADS,/arxiv_data1/oa_pdf/01/f5/jkms-30-1017.PMC4520930.pdf
• Weight Perception and Weight Control Behavior http://jkms.org   1019 http://dx.doi.org/10.3346/jkms.2015.30.8.1017RESULTS Table 1 shows general characteristics of the study population.,Non-OADS,/arxiv_data1/oa_pdf/01/f5/jkms-30-1017.PMC4520930.pdf
• Weight Perception and Weight Control Behavior 1020  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1017Table 2.,Non-OADS,/arxiv_data1/oa_pdf/01/f5/jkms-30-1017.PMC4520930.pdf
"• Weight Perception and Weight Control Behavior http://jkms.org   1021 http://dx.doi.org/10.3346/jkms.2015.30.8.1017CI, 1.19-1.63).",Non-OADS,/arxiv_data1/oa_pdf/01/f5/jkms-30-1017.PMC4520930.pdf
• Weight Perception and Weight Control Behavior 1022  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1017ference in weight control behavior.,Non-OADS,/arxiv_data1/oa_pdf/01/f5/jkms-30-1017.PMC4520930.pdf
• Weight Perception and Weight Control Behavior http://jkms.org   1023 http://dx.doi.org/10.3346/jkms.2015.30.8.1017DISCLOSURE All of the authors have no potential conflicts of interest or fi - nancial ties to disclose.,Non-OADS,/arxiv_data1/oa_pdf/01/f5/jkms-30-1017.PMC4520930.pdf
ORCID Jun Hyun Hwang http://orcid.org/0000-0001-8547-0893 Dong Hee Ryu http://orcid.org/0000-0002-2860-8849 Soon-Woo Park http:// orcid.org/0000-0001-9795-7914 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/01/f5/jkms-30-1017.PMC4520930.pdf
• Weight Perception and Weight Control Behavior 1024  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.101730.,Non-OADS,/arxiv_data1/oa_pdf/01/f5/jkms-30-1017.PMC4520930.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Computational Discrimination of Breast Cancer for Korean  Women Based on Epidemiologic Data Only Breast cancer is the second leading cancer for Korean women and its incidence rate has  been increasing annually.",Non-OADS,/arxiv_data1/oa_pdf/76/6a/jkms-30-1025.PMC4520931.pdf
"Received: 2 January 2015 Accepted: 9 April 2015 Address for Correspondence: Sungwan Kim, PhD Department of Biomedical Engineering, College of Medicine and  Institute of Medical and Biological Engineering, Seoul National  University, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea Tel: +82.2-2072-3126, Fax: +82.2-741-8597 E-mail: sungwan@snu.ac.kr Funding:  This work was supported by the 2010 Seoul National  University Brain Fusion Program Research Grant and BK21 Plus  Program through the National Research Foundation of Korea  (NRF, 2013-22A20130011025).http://dx.doi.org/10.3346/jkms.2015.30.8.1025  • J Korean Med Sci 2015; 30: 1025-1034 INTRODUCTION A breast cancer is one of leading cancers for the Korean women and its incidence rate  has been rapidly increasing every year (1).",Non-OADS,/arxiv_data1/oa_pdf/76/6a/jkms-30-1025.PMC4520931.pdf
• Discrimination of Breast Cancer Using Three Classification Algorithms 1026  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1025models are helpful for clinical diagnosis and breast cancer treat - ment planning (9).,Non-OADS,/arxiv_data1/oa_pdf/76/6a/jkms-30-1025.PMC4520931.pdf
"• Discrimination of Breast Cancer Using Three Classification Algorithms http://jkms.org   1027 http://dx.doi.org/10.3346/jkms.2015.30.8.10254,574 subjects were used in this study, including 2,291 cases  and 2,283 controls.",Non-OADS,/arxiv_data1/oa_pdf/76/6a/jkms-30-1025.PMC4520931.pdf
• Discrimination of Breast Cancer Using Three Classification Algorithms 1028  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1025fer function.,OADS,/arxiv_data1/oa_pdf/76/6a/jkms-30-1025.PMC4520931.pdf
"• Discrimination of Breast Cancer Using Three Classification Algorithms http://jkms.org   1029 http://dx.doi.org/10.3346/jkms.2015.30.8.1025differing age groups, control characteristics and yearly trends  from 1994 to 2007.",Non-OADS,/arxiv_data1/oa_pdf/76/6a/jkms-30-1025.PMC4520931.pdf
• Discrimination of Breast Cancer Using Three Classification Algorithms 1030  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1025for one thousand iterations were demonstrated as normal dis - tribution by Shapiro-Wilk Test (27).,OADS,/arxiv_data1/oa_pdf/76/6a/jkms-30-1025.PMC4520931.pdf
"• Discrimination of Breast Cancer Using Three Classification Algorithms http://jkms.org   1031 http://dx.doi.org/10.3346/jkms.2015.30.8.1025 Sensitivity  1-Specificity0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 11 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0ROC curve of SVM AUC = 0.5 U50, AUC = 0.6076 All, AUC = 0.6213 O50, AUC = 0.6415 Sensitivity  1-Specificity0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 11 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0ROC curve of ANN AUC = 0.5 U50, AUC = 0.6060 All, AUC = 0.6173 O50, AUC = 0.6383 Sensitivity  1-Specificity0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 11 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0ROC curve of BN AUC = 0.5 U50, AUC = 0.6027 All, AUC = 0.6101 O50, AUC = 0.6290 Fig.",Non-OADS,/arxiv_data1/oa_pdf/76/6a/jkms-30-1025.PMC4520931.pdf
• Discrimination of Breast Cancer Using Three Classification Algorithms 1032  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1025Fig.,Non-OADS,/arxiv_data1/oa_pdf/76/6a/jkms-30-1025.PMC4520931.pdf
"• Discrimination of Breast Cancer Using Three Classification Algorithms http://jkms.org   1033 http://dx.doi.org/10.3346/jkms.2015.30.8.1025ally, if the present method is designed in the form of a web-based  or smartphone application, women who want to know their own  risk of breast cancer will be able to access this information easi - ly in daily life.",Non-OADS,/arxiv_data1/oa_pdf/76/6a/jkms-30-1025.PMC4520931.pdf
ORCID Chiwon Lee http://orcid.org/0000-0001-7342-6190 Jung Chan Lee http://orcid.org/0000-0002-4546-0962 Boyoung Park http://orcid.org/0000-0003-1902-3184  Jonghee Bae http://orcid.org/0000-0002-2069-0366 Min Hyuk Lim http://orcid.org/0000-0003-1547-2804 Daehee Kang http://orcid.org/0000-0003-4031-5878 Keun-Young Yoo http://orcid.org/0000-0002-3726-5390 Sue K. Park http://orcid.org/0000-0001-5002-9707 Youdan Kim http://orcid.org/0000-0001-5041-8243 Sungwan Kim http://orcid.org/0000-0002-9318-849X  REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/76/6a/jkms-30-1025.PMC4520931.pdf
Available  at http://www.cancer.gov/bcrisktool/ [accessed on 8 December 2014].,Non-OADS,/arxiv_data1/oa_pdf/76/6a/jkms-30-1025.PMC4520931.pdf
• Discrimination of Breast Cancer Using Three Classification Algorithms 1034  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.102526.,Non-OADS,/arxiv_data1/oa_pdf/76/6a/jkms-30-1025.PMC4520931.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Association between Promoter Polymorphisms of TFF1 , TFF2 ,  and TFF3  and the Risk of Gastric and Diffuse Gastric Cancers in a  Korean Population Gastric cancer is one of the most common cancers in the world.",Non-OADS,/arxiv_data1/oa_pdf/fa/75/jkms-30-1035.PMC4520932.pdf
"Received: 17 December 2014 Accepted: 17 April 2015 Address for Correspondence: Jang Hee Hong, MD Department of Pharmacology, College of Medicine, Chungnam  National University, 266 Munhwa-ro, Jung-gu, Daejeon   301-131, Korea Tel: +82.42-280-8718, Fax: +82.42-280-8716 E-mail: boniii@cnu.ac.kr  Funding:  This research was supported by a grant of the Korea  Health Technology R &D Project Ministry of Health & Welfare,  Republic of Korea (grant number: HI14C1731), a research fund  of Chungnam National University, and Basic Science Research  Program through the National Research Foundation of Korea  (NRF) funded by the Ministry of Education (grant numbe: NRF- 2014R1A6A1029617).http://dx.doi.org/10.3346/jkms.2015.30.8.1035  • J Korean Med Sci 2015; 30: 1035-1041 INTRODUCTION Gastric cancer (GC) is one of the most common cancers affect - ing people worldwide.",Non-OADS,/arxiv_data1/oa_pdf/fa/75/jkms-30-1035.PMC4520932.pdf
• TFF SNPs and Gastric Cancer Risk 1036  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1035Both decreased TFF1  and TFF2  expression and increased TFF3   expression have been reported in gastric carcinoma (30).,Non-OADS,/arxiv_data1/oa_pdf/fa/75/jkms-30-1035.PMC4520932.pdf
• TFF SNPs and Gastric Cancer Risk http://jkms.org   1037 http://dx.doi.org/10.3346/jkms.2015.30.8.1035genotypes and allele frequencies of TFF  SNPs.,Non-OADS,/arxiv_data1/oa_pdf/fa/75/jkms-30-1035.PMC4520932.pdf
• TFF SNPs and Gastric Cancer Risk 1038  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1035was to investigate whether polymorphisms in TFF  were associ - ated with the risk of GC or GC subgroups in the Korean popula - tion.,Non-OADS,/arxiv_data1/oa_pdf/fa/75/jkms-30-1035.PMC4520932.pdf
• TFF SNPs and Gastric Cancer Risk http://jkms.org   1039 http://dx.doi.org/10.3346/jkms.2015.30.8.1035Table 4.,Non-OADS,/arxiv_data1/oa_pdf/fa/75/jkms-30-1035.PMC4520932.pdf
• TFF SNPs and Gastric Cancer Risk 1040  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1035risk of GC.,Non-OADS,/arxiv_data1/oa_pdf/fa/75/jkms-30-1035.PMC4520932.pdf
ORCID Jang Hee Hong http://orcid.org/0000-0002-0623-5455  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fa/75/jkms-30-1035.PMC4520932.pdf
"• TFF SNPs and Gastric Cancer Risk http://jkms.org   1041 http://dx.doi.org/10.3346/jkms.2015.30.8.1035loop structures as a common feature in breast cancer associated peptide  (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides  (spasmolysins).",Non-OADS,/arxiv_data1/oa_pdf/fa/75/jkms-30-1035.PMC4520932.pdf
• TFF SNPs and Gastric Cancer Risk http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1035Supplementary  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/fa/75/jkms-30-1035.PMC4520932.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Predictors of Asthma Control by Stepwise Treatment in Elderly  Asthmatic Patients The geriatric population is increasing, and asthma severity increases with age.",Non-OADS,/arxiv_data1/oa_pdf/af/47/jkms-30-1042.PMC4520933.pdf
"Received: 23 January 2015 Accepted: 15 April 2015 Address for Correspondence: Hae-Sim Park, MD Department of Allergy & Clinical Immunology, Ajou University  School of Medicine, 164 Worldcup-ro, Youngtong-gu,   Suwon 443-380 Korea Tel: +82.31-219-5150, Fax: +82.31-219-5154 E-mail: hspark@ajou.ac.kr Funding:  This study was supported by a grant of the Korean  Health Technology R&D Project, Ministry of Health and Welfare,  ROK (HI14C1061), and IIT Grants from AstraZeneca Korea.http://dx.doi.org/10.3346/jkms.2015.30.8.1042  • J Korean Med Sci 2015; 30: 1042-1047 INTRODUCTION The geriatric population is increasing worldwide.",Non-OADS,/arxiv_data1/oa_pdf/af/47/jkms-30-1042.PMC4520933.pdf
• Predictors of Asthma Control in Elderly Asthmatics http://jkms.org   1043 http://dx.doi.org/10.3346/jkms.2015.30.8.1042wise treatment (10) for 6 months in an elderly asthma cohort of  Korea.,Non-OADS,/arxiv_data1/oa_pdf/af/47/jkms-30-1042.PMC4520933.pdf
• Predictors of Asthma Control in Elderly Asthmatics 1044  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1042Table 1.,Non-OADS,/arxiv_data1/oa_pdf/af/47/jkms-30-1042.PMC4520933.pdf
"• Predictors of Asthma Control in Elderly Asthmatics http://jkms.org   1045 http://dx.doi.org/10.3346/jkms.2015.30.8.1042P= 0.018, respectively) as summarized in Table 2.",Non-OADS,/arxiv_data1/oa_pdf/af/47/jkms-30-1042.PMC4520933.pdf
• Predictors of Asthma Control in Elderly Asthmatics 1046  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1042were well controlled or improved in their asthma control status  did not tend to adhere to asthma medications.,Non-OADS,/arxiv_data1/oa_pdf/af/47/jkms-30-1042.PMC4520933.pdf
Approval of manuscript: all au - thors ORCID Ga-Young Ban http://orcid.org/0000-0002-7961-742X Young-Min Ye http://orcid.org/0000-0002-7517-1715 Hae-Sim Park http://orcid.org/0000-0003-2614-0303,Non-OADS,/arxiv_data1/oa_pdf/af/47/jkms-30-1042.PMC4520933.pdf
• Predictors of Asthma Control in Elderly Asthmatics http://jkms.org   1047 http://dx.doi.org/10.3346/jkms.2015.30.8.1042REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/af/47/jkms-30-1042.PMC4520933.pdf
Available at http://www.ginasth - ma.org/documents/4 [accessed on May 14 2014].,Non-OADS,/arxiv_data1/oa_pdf/af/47/jkms-30-1042.PMC4520933.pdf
Available at http://www.whocc.no/atc_ ddd_index/?code=A&showdescription=yes [accessed on May 14 2014].,OADS,/arxiv_data1/oa_pdf/af/47/jkms-30-1042.PMC4520933.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Effect of Asthma Clinical Guideline for Adults on Inhaled  Corticosteroids PrescriptionTrend: A Quasi-Experimental Study In order to increase inhaled corticosteroid (ICS) use and to reduce hospitalization,  emergency department visits and ultimately the economic burden of asthma, “Korean  Asthma Management Guideline for Adults 2007” was developed.",Non-OADS,/arxiv_data1/oa_pdf/18/ed/jkms-30-1048.PMC4520934.pdf
"http://dx.doi.org/10.3346/jkms.2015.30.8.1048  • J Korean Med Sci 2015; 30: 1048-1054 INTRODUCTION There is growing concern about the increasing prevalence, chro- nic morbidity, and mortality of asthma, an inflammatory dis - ease of the lower airway system (1).",Non-OADS,/arxiv_data1/oa_pdf/18/ed/jkms-30-1048.PMC4520934.pdf
• Effect of Asthma Guideline on Inhaled-Corticosteroids Prescription Rate http://jkms.org   1049 http://dx.doi.org/10.3346/jkms.2015.30.8.1048guideline dissemination on this trend was not evaluated.,Non-OADS,/arxiv_data1/oa_pdf/18/ed/jkms-30-1048.PMC4520934.pdf
"• Effect of Asthma Guideline on Inhaled-Corticosteroids Prescription Rate 1050  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1048of the “Korean Asthma Management Guideline for Adults 2007, ”  as well as 8 primary physicians who were not involved in the  development of the guideline.",Non-OADS,/arxiv_data1/oa_pdf/18/ed/jkms-30-1048.PMC4520934.pdf
"• Effect of Asthma Guideline on Inhaled-Corticosteroids Prescription Rate http://jkms.org   1051 http://dx.doi.org/10.3346/jkms.2015.30.8.1048 In the multilevel analysis, adjusted for random effects for 251  municipal districts, there was no significant guideline effect on  ICS prescription (odds ratio, 1.03; 95% CI, 1.00-1.06); we also  calculated the ICC for ICS prescription (Table 2).",OADS,/arxiv_data1/oa_pdf/18/ed/jkms-30-1048.PMC4520934.pdf
"• Effect of Asthma Guideline on Inhaled-Corticosteroids Prescription Rate 1052  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1048slightly increased in the sensitivity analysis, it is still under ex - pectation.",Non-OADS,/arxiv_data1/oa_pdf/18/ed/jkms-30-1048.PMC4520934.pdf
"• Effect of Asthma Guideline on Inhaled-Corticosteroids Prescription Rate http://jkms.org   1053 http://dx.doi.org/10.3346/jkms.2015.30.8.1048HJ, Nam YS.",Non-OADS,/arxiv_data1/oa_pdf/18/ed/jkms-30-1048.PMC4520934.pdf
ORCID Sang Hyuck Kim http://orcid.org/0000-0002-4851-396X Be Long Cho http://orcid.org/0000-0001-9558-689X Dong Wook Shin http://orcid.org/0000-0001-8128-8920 Seung Sik Hwang http://orcid.org/0000-0002-1558-7831 Hye Jin Lee http://orcid.org/0000-0001-5279-340X Eun Mi Ahn http://orcid.org/0000-0002-9826-0788 Jae Moon Yun http://orcid.org/0000-0003-0927-4721 Yun Hee Chung http://orcid.org/0000-0001-5521-6376 You Seon Nam http://orcid.org/0000-0002-0817-0704 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/18/ed/jkms-30-1048.PMC4520934.pdf
Available at http://guideline.or.kr/guideline/search.php?mode  =search&type=2&M sid=28&F sid=667] [accessed on June 29 2015].,Non-OADS,/arxiv_data1/oa_pdf/18/ed/jkms-30-1048.PMC4520934.pdf
Available  at http://www.wpro.who.int/health_services/service_delivery_profile_ republic_of_korea.pdf [accessed on Jung 29 2015].,Non-OADS,/arxiv_data1/oa_pdf/18/ed/jkms-30-1048.PMC4520934.pdf
• Effect of Asthma Guideline on Inhaled-Corticosteroids Prescription Rate 1054  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1048on the use and cost of health services by children with asthma.,Non-OADS,/arxiv_data1/oa_pdf/18/ed/jkms-30-1048.PMC4520934.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Low Hepatic Toxicity in Primary and Metastatic Liver Cancers  after Stereotactic Ablative Radiotherapy Using 3 Fractions  This study evaluated the incidence of hepatic toxicity after stereotactic ablative  radiotherapy (SABR) using 3 fractions to the liver, and identified the predictors for hepatic  toxicity.",Non-OADS,/arxiv_data1/oa_pdf/a2/69/jkms-30-1055.PMC4520935.pdf
"http://dx.doi.org/10.3346/jkms.2015.30.8.1055  • J Korean Med Sci 2015; 30: 1055-1061 INTRODUCTION Hepatic injury after external beam radiotherapy (EBRT) to the  liver was first described in the early 1960s; its clinical symptoms  comprised rapid weight gain, an increase in abdominal girth,  hepatomegaly, occasionally ascites or jaundice, and an eleva - tion of liver enzymes, particularly serum alkaline phosphatase  (1).",Non-OADS,/arxiv_data1/oa_pdf/a2/69/jkms-30-1055.PMC4520935.pdf
"• Low Hepatic Toxicity after Stereotactic Ablative Radiotherapy 1056  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1055MATERIALS AND METHODS Patient selection For patients with unresectable hepatocellular carcinoma (HCC),  we conducted a SABR dose-escalation study with 33-57 Gy de - livered in 3-4 fractionations between 2003 and 2008, and a  phase II SABR study with 60 Gy delivered in 3 fractionations be - tween 2008 and 2011 (16, 17).",Non-OADS,/arxiv_data1/oa_pdf/a2/69/jkms-30-1055.PMC4520935.pdf
• Low Hepatic Toxicity after Stereotactic Ablative Radiotherapy http://jkms.org   1057 http://dx.doi.org/10.3346/jkms.2015.30.8.1055(6%).,Non-OADS,/arxiv_data1/oa_pdf/a2/69/jkms-30-1055.PMC4520935.pdf
• Low Hepatic Toxicity after Stereotactic Ablative Radiotherapy 1058  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1055Table 3.,Non-OADS,/arxiv_data1/oa_pdf/a2/69/jkms-30-1055.PMC4520935.pdf
• Low Hepatic Toxicity after Stereotactic Ablative Radiotherapy http://jkms.org   1059 http://dx.doi.org/10.3346/jkms.2015.30.8.1055ty ≥ grade 2; and 2 patients (15%) experienced the progression  of CP class.,Non-OADS,/arxiv_data1/oa_pdf/a2/69/jkms-30-1055.PMC4520935.pdf
• Low Hepatic Toxicity after Stereotactic Ablative Radiotherapy 1060  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1055SABR plan was conducted to minimize the irradiation dose to  the normal liver: rV 17Gy was 724 mL and 588 mL.,Non-OADS,/arxiv_data1/oa_pdf/a2/69/jkms-30-1055.PMC4520935.pdf
ORCID Sun Hyun Bae http://orcid.org/0000-0003-0637-4110  Mi-Sook Kim http://orcid.org/0000-0002-7459-6316 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/a2/69/jkms-30-1055.PMC4520935.pdf
"• Low Hepatic Toxicity after Stereotactic Ablative Radiotherapy http://jkms.org   1061 http://dx.doi.org/10.3346/jkms.2015.30.8.1055radiation-induced liver disease, incidence and predictive factors.",Non-OADS,/arxiv_data1/oa_pdf/a2/69/jkms-30-1055.PMC4520935.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clinical Significance of Persistent Tumor in Bone Marrow during  Treatment of High-risk Neuroblastoma The records of 63 high-risk neuroblastoma patients with bone marrow (BM) tumors at  diagnosis were retrospectively reviewed.",Non-OADS,/arxiv_data1/oa_pdf/dc/69/jkms-30-1062.PMC4520936.pdf
HI13C1521).http://dx.doi.org/10.3346/jkms.2015.30.8.1062  • J Korean Med Sci 2015; 30: 1062-1067 INTRODUCTION  Neuroblastoma is the most common extracranial solid tumor  of children.,Non-OADS,/arxiv_data1/oa_pdf/dc/69/jkms-30-1062.PMC4520936.pdf
• Persistent Bone Marrow Tumor in Neuroblastoma  http://jkms.org   1063 http://dx.doi.org/10.3346/jkms.2015.30.8.1062in patients older than 1 yr or any MYCN -amplified tumors were  stratified as high-risk tumors.,Non-OADS,/arxiv_data1/oa_pdf/dc/69/jkms-30-1062.PMC4520936.pdf
• Persistent Bone Marrow Tumor in Neuroblastoma  1064  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1062in the PFS rates between groups were compared using the log- rank test.,OADS,/arxiv_data1/oa_pdf/dc/69/jkms-30-1062.PMC4520936.pdf
• Persistent Bone Marrow Tumor in Neuroblastoma  http://jkms.org   1065 http://dx.doi.org/10.3346/jkms.2015.30.8.1062BM samples without tumor in histological examination.,Non-OADS,/arxiv_data1/oa_pdf/dc/69/jkms-30-1062.PMC4520936.pdf
• Persistent Bone Marrow Tumor in Neuroblastoma  1066  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1062subsequent relapse/progression and those who did not.,Non-OADS,/arxiv_data1/oa_pdf/dc/69/jkms-30-1062.PMC4520936.pdf
• Persistent Bone Marrow Tumor in Neuroblastoma  http://jkms.org   1067 http://dx.doi.org/10.3346/jkms.2015.30.8.1062motherapy was higher in undifferentiated and MYCN -ampli - fied tumors (11).,Non-OADS,/arxiv_data1/oa_pdf/dc/69/jkms-30-1062.PMC4520936.pdf
Manuscript approval: all authors.ORCID Young Bae Choi http://orcid.org/0000-0001-7016-8827 Ki Woong Sung http://orcid.org/0000-0001-5989-4772 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/dc/69/jkms-30-1062.PMC4520936.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clinical Significance of Substaging and HER2 Expression in  Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary  Bladder The study aimed to verify the prognostic utility, therapeutic application and clinical  benefits of tumor substaging and HER2 status in papillary non-muscle invasive bladder  cancer (NMIBC).",Non-OADS,/arxiv_data1/oa_pdf/3d/ca/jkms-30-1068.PMC4520937.pdf
"http://dx.doi.org/10.3346/jkms.2015.30.8.1068  • J Korean Med Sci 2015; 30: 1068-1077 INTRODUCTION More than 75% of bladder cancer is classified as nonmuscle-in - vasive bladder cancer (NMIBC), which is confined to the mu - cosal and stroma or lamina propria (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/3d/ca/jkms-30-1068.PMC4520937.pdf
"• Her2 Expression in Nonmuscle Invasive Bladder Cancer http://jkms.org   1069 http://dx.doi.org/10.3346/jkms.2015.30.8.1068 The human epidermal growth factor receptor 2 (HER2) ex - pression has been extensively investigated as a target therapy  and is known to be a useful prognostic and therapeutic marker  in breast cancer and advanced gastric cancer (10, 11).",Non-OADS,/arxiv_data1/oa_pdf/3d/ca/jkms-30-1068.PMC4520937.pdf
• Her2 Expression in Nonmuscle Invasive Bladder Cancer 1070  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1068(11).,Non-OADS,/arxiv_data1/oa_pdf/3d/ca/jkms-30-1068.PMC4520937.pdf
"• Her2 Expression in Nonmuscle Invasive Bladder Cancer http://jkms.org   1071 http://dx.doi.org/10.3346/jkms.2015.30.8.1068 Substaging was significantly associated with tumor grade ( P<  0.001), concomitant CIS ( P= 0.005), HER2 protein expression  (P= 0.038), and HER2  gene amplification ( P= 0.002) (Table 2).",OADS,/arxiv_data1/oa_pdf/3d/ca/jkms-30-1068.PMC4520937.pdf
"• Her2 Expression in Nonmuscle Invasive Bladder Cancer 1072  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1068(range, 3.2 to 180.4 months) (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/3d/ca/jkms-30-1068.PMC4520937.pdf
• Her2 Expression in Nonmuscle Invasive Bladder Cancer http://jkms.org   1073 http://dx.doi.org/10.3346/jkms.2015.30.8.1068Fig.,Non-OADS,/arxiv_data1/oa_pdf/3d/ca/jkms-30-1068.PMC4520937.pdf
• Her2 Expression in Nonmuscle Invasive Bladder Cancer 1074  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1068Fig.,Non-OADS,/arxiv_data1/oa_pdf/3d/ca/jkms-30-1068.PMC4520937.pdf
• Her2 Expression in Nonmuscle Invasive Bladder Cancer http://jkms.org   1075 http://dx.doi.org/10.3346/jkms.2015.30.8.1068cancers (10).,Non-OADS,/arxiv_data1/oa_pdf/3d/ca/jkms-30-1068.PMC4520937.pdf
• Her2 Expression in Nonmuscle Invasive Bladder Cancer 1076  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1068therapy period ranged from 1998 to 2012.,OADS,/arxiv_data1/oa_pdf/3d/ca/jkms-30-1068.PMC4520937.pdf
ORCID  So Dug Lim http://orcid.org/0000-0003-2036-0313 Yong Mee Cho http://orcid.org/0000-0001-8766-2602 Gyu-Seog Choi http://orcid.org/0000-0001-5476-4610 Hyung Kyu Park http://orcid.org/0000-0002-5972-3516 Sung Hyun Paick http://orcid.org/0000-0002-6010-3277 Wook Youn Kim http://orcid.org/0000-0003-4024-8791 Soo-Nyung Kim http://orcid.org/0000-0003-4319-336XGhilsuk Yoon http://orcid.org/0000-0002-9941-024X  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3d/ca/jkms-30-1068.PMC4520937.pdf
• Her2 Expression in Nonmuscle Invasive Bladder Cancer http://jkms.org   1077 http://dx.doi.org/10.3346/jkms.2015.30.8.1068invasive urothelial bladder cancer with a standardized methodology:  results in 1005 patients.,Non-OADS,/arxiv_data1/oa_pdf/3d/ca/jkms-30-1068.PMC4520937.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Prevalence of Atrial Fibrillation and Relation to  Echocardiographic Parameters in a Healthy Asymptomatic Rural  Korean Population  Atrial fibrillation (AF) is the most common arrhythmia worldwide and a potent independent  risk factor for stroke.",Non-OADS,/arxiv_data1/oa_pdf/2e/06/jkms-30-1078.PMC4520938.pdf
"Received: 27 October 2014 Accepted: 27 April 2015 Address for Correspondence: Jinho Shin, MD Division of Cardiology, Internal Medicine, Hanyang University  Seoul Hospital, 222 Wangsimni-ro, Seongdong-gu,   Seoul 133-791, Korea Tel: +82.2-2290-8308, Fax: +82.2-2299-0278 E-mail: jhs2003@hanyang.ac.krhttp://dx.doi.org/10.3346/jkms.2015.30.8.1078  • J Korean Med Sci 2015; 30: 1078-1084 INTRODUCTION   Atrial fibrillation (AF) is the most common sustained arrhyth - mia in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/2e/06/jkms-30-1078.PMC4520938.pdf
"• Prevalence of atrial fibrillation in Korean rural area http://jkms.org   1079 http://dx.doi.org/10.3346/jkms.2015.30.8.10782005 and 82,802 in 2010 from Population and Housing Census  data.",OADS,/arxiv_data1/oa_pdf/2e/06/jkms-30-1078.PMC4520938.pdf
"• Prevalence of atrial fibrillation in Korean rural area 1080  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1078the independent variables based on previous studies (9) includ - ed age, diabetes, hypertension, dyslipidemia, smoking, and  drinking.",Non-OADS,/arxiv_data1/oa_pdf/2e/06/jkms-30-1078.PMC4520938.pdf
• Prevalence of atrial fibrillation in Korean rural area http://jkms.org   1081 http://dx.doi.org/10.3346/jkms.2015.30.8.1078Table 3.,Non-OADS,/arxiv_data1/oa_pdf/2e/06/jkms-30-1078.PMC4520938.pdf
"• Prevalence of atrial fibrillation in Korean rural area 1082  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1078was not a risk factor for AF in our multivariate analysis, and nor  was the inflammatory marker, C-reactive protein.",Non-OADS,/arxiv_data1/oa_pdf/2e/06/jkms-30-1078.PMC4520938.pdf
ORCID Hwan-Cheol Park http://orcid.org/0000-0002-9258-0481 Jin-Kyu Park http://orcid.org/0000-0001-7931-777X Sung Il Choi http://orcid.org/0000-0001-5927-8574 Soon-Gil Kim http://orcid.org/0000-0001-5648-3484 Mi Kyung Kim http://orcid.org/0000-0001-8503-2631 Bo Youl Choi http://orcid.org/0000-0003-0115-5736 Jinho Shin http://orcid.org/0000-0003-2872-6105REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/2e/06/jkms-30-1078.PMC4520938.pdf
• Prevalence of atrial fibrillation in Korean rural area http://jkms.org   1083 http://dx.doi.org/10.3346/jkms.2015.30.8.107817.,Non-OADS,/arxiv_data1/oa_pdf/2e/06/jkms-30-1078.PMC4520938.pdf
• Prevalence of atrial fibrillation in Korean rural area 1084  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1078Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/2e/06/jkms-30-1078.PMC4520938.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Exuberant Vasculoconnective Component in Mediastinal Mixed  Germ Cell Tumors We aimed to evaluate the histologic components of primary mediastinal mixed germ cell  tumors.",Non-OADS,/arxiv_data1/oa_pdf/28/9a/jkms-30-1085.PMC4520939.pdf
"Keywords:  Neoplasms, Germ Cell and Embryonal; Mediastinal Neoplasms; Pathology,  Vasculoconnective TissueYoon Jin Cha,1 Joungho Han,1   Kyung Soo Lee,2 and Young Mog Shim3 Departments of 1Pathology, 2Radiology, and  3Thoracic Surgery, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  Seoul, Korea Received: 1 December 2014 Accepted: 27 April 2015 Address for Correspondence: Joungho Han, MD Department of Pathology, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro  Gangnam-gu, Seoul 135-710, Korea Tel: +82.2-3410-2800, Fax: +82.2-3410-0025 E-mail: hanjho@skku.edu http://dx.doi.org/10.3346/jkms.2015.30.8.1085  • J Korean Med Sci 2015; 30: 1085-1091 INTRODUCTION  Extragonadal germ cell tumors (EGCTs) comprise 2.3%-8.2% of  germ cell tumors (GCTs) (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/28/9a/jkms-30-1085.PMC4520939.pdf
"• Vasculoconnective Component in Mediastinal Mixed Germ Cell Tumors 1086  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1085them, 8 patients were clinically and pathologically diagnosed  with a mixed GCT and finally included for further evaluation.",Non-OADS,/arxiv_data1/oa_pdf/28/9a/jkms-30-1085.PMC4520939.pdf
"• Vasculoconnective Component in Mediastinal Mixed Germ Cell Tumors http://jkms.org   1087 http://dx.doi.org/10.3346/jkms.2015.30.8.1085the pre-chemotherapy needle biopsies of 5 patients were re - viewed retrospectively, a vasculoconnective component was  observed in 4 of the 5 patients who had a vasculoconnective  component in the resected specimen (Fig.",Non-OADS,/arxiv_data1/oa_pdf/28/9a/jkms-30-1085.PMC4520939.pdf
• Vasculoconnective Component in Mediastinal Mixed Germ Cell Tumors 1088  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1085 A DB EC Fig.,Non-OADS,/arxiv_data1/oa_pdf/28/9a/jkms-30-1085.PMC4520939.pdf
• Vasculoconnective Component in Mediastinal Mixed Germ Cell Tumors http://jkms.org   1089 http://dx.doi.org/10.3346/jkms.2015.30.8.1085 A B C Fig.,Non-OADS,/arxiv_data1/oa_pdf/28/9a/jkms-30-1085.PMC4520939.pdf
• Vasculoconnective Component in Mediastinal Mixed Germ Cell Tumors 1090  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1085as an intrinsic component rather than a postchemotherapy-re - lated change.,Non-OADS,/arxiv_data1/oa_pdf/28/9a/jkms-30-1085.PMC4520939.pdf
ORCID Yoon Jin Cha http://orcid.org/0000-0003-3993-1278 Joungho Han http://orcid.org/0000-0003-4424-7008 Kyung Soo Lee http://orcid.org/0000-0001-8715-9281 Young Mog Shim http://orcid.org/0000-0001-5924-9765 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/28/9a/jkms-30-1085.PMC4520939.pdf
• Vasculoconnective Component in Mediastinal Mixed Germ Cell Tumors http://jkms.org   1091 http://dx.doi.org/10.3346/jkms.2015.30.8.1085Thorac Cardiovasc Surg 2012; 144: 438-43.,Non-OADS,/arxiv_data1/oa_pdf/28/9a/jkms-30-1085.PMC4520939.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Routine Screening and Consultation Facilitate Improvement of  Metabolic Syndrome This randomized controlled trial study aimed to investigate the effects of a lifestyle  intervention on metabolic syndrome (MetS) among middle-aged Koreans.",Non-OADS,/arxiv_data1/oa_pdf/3a/81/jkms-30-1092.PMC4520940.pdf
"NRF-2010-0004016).http://dx.doi.org/10.3346/jkms.2015.30.8.1092  • J Korean Med Sci 2015; 30: 1092-1100 INTRODUCTION Metabolic syndrome (MetS) is a cluster of risk factors for diabe - tes (1), cardiovascular disease, and all-cause mortality (2).",Non-OADS,/arxiv_data1/oa_pdf/3a/81/jkms-30-1092.PMC4520940.pdf
• Effects of Lifestyle Interventions on Metabolic Syndrome http://jkms.org   1093 http://dx.doi.org/10.3346/jkms.2015.30.8.1092Evaluation and Treatment of High Blood Cholesterol in Adults  (Adult Treatment Panel III) emphasized lifestyle modification  as an essential strategy for the risk management for cardiovas - cular diseases (14).,Non-OADS,/arxiv_data1/oa_pdf/3a/81/jkms-30-1092.PMC4520940.pdf
• Effects of Lifestyle Interventions on Metabolic Syndrome 1094  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1092participants and the dropouts at baseline (data not shown).,Non-OADS,/arxiv_data1/oa_pdf/3a/81/jkms-30-1092.PMC4520940.pdf
• Effects of Lifestyle Interventions on Metabolic Syndrome http://jkms.org   1095 http://dx.doi.org/10.3346/jkms.2015.30.8.1092fluence the binary MetS status.,Non-OADS,/arxiv_data1/oa_pdf/3a/81/jkms-30-1092.PMC4520940.pdf
• Effects of Lifestyle Interventions on Metabolic Syndrome 1096  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1092RESULTS Participant characteristics Table 3 presents baseline (T1) characteristics of the participants  per intervention group.,Non-OADS,/arxiv_data1/oa_pdf/3a/81/jkms-30-1092.PMC4520940.pdf
• Effects of Lifestyle Interventions on Metabolic Syndrome http://jkms.org   1097 http://dx.doi.org/10.3346/jkms.2015.30.8.1092both T5 and T6) continuously decreased during the follow-up  period.,Non-OADS,/arxiv_data1/oa_pdf/3a/81/jkms-30-1092.PMC4520940.pdf
• Effects of Lifestyle Interventions on Metabolic Syndrome 1098  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1092the health condition that was unfamiliar to many of the partici - pants.,Non-OADS,/arxiv_data1/oa_pdf/3a/81/jkms-30-1092.PMC4520940.pdf
"• Effects of Lifestyle Interventions on Metabolic Syndrome http://jkms.org   1099 http://dx.doi.org/10.3346/jkms.2015.30.8.1092vention programs employ fat reduction strategies in diet, which  may affect adversely to raise the HDL-cholesterol level decided  by ratio of polyunsaturated to saturated fats (37).",Non-OADS,/arxiv_data1/oa_pdf/3a/81/jkms-30-1092.PMC4520940.pdf
"Data review: Yoon N, Han Y, Kim H. Statistical analysis: Yoon N,  Han Y, Yoo S. Manuscript preparation: Yoon N, Yoo S, Han Y.  Manuscript approval: all authors ORCID Nan-He Yoon http://orcid.org/0000-0003-1268-0149 Seunghyun Yoo http://orcid.org/0000-0002-9273-1761 Hyekyeong Kim http://orcid.org/0000-0002-6246-9942 Yoonjung Han http://orcid.org/0000-0003-3117-6634 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/3a/81/jkms-30-1092.PMC4520940.pdf
• Effects of Lifestyle Interventions on Metabolic Syndrome 1100  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.10927.,Non-OADS,/arxiv_data1/oa_pdf/3a/81/jkms-30-1092.PMC4520940.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Utilizing Genetic Predisposition Score in Predicting Risk of Type  2 Diabetes Mellitus Incidence: A Community-based Cohort  Study on Middle-aged Koreans Contribution of genetic predisposition to risk prediction of type 2 diabetes mellitus (T2DM)  was investigated using a prospective study in middle-aged adults in Korea.",Non-OADS,/arxiv_data1/oa_pdf/e6/49/jkms-30-1101.PMC4520941.pdf
"Keywords:  Diabetes Mellitus; Genetic Predisposition; Hemoglobin A, GlycosylatedHye Yin Park,1,2 Hyung Jin Choi,3   and Yun-Chul Hong2,4 1Center for Clinical Preventive Medicine, Seoul  National University Bundang Hospital, Seongnam;  2Department of Preventive Medicine, Seoul National  University College of Medicine, Seoul; 3Department  of Internal Medicine, Chungbuk National University  Hospital, Cheongju; 4Institute of Environmental  Medicine, Seoul National University Medical  Research Center, Seoul, Korea Received: 13 January 2015 Accepted: 9 April 2015 Address for Correspondence: Yun-Chul Hong, MD Department of Preventive Medicine, Seoul National University  College of Medicine, 103 Daehak-ro, Jongro-gu, Seoul 110-799,  Korea Tel: +82.2-740-8394, Fax: +82.2-747-4830 E-mail: ychong1@snu.ac.krhttp://dx.doi.org/10.3346/jkms.2015.30.8.1101  • J Korean Med Sci 2015; 30: 1101-1109 INTRODUCTION Although type 2 diabetes mellitus (T2DM), a prevalent and com - plex disease, is known to be caused by combinations of genes  and environmental factors, the genetic contribution is not clear - ly evaluated.",Non-OADS,/arxiv_data1/oa_pdf/e6/49/jkms-30-1101.PMC4520941.pdf
"Whole-genome sequencing  using Affymetrix 500K Array (Affymetrix, Santa Clara, CA, USA)  was performed in 8,842 randomly selected subjects during the  baseline investigation period, and unphased genotypes were  imputed with Japanese+Chineses HapMap phase 2 haplotype  panel using IMPUTE version 2 (http://mathgen.stats.ox.ac.uk/ORIGINAL ARTICLE Endocrinology, Nutrition & Metabolism",Non-OADS,/arxiv_data1/oa_pdf/e6/49/jkms-30-1101.PMC4520941.pdf
• Genetic Polymorphism Effect on Diabetes Mellitus Prediction 1102  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1101impute).,Non-OADS,/arxiv_data1/oa_pdf/e6/49/jkms-30-1101.PMC4520941.pdf
"• Genetic Polymorphism Effect on Diabetes Mellitus Prediction http://jkms.org   1103 http://dx.doi.org/10.3346/jkms.2015.30.8.1101N2A/B ), rs5215 ( KCNJ11 ), and rs2237892 ( KCNQ1 ) showed sig - nificant association with T2DM incidence in our subjects (rs108    11661, HR 1.22 [95% CI 1.02-1.46]; rs5215, HR 1.27 [1.06-1.52],  rs2237892, HR 1.37 [1.12-1.68]), and most SNPs showed same  direction of estimate as reported by original researches (Table  2).",Non-OADS,/arxiv_data1/oa_pdf/e6/49/jkms-30-1101.PMC4520941.pdf
• Genetic Polymorphism Effect on Diabetes Mellitus Prediction 1104  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1101Table 2.,Non-OADS,/arxiv_data1/oa_pdf/e6/49/jkms-30-1101.PMC4520941.pdf
• Genetic Polymorphism Effect on Diabetes Mellitus Prediction http://jkms.org   1105 http://dx.doi.org/10.3346/jkms.2015.30.8.1101tested GPSs.,Non-OADS,/arxiv_data1/oa_pdf/e6/49/jkms-30-1101.PMC4520941.pdf
• Genetic Polymorphism Effect on Diabetes Mellitus Prediction 1106  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1101Table 4.,Non-OADS,/arxiv_data1/oa_pdf/e6/49/jkms-30-1101.PMC4520941.pdf
• Genetic Polymorphism Effect on Diabetes Mellitus Prediction http://jkms.org   1107 http://dx.doi.org/10.3346/jkms.2015.30.8.1101Table 5.,Non-OADS,/arxiv_data1/oa_pdf/e6/49/jkms-30-1101.PMC4520941.pdf
• Genetic Polymorphism Effect on Diabetes Mellitus Prediction 1108  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1101DISCLOSURE The authors have no conflicts of interest to disclose.,Non-OADS,/arxiv_data1/oa_pdf/e6/49/jkms-30-1101.PMC4520941.pdf
ORCID Hye Yin Park http://orcid.org/0000­0003­4144­1534 Hyung Jin Choi http://orcid.org/0000­0003­0593­6978 Yun-Chul Hong http://orcid.org/0000­0001­9010­7271 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e6/49/jkms-30-1101.PMC4520941.pdf
• Genetic Polymorphism Effect on Diabetes Mellitus Prediction http://jkms.org   1109 http://dx.doi.org/10.3346/jkms.2015.30.8.110126.,Non-OADS,/arxiv_data1/oa_pdf/e6/49/jkms-30-1101.PMC4520941.pdf
• Genetic Polymorphism Effect on Diabetes Mellitus Prediction http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1101Supplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/e6/49/jkms-30-1101.PMC4520941.pdf
• Genetic Polymorphism Effect on Diabetes Mellitus Prediction http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1101Supplementary Table 2.,Non-OADS,/arxiv_data1/oa_pdf/e6/49/jkms-30-1101.PMC4520941.pdf
"• Genetic Polymorphism Effect on Diabetes Mellitus Prediction http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1101Supplementary reference for reported effect estimates of selected SNPs in Caucasian population from Table 2   (1)  Zeggini E, Scott LJ, Saxena R, Voight BF , Marchini JL, Hu T, de Bakker PI, Abecasis GR, Almgren P , Andersen G, et al.",OADS,/arxiv_data1/oa_pdf/e6/49/jkms-30-1101.PMC4520941.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Lifestyle and Dietary Factors Associated with Serum  25-Hydroxyvitamin D Levels in Korean Young Adults Inadequate vitamin D status is highly prevalent in the Korean population, especially among  young adults.",Non-OADS,/arxiv_data1/oa_pdf/13/7e/jkms-30-1110.PMC4520942.pdf
"Keywords:  Vitamin D; Young Adult; Life Style; Thinness; Obesity; Breakfast; Instant  Noodle; Sugar-sweetened BeverageHee-Kyung Joh,1,2 Chun Soo Lim,3   and BeLong Cho4,5,6 1Department of Medicine, Seoul National University  College of Medicine, Seoul; 2Department of Family  Medicine, Seoul National University Health Service  Center, Seoul; 3Department of Internal Medicine,  Seoul National University Boramae Medical Center,  Seoul; 4Department of Family Medicine and Health  Promotion Center, Seoul National University  Hospital, Seoul; 5Advanced Institutes of  Convergence Technology, Seoul National University,  Seoul; 6Institute on Aging, Seoul National University  College of Medicine, Seoul, Korea Received: 11 April 2015 Accepted: 12 May 2015 Address for Correspondence: BeLong Cho, MD Department of Family Medicine, Seoul National University  Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Korea Tel: +82.2-2072-2195, Fax: +82.2-766-3276 E-mail: belong@snu.ac.krhttp://dx.doi.org/10.3346/jkms.2015.30.8.1110  • J Korean Med Sci 2015; 30: 1110-1120 INTRODUCTION Vitamin D insufficiency is emerging as a global health problem  (1), and a high proportion of Koreans are suffering from this  condition.",Non-OADS,/arxiv_data1/oa_pdf/13/7e/jkms-30-1110.PMC4520942.pdf
"• Factors Associated with Serum 25(OH)D Levels in Korean Young Adults http://jkms.org   1111 http://dx.doi.org/10.3346/jkms.2015.30.8.1110 Nonetheless, the causes of high prevalence of vitamin D in - sufficiency among young adults are not clear.",Non-OADS,/arxiv_data1/oa_pdf/13/7e/jkms-30-1110.PMC4520942.pdf
"• Factors Associated with Serum 25(OH)D Levels in Korean Young Adults 1112  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1110base in Korea, consumption frequencies of fatty fish (mackerel,  saury, tuna, or salmon) and dairy (milk, yogurt) were asked be - cause both are major food sources of vitamin D in the Korean  population (19).",Non-OADS,/arxiv_data1/oa_pdf/13/7e/jkms-30-1110.PMC4520942.pdf
• Factors Associated with Serum 25(OH)D Levels in Korean Young Adults http://jkms.org   1113 http://dx.doi.org/10.3346/jkms.2015.30.8.1110 (Continued to the next)Table 1.,Non-OADS,/arxiv_data1/oa_pdf/13/7e/jkms-30-1110.PMC4520942.pdf
• Factors Associated with Serum 25(OH)D Levels in Korean Young Adults 1114  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1110cantly lower serum 25(OH)D levels.,Non-OADS,/arxiv_data1/oa_pdf/13/7e/jkms-30-1110.PMC4520942.pdf
• Factors Associated with Serum 25(OH)D Levels in Korean Young Adults http://jkms.org   1115 http://dx.doi.org/10.3346/jkms.2015.30.8.1110similar in magnitude to the positive association between fatty  fish intake and serum 25(OH)D levels.,Non-OADS,/arxiv_data1/oa_pdf/13/7e/jkms-30-1110.PMC4520942.pdf
"• Factors Associated with Serum 25(OH)D Levels in Korean Young Adults 1116  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1110positive correlates were older age, male sex, increased physical  activity, sunlight exposure, eating breakfast regularly, consump - tion of dairy and fatty fish, and use of vitamin D-containing  supplements.",Non-OADS,/arxiv_data1/oa_pdf/13/7e/jkms-30-1110.PMC4520942.pdf
• Factors Associated with Serum 25(OH)D Levels in Korean Young Adults http://jkms.org   1117 http://dx.doi.org/10.3346/jkms.2015.30.8.1110cated that abdominal obesity was more strongly related to low  25(OH)D status than overall obesity (21).,Non-OADS,/arxiv_data1/oa_pdf/13/7e/jkms-30-1110.PMC4520942.pdf
"• Factors Associated with Serum 25(OH)D Levels in Korean Young Adults 1118  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1110relationship between SSB intake and milk or dietary vitamin D  intake (11, 34).",Non-OADS,/arxiv_data1/oa_pdf/13/7e/jkms-30-1110.PMC4520942.pdf
"• Factors Associated with Serum 25(OH)D Levels in Korean Young Adults http://jkms.org   1119 http://dx.doi.org/10.3346/jkms.2015.30.8.1110AUTHOR CONTRIBUTION Conception and coordination of the study: Joh HK, Cho B.",Non-OADS,/arxiv_data1/oa_pdf/13/7e/jkms-30-1110.PMC4520942.pdf
ORCID Hee-Kyung Joh http://orcid.org/0000-0002-7751-2405 Chun Soo Lim http://orcid.org/0000-0001-9123-6542 BeLong Cho http://orcid.org/0000-0001-9558-689X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/13/7e/jkms-30-1110.PMC4520942.pdf
"Available at  http://www.academia.edu/5346814/Guidelines_for_Data_Processing_ and_Analysis_of_the_International_Physical_Activity_Questionnaire_ IPAQ_Short_and_Long_Forms_Contents [accessed on June 29, 2015].",Non-OADS,/arxiv_data1/oa_pdf/13/7e/jkms-30-1110.PMC4520942.pdf
• Factors Associated with Serum 25(OH)D Levels in Korean Young Adults 1120  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1110eral density in older women: The Framingham Osteoporosis Study.,Non-OADS,/arxiv_data1/oa_pdf/13/7e/jkms-30-1110.PMC4520942.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clinical Features and Prognosis of Invasive Pulmonary  Aspergillosis in Korean Children with Hematologic/Oncologic  Diseases Invasive pulmonary aspergillosis (IPA) is the most frequent form of invasive fungal diseases  in immunocompromised patients.",Non-OADS,/arxiv_data1/oa_pdf/00/98/jkms-30-1121.PMC4520943.pdf
"Keywords:  Invasive Pulmonary Aspergillosis; Immunocompromised Host; Child Seung Beom Han,1,2 Seong koo Kim,1,3   E Young Bae,1,2 Jae Wook Lee,1,3   Jong-Seo Yoon,1,2 Nack-Gyun Chung,1,3  Bin Cho,1,3 Dae Chul Jeong,1   Jin Han Kang,1,2 Hack-Ki Kim,1,3   Dong-Gun Lee,2,3,4 Hyun Sil Lee,5   and Soo Ah Im5 1Department of Pediatrics, 2Vaccine Bio Research  Institute, 3Catholic Blood and Marrow  Transplantation Center, 4Division of Infectious  Diseases, Department of Internal Medicine, and  5Department of Radiology, College of Medicine, The  Catholic University of Korea, Seoul, Korea Received: 24 December 2014 Accepted: 27 April 2015 Address for Correspondence: Jong-Seo Yoon, MD Department of Pediatrics, Seoul St. Mary’s Hospital, College of  Medicine, The Catholic University of Korea, 222 Banpo-daero,  Seocho-gu, Seoul 137-701, Korea Tel: +82.2-2258-6190, Fax: +82.2-537-4544 E-mail: pedjsyoon@catholic.ac.krhttp://dx.doi.org/10.3346/jkms.2015.30.8.1121  • J Korean Med Sci 2015; 30: 1121-1128 INTRODUCTION Aspergillus  spp.",Non-OADS,/arxiv_data1/oa_pdf/00/98/jkms-30-1121.PMC4520943.pdf
• Invasive Pulmonary Aspergillosis in Children 1122  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1121eases.,Non-OADS,/arxiv_data1/oa_pdf/00/98/jkms-30-1121.PMC4520943.pdf
• Invasive Pulmonary Aspergillosis in Children http://jkms.org   1123 http://dx.doi.org/10.3346/jkms.2015.30.8.1121using a log-rank test.,Non-OADS,/arxiv_data1/oa_pdf/00/98/jkms-30-1121.PMC4520943.pdf
"• Invasive Pulmonary Aspergillosis in Children 1124  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1121within 12 weeks after antifungal therapy and 27 children who  survived longer than 12 weeks after antifungal therapy, there  were no significant differences in the distribution of host factors  and clinical and mycological criteria (data not shown).",Non-OADS,/arxiv_data1/oa_pdf/00/98/jkms-30-1121.PMC4520943.pdf
• Invasive Pulmonary Aspergillosis in Children http://jkms.org   1125 http://dx.doi.org/10.3346/jkms.2015.30.8.1121defining IFD recommended by the EORTC-MSG Consensus  Group between the two groups (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/00/98/jkms-30-1121.PMC4520943.pdf
"• Invasive Pulmonary Aspergillosis in Children 1126  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1121patients with hematologic/oncologic diseases (5, 6, 8, 27-30).",Non-OADS,/arxiv_data1/oa_pdf/00/98/jkms-30-1121.PMC4520943.pdf
• Invasive Pulmonary Aspergillosis in Children http://jkms.org   1127 http://dx.doi.org/10.3346/jkms.2015.30.8.1121the prognosis of IPA in immunocompromised children is ex - pected to be improved with the introduction of liposomal am - photericin B and caspofungin as first line antifungal agents in  the future in Korea.,Non-OADS,/arxiv_data1/oa_pdf/00/98/jkms-30-1121.PMC4520943.pdf
ORCID Seung Beom Han http://orcid.org/0000-0002-1299-2137 Seong koo Kim http://orcid.org/0000-0002-1860-3067 E Young Bae http://orcid.org/0000-0003-2777-210X Jae Wook Lee http://orcid.org/0000-0002-0735-0287 Jong-Seo Yoon http://orcid.org/0000-0002-5782-6175 Nack-Gyun Chung http://orcid.org/0000-0003-4855-390X Bin Cho http://orcid.org/0000-0001-6675-695X Dae Chul Jeong http://orcid.org/0000-0003-0934-817X Jin Han Kang http://orcid.org/0000-0003-1610-6742 Hack-Ki Kim http:// orcid.org/0000-0001-7298-4596 Dong-Gun Lee http://orcid.org/0000-0003-4655-0641 Hyun Sil Lee http://orcid.org/0000-0001-8695-9113 Soo Ah Im http://orcid.org/0000-0002-1264-3690  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/00/98/jkms-30-1121.PMC4520943.pdf
• Invasive Pulmonary Aspergillosis in Children 1128  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1121in paediatric patients with cancer or allogeneic haemopoietic stem-cell  transplantation.,Non-OADS,/arxiv_data1/oa_pdf/00/98/jkms-30-1121.PMC4520943.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Differences in Features and Course of Mucosal Type Eosinophilic  Gastroenteritis between Korean Infants and Children Eosinophilic gastroenteritis (EGE) is a disorder characterized by eosinophilic infiltration of  the bowel wall and various gastrointestinal (GI) manifestations.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/jkms-30-1129.PMC4520944.pdf
"Keywords:  Eosinophilic Gastroenteritis; Histology; Endoscopy; Infants; ChildBong Seok Choi,1 Suk Jin Hong,2   Suk Hyun Park,1 Heng Mi Kim,1   and Byung-Ho Choe1 1Department of Pediatrics, Kyungpook National  University School of Medicine, Daegu; 2Department  of Pediatrics, Catholic University of Daegu School of  Medicine, Daegu, Korea Received: 13 January 2015 Accepted: 9 April 2015 Address for Correspondence: Byung-Ho Choe, MD Department of Pediatrics, Kyungpook National University School  of Medicine, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, Korea Tel: +82.53-200-5704, Fax: +82.53-425-6683 E-mail: bhchoi@knu.ac.krhttp://dx.doi.org/10.3346/jkms.2015.30.8.1129  • J Korean Med Sci 2015; 30: 1129-1135 INTRODUCTION Eosinophilic gastroenteritis (EGE) is an uncommon inflamma - tory disorder of the gastrointestinal (GI) tract of unknown etiol - ogy.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/jkms-30-1129.PMC4520944.pdf
"• Eosinophilic Gastroenteritis in Children 1130  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1129ic infection, vasculitis, and other causes of acute gastroenteritis  (infection, drug) were excluded.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/jkms-30-1129.PMC4520944.pdf
"• Eosinophilic Gastroenteritis in Children http://jkms.org   1131 http://dx.doi.org/10.3346/jkms.2015.30.8.1129 In the pEGE group, initial symptoms included melena (44.4%),  recurrent abdominal pain (33.3%), hematemesis (22.2%), and  vomiting (11.1%) (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/jkms-30-1129.PMC4520944.pdf
• Eosinophilic Gastroenteritis in Children 1132  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1129Fig.,Non-OADS,/arxiv_data1/oa_pdf/0d/b5/jkms-30-1129.PMC4520944.pdf
• Eosinophilic Gastroenteritis in Children http://jkms.org   1133 http://dx.doi.org/10.3346/jkms.2015.30.8.1129restriction.,Non-OADS,/arxiv_data1/oa_pdf/0d/b5/jkms-30-1129.PMC4520944.pdf
"• Eosinophilic Gastroenteritis in Children 1134  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1129study showed a lower incidence of eosinophilia, elevated IgE  levels, or allergic factors than the previous reports; 14% (2 cas - es) of patients had peripheral eosinophilia, 14% (2 cases) of pa - tients had elevated serum IgE levels, 14% (2 cases) of patients  had allergy to certain foods, and only one patient (7%) had a  history of atopy.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/jkms-30-1129.PMC4520944.pdf
• Eosinophilic Gastroenteritis in Children http://jkms.org   1135 http://dx.doi.org/10.3346/jkms.2015.30.8.1129ORCID  Byung-Ho Choe http://orcid.org/0000-0001-9899-9120 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0d/b5/jkms-30-1129.PMC4520944.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Establishment of Reference Ranges for Prostate Volume and  Annual Prostate Volume Change Rate in Korean Adult Men:  Analyses of a Nationwide Screening Population We aimed to determine normal reference ranges for prostate volume (PV) and annual PV  change rate in a Korean nationwide screening population.",Non-OADS,/arxiv_data1/oa_pdf/56/de/jkms-30-1136.PMC4520945.pdf
"Keywords:  Prostate; Benign Prostatic Hyperplasia; Growth; KoreaJinsung Park,1 Dong-Gi Lee,2   Beomseok Suh,3 Sung Yong Cho,4   In Ho Chang,5 Sung Hyun Paick,6   and Hyung-Lae Lee2 1Department of Urology, Eulji University Hospital,  Daejeon; 2Department of Urology, Kyung Hee  University School of Medicine, Seoul; 3Department  of Family Medicine, Seoul National University  Hospital, Seoul; 4Department of Urology, Boramae  Medical Center, Seoul; 5Department of Urology,  Chung-Ang University College of Medicine, Seoul;  6Department of Urology, Konkuk University Hospital,  Seoul, Korea Received: 29 December 2014 Accepted: 27 May 2015 Address for Correspondence: Hyung-Lae Lee, MD Department of Urology, Kyung Hee University Hospital at  Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul 134-727,  Korea  Tel: +82.2-440-7735, Fax: +82.2-440-7744 E-mail: hllee61@hanmail.net http://dx.doi.org/10.3346/jkms.2015.30.8.1136  • J Korean Med Sci 2015; 30: 1136-1142 INTRODUCTION Benign prostatic hyperplasia (BPH) is a major cause of lower  urinary tract symptoms (LUTS) in aging men (1).",Non-OADS,/arxiv_data1/oa_pdf/56/de/jkms-30-1136.PMC4520945.pdf
• Prostate Volume and Volume Change in Korean Men http://jkms.org   1137 http://dx.doi.org/10.3346/jkms.2015.30.8.11362004 and December 2012.,Non-OADS,/arxiv_data1/oa_pdf/56/de/jkms-30-1136.PMC4520945.pdf
"• Prostate Volume and Volume Change in Korean Men 1138  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1136tervals (CIs), was generated (Table 3).",OADS,/arxiv_data1/oa_pdf/56/de/jkms-30-1136.PMC4520945.pdf
"• Prostate Volume and Volume Change in Korean Men http://jkms.org   1139 http://dx.doi.org/10.3346/jkms.2015.30.8.1136BMI, serum PSA level, and baseline PV , after considering varia - tion over time, are shown in Table 4.",Non-OADS,/arxiv_data1/oa_pdf/56/de/jkms-30-1136.PMC4520945.pdf
"• Prostate Volume and Volume Change in Korean Men 1140  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1136inconvenience, and the cost of the examination, particularly in  the primary care setting.",Non-OADS,/arxiv_data1/oa_pdf/56/de/jkms-30-1136.PMC4520945.pdf
"• Prostate Volume and Volume Change in Korean Men http://jkms.org   1141 http://dx.doi.org/10.3346/jkms.2015.30.8.1136differed depending on age (13, 20, 29), BMI (16, 17), serum PSA  level (6, 9), and baseline PV (10, 13).",Non-OADS,/arxiv_data1/oa_pdf/56/de/jkms-30-1136.PMC4520945.pdf
ORCID Jinsung Park http://orcid.org/0000-0001-6158-3359 Dong-Gi Lee http://orcid.org/0000-0001-7369-9252 Hyung-Lae Lee http://orcid.org/0000-0002-4338-7423 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/56/de/jkms-30-1136.PMC4520945.pdf
• Prostate Volume and Volume Change in Korean Men 1142  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1136Urol 2000; 38: 563-8.,Non-OADS,/arxiv_data1/oa_pdf/56/de/jkms-30-1136.PMC4520945.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Survival Outcomes and Predictive Factors for Female Urethral  Cancer: Long-term Experience with Korean Patients The aim of this study was to evaluate female urethral cancer (UCa) patients treated and  followed-up during a time period spanning more than 20 yr at single institution in Korea.",Non-OADS,/arxiv_data1/oa_pdf/dd/91/jkms-30-1143.PMC4520946.pdf
"Keywords:  Female; Urethral Neoplasms; Survival; Outcome AssessmentMinyong Kang,1 Chang Wook Jeong,2  Cheol Kwak,2 Hyeon Hoe Kim,2   and Ja Hyeon Ku2 1Department of Urology, Seoul National University  Bundang Hospital, Seongnam; 2Department of  Urology, Seoul National University Hospital, Seoul,  Korea Received: 31 December 2014 Accepted: 15 April 2015 Address for Correspondence: Ja Hyeon Ku, MD Department of Urology, Seoul National University Hospital,   101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea Tel: +82.2-2072-0361, Fax: +82.2-742-4665 E-mail: randyku@hanmail.nethttp://dx.doi.org/10.3346/jkms.2015.30.8.1143  • J Korean Med Sci 2015; 30: 1143-1149 INTRODUCTION Female urethral cancer (UCa) is a rare malignancy; it accounts  for approximately 1% of all female urological cancer (1).",Non-OADS,/arxiv_data1/oa_pdf/dd/91/jkms-30-1143.PMC4520946.pdf
"• Long-term Data for Female Urethral Cancer in Korean Population 1144  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1143modalities at presentation included mass excision, urethrecto - my, and pelvic exenteration.",Non-OADS,/arxiv_data1/oa_pdf/dd/91/jkms-30-1143.PMC4520946.pdf
• Long-term Data for Female Urethral Cancer in Korean Population http://jkms.org   1145 http://dx.doi.org/10.3346/jkms.2015.30.8.1143Fig.,Non-OADS,/arxiv_data1/oa_pdf/dd/91/jkms-30-1143.PMC4520946.pdf
• Long-term Data for Female Urethral Cancer in Korean Population 1146  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1143Fig.,OADS,/arxiv_data1/oa_pdf/dd/91/jkms-30-1143.PMC4520946.pdf
• Long-term Data for Female Urethral Cancer in Korean Population http://jkms.org   1147 http://dx.doi.org/10.3346/jkms.2015.30.8.1143Table 3.,Non-OADS,/arxiv_data1/oa_pdf/dd/91/jkms-30-1143.PMC4520946.pdf
• Long-term Data for Female Urethral Cancer in Korean Population 1148  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1143compared to their counterparts.,Non-OADS,/arxiv_data1/oa_pdf/dd/91/jkms-30-1143.PMC4520946.pdf
• Long-term Data for Female Urethral Cancer in Korean Population http://jkms.org   1149 http://dx.doi.org/10.3346/jkms.2015.30.8.1143ORICD  Minyong Kang http://orcid.org/0000-0002-6966-8813 Chang Wook Jeong http://orcid.org/0000-0002-2200-5019 Cheol Kwak http://orcid.org/0000-0002-1987-2111 Hyeon Hoe Kim http://orcid.org/0000-0001-6600-4539 Ja Hyeon Ku http://orcid.org/0000-0002-0391-2342 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/dd/91/jkms-30-1143.PMC4520946.pdf
• Long-term Data for Female Urethral Cancer in Korean Population http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1143Fig.,OADS,/arxiv_data1/oa_pdf/dd/91/jkms-30-1143.PMC4520946.pdf
• Long-term Data for Female Urethral Cancer in Korean Population http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1143Fig.,OADS,/arxiv_data1/oa_pdf/dd/91/jkms-30-1143.PMC4520946.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Trends in the Use of Chemotherapy before and after Radical  Cystectomy in Patients with Muscle-invasive Bladder Cancer in  Korea  We investigated trends in perioperative chemotherapy use, and determined factors  associated with neoadjuvant chemotherapy (NAC) and adjuvant chemotherapy (AC) use in  Korean patients with muscle- invasive bladder cancer (MIBC).",Non-OADS,/arxiv_data1/oa_pdf/b2/f1/jkms-30-1150.PMC4520947.pdf
"Received: 31 December 2014 Accepted: 17 April 2015 Address for Correspondence: Bumsik Hong, MD Department of Urology, Asan Medical Center, 88 Olympic-ro   43 gil, Songpa-gu, Seoul 138-736, Korea Tel: +82.2-720-1684, Fax: +82.2-720-3728 E-mail: bshong@amc.seoul.kr Funding:  This research was supported in part by the Korean  Urologic Oncology Society Grant 14-04.http://dx.doi.org/10.3346/jkms.2015.30.8.1150  • J Korean Med Sci 2015; 30: 1150-1156 INTRODUCTION Reports from annual surveys of bladder cancer (BC) estimate  that about 380,000 patients worldwide are newly diagnosed with  BC each year, and that there are about 150,000 BC-related deaths  each year, which verifies that BC is one of the top 10 cancers  worldwide (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/b2/f1/jkms-30-1150.PMC4520947.pdf
"• Multicenter Experience of Neoadjuvant and Adjuvant Chemotherapy in Korea http://jkms.org   1151 http://dx.doi.org/10.3346/jkms.2015.30.8.1150have also suggested significant benefits associated with NAC (8,  9).",Non-OADS,/arxiv_data1/oa_pdf/b2/f1/jkms-30-1150.PMC4520947.pdf
• Multicenter Experience of Neoadjuvant and Adjuvant Chemotherapy in Korea 1152  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1150Ethics statement This study was approved by the ethics committees and the in - stitutional review boards at each hospital (IRB No.,Non-OADS,/arxiv_data1/oa_pdf/b2/f1/jkms-30-1150.PMC4520947.pdf
• Multicenter Experience of Neoadjuvant and Adjuvant Chemotherapy in Korea http://jkms.org   1153 http://dx.doi.org/10.3346/jkms.2015.30.8.1150use of perioperative chemotherapy (Tables 2 and 3).,Non-OADS,/arxiv_data1/oa_pdf/b2/f1/jkms-30-1150.PMC4520947.pdf
"• Multicenter Experience of Neoadjuvant and Adjuvant Chemotherapy in Korea 1154  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1150(A), and cisplatin (C) (MVAC) (20).",Non-OADS,/arxiv_data1/oa_pdf/b2/f1/jkms-30-1150.PMC4520947.pdf
"• Multicenter Experience of Neoadjuvant and Adjuvant Chemotherapy in Korea http://jkms.org   1155 http://dx.doi.org/10.3346/jkms.2015.30.8.1150used NAC regimen was a combination of gemcitabine and cis - platin (48.0%), which has a more favorable toxicity profile than  the MVAC treatment regimen used in the SWOG trial (7).",Non-OADS,/arxiv_data1/oa_pdf/b2/f1/jkms-30-1150.PMC4520947.pdf
ORCID  BumSik Hong http://orcid.org/0000-0003-1991-1229  Ho Kyung Seo http://orcid.org/0000-0003-2601-1093 Sung han Kim http://orcid.org/0000-0002-1689-5203  Hee Chul Shin http://orcid.org/0000-0003-3144-1944 Sung Ja Chang http://orcid.org/0000-0002-2245-5159 Sooin Yun http://orcid.org/0000-0003-2691-7776 Jungnam Joo http://orcid.org/0000-0001-6961-8122 Ja Hyeon Ku http://orcid.org/0000-0002-0391-2342 Hyung Suk Kim http://orcid.org/0000-0002-3661-275X Hwang Gyun Jeon http://orcid.org/0000-0002-5613-8389 Byong Chang Jeong http://orcid.org/0000-0002-5399-2184 In Gab Jeong http://orcid.org/0000-0003-4093-832X Seok Ho Kang http://orcid.org/0000-0002-1524-5233 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b2/f1/jkms-30-1150.PMC4520947.pdf
• Multicenter Experience of Neoadjuvant and Adjuvant Chemotherapy in Korea 1156  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.11502010; 127: 2893-917.,Non-OADS,/arxiv_data1/oa_pdf/b2/f1/jkms-30-1150.PMC4520947.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Epigenetic Role of Histone 3 Lysine Methyltransferase and  Demethylase in Regulating Apoptosis Predicting the Recurrence  of Atypical Meningioma Alteration of apoptosis is related with progression and recurrence of atypical meningiomas  (AMs).",Non-OADS,/arxiv_data1/oa_pdf/d6/a9/jkms-30-1157.PMC4520948.pdf
"Keywords:  Atypical Meningioma; Apoptosis; Histone Modification; Recurrence; EpigeneticsSang Hyuk Lee,1 Eun Hee Lee,2   Sung-Hun Lee,3 Young Min Lee,1   Hyung Dong Kim,4 and Young Zoon Kim1 1Department of Neurosurgery and Division of  Neurooncology, Samsung Changwon Hospital,  Sungkyunkwan University School of Medicine,  Changwon; 2Department of Pathology, Samsung  Changwon Hospital, Sungkyunkwan University  School of Medicine, Changwon, Korea; 3Department  of Molecular and Cellular Oncology, The University  of Texas MD Anderson Cancer Center, Houston, TX,  USA; 4Department of Neurosurgery, Dong-A  University Medical Center, Dong-A University  College of Medicine, Busan, Korea Received: 13 December 2014 Accepted: 7 April 2015 Address for Correspondence: Young Zoon Kim, MD Department of Neurosurgery and Division of Neurooncology,  Samsung Changwon Hospital, Sungkyunkwan University School  of Medicine, 158 Paryong-ro, Masan Hoewon-gu, Changwon  630-723, Korea Tel: +82.55-290-6561, Fax: +82.55-290-6259 E-mail: yzkim@skku.edu Funding:  Laboratory experiment of this study was supported  financially by the research fund of Samsung Changwon Hospital.http://dx.doi.org/10.3346/jkms.2015.30.8.1157  • J Korean Med Sci 2015; 30: 1157-1166 INTRODUCTION  Atypical meningiomas (AMs) are reported to account for 20%- 35% of all meningiomas; they represent an intermediate sub - type between benign and anaplastic meningiomas in the World  Health Organization (WHO) classification (1-4).",Non-OADS,/arxiv_data1/oa_pdf/d6/a9/jkms-30-1157.PMC4520948.pdf
• Histone Modification in Recurrence of Meningioma 1158  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1157pase-8 (21).,Non-OADS,/arxiv_data1/oa_pdf/d6/a9/jkms-30-1157.PMC4520948.pdf
"• Histone Modification in Recurrence of Meningioma http://jkms.org   1159 http://dx.doi.org/10.3346/jkms.2015.30.8.1157ing from 700 to 1,000, in relation with the cellularity of the tu - mor specimen.",Non-OADS,/arxiv_data1/oa_pdf/d6/a9/jkms-30-1157.PMC4520948.pdf
"• Histone Modification in Recurrence of Meningioma 1160  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1157expression between apoptosis-associated factors and histone  modifying enzymes: 1) all the samples that had immunohisto - chemical overexpression of MLL2 (n = 31) also showed immu - nohistochemical overexpression of UTX (n = 31) identically; 2)  of the 32 samples with immunohistochemically overexpressed  survivin, 30 samples (93.8%) had overexpression of MLL2 and  UTX simultaneously, which means that UTX and MLL2 could  induce the expression of survivin ; 3) of the 36 samples with im - munohistochemically overexpressed BCL2, 31 samples (86.1%)  had also overexpression of MLL2 and UTX, which means that  UTX and MLL2 could induce the expression of BCL2; 4) of the  20 samples with immunohistochemically low expressed BAX,  19 samples (95.0%) showed overexpression of KDM5c simulta - neously, which means that KDM5c could suppress the expres - sion of BAX; 5) of the 31 samples with immunohistochemically  low expressed CASP3, 28 samples (90.3%) showed overexpres - sion of JMJD5 simultaneously, which means that JMJD5 could  suppress the expression of CASP3 (Fig.",Non-OADS,/arxiv_data1/oa_pdf/d6/a9/jkms-30-1157.PMC4520948.pdf
"• Histone Modification in Recurrence of Meningioma http://jkms.org   1161 http://dx.doi.org/10.3346/jkms.2015.30.8.1157Recurrence and clinical outcome The mean follow-up time from date of surgical resection was  47.7 months (range, 8.4-132.1 months).",Non-OADS,/arxiv_data1/oa_pdf/d6/a9/jkms-30-1157.PMC4520948.pdf
"• Histone Modification in Recurrence of Meningioma 1162  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1157(P< 0.001), and immunohistochemically low expression of  KDM5c ( P< 0.001) was associated with recurrence in univari - ate analysis (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/d6/a9/jkms-30-1157.PMC4520948.pdf
"• Histone Modification in Recurrence of Meningioma http://jkms.org   1163 http://dx.doi.org/10.3346/jkms.2015.30.8.11570.001) and BAX (HR of 6.338, P< 0.001), and immunohistoche- mical overexpression of survivin (HR of 4.415, P= 0.007), BCL2  (HR of 3.699, P= 0.013) and MDM2 (HR of 2.946, P= 0.037)  (Table 5).",Non-OADS,/arxiv_data1/oa_pdf/d6/a9/jkms-30-1157.PMC4520948.pdf
"• Histone Modification in Recurrence of Meningioma 1164  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1157residues within N-terminal tail (K4, K9, K27, and K36).",Non-OADS,/arxiv_data1/oa_pdf/d6/a9/jkms-30-1157.PMC4520948.pdf
"• Histone Modification in Recurrence of Meningioma http://jkms.org   1165 http://dx.doi.org/10.3346/jkms.2015.30.8.1157of Biostatistics, Samsung Changwon Hospital) for assistance with  statistical analysis, and Hyeon Wook Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/d6/a9/jkms-30-1157.PMC4520948.pdf
ORCID Sang Huck Lee http://orcid.org/0000-0003-4225-5485 Eun Hee Lee http://orcid.org/0000-0003-0844-9120 Sung-Hun Lee http://orcid.org/0000-0002-2172-7888  Young Min Lee http://orcid.org/0000-0002-0348-7577  Hyung Dong Kim http://orcid.org/0000-0002-8320-971X  Young Zoon Kim http://orcid.org/0000-0001-9724-3081 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d6/a9/jkms-30-1157.PMC4520948.pdf
• Histone Modification in Recurrence of Meningioma 1166  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.115723.,Non-OADS,/arxiv_data1/oa_pdf/d6/a9/jkms-30-1157.PMC4520948.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Korean Version of the Pediatric Symptom Checklist:  Psychometric Properties in Korean School-aged Children Psychosocial problems increase the risk for mental health problems and increase the need  for health care services in children and adolescents.",Non-OADS,/arxiv_data1/oa_pdf/ef/a7/jkms-30-1167.PMC4520949.pdf
"Keywords:  Psychosocial Problems, Pediatric Symptom Checklist, Child Behavior Checklist,  Cut-offDoug Hyun Han,1 Jungmin Woo,2   Jae Hoon Jeong,3 Sunyung Hwang,3   and Un-Sun Chung3 1Department of Psychiatry, Chung Ang University  Hospital, Seoul; 2Department of Psychiatry, School  of Medicine, Catholic University of Daegu;  3Department of Psychiatry, Kyungpook National  University Hospital, Daegu, Korea Received: 3 February 2015 Accepted: 27 April 2015 Address for Correspondence: Un-Sun Chung, MD Department of Psychiatry, Kyungpook National University,  School of Medicine, School Mental Health Resources and  Research Center, Kyungpook National University Children’s  Hospital, 807 Hoguk-ro, Buk-gu, Daegu 702-210, Korea Tel: +82.53-200-6414, Fax: +82.53-426-5361 E-mail: chungunsun@hanmail.nethttp://dx.doi.org/10.3346/jkms.2015.30.8.1167  • J Korean Med Sci 2015; 30: 1167-1174 INTRODUCTION  Numerous studies and reports have suggested that psychoso - cial problems increase the risk for mental health problems and  increase the need for health care services in children and ado - lescents (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/ef/a7/jkms-30-1167.PMC4520949.pdf
• Pediatric Symptoms Checklist for Psychometric Properties 1168  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1167Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ef/a7/jkms-30-1167.PMC4520949.pdf
• Pediatric Symptoms Checklist for Psychometric Properties http://jkms.org   1169 http://dx.doi.org/10.3346/jkms.2015.30.8.1167diagnosis of the clinical group made by the child and adoles - cent psychiatrists had been described in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ef/a7/jkms-30-1167.PMC4520949.pdf
"• Pediatric Symptoms Checklist for Psychometric Properties 1170  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1167participants in the lower-middle social economic status com - pared to the non-clinical group ( χ2= 83.50, P< 0.001) (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/ef/a7/jkms-30-1167.PMC4520949.pdf
"• Pediatric Symptoms Checklist for Psychometric Properties http://jkms.org   1171 http://dx.doi.org/10.3346/jkms.2015.30.8.1167confidence interval, 0.065-0.072], root-mean-square residual  [RMR] = 0.015).",Non-OADS,/arxiv_data1/oa_pdf/ef/a7/jkms-30-1167.PMC4520949.pdf
"• Pediatric Symptoms Checklist for Psychometric Properties 1172  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.11670.91) and the Dutch version of the PSC (Cronbach’s alpha = 0.89)  also have been reported to have excellent internal consistency  (14, 19).",Non-OADS,/arxiv_data1/oa_pdf/ef/a7/jkms-30-1167.PMC4520949.pdf
• Pediatric Symptoms Checklist for Psychometric Properties http://jkms.org   1173 http://dx.doi.org/10.3346/jkms.2015.30.8.1167DISCLOSURE  The authors have no conflicts of interest to disclose.,Non-OADS,/arxiv_data1/oa_pdf/ef/a7/jkms-30-1167.PMC4520949.pdf
ORCID Doug Hyun Han http://orcid.org/0000-0002-8314-0767 Jungmin Woo http://orcid.org/0000-0001-7180-9972 Jae Hoon Jeong http://orcid.org/0000-0003-2543-3307 Sunyung Hwang http://orcid.org/0000-0002-1796-8988 Un-Sun Chung http://orcid.org/0000-0003-3871-1425 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ef/a7/jkms-30-1167.PMC4520949.pdf
• Pediatric Symptoms Checklist for Psychometric Properties 1174  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1167tig 2013; 10: 336-45.,Non-OADS,/arxiv_data1/oa_pdf/ef/a7/jkms-30-1167.PMC4520949.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Analysis of Predisposing Factors for Hearing Loss in Adults We aimed to estimate the effects of various risk factors on hearing level in Korean adults,  using data from the Korea National Health and Nutrition Examination Survey.",Non-OADS,/arxiv_data1/oa_pdf/65/00/jkms-30-1175.PMC4520950.pdf
"Received: 24 November 2014 Accepted: 27 April 2015 Address for Correspondence: Hyung-Jong Kim, MD Department of Otorhinolaryngology-Head & Neck Surgery,  Hallym University College of Medicine, Hallym University Sacred  Heart Hospital, 22 Gwanpyeong-ro 170-beon-gil, Dongan-gu,  Anyang 431-796, Korea Tel: +82.31-380-3849, Fax: +82.31-386-3860  E-mail: hjk1000@hallym.ac.kr http://dx.doi.org/10.3346/jkms.2015.30.8.1175  • J Korean Med Sci 2015; 30: 1175-1182 INTRODUCTION Hearing loss is one of the most common problems facing older  adults (1).",Non-OADS,/arxiv_data1/oa_pdf/65/00/jkms-30-1175.PMC4520950.pdf
"• Related Factors of Hearing Loss 1176  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1175ex cluded the following participants from this analysis: partici - pants under 20 yr old (6,676 participants); participants who did  not perform the audiometric test or physical examination (4,512  participants); participants with an abnormal tympanic mem - brane (1,518 participants); participants who had incomplete  BMI, educational level, income, smoking, or alcohol data; and  participants with a history of hypertension, hyperlipidemia,  myo  cardial infarction or angina, and diabetes mellitus (190  participants).",Non-OADS,/arxiv_data1/oa_pdf/65/00/jkms-30-1175.PMC4520950.pdf
"• Related Factors of Hearing Loss http://jkms.org   1177 http://dx.doi.org/10.3346/jkms.2015.30.8.1175A difference in 1 yr was associated with 0.815 dB (95% CI: 0.785,  0.846, P< 0.001) higher thresholds, annually (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/65/00/jkms-30-1175.PMC4520950.pdf
"• Related Factors of Hearing Loss 1178  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1175 Compared to the heavy drinking group (more than 4 times  per week), the estimated threshold values of participants who  drank less than once a month and those who drank 2-4 times a  month were -1.900 dB (95% CI: -3.332, -0.467, P= 0.009) and  -1.982 dB (95% CI: -3.318, -0.645, P= 0.004), respectively.",Non-OADS,/arxiv_data1/oa_pdf/65/00/jkms-30-1175.PMC4520950.pdf
"• Related Factors of Hearing Loss http://jkms.org   1179 http://dx.doi.org/10.3346/jkms.2015.30.8.1175inferior hearing compared to the high education level group  (graduate college), at all frequencies (0.5 kHz, P< 0.001; 1 kHz,  P< 0.001; 2 kHz, P< 0.001; 3 kHz, P< 0.001; 4 kHz, P< 0.001; 6  kHz, P< 0.001).",Non-OADS,/arxiv_data1/oa_pdf/65/00/jkms-30-1175.PMC4520950.pdf
• Related Factors of Hearing Loss 1180  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1175cohol 4 times per week.,Non-OADS,/arxiv_data1/oa_pdf/65/00/jkms-30-1175.PMC4520950.pdf
• Related Factors of Hearing Loss http://jkms.org   1181 http://dx.doi.org/10.3346/jkms.2015.30.8.1175DISCLOSURE The authors have no potential conflicts of interest to disclose.,Non-OADS,/arxiv_data1/oa_pdf/65/00/jkms-30-1175.PMC4520950.pdf
ORCID  Joong Seob Lee http://orcid.org/0000-0003-4763-2091 Hyo Geun Choi http://orcid.org/0000-0003-1655-9549 Sung Kwang Hong http://orcid.org/0000-0002-7048-160X Jeong Hun Jang http://orcid.org/0000-0003-1707-5714 Songyong Sim http://orcid.org/0000-0001-8428-6154 Bumjung Park http://orcid.org/0000-0001-6074-6339 Hyo-Jeong Lee http://orcid.org/0000-0003-2258-0803 Hyung-Jong Kim http://orcid.org/0000-0001-9020-6026 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/65/00/jkms-30-1175.PMC4520950.pdf
"• Related Factors of Hearing Loss 1182  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1175ment in the United States: audiometric evidence from the National  Health and Nutrition Examination Survey, 1999 to 2004.",Non-OADS,/arxiv_data1/oa_pdf/65/00/jkms-30-1175.PMC4520950.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Dicer Is Down-regulated and Correlated with Drosha in  Idiopathic Sudden Sensorineural Hearing Loss Previously, we reported the expression levels of specific microRNA machinery components,  DGCR8 and AGO2, and their clinical association in patients with idiopathic sudden hearing  loss (SSNHL).",Non-OADS,/arxiv_data1/oa_pdf/b9/6f/jkms-30-1183.PMC4520951.pdf
"Keywords:  MicroRNA Biogenesis; Idiopathic Sudden Sensorineural Hearing Loss; Dicer;  DroshaShin Kim,1 Jae-ho Lee,2 and Sung-Il Nam3 Departments of 1Immunology, 2Anatomy, and  3Otorhinolaryngology, School of Medicine,   Keimyung University, Daegu, Korea  Received: 8 December 2014 Accepted: 30 April 2015 Address for Correspondence: Sung-Il Nam, MD Department of Otorhinolaryngology, Keimyung University  School of Medicine, 56 Dalseong-ro, Jung-gu, Daegu 700-712,  Korea Tel: +82.53-250-7159, Fax: +82.53-256-0325 E-mail: entnamsi@dsmc.or.krhttp://dx.doi.org/10.3346/jkms.2015.30.8.1183  • J Korean Med Sci 2015; 30: 1183-1188 INTRODUCTION Sudden sensorineural hearing loss (SSNHL) is a medical emer - gency.",Non-OADS,/arxiv_data1/oa_pdf/b9/6f/jkms-30-1183.PMC4520951.pdf
"• Dicer mRNA Expression Level in Sudden Sensorineural Hearing Loss 1184  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1183other miRNA-related components such as Dicer and Drosha,  and their clinical associations in patients with SSNHL.",Non-OADS,/arxiv_data1/oa_pdf/b9/6f/jkms-30-1183.PMC4520951.pdf
• Dicer mRNA Expression Level in Sudden Sensorineural Hearing Loss http://jkms.org   1185 http://dx.doi.org/10.3346/jkms.2015.30.8.1183Table 2.,Non-OADS,/arxiv_data1/oa_pdf/b9/6f/jkms-30-1183.PMC4520951.pdf
• Dicer mRNA Expression Level in Sudden Sensorineural Hearing Loss 1186  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1183blood cells of patients with SSNHL and healthy controls.,Non-OADS,/arxiv_data1/oa_pdf/b9/6f/jkms-30-1183.PMC4520951.pdf
• Dicer mRNA Expression Level in Sudden Sensorineural Hearing Loss http://jkms.org   1187 http://dx.doi.org/10.3346/jkms.2015.30.8.1183of SSNHL patients.,Non-OADS,/arxiv_data1/oa_pdf/b9/6f/jkms-30-1183.PMC4520951.pdf
ORCID  Shin Kim http://orcid.org/0000-0002-1099-5027 Jae-ho Lee http://orcid.org/0000-0002-5562-0720 Sung-Il Nam http://orcid.org/0000-0002-4871-1755 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b9/6f/jkms-30-1183.PMC4520951.pdf
• Dicer mRNA Expression Level in Sudden Sensorineural Hearing Loss 1188  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.11832641-50.,Non-OADS,/arxiv_data1/oa_pdf/b9/6f/jkms-30-1183.PMC4520951.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Mechanical Antiallodynic Effect of Intrathecal Nefopam in a Rat  Neuropathic Pain Model Nefopam has a pharmacologic profile distinct from that of opioids or other anti- inflammatory drugs.",Non-OADS,/arxiv_data1/oa_pdf/49/78/jkms-30-1189.PMC4520952.pdf
"Keywords:  Mechanical Allodynia; Nefopam; Neuropathic Pain; Spinal Nerve LigationKyung-Hoon Kim,1 Gyeong-Jo Byeon,1  Hee-Young Kim,1 Seung-Hoon Baek,1  Sang-Wook Shin,1 and Sung-Tae Koo2 1Department of Anesthesia and Pain Medicine,  Pusan National University School of Medicine;  Research Institute for Convergence of biomedical  science and technology Pusan National University  Yangsan Hospital, Yangsan; 2Division of Meridian  and Structural Medicine, Pusan National University  School of Korean Medicine, Yangsan, Korea Received: 20 October 2014 Accepted: 29 April 2015 Address for Correspondence: Gyeong-Jo Byeon, MD Department of Anesthesia and Pain Medicine, Pusan National  University Yangsan Hospital, Geumo-ro 20, Yangsan 626-770,  Korea Tel: +82.55-360-2129, Fax: +82.55-360-2149 E-mail: byeongj@pusan.ac.kr Funding:  This study was supported by Research institute for  Convergence of biomedical science and technology (30-2014- 002) Pusan National University Yangsan Hospital.http://dx.doi.org/10.3346/jkms.2015.30.8.1189  • J Korean Med Sci 2015; 30: 1189-1196 INTRODUCTION Neuropathic pain is defined as pain resulting from damage or  dysfunction of peripheral nerves and as a result of injury or dis - ease of the somatosensory system.",Non-OADS,/arxiv_data1/oa_pdf/49/78/jkms-30-1189.PMC4520952.pdf
"• Mechanical Antiallodynic Effect of Intrathecal Nefopam 1190  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1189MATERIALS AND METHODS Animals Twenty-eight male Sprague-Dawley rats, initially weighing 150- 250 g, were used.",Non-OADS,/arxiv_data1/oa_pdf/49/78/jkms-30-1189.PMC4520952.pdf
"• Mechanical Antiallodynic Effect of Intrathecal Nefopam http://jkms.org   1191 http://dx.doi.org/10.3346/jkms.2015.30.8.1189sections were posted on gelatin coated slides, and dried for 2 hr  at room temperature.",Non-OADS,/arxiv_data1/oa_pdf/49/78/jkms-30-1189.PMC4520952.pdf
• Mechanical Antiallodynic Effect of Intrathecal Nefopam 1192  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1189multiple post hoc analysis.,Non-OADS,/arxiv_data1/oa_pdf/49/78/jkms-30-1189.PMC4520952.pdf
"• Mechanical Antiallodynic Effect of Intrathecal Nefopam http://jkms.org   1193 http://dx.doi.org/10.3346/jkms.2015.30.8.1189Nefopam suppressed microglial and astrocytic activation  in the SNL rat model Fourteen days after intrathecal injection of nefopam, the CD11b  and GFAP immunofluorescence intensities decreased on the  ipsilateral L5 spinal cord region in groups N10 and N100 (Fig.",Non-OADS,/arxiv_data1/oa_pdf/49/78/jkms-30-1189.PMC4520952.pdf
• Mechanical Antiallodynic Effect of Intrathecal Nefopam 1194  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1189Fig.,Non-OADS,/arxiv_data1/oa_pdf/49/78/jkms-30-1189.PMC4520952.pdf
"• Mechanical Antiallodynic Effect of Intrathecal Nefopam http://jkms.org   1195 http://dx.doi.org/10.3346/jkms.2015.30.8.1189of action for monoamines that mediate descending inhibitory  pain modulation (18, 19).",Non-OADS,/arxiv_data1/oa_pdf/49/78/jkms-30-1189.PMC4520952.pdf
Revision of the article  for important intellectual content: Koo ST. ORCID Gyeong-Jo Byeon http://orcid.org/0000-0001-5333-3894 Sung-Tae Koo http://orcid.org/0000-0001-7773-3905 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/49/78/jkms-30-1189.PMC4520952.pdf
• Mechanical Antiallodynic Effect of Intrathecal Nefopam 1196  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1189model of neuropathy are prevented by a cyclic analog of orphenadrine.,Non-OADS,/arxiv_data1/oa_pdf/49/78/jkms-30-1189.PMC4520952.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Randomized Comparison of Actual and Ideal Body Weight for  Size Selection of the Laryngeal Mask Airway Classic in  Overweight Patients Size selection of the laryngeal mask airway (LMA) Classic based on actual body weight  remains a common practice.",Non-OADS,/arxiv_data1/oa_pdf/8a/c7/jkms-30-1197.PMC4520953.pdf
"Keywords:  Airway Management; Laryngeal Masks; Body Weight; ComplicationsMin-Soo Kim, Jong Seok Lee,   Sang Beom Nam, Hyo Jong Kang,   and Ji Eun Kim Department of Anesthesiology and Pain Medicine,  Anesthesia and Pain Research Institute, Yonsei  University College of Medicine, Seoul, Korea Received: 4 February 2015 Accepted: 9 April 2015 Address for Correspondence: Ji Eun Kim, MD Department of Anesthesiology and Pain Medicine, Anesthesia  and Pain Research Institute, Yonsei University College of  Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea Tel: +82.2-2227-4614, Fax: +82.2-2227-7897  E-mail: beye98@yuhs.achttp://dx.doi.org/10.3346/jkms.2015.30.8.1197  • J Korean Med Sci 2015; 30: 1197-1202 INTRODUCTION Adequate size selection is of utmost importance in ensuring the  performance and safety of supraglottic airway devices (1).",Non-OADS,/arxiv_data1/oa_pdf/8a/c7/jkms-30-1197.PMC4520953.pdf
"• Size Selection of Laryngeal Mask Airway Classic 1198  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1197the LMA Classic, body mass index ≥ 25 kg/m2, and the presence  of a difference between LMA sizes based on actual body weight  and ideal body weight.",Non-OADS,/arxiv_data1/oa_pdf/8a/c7/jkms-30-1197.PMC4520953.pdf
• Size Selection of Laryngeal Mask Airway Classic http://jkms.org   1199 http://dx.doi.org/10.3346/jkms.2015.30.8.1197Fig.,Non-OADS,/arxiv_data1/oa_pdf/8a/c7/jkms-30-1197.PMC4520953.pdf
• Size Selection of Laryngeal Mask Airway Classic 1200  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1197ed in the actual weight group than in the ideal weight group.,Non-OADS,/arxiv_data1/oa_pdf/8a/c7/jkms-30-1197.PMC4520953.pdf
• Size Selection of Laryngeal Mask Airway Classic http://jkms.org   1201 http://dx.doi.org/10.3346/jkms.2015.30.8.1197ideal body weight group than in the actual weight group.,Non-OADS,/arxiv_data1/oa_pdf/8a/c7/jkms-30-1197.PMC4520953.pdf
ORCID Min-Soo Kim http://orcid.org/0000-0001-8760-4568 Jong Seok Lee http://orcid.org/0000-0002-7945-2530 Sang Beom Nam http://orcid.org/0000-0002-9704-1866 Hyo Jong Kang http://orcid.org/0000-0002-4952-5524 Ji Eun Kim http://orcid.org/0000-0002-1598-5936 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8a/c7/jkms-30-1197.PMC4520953.pdf
• Size Selection of Laryngeal Mask Airway Classic 1202  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.11974.,Non-OADS,/arxiv_data1/oa_pdf/8a/c7/jkms-30-1197.PMC4520953.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Neonatal Iliopsoas Abscess: The First Korean Case Iliopsoas abscess (IPA) is rare in neonates.",Non-OADS,/arxiv_data1/oa_pdf/b7/07/jkms-30-1203.PMC4520954.pdf
"Keywords:  Psoas Abscess; Infant, Newborn; Staphylococcus aureusYoung-Mi Han,1 Ah-Young Kim,1  Ryoung-Kyoung Lim,1 Kyung-Hee Park,1  Shin-Yun Byun,1 Soo-Hong Kim,2   and Hae-Young Kim2 1Division of Neonatology, Department of Pediatrics,  2Department of Pediatric Surgery, Pusan National  University School of Medicine, Yangsan, Korea Received: 28 July 2014 Accepted: 3 December 2014 Address for Correspondence: Shin-Yun Byun, MD Department of Pediatrics, Pusan National University Children’s  Hospital, 20 Geumo-ro, Yangsan 626-787, Korea Tel: +82.55-360-2180, Fax: +82.55-360-2181   E-mail: byun410@hanmail.net Funding:  This study was supported by a 2014 research grant  from Pusan National University Yangsan Hospital.http://dx.doi.org/10.3346/jkms.2015.30.8.1203  • J Korean Med Sci 2015; 30: 1203-1206 INTRODUCTION Iliopsoas abscess (IPA) is a rare disease, especially in neonates.",Non-OADS,/arxiv_data1/oa_pdf/b7/07/jkms-30-1203.PMC4520954.pdf
"• A Case of Neonatal Iliopsoas Abscess 1204  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1203aspirated by needle, the abscess cavity was irrigated thoroughly  using normal saline, and a Penrose drain was inserted into the  abscess cavity.",Non-OADS,/arxiv_data1/oa_pdf/b7/07/jkms-30-1203.PMC4520954.pdf
"• A Case of Neonatal Iliopsoas Abscess http://jkms.org   1205 http://dx.doi.org/10.3346/jkms.2015.30.8.1203case, only swelling and bluish discoloration of the groin and  femoral regions developed, whereas poor movement of the leg  and high fever were not observed.",Non-OADS,/arxiv_data1/oa_pdf/b7/07/jkms-30-1203.PMC4520954.pdf
ORCID Young Mi Han http://orcid.org/0000-0002-6120-0490 Ah-Young Kim http://orcid.org/0000-0002-4458-1973 Ryoung-Kyoung Lim http://orcid.org/0000-0002-5109-7864 Kyung-Hee Park http://orcid.org/0000-0002-1028-4225 Shin-Yun Byun http://orcid.org/0000-0002-9034-5533 Soo-Hong Kim http://orcid.org/0000-0001-7085-5969 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b7/07/jkms-30-1203.PMC4520954.pdf
• A Case of Neonatal Iliopsoas Abscess 1206  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1203abscess associated with right hip septic arthritis in a neonate.,Non-OADS,/arxiv_data1/oa_pdf/b7/07/jkms-30-1203.PMC4520954.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357An Appropriate Lower Respiratory Tract Specimen Is Essential  for Diagnosis of Middle East Respiratory Syndrome (MERS) Jae Hoon Lee,1 Chang-Seop Lee,2,3 and Heung-Bum Lee2,3 1Department of Internal Medicine and Institute of Wonkwang Medical Science, Wonkwang University College of Medicine, Iksan; 2Department of Internal Medicine,  Chonbuk National University Medical School, 3Research Institute of Clinical Medicine of Chonbuk National University, Chonbuk National University Hospital, Jeonju, Koreahttp://dx.doi.org/10.3346/jkms.2015.30.8.1207  • J Korean Med Sci 2015; 30: 1207-1208 The editorial, “Better understanding on MERS Coronavirus  (MERS-CoV) outbreak in Korea, ” was previously published by  Lee (1).",Non-OADS,/arxiv_data1/oa_pdf/1a/a5/jkms-30-1207.PMC4520955.pdf
• Lower Respiratory Tract Specimen Is Essential 1208  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1207agnostic accuracy (10-13).,Non-OADS,/arxiv_data1/oa_pdf/1a/a5/jkms-30-1207.PMC4520955.pdf
ORCID Jae Hoon Lee http://orcid.org/0000-0002-0897-2838 Chang-Seop Lee http://orcid.org/0000-0002-2897-2202 Heung-Bum Lee http://orcid.org/0000-0002-8267-8434 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1a/a5/jkms-30-1207.PMC4520955.pdf
Available at http://www.mers.go.kr/mers/ html/jsp/main.jsp [accessed on July 2 2015].,Non-OADS,/arxiv_data1/oa_pdf/1a/a5/jkms-30-1207.PMC4520955.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2015.30.8.1209  • J Korean Med Sci 2015; 30: 1209-1210 Letter to the editor: Knowledge and Attitude of Nursing  Personnel towards Depression in  General Hospitals: The Korean   Perspective   Nik Kosai,1 Reynu Rajan,1 and Srijit Das2 1Upper Gastrointestinal and Bariatrics Surgery, Department of Surgery,   2Department of Anatomy, Universiti Kebangsaan Malaysia Medical Centre,   Kuala Lumpur, Malaysia  Dear editor: We read with much interest the published article “Knowledge  and Attitude of 851 Nursing Personnel toward Depression in  General Hospitals of Korea” by Park et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/ef/jkms-30-1209.PMC4520956.pdf
"• Nursing Personnel toward Depression  1210  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.1209few inquiries about one’s depressive symptoms, and stigma of  depressive disorders, etc.",Non-OADS,/arxiv_data1/oa_pdf/f5/ef/jkms-30-1209.PMC4520956.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357MERS Countermeasures as One of Global Health Security  Agenda  Jong-Koo Lee Director, JW LEE Center for Global Medicine, Department of Family Medicine, Seoul National University College of Medicine, Seoul, Koreahttp://dx.doi.org/10.3346/jkms.2015.30.8.997  • J Korean Med Sci 2015; 30: 997-998 More than one month has passed by since the first case of Mid - dle East Respiratory Syndrome Coronavirus (MERS-CoV) was  confirmed in Republic of Korea (ROK) on May 20, 2015 (1).",Non-OADS,/arxiv_data1/oa_pdf/2d/b6/jkms-30-997.PMC4520957.pdf
"Lee J-K • MERS Countermeasures as One of Global Health Security Agenda 998  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.997department and intensive care unit should be equipped with an  NPIR, with its costs paid by the government.",Non-OADS,/arxiv_data1/oa_pdf/2d/b6/jkms-30-997.PMC4520957.pdf
"Avail - able at http://www.mers.go.kr/mers/html/jsp/main.jsp [accessed on  June 30, 2015].",Non-OADS,/arxiv_data1/oa_pdf/2d/b6/jkms-30-997.PMC4520957.pdf
Available at http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/2d/b6/jkms-30-997.PMC4520957.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Celebrating the Latest Release of the Journal Impact Factors:  Thinking Globally, Acting Locally Sung-Tae Hong1 and Armen Yuri Gasparyan2 1Editor-in-Chief, Journal of Korean Medical Science, Korean Academy of Medical Sciences, Seoul, Korea; 2Section Editor, Journal of Korean Medical Science, Departments  of Rheumatology and Research & Development, Dudley Group NHS Foundation Trust (Teaching Trust of University of Birmingham, UK), Russells Hall Hospital, Dudley,  West Midlands, UKhttp://dx.doi.org/10.3346/jkms.2015.30.8.999  • J Korean Med Sci 2015; 30: 999-1000 Citation-based metrics are recognized measures of vitality and  importance of scholarly journals, which facilitate distribution of  information and influence scientific progress worldwide.",Non-OADS,/arxiv_data1/oa_pdf/a4/34/jkms-30-999.PMC4520958.pdf
"• Celebrating the Latest Release of the Journal Impact Factors: Thinking Globally, Acting Locally 1000  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.8.999measures are equally dangerous for indexing status of a journal.",Non-OADS,/arxiv_data1/oa_pdf/a4/34/jkms-30-999.PMC4520958.pdf
"Research managers  and policy makers, in turn, should prioritize and invest more in  local archives, repositories, and bibliographic databases such  as the KoreaMed (http://koreamed.org), KoreaMed Synapse  (http://synapse.koreamed.org), Korean Medical Citation Index  (KoMCI at http://www.komci.org), and the Korea Citation In - dex (KCI, https://www.kci.go.kr/kciportal/main.kci).",Non-OADS,/arxiv_data1/oa_pdf/a4/34/jkms-30-999.PMC4520958.pdf
"Pre-Percutaneous Coronary Intervention Intravascular  Ultrasound Findings in Acute Myocardial Infarction Plaque rupture Rupture of vulnerable plaque and/or endothelial erosions with  subsequent thrombus formation are the main mechanisms implicated Review Article http://dx.doi.org/10.4070/kcj.2015.45.4.259 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Role of Intravascular Ultrasound in Patients with Acute   Myocardial Infarction Young Joon Hong, MD, Youngkeun Ahn, MD, and Myung Ho Jeong, MD Division of Cardiology of Chonnam National University Hospital, Heart Convergence Research Center Nominated by Korea Ministry of Health and Welfare,   Gwangju, Korea Rupture of a vulnerable plaque and subsequent thrombus formation are important mechanisms leading to the development of an acute  myocardial infarction (AMI).",Non-OADS,/arxiv_data1/oa_pdf/02/0f/kcj-45-259.PMC4521102.pdf
260  IVUS in AMI http://dx.doi.org/10.4070/kcj.2015.45.4.259 www.e-kcj.org in the pathogenesis of AMI.,OADS,/arxiv_data1/oa_pdf/02/0f/kcj-45-259.PMC4521102.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.4.259 www.e-kcj.org ST-segment elevation myocardial infarction (STEMI) and 29%  patients with non-ST-segment elevation myocardial infarction  (NSTEMI) (p=0.002); furthermore, multiple plaque ruptures tended  to be more frequent in patients with STEMI, as compared with those  with NSTEMI (19% vs. 13%, p=0.14).",Non-OADS,/arxiv_data1/oa_pdf/02/0f/kcj-45-259.PMC4521102.pdf
"262  IVUS in AMI http://dx.doi.org/10.4070/kcj.2015.45.4.259 www.e-kcj.org cap with heavy infiltration of activated macrophage foam cells,  indicating ongoing inflammation at the site of plaque disruption.",Non-OADS,/arxiv_data1/oa_pdf/02/0f/kcj-45-259.PMC4521102.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.4.259 www.e-kcj.org Intravascular ultrasound predictors of stent thrombosis Many IVUS predictors for early stent thrombosis (EST) including  under expansion of stents, smaller final lumen area and inflow/outflow  disease (residual stenosis or dissection) have been reported.44-47)  Previously, we reported that plaque burden at the minimum lumen site  was significantly greater, and pre-PCI plaque rupture and IVUS- detected thrombus were observed more frequently, and post-stenting  tissue prolapse was observed more frequently in patients with EST, as  compared with those without EST (68.8% vs. 32.6%, p=0.003); and  tissue prolapse was an independent predictor of EST.48) Role of Intravascular ultrasound to Detect Plaque  Progression/Regression Several IVUS studies have demonstrated the benefits of statin  therapy in regression or non progression of coronary plaque.",Non-OADS,/arxiv_data1/oa_pdf/02/0f/kcj-45-259.PMC4521102.pdf
264  IVUS in AMI http://dx.doi.org/10.4070/kcj.2015.45.4.259 www.e-kcj.org 2004;44:300-4.,Non-OADS,/arxiv_data1/oa_pdf/02/0f/kcj-45-259.PMC4521102.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.259 www.e-kcj.org 38.,Non-OADS,/arxiv_data1/oa_pdf/02/0f/kcj-45-259.PMC4521102.pdf
"Data from the  Framingham Heart Study indicated that an increased left ventricular Review Article http://dx.doi.org/10.4070/kcj.2015.45.4.266 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Diabetic Cardiomyopathy; Summary of 41 Years Samet Yilmaz, MD1, Ugur Canpolat, MD1, Sinan Aydogdu, MD1, and Hanna Emily Abboud, MD2 1Turkey Yuksek Ihtisas Education and Research Hospital, Cardiology Clinic, Ankara, Turkey 2Division of Nephrology, University of Texas Health Science Center, San Antonio, TX, USA Patients with diabetes have an increased risk for development of cardiomyopathy, even in the absence of well known risk factors like  coronary artery disease and hypertension.",Non-OADS,/arxiv_data1/oa_pdf/51/50/kcj-45-266.PMC4521103.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.4.266 www.e-kcj.org (LV) mass and wall thickness were more prominent symptoms in  diabetic female patients.6) However, the Strong Heart Study showed  that both men and women with diabetes had higher LV masses and  wall thickness.7) Studies with magnetic resonance imaging (MRI)  showed that insulin resistance and impaired glucose levels were  consistently and independently associated with LV hypertrophy and  LV mass to LV end diastolic volume ratio.8)  Hypertrophy of cardiomyocytes appears to be a frequently  observed feature but not a prerequisite of DCM.",Non-OADS,/arxiv_data1/oa_pdf/51/50/kcj-45-266.PMC4521103.pdf
"268  Diabetic Cardiomyopathy http://dx.doi.org/10.4070/kcj.2015.45.4.266 www.e-kcj.org through L-type Ca channels, and induces calcium release from  sarcoplasmic reticulum through the ryanodine receptors, which is  the main mechanism for contraction.",Non-OADS,/arxiv_data1/oa_pdf/51/50/kcj-45-266.PMC4521103.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.266 www.e-kcj.org cell death.,Non-OADS,/arxiv_data1/oa_pdf/51/50/kcj-45-266.PMC4521103.pdf
"270  Diabetic Cardiomyopathy http://dx.doi.org/10.4070/kcj.2015.45.4.266 www.e-kcj.org Hyperglycemia during diabetes has been recognized as a key  factor in the diabetes-induced myocardial defects, including diabetic  cardiomyopathy through structural abnormalities in the  myocardium (cardiac hypertrophy, fibrosis, myofibril defects, and  cardiomyocyte aberrations) and myocardial mitochondrial defects,  such as mitochondrial swelling and fewer number of mitochondria.",Non-OADS,/arxiv_data1/oa_pdf/51/50/kcj-45-266.PMC4521103.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.266 www.e-kcj.org   3.,Non-OADS,/arxiv_data1/oa_pdf/51/50/kcj-45-266.PMC4521103.pdf
272  Diabetic Cardiomyopathy http://dx.doi.org/10.4070/kcj.2015.45.4.266 www.e-kcj.org 2006;290:F927-36.,Non-OADS,/arxiv_data1/oa_pdf/51/50/kcj-45-266.PMC4521103.pdf
"In addition, there was a difference Editorial http://dx.doi.org/10.4070/kcj.2015.45.4.273 Print ISSN 1738-5520  • On-line ISSN 1738-5555 The Theory of Relativity in E (ectopy) and C (coupling):   Who Will Prove It?",Non-OADS,/arxiv_data1/oa_pdf/da/e3/kcj-45-273.PMC4521104.pdf
274  Coupling Interval and Symptom in Ventricular Premature Complexes http://dx.doi.org/10.4070/kcj.2015.45.4.273 www.e-kcj.org in medication history between the two groups.,Non-OADS,/arxiv_data1/oa_pdf/da/e3/kcj-45-273.PMC4521104.pdf
"In Korea, like other developed countries, a  national effort has resulted in a decrease in the overall incidence of  AMI over the last few years.2) However, there is no significant Original Article http://dx.doi.org/10.4070/kcj.2015.45.4.275 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Clinical Characteristics and Outcomes of Acute ST-Segment Elevation  Myocardial Infarction in Younger Korean Adults Seung Hun Lee, MD1, Ju Han Kim, MD1, Myung Ho Jeong, MD1, Hyukjin Park, MD1, Yun Ah Jeong, MD1,   Youngkeun Ahn, MD1, Jong Hyun Kim, MD2, Shung Chull Chae, MD3, Young Jo Kim, MD4, Seung Ho Hur, MD5,   In Whan Seong, MD6, Taek Jong Hong, MD7, Donghoon Choi, MD8, Myeong Chan Cho, MD9, Chong Jin Kim, MD10,   Ki Bae Seung, MD11, Wook Sung Chung, MD11, Yang Soo Jang, MD8, Jeong Gwan Cho, MD1, Jong Chun Park, MD1,  Seung Jung Park, MD12, and Other Korea Acute Myocardial Infarction Registry Investigators    1The Heart Center of Chonnam National University Hospital, Gwangju, 2The Cardiovascular Center, Hanseo Hospital, Busan, 3Department of Internal Medicine, Kyungpook  National University Hospital, Daegu, 4Department of Internal Medicine, Yeungnam University Hospital, Daegu, 5Department of Internal Medicine, Keimyung University  Dongsan Medical Center, Daegu, 6Department of Internal Medicine, Chungnam National University Hospital, Daejeon, 7Department of Internal Medicine, Pusan National  University Hospital, Busan, 8Department of Internal Medicine, Yonsei University Severans Hospital, Seoul, 9Department of Internal Medicine, Chungbuk National University  Hospital, Cheongju, 10Department of Internal Medicine, Kyunghee University College of Medicine, Seoul, 11Department of Internal Medicine, The Catholic University of  Korea Hospital, Seoul, 12Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Background and Objectives:  This study aims to investigate the clinical features, angiographic findings, and outcomes of younger Korean  ST-segment elevation myocardial infarction (STEMI) patients.",Non-OADS,/arxiv_data1/oa_pdf/86/5e/kcj-45-275.PMC4521105.pdf
276  Clinical Characteristics and Outcomes of Younger Korean Adults with STEMI  http://dx.doi.org/10.4070/kcj.2015.45.4.275 www.e-kcj.org change in the incidence of AMI in younger patients.,Non-OADS,/arxiv_data1/oa_pdf/86/5e/kcj-45-275.PMC4521105.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.275 www.e-kcj.org regression analyses were performed using all available variables that  could be of potential relevance in determining the impact of  different age groups on clinical outcomes.,OADS,/arxiv_data1/oa_pdf/86/5e/kcj-45-275.PMC4521105.pdf
"278  Clinical Characteristics and Outcomes of Younger Korean Adults with STEMI  http://dx.doi.org/10.4070/kcj.2015.45.4.275 www.e-kcj.org characteristics, angiographic findings, and procedural findings were  analyzed by the univariate logistic regression analysis.",OADS,/arxiv_data1/oa_pdf/86/5e/kcj-45-275.PMC4521105.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.4.275 www.e-kcj.org Baseline coronary angiographic findings and procedure   characteristics The young and old age groups showed a similar door-to-balloon  time (106.4 min vs. 106.6 min, p=0.847) (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/86/5e/kcj-45-275.PMC4521105.pdf
"280  Clinical Characteristics and Outcomes of Younger Korean Adults with STEMI  http://dx.doi.org/10.4070/kcj.2015.45.4.275 www.e-kcj.org involved more frequently, while the right coronary artery was  involved more frequently in the old age group.",Non-OADS,/arxiv_data1/oa_pdf/86/5e/kcj-45-275.PMC4521105.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.275 www.e-kcj.org and modifiable cause of AMI in younger patients in our study.,Non-OADS,/arxiv_data1/oa_pdf/86/5e/kcj-45-275.PMC4521105.pdf
282  Clinical Characteristics and Outcomes of Younger Korean Adults with STEMI  http://dx.doi.org/10.4070/kcj.2015.45.4.275 www.e-kcj.org Table 6.,Non-OADS,/arxiv_data1/oa_pdf/86/5e/kcj-45-275.PMC4521105.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.4.275 www.e-kcj.org The younger STEMI patients complained of typical chest pain  more frequently, but they experienced angina less frequently before  hospitalization.",Non-OADS,/arxiv_data1/oa_pdf/86/5e/kcj-45-275.PMC4521105.pdf
284  Clinical Characteristics and Outcomes of Younger Korean Adults with STEMI  http://dx.doi.org/10.4070/kcj.2015.45.4.275 www.e-kcj.org Diet 2005;94:1-12.,Non-OADS,/arxiv_data1/oa_pdf/86/5e/kcj-45-275.PMC4521105.pdf
"Previous studies have inconsistently  reported the roles of hs-CRP and NT-proBNP in the progression of  infarct expansion and left ventricular (LV) remodeling after acute  MI.11- 14 ) In the present study, we sought to investigate the  relationship between the levels of serially measured serum hs-CRP Original Article http://dx.doi.org/10.4070/kcj.2015.45.4.285 Print ISSN 1738-5520  • On-line ISSN 1738-5555 The Relationship among N-Terminal Pro-B-Type Natriuretic Peptide,  High-Sensitivity C-Reactive Protein and Infarct Size in Patients     with Acute ST-Elevation Myocardial Infarction  Doo Sun Sim, MD1, Youngkeun Ahn, MD1, Yun-Hyeon Kim, MD2,  Hyun Ju Seon, MD2, Keun Ho Park, MD1,   Hyun Ju Yoon, MD1, Nam Sik Yoon, MD1, Kye Hun Kim, MD1, Young Joon Hong, MD1, Hyung Wook Park, MD1,   Ju Han Kim, MD1, Myung Ho Jeong, MD1, Jeong Gwan Cho, MD1, and Jong Chun Park, MD1 1Department of Cardiology, Cardiovascular Center of Chonnam National University Hospital, Chonnam National University Research Institute of Medical Sciences, Gwangju,  2Department of Radiology, Chonnam National University Hospital, Gwangju, Korea Background and Objectives:  We sought to investigate the relationship between levels of high-sensitivity C-reactive protein (hs-CRP) and  N-terminal pro-B-type natriuretic peptide (NT-proBNP) and the infarct size and left ventricular (LV) volume after acute myocardial  infarction (MI).",Non-OADS,/arxiv_data1/oa_pdf/60/8b/kcj-45-285.PMC4521106.pdf
"286  Levels of NT-proBNP and hs-CRP and Infarct Size  http://dx.doi.org/10.4070/kcj.2015.45.4.285 www.e-kcj.org and NT-proBNP and parameters of infarct size, LV function, and LV  volume after acute MI using delayed enhancement (DE)  multidetector computed tomography (MDCT) and two-dimensional  (2D) echocardiography.",OADS,/arxiv_data1/oa_pdf/60/8b/kcj-45-285.PMC4521106.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.285 www.e-kcj.org Germany) with a retrospective ECG-gated dose modulation  technique.,Non-OADS,/arxiv_data1/oa_pdf/60/8b/kcj-45-285.PMC4521106.pdf
"288  Levels of NT-proBNP and hs-CRP and Infarct Size  http://dx.doi.org/10.4070/kcj.2015.45.4.285 www.e-kcj.org not fit a normal distribution, as evaluated by the Kolmogorov- Smirnov test.",Non-OADS,/arxiv_data1/oa_pdf/60/8b/kcj-45-285.PMC4521106.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.4.285 www.e-kcj.org by the median values at the baseline, and 24 hours and two months  later, respectively.",OADS,/arxiv_data1/oa_pdf/60/8b/kcj-45-285.PMC4521106.pdf
"290  Levels of NT-proBNP and hs-CRP and Infarct Size  http://dx.doi.org/10.4070/kcj.2015.45.4.285 www.e-kcj.org after primary PCI accurately quantifies the infarct size without the  need for additional contrast injection in patients with ST-elevation  MI,21) whereas nuclear testing or cardiac magnetic resonance  imaging (MRI) is difficult to perform in an acute setting and the  gadolinium-enhanced region on an MRI may include interstitial  edema in reversibly injured myocardium within the periinfarct zone.",Non-OADS,/arxiv_data1/oa_pdf/60/8b/kcj-45-285.PMC4521106.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.4.285 www.e-kcj.org outcomes.1-4) However, there are few reports on the relationship  between CRP level and the degree of myocardial damage over time  after acute MI.",Non-OADS,/arxiv_data1/oa_pdf/60/8b/kcj-45-285.PMC4521106.pdf
"292  Levels of NT-proBNP and hs-CRP and Infarct Size  http://dx.doi.org/10.4070/kcj.2015.45.4.285 www.e-kcj.org ECG,14) or cardiac MRI,30) and may provide a theoretical basis for the  prognostic benefit of NT-proBNP in patients with acute MI.",Non-OADS,/arxiv_data1/oa_pdf/60/8b/kcj-45-285.PMC4521106.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.285 www.e-kcj.org with primary angioplasty for acute myocardial infarction: myocardial  blush grade.,Non-OADS,/arxiv_data1/oa_pdf/60/8b/kcj-45-285.PMC4521106.pdf
"Inclusion criteria were predominant  VPCs exhibiting ECG characteristics suggestive of outflow tract (OT)  origin (right or left bundle branch morphology and an inferior axis),  age≥19 years, frequent VPCs (>10% VPC burden per 24 hours)  according to 24-hr Holter ECG monitoring at enrollment without Original Article http://dx.doi.org/10.4070/kcj.2015.45.4.294 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Coupling Interval Ratio Is Associated with Ventricular Premature  Complex-Related Symptoms  Kyoung-Min Park, MD, Sung Il Im, MD, Kwang Jin Chun, MD, Jin Kyung Hwang, MD, Seung-Jung Park, MD,   June Soo Kim, MD, and Young Keun On, MD Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Background and Objectives:  Frequent ventricular premature complex (VPC) is one of the most common arrhythmia syndromes.",Non-OADS,/arxiv_data1/oa_pdf/d8/42/kcj-45-294.PMC4521107.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.4.294 www.e-kcj.org undergo medical or procedural VPC suppression, full description of  symptoms in the medical records including questionnaire and Holter  monitoring, and baseline echocardiography and Holter monitoring  at enrollment.",Non-OADS,/arxiv_data1/oa_pdf/d8/42/kcj-45-294.PMC4521107.pdf
"296  Prediction of Ventricular Premature Complex-Related Symptoms  http://dx.doi.org/10.4070/kcj.2015.45.4.294 www.e-kcj.org were performed using digital calipers at 100 mm/s, on the Muse®  Cardiology Information System (GE Healthcare, Piscataway, NJ,  USA).",OADS,/arxiv_data1/oa_pdf/d8/42/kcj-45-294.PMC4521107.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.294 www.e-kcj.org Statistical analysis  Pearson’s product moment correlation coefficient was calculated  to quantify inter-rater variability in the measurement of both VPC  QRS duration and VPC coupling interval.,OADS,/arxiv_data1/oa_pdf/d8/42/kcj-45-294.PMC4521107.pdf
298  Prediction of Ventricular Premature Complex-Related Symptoms  http://dx.doi.org/10.4070/kcj.2015.45.4.294 www.e-kcj.org branch block pattern (p=0.31) between Groups A and B (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/d8/42/kcj-45-294.PMC4521107.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.4.294 www.e-kcj.org origin, CI between the preceding sinus beat and VPC, and QRS  width, might have differing hemodynamic effects on the heart and  thereby produce differing symptoms.",Non-OADS,/arxiv_data1/oa_pdf/d8/42/kcj-45-294.PMC4521107.pdf
300  Prediction of Ventricular Premature Complex-Related Symptoms  http://dx.doi.org/10.4070/kcj.2015.45.4.294 www.e-kcj.org   2.,Non-OADS,/arxiv_data1/oa_pdf/d8/42/kcj-45-294.PMC4521107.pdf
"AF causes various anatomical and electrical changes in the atria,  which play a pathological role generating and maintaining the Original Article http://dx.doi.org/10.4070/kcj.2015.45.4.301 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Prognostic Implications of Right and Left Atrial Enlargement after  Radiofrequency Catheter Ablation in Patients with Nonvalvular   Atrial Fibrillation Jeonggeun Moon, MD1*, Hye-Jeong Lee, MD2*, Jong-Youn Kim, MD3, Hui-Nam Pak, MD3, Moon-Hyoung Lee, MD3,  Young Jin Kim, MD2, and Boyoung Joung, MD3 1Cardiology Division, Department of Internal Medicine, Gachon University of Medicine and Science, Incheon,   2Department of Radiology, Research Institute of Radiological Science, 3Division of Cardiology, Department of Internal Medicine, Yonsei University College  of Medicine, Seoul, Korea Background and Objectives:  The prognostic role of the right atrium (RA) compared with that of the left atrium (LA) is unclear in  patients with atrial fibrillation (AF).",Non-OADS,/arxiv_data1/oa_pdf/75/5c/kcj-45-301.PMC4521108.pdf
302  Prognostic Implications of Atrial Size after the RFCA for AF http://dx.doi.org/10.4070/kcj.2015.45.4.301 www.e-kcj.org arrhythmia.3)4) Patients with more severe left atrial (LA) disease  experience earlier and more frequent AF recurrence after the index  RFCA.,Non-OADS,/arxiv_data1/oa_pdf/75/5c/kcj-45-301.PMC4521108.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.301 www.e-kcj.org (60–80 mL iopamidol followed by 30 mL 30% blended iopamidol  with saline and 20 mL saline at 5 mL/s).,Non-OADS,/arxiv_data1/oa_pdf/75/5c/kcj-45-301.PMC4521108.pdf
"304  Prognostic Implications of Atrial Size after the RFCA for AF http://dx.doi.org/10.4070/kcj.2015.45.4.301 www.e-kcj.org Right atrial volume as a predictor of early recurrence after  the index radiofrequency catheter ablation Comparisons of clinical characteristics, echocardiographic  parameters, MDCT findings, and electrophysiological  characteristics between patients with early recurrence and  subjects without early recurrence are shown in Table 2.",Non-OADS,/arxiv_data1/oa_pdf/75/5c/kcj-45-301.PMC4521108.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.301 www.e-kcj.org Table 2.,OADS,/arxiv_data1/oa_pdf/75/5c/kcj-45-301.PMC4521108.pdf
306  Prognostic Implications of Atrial Size after the RFCA for AF http://dx.doi.org/10.4070/kcj.2015.45.4.301 www.e-kcj.org are summarized in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/75/5c/kcj-45-301.PMC4521108.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.4.301 www.e-kcj.org patients with AF.5-8) Many forms of atriopathies induced by AF play  a key role in the occurrence and maintenance of the arrhythmia (so  called “AF begets AF”).4)9)10) However, this knowledge is mainly based  on LA studies, whereas little is known about the potential  relationship between RA disease and pathophysiology/prognosis of  AF.",Non-OADS,/arxiv_data1/oa_pdf/75/5c/kcj-45-301.PMC4521108.pdf
"308  Prognostic Implications of Atrial Size after the RFCA for AF http://dx.doi.org/10.4070/kcj.2015.45.4.301 www.e-kcj.org than LA size, for early recurrence in carefully selected patients for  RFCA who have a “not-so-large” LA.",Non-OADS,/arxiv_data1/oa_pdf/75/5c/kcj-45-301.PMC4521108.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.301 www.e-kcj.org tachyarrhythmias following radiofrequency catheter ablation of atrial  fibrillation.,Non-OADS,/arxiv_data1/oa_pdf/75/5c/kcj-45-301.PMC4521108.pdf
"Given its importance in preventing  potentially fatal clinical crises, patient education about self-care  behaviors is a key component of HF management in the chronic  progression of HF disease.5) Cognitive decline may affect a person’s decision-making capacity  in terms of self-care and interfere with their ability to comply with Original Article http://dx.doi.org/10.4070/kcj.2015.45.4.310 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Cognitive Function and Self-Care in Patients   with Chronic Heart Failure Jin Shil Kim, PhD1, Seon Young Hwang, PhD2, Jae Lan Shim, MS2, and Myung Ho Jeong, MD3 1College of Nursing, Gachon University, Incheon, 2College of Nursing, Hanyang University, Seoul, 3Department of Cardiology, Chonnam National University, Gwangju, Korea  Background and Objectives:  This study examined the association of cognitive function with self-care and major adverse cardiac events  (MACE) among heart failure (HF) patients.",Non-OADS,/arxiv_data1/oa_pdf/7c/f2/kcj-45-310.PMC4521109.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.4.310 www.e-kcj.org treatment requirements, and to recognize and manage symptom  exacerbation.5-7) Cognitive decline in HF often presents deficits in  one or more domains of cognition that include attention, memory,  executive function, and psychomotor speed.7-9) Cognitive decline or  frailty is a particular concern in elderly outpatients with reduced or  preserved HF and concomitant comorbidities that complicate early  HF diagnosis and management.10 ) 11 )  Despite the substantial deficits in  one or more areas, few studies have investigated cognitive function  in these multiple domains using a comprehensive test battery in  Korea.",Non-OADS,/arxiv_data1/oa_pdf/7c/f2/kcj-45-310.PMC4521109.pdf
"312  Cognition and Self-Care in Heart Failure Patients http://dx.doi.org/10.4070/kcj.2015.45.4.310 www.e-kcj.org Failure Index21) which included three subscale scores associated with  self-care maintenance (10 items; behavioral adherence to some of  the major treatment recommendations such as checking weight  and ankle swelling, exercise, taking medication, keeping physician’s  appointment, and low-sodium diet), self-care management (6 items;  when dyspnea or leg edema occur, ability to recognize symptom  changes, implement remedies, and evaluate their effectiveness), and  self-care confidence (6 items; confidence to engage in each phase  of the self-care process).",Non-OADS,/arxiv_data1/oa_pdf/7c/f2/kcj-45-310.PMC4521109.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.310 www.e-kcj.org interviews.,Non-OADS,/arxiv_data1/oa_pdf/7c/f2/kcj-45-310.PMC4521109.pdf
"314  Cognition and Self-Care in Heart Failure Patients http://dx.doi.org/10.4070/kcj.2015.45.4.310 www.e-kcj.org event-free survivors and those with MACE, event-free survival was  associated significantly with higher global cognitive function  (K-MMSE; 23.9 vs. 27.1; t=2.30 p=0.024).",Non-OADS,/arxiv_data1/oa_pdf/7c/f2/kcj-45-310.PMC4521109.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.4.310 www.e-kcj.org as indicated by NYHA class II or higher, also had poorer self-care  confidence compared with those who were asymptomatic (NYHA  class I).",Non-OADS,/arxiv_data1/oa_pdf/7c/f2/kcj-45-310.PMC4521109.pdf
Available from: http://www.hira.,Non-OADS,/arxiv_data1/oa_pdf/7c/f2/kcj-45-310.PMC4521109.pdf
"316  Cognition and Self-Care in Heart Failure Patients http://dx.doi.org/10.4070/kcj.2015.45.4.310 www.e-kcj.org of patient characteristics, psychologic status, and cognitive function as  predictors of self-care in persons with chronic heart failure.",Non-OADS,/arxiv_data1/oa_pdf/7c/f2/kcj-45-310.PMC4521109.pdf
"The incidence of KD is higher in the period between winter and  spring when children are often susceptible to numerous respiratory  viruses.5)9) Many studies have been carried out to identify infectious  agents responsible for KD.4)5)10) However, there is no definitive  conclusion regarding this subject.Original Article http://dx.doi.org/10.4070/kcj.2015.45.4.317 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Cardiac Function in Kawasaki Disease Patients with Respiratory  Symptoms Seul Bee Lee, MD, Han Seul Choi, MD, Sejung Son, MD, and Young Mi Hong, MD Department of Pediatrics, Ewha Womans University School of Medicine, Seoul, Korea Background and Objectives:  Respiratory symptoms are often observed in children with Kawasaki disease (KD) during the acute phase.",Non-OADS,/arxiv_data1/oa_pdf/c6/25/kcj-45-317.PMC4521110.pdf
318  Cardiac Function in Kawasaki Disease with Respiratory Symptoms  http://dx.doi.org/10.4070/kcj.2015.45.4.317 www.e-kcj.org Respiratory symptoms are frequently observed in children with  KD during the acute phase.5 )11 ) Jordan-Villegas et al.12) reported that  patients with KD who carry respiratory viruses more frequently  showed coronary artery dilatation and were more often diagnosed  with incomplete KD.,Non-OADS,/arxiv_data1/oa_pdf/c6/25/kcj-45-317.PMC4521110.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.317 www.e-kcj.org was measured from the end of the A’ wave to the onset of the S’  wave.,OADS,/arxiv_data1/oa_pdf/c6/25/kcj-45-317.PMC4521110.pdf
"320  Cardiac Function in Kawasaki Disease with Respiratory Symptoms  http://dx.doi.org/10.4070/kcj.2015.45.4.317 www.e-kcj.org found in 72.7% of the patients, cervical lymphadenopathy in 18.2%,  skin rash in 52.3%, lip and/or oral mucosal abnormality in 31.8%,  palm and/or sole erythema and edema in 22.7%, and BCG site  injection in 22.7% of cases.",Non-OADS,/arxiv_data1/oa_pdf/c6/25/kcj-45-317.PMC4521110.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.317 www.e-kcj.org Comparison of respiratory viruses between Kawasaki disease  patients and the control group  There were no significant differences in positive rates of PCR  between group 2 and group 3 (72.7% vs. 78.0%).,Non-OADS,/arxiv_data1/oa_pdf/c6/25/kcj-45-317.PMC4521110.pdf
322  Cardiac Function in Kawasaki Disease with Respiratory Symptoms  http://dx.doi.org/10.4070/kcj.2015.45.4.317 www.e-kcj.org Response to intravenous immunoglobulin between Kawasaki  disease patients without respiratory symptoms and those  with respiratory symptoms IVIG responders showed improvement in fever and other  symptoms after IVIG administration.,Non-OADS,/arxiv_data1/oa_pdf/c6/25/kcj-45-317.PMC4521110.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.317 www.e-kcj.org respiratory diseases.,Non-OADS,/arxiv_data1/oa_pdf/c6/25/kcj-45-317.PMC4521110.pdf
324  Cardiac Function in Kawasaki Disease with Respiratory Symptoms  http://dx.doi.org/10.4070/kcj.2015.45.4.317 www.e-kcj.org 14.,Non-OADS,/arxiv_data1/oa_pdf/c6/25/kcj-45-317.PMC4521110.pdf
"325 Copyright © 2015 The Korean Society of CardiologyKorean Circulation JournalIntroduction The dominant paradigm indicating that in adults, the formation Original Article http://dx.doi.org/10.4070/kcj.2015.45.4.325 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Absence of Correlation between Changes in the Number   of Endothelial Progenitor Cell Subsets Armin Attar, MD1,2,3, Kamran Aghasadeghi, MD1,4, Mohammad Ebrahim Parsanezhad, MD5,6,   Bahia Namavar Jahromi, MD7, and Mojtaba Habibagahi, PhD8 1Department of Cardiovascular Medicine, 2Cell and Molecular Medicine Research Club, 3Student Research Committee, 4Cardiovascular Research Center,   5Department of OB-GYN, Division of Infertility and Reproductive Medicine, 6Infertility and Reproductive Medicine Research Center,   7Perinatology Research Center, Infertility Reaserch Center, Department ofOB-GYN, 8Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran Background and Objectives:  Previously, various methodologies were used to enumerate the endothelial progenitor cells (EPCs).",Non-OADS,/arxiv_data1/oa_pdf/50/8b/kcj-45-325.PMC4521111.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/ by- nc/3.0) which permits unrestricted non-commercial use, distribution, and repro duction  in any medium, p rovided the original work is properly cited.of new blood vessels occurs only by migration and proliferation of  mature endothelial cells (ECs) in a process termed ‘angiogenesis’  was overturned in recent years by the discovery of endothelial  progenitor cells (EPCs), which differentiate into ECs in a process  referred to as vasculogenesis.1) Currently, several assessment  techniques and definitions have been proposed for EPCs, since they  were first described by Asahara et al.2) Hill et al.3) using culturing  techniques, introduced a colony-forming assay {colony forming unit  Hill (CFU-Hill’s)} in the field.3) They showed that there was a significant  inverse correlation between the concentration of CFU-Hill and  Framingham cardiovascular risk score in human subjects.",Non-OADS,/arxiv_data1/oa_pdf/50/8b/kcj-45-325.PMC4521111.pdf
326  Endothelial Progenitor Cell Subset Correlation http://dx.doi.org/10.4070/kcj.2015.45.4.325 www.e-kcj.org several flow cytometric assays have been proposed to measure the  frequency of circulating EPCs.,Non-OADS,/arxiv_data1/oa_pdf/50/8b/kcj-45-325.PMC4521111.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.4.325 www.e-kcj.org literature, we enumerated the 14 cell populations listed in Table 1.",OADS,/arxiv_data1/oa_pdf/50/8b/kcj-45-325.PMC4521111.pdf
"328  Endothelial Progenitor Cell Subset Correlation http://dx.doi.org/10.4070/kcj.2015.45.4.325 www.e-kcj.org p=0.001), but it was not correlated with the number of  CD34+CD133+ cells (coefficient= 0.478, p=0.193).",OADS,/arxiv_data1/oa_pdf/50/8b/kcj-45-325.PMC4521111.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.4.325 www.e-kcj.org relative changes in the number of CACs/mL and CACs/106 MNCs  were not correlated (coefficient=0.349, p=0.358).",OADS,/arxiv_data1/oa_pdf/50/8b/kcj-45-325.PMC4521111.pdf
330  Endothelial Progenitor Cell Subset Correlation http://dx.doi.org/10.4070/kcj.2015.45.4.325 www.e-kcj.org as the changes in their number are strongly associated with several  cardiovascular diseases.,Non-OADS,/arxiv_data1/oa_pdf/50/8b/kcj-45-325.PMC4521111.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.325 www.e-kcj.org progenitor/stem cells instead of EPCs.,Non-OADS,/arxiv_data1/oa_pdf/50/8b/kcj-45-325.PMC4521111.pdf
Supplementary Materials The online-only Data Supplement is available with this article at  http://dx.doi.org/10.4070/kcj.2015.45.4.325.,Non-OADS,/arxiv_data1/oa_pdf/50/8b/kcj-45-325.PMC4521111.pdf
332  Endothelial Progenitor Cell Subset Correlation http://dx.doi.org/10.4070/kcj.2015.45.4.325 www.e-kcj.org 8.,Non-OADS,/arxiv_data1/oa_pdf/50/8b/kcj-45-325.PMC4521111.pdf
"The septal e’ was higher Case Report http://dx.doi.org/10.4070/kcj.2015.45.4.333 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Constrictive Pericarditis Long after a Gunshot Wound Jung-Ho Choi, MD1, Jae-Sun Uhm, MD1, Sang-Eun Lee, MD1, Kyung-Hyeon Chun, MD1, Hye-Jeong Lee, MD2,   Seung Hyun Lee, MD3, Geu-Ru Hong, MD1, and Moon-Hyoung Lee, MD1 1Departments of Cardiology, 2Radiology, and 3Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea  Constrictive pericarditis is an uncommon post-inflammatory disorder characterized by a variably thickened, fibrotic, and frequently  calcified, pericardium.",Non-OADS,/arxiv_data1/oa_pdf/b3/e8/kcj-45-333.PMC4521112.pdf
"334  Constrictive Pericarditis due to the Bullet http://dx.doi.org/10.4070/kcj.2015.45.4.333 www.e-kcj.org than the lateral e’ (12 cm/sec and 10 cm/sec, respectively).",Non-OADS,/arxiv_data1/oa_pdf/b3/e8/kcj-45-333.PMC4521112.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.333 www.e-kcj.org echocardiographic evidence of constrictive physiology.,Non-OADS,/arxiv_data1/oa_pdf/b3/e8/kcj-45-333.PMC4521112.pdf
336  Constrictive Pericarditis due to the Bullet http://dx.doi.org/10.4070/kcj.2015.45.4.333 www.e-kcj.org for patients with chronic constrictive pericarditis.,Non-OADS,/arxiv_data1/oa_pdf/b3/e8/kcj-45-333.PMC4521112.pdf
"Case Report http://dx.doi.org/10.4070/kcj.2015.45.4.337 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Primary Aortoenteric Fistula of a Saccular Aneurysm:   Case Study and Literature Review Gianfranco Varetto, MD, Lorenzo Gibello, MD, Alessandra Trevisan, MD, Claudio Castagno, MD,   Paolo Garneri, MD, and Pietro Rispoli, MD Division of Vascular Surgery, Department of Surgical Sciences, AOU Città della Salute e della Scienza, Torino, Italy Primary aortoenteric fistula is a direct communication between the aorta and intestinal lumen and it represents a rare but potentially lethal  complication of an abdominal aortic aneurysm.",Non-OADS,/arxiv_data1/oa_pdf/48/32/kcj-45-337.PMC4521113.pdf
An Unusual Presentation of Aortic Aneurysm http://dx.doi.org/10.4070/kcj.2015.45.4.337 www.e-kcj.org338  The patient required the transfusion of four units of packed red  blood cells.,Non-OADS,/arxiv_data1/oa_pdf/48/32/kcj-45-337.PMC4521113.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.337 www.e-kcj.org339 usually self-limiting by formation of a blood clot in the aorto-enteric  fistula.,Non-OADS,/arxiv_data1/oa_pdf/48/32/kcj-45-337.PMC4521113.pdf
"We report a case of a neonate  who had profound TR caused by a ruptured tricuspid valve papillary  muscle and required urgent surgical treatment.Case Report http://dx.doi.org/10.4070/kcj.2015.45.4.340 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Ruptured Tricuspid Valve Papillary Muscle in a Neonate   with Intractable Persistent Fetal Circulation  Ja Kyoung Yoon, MD1, Hye Rim Kim, MD1, Hye Won Kwon, MD1, Bo Sang Kwon, MD1, Gi Beom Kim, MD1,   Eun Jung Bae, MD1, Chung Il Noh, MD1, and Woong Han Kim, MD2 1Departments of Pediatrics and 2Thoracic & Cardiovascular Surgery, Seoul National University Children’s Hospital, Seoul, Korea Unguarded tricuspid regurgitation (TR) due to a flail tricuspid leaflet is a rare condition of newborn cyanosis.",Non-OADS,/arxiv_data1/oa_pdf/4f/34/kcj-45-340.PMC4521114.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.4.340 www.e-kcj.org341 including the infusion of sodium bicarbonate, diuretics, and  complete sedation, failed to improve the hy -poxemia and low  cardiac output.",Non-OADS,/arxiv_data1/oa_pdf/4f/34/kcj-45-340.PMC4521114.pdf
"A Ruptured Tricuspid Valve Papillary Muscle in a Neonate http://dx.doi.org/10.4070/kcj.2015.45.4.340 www.e-kcj.org342  the repair, his cyanosis disappeared, and his cardiac output  improved dramatically.",Non-OADS,/arxiv_data1/oa_pdf/4f/34/kcj-45-340.PMC4521114.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.340 www.e-kcj.org343 TR.,Non-OADS,/arxiv_data1/oa_pdf/4f/34/kcj-45-340.PMC4521114.pdf
"After the one-and-a-half ventricle  repair, the patient’s symptoms improved dramatically and, against Case Report http://dx.doi.org/10.4070/kcj.2015.45.4.344 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Transvascular Implantation of an Implantable Cardioverter-Defibrillator  in a Patient Who has Undergone One-and-a-Half Ventricle Repair Pil-Sung Yang, MD1, Je Wook Park, MD1, Yong-Joon Lee, MD1, Dong-Jun Kim, MD1,   Seng Chan You, MD1, Dong Hyuk Park, MD1, Jae-Sun Uhm, MD1, and Nam Kyun Kim, MD2 1Departments of Cardiology and 2Pediatric Cardiology, Arrhythmia Center, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea Implantable cardioverter-defibrillator (ICD) therapy is acknowledged as a valid treatment method for the effective prevention of sudden  cardiac death, which is a major cause of mortality in adult congenital heart disease patients.",Non-OADS,/arxiv_data1/oa_pdf/df/8a/kcj-45-344.PMC4521115.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.4.344 www.e-kcj.org our advice, he stopped visiting the clinic.",Non-OADS,/arxiv_data1/oa_pdf/df/8a/kcj-45-344.PMC4521115.pdf
346  ICD Implantation in Patient with One-and-a-Half Ventricle Repair http://dx.doi.org/10.4070/kcj.2015.45.4.344 www.e-kcj.org a catheter through the femoral vein and performed a right  subclavian vein angiogram to confirm an intact flow through the  connection between the SVC and the pulmonary artery.,Non-OADS,/arxiv_data1/oa_pdf/df/8a/kcj-45-344.PMC4521115.pdf
http://dx.doi.org/10.4070/kcj.2015.45.4.344 www.e-kcj.org 2.,Non-OADS,/arxiv_data1/oa_pdf/df/8a/kcj-45-344.PMC4521115.pdf
"Korean Circulation Journal348 Copyright © 2015 The Korean Society of CardiologyKorean Circ J 2015;45:216-224   http://dx.doi.org/10.4070/kcj.2015.45.3.216 In this article, on page 218, Fig.",Non-OADS,/arxiv_data1/oa_pdf/13/bd/kcj-45-348.PMC4521116.pdf
"Before correction                                             After correctionErratum: Figure Corrections http://dx.doi.org/10.4070/kcj.2015.45.4.348 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Erratum to: Small Left Atrial Size Complicating Percutaneous   Transcatheter Device Closure of Secundum Atrial Septal Defect   with Conventional Approach Hong Ki Ko, MD1, So Yeon Kang, MD2, Jeong Jin Yu, MD2, Jae-Kon, Ko, MD2, and Young-Hwue Kim, MD2 1Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine, Suwon,   2Division of Pediatric Cardiology, Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea D  LABalloon B  Pulmonary vein LA RA D  RABalloon B  Pulmonary vein LA LA",Non-OADS,/arxiv_data1/oa_pdf/13/bd/kcj-45-348.PMC4521116.pdf
"Korean Circulation Journal349 Copyright © 2015 The Korean Society of CardiologyKorean Circ J 2015;45:225-233  http://dx.doi.org/10.4070/kcj.2015.45.3.225 In this article, on page 230, Fig.",Non-OADS,/arxiv_data1/oa_pdf/c9/c0/kcj-45-349.PMC4521117.pdf
"Before correction                                                          After correctionErratum: Figure Corrections http://dx.doi.org/10.4070/kcj.2015.45.4.349 Print ISSN 1738-5520  • On-line ISSN 1738-5555 Erratum to: Additive Beneficial Effects of Valsartan Combined with  Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive  Patients Ji-Yong Jang, MD1, Sang-Hak Lee, MD1, Byung Soo Kim, MD2, Hong Seog Seo, MD3, Woo-Shik Kim, MD4,   Youngkeun Ahn, MD5 , Nae-Hee Lee, MD6, Kwang Kon Koh, MD7, Tae-Soo Kang, MD8, Sang-Ho Jo, MD9, Bum-Kee Hong, MD10,  Jang-Ho Bae, MD11, Hyoung-Mo Yang, MD12, Kwang Soo Cha, MD13, Bum Soo Kim, MD14, Choong Hwan Kwak, MD15,  Deok-Kyu Cho, MD16, Ung Kim, MD17, Joo-Hee Zo, MD18, Duk-Hyun Kang, MD19, Wook Bum Pyun, MD20,   Kook Jin Chun, MD21, June Namgung, MD22, Tae-Joon Cha, MD23, Jae-Hyeon Juhn24, YeiLi Jung24, and Yangsoo Jang, MD1 1Division of Cardiology and Cardiovascular Research  Institute, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, 2Division of Cardiology, Department of Internal Medicine, Daedong Hospital, Busan, 3Division of Cardiology, Cardiovascular Center, Korea University Guro Hospital, Korea  University College of Medicine, Seoul, 4Division of Cardiology, Department of Internal Medicine, Kyung Hee University Medical Center, Seoul, 5Department of Cardiology,  Heart Research Center of Chonnam National University Hospital, Gwangju, 6Department of Cardiology, Soon Chun Hyang University Bucheon Hospital, Bucheon, 7Department of Cardiology, Gachon University Gil Medical Center, Incheon, 8Division of Cardiology, Dankook University College of Medicine, Cheonan,9Division of   Cardiology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, 10Division of Cardiology, Department of Internal Medicine, Gangnam  Severance Hospital, Yonsei University College of Medicine, Seoul, 11Division of Cardiology, Department of Internal Medicine, Konyang University Hospital, Daejeon,  12Department of Cardiology, Ajou University Medical Center, Suwon, 13Division of Cardiology, Pusan National University Hospital, Busan, 14Division of Cardiology,   Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, 15Division of Cardiology, Department of Internal   Medicine, Gyeongsang National University Hospital and Gyeongsang National University School of Medicine, Jinju, 16Department of Cardiology, Myongji Hospital  Cardiovascular Center, Goyang, 17Division of Cardiology, Department of Internal Medicine, Yeungnam University Hospital, Daegu, 18Division of Cardiology, Department of  Internal Medicine, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, 19Division of Cardiology, Asan Medical Center, University of  Ulsan College of Medicine, Seoul,  20Division of Cardiology, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul,  21Department of  Cardiology, Pusan National University Yangsan Hospital, Yangsan,  22Division of Cardiology, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang,   23Division of Cardiology, Department of Internal Medicine, Kos in University Gospel Hospital, Busan,  24Clinical Development Department, LG Life Sciences Ltd., Seoul, Korea sitDBPChange of BP at week 8 (least squares mean mm Hg)sitDBP p=0.020 -5 -10 -15p=0.42p<0.001 p=0.006A   sitDBPChange of BP at week 8 (least squares mean mm Hg)sitSBP p=0.020 -5 -10 -15p=0.42p<0.001 p=0.006A",Non-OADS,/arxiv_data1/oa_pdf/c9/c0/kcj-45-349.PMC4521117.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 789 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/50/dyu122.PMC4521121.pdf
These outputs are central to their policy-driven approach.DSS releases an annual report about each wave (these can be found at http://dss.gov.au/lsic).,OADS,/arxiv_data1/oa_pdf/24/50/dyu122.PMC4521121.pdf
Technical papers and publications relating to the development of LSIC can be found on the DSS website (http://dss.gov.au/lsic).,OADS,/arxiv_data1/oa_pdf/24/50/dyu122.PMC4521121.pdf
The LSIC webpage (http://dss.gov.au/lsic) and Supplementary Material F (available as Supplementary data atIJEonline) provide additional infor- mation on the LSIC data and access arrangements.,OADS,/arxiv_data1/oa_pdf/24/50/dyu122.PMC4521121.pdf
"2010. http://www.abs.gov.au/AUSSTATS/abs@.nsf/ lookup/4704.0Main þFeatures1Oct þ2010 (26 August 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/24/50/dyu122.PMC4521121.pdf
"Goodman R. SDQ: Information for Researchers and Professionals About the Strengths & Difﬁculties Questionnaires .2011. http://www.sdqinfo.org/ (20 September 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/24/50/dyu122.PMC4521121.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 919 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/01/dyv006.PMC4521124.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 870 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/bd/dyv081.PMC4521130.pdf
Funding This work was supported by Autism Speaks (http://www.autismspeaks.,Non-OADS,/arxiv_data1/oa_pdf/25/bd/dyv081.PMC4521130.pdf
org/; Basic and Clinical Grant #7618) and the Swedish Research Council (http://www.vr.se/; Grant # 2012-2264).,Non-OADS,/arxiv_data1/oa_pdf/25/bd/dyv081.PMC4521130.pdf
Thedata linkages and staff costs have also been supported by grants fromthe: Stockholm County Council (http://www.sll.se/; Grant # 2007008);Swedish Council for Working Life and Social Research (http://www.forte.se/; Grant # 2007-2064); Swedish Research Council (http://www.vr.se/; Grant # 523-2010-1052); and Swedish Regional agreement onmedical training and clinical research (ALF).,Non-OADS,/arxiv_data1/oa_pdf/25/bd/dyv081.PMC4521130.pdf
6/27/2013 http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/25/bd/dyv081.PMC4521130.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 862 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/e3/dyv114.PMC4521134.pdf
"24 February 2014. http://blogs.nature.com/ news/2014/02/evidence-of-misconduct-cardiologist.html(17 March 2014, date last accessed) .",Non-OADS,/arxiv_data1/oa_pdf/e3/e3/dyv114.PMC4521134.pdf
"http://apps.who.int/trialsearch/Trial2.aspx?TrialID ¼EUCTR2007-007699- 40-BE (17 December 2014, date last accessed) .",Non-OADS,/arxiv_data1/oa_pdf/e3/e3/dyv114.PMC4521134.pdf
"ID 2007-007699-40. https://www.clinicaltrialsregi ster.eu/ctr-search/trial/2007- 007699-40/BE (17 December 2014, date last accessed) .",Non-OADS,/arxiv_data1/oa_pdf/e3/e3/dyv114.PMC4521134.pdf
"http://retractionwatch.com/2013/08/26/author-with-six-recent-corrections-retracts-jbc-paper-questioned- on-pubpeer/ (16 December 2014, date last accessed) .",Non-OADS,/arxiv_data1/oa_pdf/e3/e3/dyv114.PMC4521134.pdf
"http://www.forbes.com/sites/lar-ryhusten/2014/01/15/medicine-or-mass-murder-guideline-based-on-discredited-research-may-have-caused-800000-deaths-in- europe-over-the-last-5-years/ (17 March 2014, date last accessed) .",Non-OADS,/arxiv_data1/oa_pdf/e3/e3/dyv114.PMC4521134.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 906 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/0a/dyv117.PMC4521135.pdf
http://www.who.int/immunization/sage/meetings/ 2014/april/3_NSE_Epidemiology_review_Report_to_SAGE_ 14_Mar_FINAL.pdf 42.,Non-OADS,/arxiv_data1/oa_pdf/32/0a/dyv117.PMC4521135.pdf
66. http://www.sightandlife.org/ﬁleadmin/data/Magazine/2013/27_ 1_2013/Congress_report_a_framework_for_shifting_from_uni- versal_vitamin_a_supplementation.pdf.,Non-OADS,/arxiv_data1/oa_pdf/32/0a/dyv117.PMC4521135.pdf
http://wphna.org/wp-content/uploads/2014/12/2014- 11-GAVA-rebuttal-of-IJE-commentary-here.pdf.,Non-OADS,/arxiv_data1/oa_pdf/32/0a/dyv117.PMC4521135.pdf
EditorialAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2015.5.3.133 Asia Pac Allergy 2015;5:133-135 Copyright © 2015.,Non-OADS,/arxiv_data1/oa_pdf/ad/e5/apa-5-133.PMC4521161.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/ad/e5/apa-5-133.PMC4521161.pdf
"apallergy.org  Wang JYAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2015.5.3.133134   effect of exposure to antibiotics in the first year of life influences  the development of common allergic diseases in later childhood,  i.e., increase the risk of asthma, allergic rhinitis, and atopic  dermatitis to nearly two folds in general population of Taiwan  [10], although confounding by familial factors and by respiratory  infections are difficult to exclude.",Non-OADS,/arxiv_data1/oa_pdf/ad/e5/apa-5-133.PMC4521161.pdf
apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.133The sticky relationship between allergies and infections13511.,Non-OADS,/arxiv_data1/oa_pdf/ad/e5/apa-5-133.PMC4521161.pdf
Current reviewAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2015.5.3.136 Asia Pac Allergy 2015;5:136-144Chronic cough: an Asian perspective.,Non-OADS,/arxiv_data1/oa_pdf/4d/4c/apa-5-136.PMC4521162.pdf
"http://apallergy.org INTRODUCTION Asia is one of the largest, most populous, diverse, and dynamic  continents.",Non-OADS,/arxiv_data1/oa_pdf/4d/4c/apa-5-136.PMC4521162.pdf
Chronic cough epidemiology in Asia137 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.136 disease situations in this previously mostly agricultural region.,Non-OADS,/arxiv_data1/oa_pdf/4d/4c/apa-5-136.PMC4521162.pdf
"Song WJ, et al.Asia Pacific allergy138 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.136respectively [16].",OADS,/arxiv_data1/oa_pdf/4d/4c/apa-5-136.PMC4521162.pdf
Chronic cough epidemiology in Asia139 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.136documented in several studies.,Non-OADS,/arxiv_data1/oa_pdf/4d/4c/apa-5-136.PMC4521162.pdf
"Song WJ, et al.Asia Pacific allergy140 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.136in traffic policemen has been attributed to pollution from vehicle  exhaust fumes because these traffic policemen work in traffic and  are directly exposed to such fumes [55].",Non-OADS,/arxiv_data1/oa_pdf/4d/4c/apa-5-136.PMC4521162.pdf
Chronic cough epidemiology in Asia141 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.136Central Asia No studies in Central Asia were identified in this literature search.,Non-OADS,/arxiv_data1/oa_pdf/4d/4c/apa-5-136.PMC4521162.pdf
Available from: http://en.wikipedia.org/wiki/Asia.,Non-OADS,/arxiv_data1/oa_pdf/4d/4c/apa-5-136.PMC4521162.pdf
"Song WJ, et al.Asia Pacific allergy142 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.1364.",OADS,/arxiv_data1/oa_pdf/4d/4c/apa-5-136.PMC4521162.pdf
Chronic cough epidemiology in Asia143 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.136People’s Democratic Republic.,Non-OADS,/arxiv_data1/oa_pdf/4d/4c/apa-5-136.PMC4521162.pdf
"Song WJ, et al.Asia Pacific allergy144 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.136developed countries: an update.",OADS,/arxiv_data1/oa_pdf/4d/4c/apa-5-136.PMC4521162.pdf
"http://dx.doi.org/10.5415/apallergy.2015.5.3.145 Asia Pac Allergy 2015;5:145-155 http://apallergy.orgAssociation of prevalence of rhinitis, atopic  eczema, rhinoconjunctivitis and wheezing with  mortality from infectious diseases and with  antibiotic susceptibility at a country level Claudia Fsadni1,2,*, Peter Fsadni1,2, Stephen Fava1,2, and Stephen Montefort1,2 1Department of Medicine, Mater Dei Hospital, Msida, MSD 2090, Malta 2Faculty of Medicine and Surgery, University of Malta, Msida, MSD 2090, Malta Background:  It was previously reported that there is a positive correlation between incidence of type 1 diabetes and prevalence  of asthma and atopic eczema.",Non-OADS,/arxiv_data1/oa_pdf/3c/c0/apa-5-145.PMC4521163.pdf
Asia Pacific allergy146 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.145INTRODUCTION Atopic eczema is a chronic inflammatory skin condition that  appears to be potentially associated with genetic and acquired  defects in the proteins and lipids in the outer layer of the  epidermis.,Non-OADS,/arxiv_data1/oa_pdf/3c/c0/apa-5-145.PMC4521163.pdf
Association of atopy with infectious disease mortality147 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.145documented.,Non-OADS,/arxiv_data1/oa_pdf/3c/c0/apa-5-145.PMC4521163.pdf
Asia Pacific allergy148 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.145Table 1.,Non-OADS,/arxiv_data1/oa_pdf/3c/c0/apa-5-145.PMC4521163.pdf
Association of atopy with infectious disease mortality149 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.145United States 8.5 34.6 21.7 17.9 16.0   11.3   0.2 0.3 0 0.1 Barbados 5.0 16.4  11.0 56.8   19.3   N/A 1.0 0 0.3 Austria 5.2 21.6 11.6 10.4  2.8      7.1   0.4 0 0 0 Belgium 6.7 36.4 12.0 14.5 7.7   20.2   0.6 0.4 0 0 Estonia 5.7 21.9 10.8  5.0 14.1   19.1   5.3 0.1 0 0 Finland 15.6 37.1 16.0 16.7 4.5   21.9   1.0 0.3 0 0.1 France 10.0 46.5 13.5 16.1 7.4   13.7   1.0 0.5 0 0.1 Germany 6.9 29.0 13.8 13.4 7.9   11.0   0.4 0.2 0 0 Greece 3.1 14.4  3.7 6.3 3.5   14.1   0.5 0 0 0 Italy 5.7 27.3  8.9 13.6 5.4   14.1   0.4 0 0 0.1 Latvia 4.9 22.3  8.4  5.0 27.6   12.3   9.4 0.4 0 0.3 Lithuania 1.7 27.6  8.2 5.6 13.0     8.8   8.1 0.1 0 0.1 Poland 5.4 18.3 8.1 9.5  5.9   12.9   2.3 0.1 0 0 Portugal 4.4 21.1 9.5 7.3 24.4   28.8   2.4 0.1 0 0.1 Romania 6.3 11.5  3.0 5.2 16.6   26.7   9.0 1.0 0 0 Spain 4.4 32.1 10.3 15.0 10.1   10.7   0.7 0.3 0 0 Sweden 14.5 23.0 12.9 11.7  5.3    11.7   0.3 0.2 0 0.2 United   Kingdom8.8 34.3 32.2 18.4  5.1   45.8   0.5 0.5 0 0 Ireland 13.6 41.8 29.1 20.0  5.5  43.0   0.9 0.1 0 0.1 Russia 4.0 19.7  7.15  7.0 33.0  21.0  18.4 0.8 0 0.1 Ukraine 5.3 20.7  12.9 11.,Non-OADS,/arxiv_data1/oa_pdf/3c/c0/apa-5-145.PMC4521163.pdf
Asia Pacific allergy150 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.145may lead to an increased risk of both atopic and infectious diseases.,Non-OADS,/arxiv_data1/oa_pdf/3c/c0/apa-5-145.PMC4521163.pdf
Association of atopy with infectious disease mortality151 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.145due to the fact that such respiratory conditions are usually nonfatal  and we studied mortality data rather than incidence of infections.,Non-OADS,/arxiv_data1/oa_pdf/3c/c0/apa-5-145.PMC4521163.pdf
Asia Pacific allergy152 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.145Strengths and limitations This ecological study is based on international research projects  involving large numbers of patients of the same age groups.,Non-OADS,/arxiv_data1/oa_pdf/3c/c0/apa-5-145.PMC4521163.pdf
"Association of atopy with infectious disease mortality153 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.145classification, coding and diagnosis in different countries and  centers.",Non-OADS,/arxiv_data1/oa_pdf/3c/c0/apa-5-145.PMC4521163.pdf
Available from: http://isaac.auckland.ac.nz.,Non-OADS,/arxiv_data1/oa_pdf/3c/c0/apa-5-145.PMC4521163.pdf
Available from: http://www.who.int/ healthinfo/paper54.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3c/c0/apa-5-145.PMC4521163.pdf
Available from: http://www.who.int/whr/2004/en/.,OADS,/arxiv_data1/oa_pdf/3c/c0/apa-5-145.PMC4521163.pdf
"Asia Pacific allergy154 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.145Sorg C, Muller-Tidow C, Sunderkotter C, Kucharzik T, Spahn TW.",OADS,/arxiv_data1/oa_pdf/3c/c0/apa-5-145.PMC4521163.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/c0/apa-5-145.PMC4521163.pdf
"Association of atopy with infectious disease mortality155 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.145ML, Dubois AM, Gold DR, Ryan LM, Weiss ST, Celedon JC.",Non-OADS,/arxiv_data1/oa_pdf/3c/c0/apa-5-145.PMC4521163.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2015.5.3.156 Asia Pac Allergy 2015;5:156-162 http://apallergy.orgImmunoglobulin E to allergen components of  house dust mite in Korean children with allergic  disease Hwan Soo Kim, Sung Hee Kang, Sulmui Won, Eu Kyoung Lee, Yoon Hong Chun, Jong-Seo Yoon*, Hyun Hee Kim,    and Jin Tack Kim Department of Pediatrics, The Catholic University of Korea College of Medicine, Seoul 137-701, Korea Background:  House dust mites (HDMs) are important sources of indoor allergens.",Non-OADS,/arxiv_data1/oa_pdf/46/1a/apa-5-156.PMC4521164.pdf
Mite component in allergic children157 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.156 INTRODUCTION House dust mites (HDMs) are important sources of indoor  allergens [1].,Non-OADS,/arxiv_data1/oa_pdf/46/1a/apa-5-156.PMC4521164.pdf
Asia Pacific allergy158 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.156episodes of shortness of breath or exercise-induced shortness  of breath or cough.,Non-OADS,/arxiv_data1/oa_pdf/46/1a/apa-5-156.PMC4521164.pdf
"Mite component in allergic children159 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.156Correlation between total IgE and specific IgE to HDM  and its components We found a moderate positive correlation between total IgE and  specific IgE to Der p, Der f, Der p 2, and Der p 10 and low positive  correlation between total IgE and Der p 1 specific IgE (Table 3).DISCUSSION HDM are major allergen sources for almost 50% of allergic  patients [26].",Non-OADS,/arxiv_data1/oa_pdf/46/1a/apa-5-156.PMC4521164.pdf
Asia Pacific allergy160 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.156were similar to previous studies from temperate climate.,Non-OADS,/arxiv_data1/oa_pdf/46/1a/apa-5-156.PMC4521164.pdf
"Mite component in allergic children161 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.156Der p 10 (tropomyosin) is a minor mite allergen but prominent  in seafood, and cross-reactivity is extremely frequent [29].",Non-OADS,/arxiv_data1/oa_pdf/46/1a/apa-5-156.PMC4521164.pdf
Available from: http://www.iuisonline.org/index.php?option=com_ content&view=article&id=47&Itemid=54.,Non-OADS,/arxiv_data1/oa_pdf/46/1a/apa-5-156.PMC4521164.pdf
Asia Pacific allergy162 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.156mation of asthmatic mice through TLR4 pathway in airway epithelial  cells.,Non-OADS,/arxiv_data1/oa_pdf/46/1a/apa-5-156.PMC4521164.pdf
"http://dx.doi.org/10.5415/apallergy.2015.5.3.163 Asia Pac Allergy 2015;5:163-169 http://apallergy.orgEffect of high-dose sublingual immunotherapy  on respiratory infections in children allergic to  house dust mite Salvatore Barberi1, Giorgio Ciprandi2,*, Elvira Verduci1, Enza D’Auria1, Piercarlo Poli1, Benedetta Pietra1,    Cristoforo Incorvaia3, Serena Buttafava4, Franco Frati4, and Enrica Riva1 1Department of Pediatrics, San Paolo Hospital, 20142 Milan, Italy  2Department of Medicine, IRCCS-Azienda Ospedaliera Universitaria San Martino, 16132  Genoa, Italy 3Allergy/Pulmonary Rehabilitation, ICP Hospital, 20100 Milan, Italy 4Medical and Scientific Department, Stallergenes Italy, 20155 Milan, Italy Background : Allergic rhinitis is characterized by eosinophil inflammation.",Non-OADS,/arxiv_data1/oa_pdf/3d/ec/apa-5-163.PMC4521165.pdf
"Barberi S, et al.Asia Pacific allergy164 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.163INTRODUCTION Social and economic costs of allergic rhinitis (AR) are relevant as  AR may significantly impact school attendance and performance,  quality of life, sleep, and is associated with many comorbidities,  including asthma and respiratory  infections (RI)  [1, 2].",Non-OADS,/arxiv_data1/oa_pdf/3d/ec/apa-5-163.PMC4521165.pdf
Allergen immunotherapy and infections165 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.163symptom duration [1].,Non-OADS,/arxiv_data1/oa_pdf/3d/ec/apa-5-163.PMC4521165.pdf
"Barberi S, et al.Asia Pacific allergy166 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.163sufficient based a supposed difference in efficacy of at least 20%.",Non-OADS,/arxiv_data1/oa_pdf/3d/ec/apa-5-163.PMC4521165.pdf
Allergen immunotherapy and infections167 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.163(Fig.,Non-OADS,/arxiv_data1/oa_pdf/3d/ec/apa-5-163.PMC4521165.pdf
"Barberi S, et al.Asia Pacific allergy168 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.163chemokines, and mediators, including adhesion molecules, were  not evaluated; the SLIT treatment duration was short (6 months)  as well as the clinical observation period was short.",OADS,/arxiv_data1/oa_pdf/3d/ec/apa-5-163.PMC4521165.pdf
"Allergen immunotherapy and infections169 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.163Valovirta E, Van Bever H, Vichyanond P , Wahn U, Yusuf O. Sublingual  immunotherapy: World Allergy Organization position paper 2013  update.",Non-OADS,/arxiv_data1/oa_pdf/3d/ec/apa-5-163.PMC4521165.pdf
"Original ArticleAsia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2015.5.3.170 Asia Pac Allergy 2015;5:170-176Repeat oral food challenges in peanut and tree  nut allergic children with a history of mild/   moderate reactions Brynn Kevin Wainstein1,2,* and Rebecca Anne Saad1 1Department of Immunology and Infectious Diseases, Sydney Children’s Hospital, Sydney, NSW 2031, Australia  2School of Women’s and Children’s Health, University of New South Wales, Sydney, NSW 2052, Australia   Background:  In peanut and tree nut allergic children a history of anaphylaxis is associated with subsequent severe reactions.",Non-OADS,/arxiv_data1/oa_pdf/29/33/apa-5-170.PMC4521166.pdf
"http://apallergy.org INTRODUCTION Allergy to peanuts and tree nuts (TN) are often severe, may be life threatening and even fatal [1-3].",Non-OADS,/arxiv_data1/oa_pdf/29/33/apa-5-170.PMC4521166.pdf
 Repeat food challenges in nut allergy171 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.170 for children with nut allergies [5].,Non-OADS,/arxiv_data1/oa_pdf/29/33/apa-5-170.PMC4521166.pdf
Wainstein BK and Saad RAAsia Pacific allergy172 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.170Definitions and stopping criteria We used the Australasian Society of Clinical Immunology and  Allergy definition of anaphylaxis [18].,Non-OADS,/arxiv_data1/oa_pdf/29/33/apa-5-170.PMC4521166.pdf
" Repeat food challenges in nut allergy173 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.170the first and the second OFC for all participants was 35.5 ± 16.5  months (range , 12–72 months).",Non-OADS,/arxiv_data1/oa_pdf/29/33/apa-5-170.PMC4521166.pdf
Wainstein BK and Saad RAAsia Pacific allergy174 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.170the 2nd.,Non-OADS,/arxiv_data1/oa_pdf/29/33/apa-5-170.PMC4521166.pdf
 Repeat food challenges in nut allergy175 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.170pre-OFC SPT results and found a resolution rate for PN and TN  allergy of 38.5%.,OADS,/arxiv_data1/oa_pdf/29/33/apa-5-170.PMC4521166.pdf
Wainstein BK and Saad RAAsia Pacific allergy176 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.1706.,Non-OADS,/arxiv_data1/oa_pdf/29/33/apa-5-170.PMC4521166.pdf
Available from: http://www.allergy.,Non-OADS,/arxiv_data1/oa_pdf/29/33/apa-5-170.PMC4521166.pdf
"Hypothesis & Experience  Case Report http://dx.doi.org/10.5415/apallergy.2015.5.3.177 Asia Pac Allergy 2015;5:177-180Chlorpheniramine-induced anaphylaxis     diagnosed by basophil activation test Hyun-Seung Lee1,2,†, Woo-Jung Song1,2,†, Ji-Won Lee1,2, Young-Yoon Cho1, Han-Ki Park1,2, Min-Gyu Kang1,2,    Sang-Heon Cho1,2, and Seong-Wook Sohn3,* 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea 2Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul  110 -799 , Korea 3Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang 410-773, Korea Chlorpheniramine is a widely prescribed H1-antihistamine for relieving urticaria or histamine-mediated allergic reactions.",Non-OADS,/arxiv_data1/oa_pdf/83/3b/apa-5-177.PMC4521167.pdf
"http://apallergy.org INTRODUCTION Chlorpheniramine is one of the most classical H1-antihistamine s,  primarily prescribed for histamine-mediated hypersensitivity re -actions such as urticaria.",Non-OADS,/arxiv_data1/oa_pdf/83/3b/apa-5-177.PMC4521167.pdf
"Lee HS, et al.Asia Pacific allergy178 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.177IgE-mediated mechanisms have been suggested.",OADS,/arxiv_data1/oa_pdf/83/3b/apa-5-177.PMC4521167.pdf
Chlorpheniramine anaphylaxis179 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.177DISCUSSION The present report describes a case with chlorpheniramine-in - duced anaphylaxis.,Non-OADS,/arxiv_data1/oa_pdf/83/3b/apa-5-177.PMC4521167.pdf
"Lee HS, et al.Asia Pacific allergy180 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.177study of a case.",OADS,/arxiv_data1/oa_pdf/83/3b/apa-5-177.PMC4521167.pdf
Educational & Teaching Material  Case Reporthttp://dx.doi.org/10.5415/apallergy.2015.5.3.181 Asia Pac Allergy 2015;5:181-186 Intravenous tacrolimus and cyclosporine induced  anaphylaxis: what is next?,Non-OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
"http://apallergy.org INTRODUCTION Tacrolimus and cyclosporine have been approved for the pre - vention of graft versus-host disease (GVHD), which is the major  cause of morbidity and mortality after allogeneic bone marrow  transplantation.",Non-OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
"Kang SY, et al.Asia Pacific allergy182  apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.181also known as polyethoxylated castor oil, was suspected to induce  the reaction.",Non-OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
"Cremophor and Polysorbate 80-induced anaphylaxis183 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.181first considered the cause of anaphylaxis, because the patient  had a medical history of anaphylactic reaction due to vitamin K1  (phytonadione) that might contain polyethoxylated castor oil.",Non-OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
"Kang SY, et al.Asia Pacific allergy184  apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.181Table 2.",Non-OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
Cremophor and Polysorbate 80-induced anaphylaxis185 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.181glycerides and may be the drug of choice for anaphylaxis with  intravenous cyclosporine.,Non-OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
Available from: http://packageinserts.bms.,Non-OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
Available from: http://www.rxabbvie.com/pdf/ kaletratabpi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
"Kang SY, et al.Asia Pacific allergy186 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.181AbbVie; c2015 [cited 2015 Jul 10].",OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
Available from: http://norvir.com/ important-safety-information.cfm.,Non-OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
Available  from: http://www.hospira.com/en/search?q=phytonadione&fq=on.,OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
Available from:  http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/ con1412572274774.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
Available from: http://labeling.pfizer.,Non-OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
Available from: http://www.rochecanada.com/ content/dam/internet/corporate/rochecanada/en_CA/documents/ Research/ClinicalTrialsForms/Products/ConsumerInformation/Mono - graphsandPublicAdvisories/Kytril/Kytril_PM_CIE.pdf.,OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
Available from: http://www.gene.com/download/ pdf/pegasys_prescribing.pdf.,OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
Available from: http://www.cdc.gov/vaccines/pubs/pinkbook/ downloads/appendices/B/excipient-table-2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
Available from: http://www.remicade.com/shared/product/ remicade/prescribing-information.pdf 29. Genentech Inc. Prescribing information for Actemra (tocilizumab) [Inter - net].,OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
Avail - able from: http://www.gene.com/download/pdf/actemra_prescribing.,Non-OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
Avail - able from: https://www.gsksource.com/pharma/content/dam/GlaxoS - mithKline/US/en/Prescribing_Information/Benlysta/pdf/BENLYSTA-PI- MG.PDF.,Non-OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
Available from: http://products.sanofi.us/lemtrada/lemtrada.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
Available from: http://www.tysabri.com/prescribingInfo.,Non-OADS,/arxiv_data1/oa_pdf/3a/36/apa-5-181.PMC4521168.pdf
"http://dx.doi.org/10.5415/apallergy.2015.5.3.187 Asia Pac Allergy 2015;5:187-190Gynecomastia induced by H1-antihistamine  (ebastine) in a patient with idiopathic anaphylaxis Hwa Sik Jung, Chan-Ho Park, Young Tae Park, Mi Ae Bae, Youn Im Lee, Byung Ju Kang, Yangjin Jegal, Jong Joon Ahn,   and Taehoon Lee* Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan  682-714 , Korea H1-antihistamine is generally a well-tolerated and safe drug.",Non-OADS,/arxiv_data1/oa_pdf/86/25/apa-5-187.PMC4521169.pdf
http://apallergy.org INTRODUCTION H1-antihistamine is one of the most commonly used drugs in  the world [1].,Non-OADS,/arxiv_data1/oa_pdf/86/25/apa-5-187.PMC4521169.pdf
"Jung HS, et al.Asia Pacific allergy188 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.187antihistamine are very scarce.",Non-OADS,/arxiv_data1/oa_pdf/86/25/apa-5-187.PMC4521169.pdf
"H1-antihistamine (ebastine) -induced gynecomastia189 apallergy.org http://dx.doi.org/10.5415/apallergy.2015.5.3.187gynecomastia in adults, with the exception of idiopathic causes.",Non-OADS,/arxiv_data1/oa_pdf/86/25/apa-5-187.PMC4521169.pdf
"Jung HS, et al.Asia Pacific allergy190 apallergy.org  http://dx.doi.org/10.5415/apallergy.2015.5.3.187hypogonadotropic hypogonadism (androgen-deficiency), and  the resulting relative increases in estrogen could lead to gyne - comastia [8].",Non-OADS,/arxiv_data1/oa_pdf/86/25/apa-5-187.PMC4521169.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/fb/main.PMC4521214.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE45510 .2.,OADS,/arxiv_data1/oa_pdf/09/fb/main.PMC4521214.pdf
http://dx.doi.org/10.1016/j.gdata.2015.06.029 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/fb/main.PMC4521214.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/fb/main.PMC4521214.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/09/fb/main.PMC4521214.pdf
"The detailed protocol of 3SEQ library construction can be accessed using the following link, http://med.stanford.edu/labs/vanderijn-west/ documents/3endRNAseqlibraryconstruction_update_11_4_2014.doc .",OADS,/arxiv_data1/oa_pdf/09/fb/main.PMC4521214.pdf
"3SEQ data analysis Sequence reads (fastq format), ﬁrstﬁltered for read quality, were re- ﬁltered by fastx (fastx_artifacts_ ﬁlter-v-Q 33, http://hannonlab.cshl.",OADS,/arxiv_data1/oa_pdf/09/fb/main.PMC4521214.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Neuroendoscopic treatment of symptomatic giant Virchow–Robin  spaces Kyle Anthony Smith, Paul Lavin1, Roukoz Chamoun Department of Neurosurgery, University of Kansas Medical Center, 1School of Medicine, University of Kansas Medical Center, Kansas City, KS, USA E‑mail: *Kyle Anthony Smith ‑ ksmith9@kumc.edu; Paul Lavin ‑ plavin@kumc.edu; Roukoz Chamoun ‑ rchamoun@kumc.edu   *Corresponding Author Received: 11 February 15  Accepted: 22 May 15  Published: 20 July 15 Abstract Background: Virchow–Robin spaces (VRS) or perivascular spaces are interstitial  cystic spaces surrounding the vasculature of brain parenchyma and course from  the subarachnoid space.",Non-OADS,/arxiv_data1/oa_pdf/ff/77/SNI-6-120.PMC4521222.pdf
Surg Neurol Int 2015;6:120. http://surgicalneurologyint.com/surgicalint_articles/Neuroendoscopic-treatment-of-symptomatic-giant-Virchow–Robin-spaces/ Copyright: © 2015 Smith KA.,Non-OADS,/arxiv_data1/oa_pdf/ff/77/SNI-6-120.PMC4521222.pdf
"Surgical Neurology International 2015, 6:120  http://www.surgicalneurologyint.com/content/6/1/120on extreme lateral gaze.",Non-OADS,/arxiv_data1/oa_pdf/ff/77/SNI-6-120.PMC4521222.pdf
"Surgical Neurology International 2015, 6:120  http://www.surgicalneurologyint.com/content/6/1/120DISCUSSION Virchow–Robin spaces are interstitial fluid‑filled  potential spaces that surround cerebral arteries and  arterioles.",Non-OADS,/arxiv_data1/oa_pdf/ff/77/SNI-6-120.PMC4521222.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comErratum Pedunculated intraventricular subependymoma: Review of the  literature and illustration of classical presentation through a  clinical case: Erratum In the article, “Pedunculated intraventricular subependymoma: Review of the literature and illustration of classical  presentation through a clinical case”, which appeared in the article number 117, Issue 1, Vol 5 of Surgical Neurology  International[1], the acknowledgement section is missing.",Non-OADS,/arxiv_data1/oa_pdf/7d/e9/SNI-6-124.PMC4521223.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comAbstract Background:  Gilles de la Tourette Syndrome (GTS) is a complex neuropsychiatric  disorder, characterized by chronic motor and vocal tics, associated in 50–90% of  cases with psychiatric comorbidities.",Non-OADS,/arxiv_data1/oa_pdf/c5/7b/SNI-6-122.PMC4521224.pdf
"Surg Neurol Int 2015;6:122. http://surgicalneurologyint.com/surgicalint_articles/T emporary-deep-brain-stimulation-in-Gilles-de-la-T ourette-syndrome:-A feasible-approach?/ Copyright: © 2015 Zekaj E. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/c5/7b/SNI-6-122.PMC4521224.pdf
"Surgical Neurology International 2015, 6:122  http://www.surgicalneurologyint.com/content/6/1/122CASE REPORT We present a patient with GTS,[10] who at the  age of 17 years underwent bilateral deep brain  stimulation (DBS) for severe and refractory GTS.",Non-OADS,/arxiv_data1/oa_pdf/c5/7b/SNI-6-122.PMC4521224.pdf
"Surgical Neurology International 2015, 6:122  http://www.surgicalneurologyint.com/content/6/1/122to standardize the procedure and the strict eligibility  criteria for DBS, foremost for subjects per definition  refractory to conventional treatment.",Non-OADS,/arxiv_data1/oa_pdf/c5/7b/SNI-6-122.PMC4521224.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comAbstract Background: The treatment of a rare, nontraumatic, fusiform aneurysm of the  anterior temporal artery (ATA) via endovascular techniques is presented, and  procedural nuances are highlighted.",Non-OADS,/arxiv_data1/oa_pdf/66/99/SNI-6-119.PMC4521225.pdf
Surg Neurol Int 2015;6:119. http://surgicalneurologyint.com/surgicalint_articles/Endovascular-management-of-fusiform-aneurysm-of-anterior-temporal-artery:-T echnical-report/ Copyright: © 2015 Pabaney AH.,Non-OADS,/arxiv_data1/oa_pdf/66/99/SNI-6-119.PMC4521225.pdf
"Surgical Neurology International 2015, 6:119  http://www.surgicalneurologyint.com/content/6/1/119of the head revealed a hyperdense mass in the left  temporal lobe immediately inferior to the Sylvian fissure.",Non-OADS,/arxiv_data1/oa_pdf/66/99/SNI-6-119.PMC4521225.pdf
"Surgical Neurology International 2015, 6:119  http://www.surgicalneurologyint.com/content/6/1/119focused on fusiform aneurysms of the vertebrobasilar  system.",Non-OADS,/arxiv_data1/oa_pdf/66/99/SNI-6-119.PMC4521225.pdf
"Surgical Neurology International 2015, 6:119  http://www.surgicalneurologyint.com/content/6/1/119vessel occlusion was noted on angiography.",Non-OADS,/arxiv_data1/oa_pdf/66/99/SNI-6-119.PMC4521225.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comAbstract Background:  Have USA total neurological deaths (TNDs) of adults (55–74) and  the over 75’s risen more than in twenty Western Countries?",Non-OADS,/arxiv_data1/oa_pdf/c1/85/SNI-6-123.PMC4521226.pdf
"Surg Neurol Int 2015;6:123. http://surgicalneurologyint.com/surgicalint_articles/Neurological-deaths-of-American-adults-(55–74)-and-the-over-75’s-by-sex-compared-with-20-Western-countries-1989– 2010:-Cause-for-concern/ Copyright: © 2015 Pritchard  C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,   distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/c1/85/SNI-6-123.PMC4521226.pdf
"Surgical Neurology International 2015, 6:123  http://www.surgicalneurologyint.com/content/6/1/123conditions, prion disorders, degenerative diseases,  including Creutzfeldt Jacob’s disease (CJD), and new  variant CJD[50] though the incidence of the later appears  to have relatively stabilized, returning close to pre‑2000  levels.",Non-OADS,/arxiv_data1/oa_pdf/c1/85/SNI-6-123.PMC4521226.pdf
"Surgical Neurology International 2015, 6:123  http://www.surgicalneurologyint.com/content/6/1/123issue of different countries having varied health policy  strategies, which to a degree might influence treatment  priorities and therefore changes of mortality rates over  time.",Non-OADS,/arxiv_data1/oa_pdf/c1/85/SNI-6-123.PMC4521226.pdf
"Surgical Neurology International 2015, 6:123  http://www.surgicalneurologyint.com/content/6/1/123Total neurological death over 75’s Current male over 75’s TND rates were highest in Finland  19,887 pm to the lowest in Greece 1166 pm, with the TC  average rising by 114% with rates more than doubling in  11 countries.",Non-OADS,/arxiv_data1/oa_pdf/c1/85/SNI-6-123.PMC4521226.pdf
"Surgical Neurology International 2015, 6:123  http://www.surgicalneurologyint.com/content/6/1/123Table 2: Contd... Country 1989-1991 versus latest year Current and 1989-1991 rankTND Male Female Ratio 1.85 2.44 11‑3=Belgium 5766 6175 2008‑2010 7953 9558 Ratio 1.38 1.55 12‑8=Netherlands 3598 3158 2009‑2011 7699 11,283 Ratio 2.14 3.57 13‑12=New Zealand 3227 3289 2007‑2009 7038 9075 Ratio 2.18 2.76 14‑5=UK 4785 4662 2008‑2010 6862 9144 Ratio 1.43 1.96 15‑9=Ireland 3403 3282 2008‑2010 6035 7100 Ratio 1.77 2.16 16‑15=Italy 2761 2466 2008‑2010 5806 6960 Ratio 2.10 2.82 17‑17=Germany 1990‑1992 2378 1805 2008‑2010 4472 5091 Ratio 1.88 2.82 18‑18=Austria 1978 1465 2008‑2010 4238 4455 Ratio 2.14 3.03 19‑20=Portugal 1050 817 2008‑2010 4093 4042 Ratio 3.90 4.96 20‑21=Japan 844 729 2008‑2010 1540 1480 Ratio 1.82 2.03 21‑19=Greece 1127 1045 2008‑2010 1166 1479 Ratio 1.03 1.42 Elderly male and female combined neurological death ρ=+0.9487, P<0.001.",Non-OADS,/arxiv_data1/oa_pdf/c1/85/SNI-6-123.PMC4521226.pdf
"Surgical Neurology International 2015, 6:123  http://www.surgicalneurologyint.com/content/6/1/123Changes over the period odds ratios cancer  mortality rate to total neurological death Neurological to cancer deaths In Table 3 the final column shows the ORs of TND to  CMR for both sexes.",Non-OADS,/arxiv_data1/oa_pdf/c1/85/SNI-6-123.PMC4521226.pdf
"Surgical Neurology International 2015, 6:123  http://www.surgicalneurologyint.com/content/6/1/123The USA female OR was 1:1.80 and was the highest of  all the countries.",Non-OADS,/arxiv_data1/oa_pdf/c1/85/SNI-6-123.PMC4521226.pdf
"Surgical Neurology International 2015, 6:123  http://www.surgicalneurologyint.com/content/6/1/123Odds ratios over 75’s In regard to the over 75’s TND to CDD ORs males  more than doubled in 20 countries, with an average of  1:3.84.",Non-OADS,/arxiv_data1/oa_pdf/c1/85/SNI-6-123.PMC4521226.pdf
"Surgical Neurology International 2015, 6:123  http://www.surgicalneurologyint.com/content/6/1/123The USA OR at 1:9.89 was the third biggest of all  countries.",Non-OADS,/arxiv_data1/oa_pdf/c1/85/SNI-6-123.PMC4521226.pdf
"Surgical Neurology International 2015, 6:123  http://www.surgicalneurologyint.com/content/6/1/123•	 Research	 on	MND,	which	is	part	of	TND,	has	yielded	 some inconsistencies for while some studies found  little change in MND rates, and some attributed  to the rises to improved categorization,[1,18,19,23]  but others demonstrated what appears to be an  unequivocal upward trend in MND in a number  of countries.",Non-OADS,/arxiv_data1/oa_pdf/c1/85/SNI-6-123.PMC4521226.pdf
"Surgical Neurology International 2015, 6:123  http://www.surgicalneurologyint.com/content/6/1/123to neurology.",Non-OADS,/arxiv_data1/oa_pdf/c1/85/SNI-6-123.PMC4521226.pdf
Available from: http://www.cjd.,Non-OADS,/arxiv_data1/oa_pdf/c1/85/SNI-6-123.PMC4521226.pdf
"Surgical Neurology International 2015, 6:123  http://www.surgicalneurologyint.com/content/6/1/123tertiary referral centre.",Non-OADS,/arxiv_data1/oa_pdf/c1/85/SNI-6-123.PMC4521226.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comAbstract Background:  Craniotomies involving the midline are regular practice in  neurosurgery, during which injury to the superior sagittal sinus (SSS), an uncommon  yet devastating event, may occur.",Non-OADS,/arxiv_data1/oa_pdf/d4/e2/SNI-6-121.PMC4521227.pdf
Surg Neurol Int 2015;6:121. http://surgicalneurologyint.com/surgicalint_articles/Midline-as-a-landmark-for-the-position-of-the-superior-sagittal-sinus-on-the-cranial-vault:-An-anatomical-and-imaging-study/ Copyright: © 2015 Reis CVC.,Non-OADS,/arxiv_data1/oa_pdf/d4/e2/SNI-6-121.PMC4521227.pdf
"Surgical Neurology International 2015, 6:121  http://www.surgicalneurologyint.com/content/6/1/121anatomical structures to be described.",Non-OADS,/arxiv_data1/oa_pdf/d4/e2/SNI-6-121.PMC4521227.pdf
"Surgical Neurology International 2015, 6:121  http://www.surgicalneurologyint.com/content/6/1/121In all specimens, the SSS was a single structure.",Non-OADS,/arxiv_data1/oa_pdf/d4/e2/SNI-6-121.PMC4521227.pdf
"Surgical Neurology International 2015, 6:121  http://www.surgicalneurologyint.com/content/6/1/121and consistently had the smallest tumors of the series.",Non-OADS,/arxiv_data1/oa_pdf/d4/e2/SNI-6-121.PMC4521227.pdf
"Surgical Neurology International 2015, 6:121  http://www.surgicalneurologyint.com/content/6/1/121the position of the entire length of the SSS, including  the segment covered by the suture.",Non-OADS,/arxiv_data1/oa_pdf/d4/e2/SNI-6-121.PMC4521227.pdf
"Surgical Neurology International 2015, 6:121  http://www.surgicalneurologyint.com/content/6/1/121The posterior transcallosal approach exposes about half  of the course of the SSS anterior to L. The borders of  the craniotomy can expose the margin or the entire  width of the SSS at BL and L. Because the SSS is usually  displaced toward the right in this region, we recommend  applying the same surgical principles described for  reaching rolandic parasagittal lesions through a posterior  transcallosal approach.",Non-OADS,/arxiv_data1/oa_pdf/d4/e2/SNI-6-121.PMC4521227.pdf
Reference: http://www.regulations.gov/#!documentDetail;D 5FDA-2006-N-0515Marchioni Beery R.M.,Non-OADS,/arxiv_data1/oa_pdf/8c/8c/JCTH-2-266.PMC4521232.pdf
doi: http://dx.doi.org/10.1160/TH04-08-0523.,Non-OADS,/arxiv_data1/oa_pdf/48/bc/JCTH-2-234.PMC4521234.pdf
"[10] http://www.cdc.gov, accessed September 2014.",Non-OADS,/arxiv_data1/oa_pdf/48/bc/JCTH-2-234.PMC4521234.pdf
doi: http://dx.doi.org/10.1016/ j.jinf.2006.03.031.,OADS,/arxiv_data1/oa_pdf/48/bc/JCTH-2-234.PMC4521234.pdf
"[44] http://clinicaltrials.gov/show/NCT02175758, accessed November 2014.",Non-OADS,/arxiv_data1/oa_pdf/1b/5f/JCTH-2-247.PMC4521235.pdf
"[46] http://apps.who.int/iris/bitstream/10665/111747/1/9789241548755_eng .pdf, accessed October 2014.Aziz S.: HCV infection in children less than 12 years in developing countries 252 Journal of Clinical and Translational Hepatology 2014 vol.",Non-OADS,/arxiv_data1/oa_pdf/1b/5f/JCTH-2-247.PMC4521235.pdf
"[8] http://www.eltr.org, accessed January 2014.",Non-OADS,/arxiv_data1/oa_pdf/3a/9f/JCTH-2-189.PMC4521242.pdf
"[87] http://www.hcvguidelines.org/, accessed May 2014.Kakati B. et al: HCV recurrence after orthotopic liver transplantation 196 Journal of Clinical and Translational Hepatology 2014 vol.",Non-OADS,/arxiv_data1/oa_pdf/3a/9f/JCTH-2-189.PMC4521242.pdf
"References [1] IARC; ,http://www-dep.iarc.fr/ .",Non-OADS,/arxiv_data1/oa_pdf/e0/f1/JCTH-2-176.PMC4521243.pdf
2012. http://www.ilts.org/uploads/4_wang.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e0/f1/JCTH-2-176.PMC4521243.pdf
"[29] http://www.ustransplant.org/annual_reports/current/, accessed Nov 2011.",Non-OADS,/arxiv_data1/oa_pdf/e0/f1/JCTH-2-176.PMC4521243.pdf
"References [1] http://www.who.int/wer, accessed Sept 2010.",OADS,/arxiv_data1/oa_pdf/e7/e5/JCTH-2-212.PMC4521248.pdf
"[27] http://www.who.int/mediacentre/factsheets/fs115/en/, accessed Oct 2010.",Non-OADS,/arxiv_data1/oa_pdf/e7/e5/JCTH-2-212.PMC4521248.pdf
[20] http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ UCM174090.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/c7/JCTH-2-074.PMC4521262.pdf
"[30] http://www.acep.org/content.aspx?id 526830, Accessed on December 28, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c1/c7/JCTH-2-074.PMC4521262.pdf
[36] http://clinicaltrials.gov/show/NCT01079091.,Non-OADS,/arxiv_data1/oa_pdf/c1/c7/JCTH-2-074.PMC4521262.pdf
[38] http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy_8.,Non-OADS,/arxiv_data1/oa_pdf/c1/c7/JCTH-2-074.PMC4521262.pdf
"References [1] http://nccam.nih.gov/health/whatiscam/chinesemed.htm, accessed 10 January 2014 [2] Tang JL, Liu BY, Ma KW.",Non-OADS,/arxiv_data1/oa_pdf/2d/8c/JCTH-2-080.PMC4521264.pdf
"[8] http://livertox.nih.gov/ChineseA ndOtherAsianHerbalMedicines.htm, accessed 10 January 2014 [9] Teschke R, Wolff A, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: A tabular compilation of reported cases.",Non-OADS,/arxiv_data1/oa_pdf/2d/8c/JCTH-2-080.PMC4521264.pdf
"[21] http://livertox.nih.gov/BaJiaoLian.htm, accessed 10 January 2014.",Non-OADS,/arxiv_data1/oa_pdf/2d/8c/JCTH-2-080.PMC4521264.pdf
"[33] http://livertox.nih.gov/Ephedra.htm, accessed 10 January 2014 [34] Hwang SH, Park JA, Jang YS, Lee KM, Lee DS, Ahn BM, et al.",OADS,/arxiv_data1/oa_pdf/2d/8c/JCTH-2-080.PMC4521264.pdf
"[47] http://livertox.nih.gov/ChiRYun.htm, accessed 10 January 2014.",Non-OADS,/arxiv_data1/oa_pdf/2d/8c/JCTH-2-080.PMC4521264.pdf
"[52] http://livertox.nih.gov/ShoSaikoTo_DaiSaikoTo.htm, accessed 10 January 2014.",Non-OADS,/arxiv_data1/oa_pdf/2d/8c/JCTH-2-080.PMC4521264.pdf
"[67] http://livertox.nih.gov/JinBuHuan.htm, accessed 10 January 2014.",Non-OADS,/arxiv_data1/oa_pdf/2d/8c/JCTH-2-080.PMC4521264.pdf
"[94] http://livertox.nih.gov/ShouWuPian.htm, accessed 10 January 2014.",Non-OADS,/arxiv_data1/oa_pdf/2d/8c/JCTH-2-080.PMC4521264.pdf
Received: 13 March 2013; Revised: 15 May 2013; Accepted: 15 May 2013 qDOI of original article: http://dx.doi.org/10.14218/JCTH.2013.00006.,Non-OADS,/arxiv_data1/oa_pdf/1b/31/JCTH-1-051.PMC4521267.pdf
204. http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/1b/31/JCTH-1-051.PMC4521267.pdf
& http://www.who.int/ immunization/topics/hepatitis_b/en/Accessed November 2012.,Non-OADS,/arxiv_data1/oa_pdf/1b/31/JCTH-1-051.PMC4521267.pdf
Received: 21 January 2013; Revised: 9 March 2013; Accepted: 15 March 2013 qDOI of original article: http://dx.doi.org/10.14218/JCTH.2013.004XX.,Non-OADS,/arxiv_data1/oa_pdf/ef/7b/JCTH-1-033.PMC4521268.pdf
"ncbi.nlm.nih.gov], Ensembl [http://asia.ensembl.org/index.",Non-OADS,/arxiv_data1/oa_pdf/7d/ac/JCTH-1-045.PMC4521269.pdf
"html], and the MEXT Integrated Database Project [http:// dbcls.rois.ac.jp]) through international SNP discovery pro- jects such as the Human Genome Project,1the International HapMap project (http://hapmap.ncbi.nlm.nih.gov/index.html.",OADS,/arxiv_data1/oa_pdf/7d/ac/JCTH-1-045.PMC4521269.pdf
Received: 2 April 2013; Revised: 13 May 2013; Accepted: 22 May 2013 qDOI of original article: http://dx.doi.org/10.14218/JCTH.2013.010XX.,Non-OADS,/arxiv_data1/oa_pdf/7d/ac/JCTH-1-045.PMC4521269.pdf
Received: 12 March 2013; Revised: 14 May 2013; Accepted: 14 May 2013 qDOI of original article: http://dx.doi.org/10.14218/JCTH.2013.007XX.,Non-OADS,/arxiv_data1/oa_pdf/a0/0d/JCTH-1-009.PMC4521270.pdf
Received: 14 May 2013; Revised: 22 June 2013; Accepted: 23 June 2013 qDOI of original article: http://dx.doi.org/10.14218/JCTH.2013.00008.,Non-OADS,/arxiv_data1/oa_pdf/d4/69/JCTH-1-075.PMC4521271.pdf
Received: 13 February 2013; Revised: 15 May 2013; Accepted: 17 May 2013 qDOI of original article: http://dx.doi.org/10.14218/JCTH.2013.005XX.,Non-OADS,/arxiv_data1/oa_pdf/9d/85/JCTH-1-039.PMC4521272.pdf
"Farmington, CT June 2013 Conflict of interest None qDOI of original article: http://dx.doi.org/10.14218/JCTH.2013.000XX.",Non-OADS,/arxiv_data1/oa_pdf/3d/44/JCTH-1-001.PMC4521273.pdf
Received: 14 May 2013; Revised: 26 June 2013; Accepted: 28 June 2013 qDOI of original article: http://dx.doi.org/10.14218/JCTH.2013.00007.,Non-OADS,/arxiv_data1/oa_pdf/42/54/JCTH-1-002.PMC4521274.pdf
http://www.unos.org/docs/ Liver_patient.pdf.,Non-OADS,/arxiv_data1/oa_pdf/42/54/JCTH-1-002.PMC4521274.pdf
Received: 4 April 2013; Revised: 30 May 2013; Accepted: 4 June 2013 qDOI of original article: http://dx.doi.org/10.14218/JCTH.2013.D002X.,Non-OADS,/arxiv_data1/oa_pdf/51/df/JCTH-1-059.PMC4521275.pdf
Available at: http://who-umc.org/Graphics/24734.pdf Accessed 30 March 2013.,Non-OADS,/arxiv_data1/oa_pdf/51/df/JCTH-1-059.PMC4521275.pdf
Available at: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/51/df/JCTH-1-059.PMC4521275.pdf
Available at: http://www.nih.gov/news/health/oct2012/niddk-12.htm Accessed 30 March 2013.,Non-OADS,/arxiv_data1/oa_pdf/51/df/JCTH-1-059.PMC4521275.pdf
"A follow-up study of more than 1,600 Italian male workers indicated that autoclave workers with the highest exposures to vinyl chloride had an almost 10-fold increased risk of HCC compared to workers with low or no exposure.32 In addition to aflatoxins, alcohol, and vinyl chloride, the IARC lists older high-dose combined oral contraceptives, plutonium, and thorium-232 and its decay products (colloidal thorium dioxide [Thorotrast], used as an angiographic agent) as agents with sufficient evidence in humans to be identified as liver carcinogens (http://monographs.iarc.fr/ENG/ Classification/Table4.pdf).",Non-OADS,/arxiv_data1/oa_pdf/3e/b3/JCTH-1-138.PMC4521280.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/4.0/ Supplementary Information accompanies the paper on Journal of Human Genetics website (http://www.nature.com/jhg)Polymorphisms in DCDC2 andS100B associate with developmental dyslexia HM a t s s o n et al 401 Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/c2/b3/jhg201537a.PMC4521290.pdf
"The sequence alignment ﬁles were processed by Picard (v1.55, http://picard.sourceforge.net) to mark up duplicated reads and calculate summary statistics.",OADS,/arxiv_data1/oa_pdf/dd/4e/jhg201478a.PMC4521291.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Journal of Human Genetics website (http://www.nature.com/jhg)Genetic heterogeneity of prelingual hearing loss YL u et al 607 Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/dd/4e/jhg201478a.PMC4521291.pdf
Variants were called by the Genome Analysis T oolkit (http://www.broadinstitute.org/gatk/) and annotated using ANNOV AR (http://www.openbioinfor- matics.org/annovar/) after excluding thecommon variants registered in the commondbSNP135 database (minor allele frequency X0.01).,OADS,/arxiv_data1/oa_pdf/1f/05/jhg201475a.PMC4521292.pdf
"To view a copy ofthis license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/Correspondence 590 Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/1f/05/jhg201475a.PMC4521292.pdf
"By collecting and cataloging genetic and clinical information on Japanese FAD and FTDP-17, we developedan original database designated as Japanese Familial Alzheimer's Disease Database, which is accessible at http://alzdb.bri.",OADS,/arxiv_data1/oa_pdf/fe/1d/jhg201515a.PMC4521293.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Journal of Human Genetics website (http://www.nature.com/jhg)0%10%20%30%40%50% PSEN1 APP MAPT PSEN1 APP MAPT PSEN1 APP MAPT PSEN1 APP MAPT PSEN1 APP MAPT Psychiatric symptom Mood disorder Spastic paraparesis Parkinsonism/Rigidity Epilepsy/SeizureFrequency of symptoms *** ** ** ** * * Psychiatric symptomMood disorderSpastic paraparesisParkinsonism/ RigidityEpilepsy/ Seizure Figure 2 Frequency of each clinical manifestation in patients with Japanese FAD and FTDP-17.",Non-OADS,/arxiv_data1/oa_pdf/fe/1d/jhg201515a.PMC4521293.pdf
Detailedinformation about these phenotypes can be found at http://www2.cscc.unc.,Non-OADS,/arxiv_data1/oa_pdf/6c/22/jhg201415a.PMC4521294.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Journal of Human Genetics website (http://www.nature.com/jhg)Quantifying the uncertainty in heritability NA Furlotte et al 275 Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/6c/22/jhg201415a.PMC4521294.pdf
"2More than 160 mutations have been found in SLC26A4 (Pendred/BOR Homepage, http://www.healthcare.uiowa.edu/labs/pendredandbor/),and different mutational spectrums among different ethnic groups have been reported.",Non-OADS,/arxiv_data1/oa_pdf/43/f1/jhg201412a.PMC4521295.pdf
"Statistical and population genetic analyses Molecular diversity, population structure estimates and genetic distancesbetween populations were calculated using Arlequin v. 3.11 (http://cmpg.unibe.ch/software/arlequin3).",OADS,/arxiv_data1/oa_pdf/aa/ed/jhg201462a.PMC4521296.pdf
"R: A Language and Environment for Statistical Computing (2014), http://www.r-project.org.",Non-OADS,/arxiv_data1/oa_pdf/aa/ed/jhg201462a.PMC4521296.pdf
bioRxiv doi:http://dx.doi.org/10.1101/005603 (2014).,Non-OADS,/arxiv_data1/oa_pdf/aa/ed/jhg201462a.PMC4521296.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on Journal of Human Genetics website (http://www.nature.com/jhg)Genetic diversity in West Timor MK Tumonggor et al 503 Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/aa/ed/jhg201462a.PMC4521296.pdf
"International Journal of Preventive Medicine 2015, 6:58 http://www.ijpvmjournal.net/content/6/1/58cancers.",Non-OADS,/arxiv_data1/oa_pdf/9c/da/IJPVM-6-58.PMC4521298.pdf
"International Journal of Preventive Medicine 2015, 6:58 http://www.ijpvmjournal.net/content/6/1/58Cr, NO, and MDA levels, kidney weight  (KW), and  bodyweight  (BW).",Non-OADS,/arxiv_data1/oa_pdf/9c/da/IJPVM-6-58.PMC4521298.pdf
"International Journal of Preventive Medicine 2015, 6:58 http://www.ijpvmjournal.net/content/6/1/58rats.",Non-OADS,/arxiv_data1/oa_pdf/9c/da/IJPVM-6-58.PMC4521298.pdf
"International Journal of Preventive Medicine 2015, 6:58 http://www.ijpvmjournal.net/content/6/1/58therapy is higher in males.",Non-OADS,/arxiv_data1/oa_pdf/9c/da/IJPVM-6-58.PMC4521298.pdf
"International Journal of Preventive Medicine 2015, 6:58 http://www.ijpvmjournal.net/content/6/1/58muscle glycogen but does not enhance running endurance in untrained rats.",Non-OADS,/arxiv_data1/oa_pdf/9c/da/IJPVM-6-58.PMC4521298.pdf
"International Journal of Preventive Medicine 2015, 6:65 http://www.ijpvmjournal.net/content/6/1/65INTRODUCTION Vitamins are organic substances, which are required  by the body in small amounts to maintain life and  health.",Non-OADS,/arxiv_data1/oa_pdf/ff/65/IJPVM-6-65.PMC4521299.pdf
"International Journal of Preventive Medicine 2015, 6:65 http://www.ijpvmjournal.net/content/6/1/65RESULTS Results are shown in Tables 1‑3.",Non-OADS,/arxiv_data1/oa_pdf/ff/65/IJPVM-6-65.PMC4521299.pdf
"International Journal of Preventive Medicine 2015, 6:65 http://www.ijpvmjournal.net/content/6/1/65intake, and increased oxidative stress among this  population of pregnant women may have been responsible  for the marked decrease in Vitamins A and E observed  throughout the trimesters.",Non-OADS,/arxiv_data1/oa_pdf/ff/65/IJPVM-6-65.PMC4521299.pdf
Available from: http://www.who.int/vmnis/ vitamina/prevalence/report/en/.,Non-OADS,/arxiv_data1/oa_pdf/ff/65/IJPVM-6-65.PMC4521299.pdf
Available from: http://www.who.int/vmnis/ vitamina/prevalence/report/en/ [Last accessed on 2015 Mar 23].,OADS,/arxiv_data1/oa_pdf/ff/65/IJPVM-6-65.PMC4521299.pdf
"International Journal of Preventive Medicine 2015, 6:62 http://www.ijpvmjournal.net/content/6/1/62world suffer from calcium deficiency[3] and 31–47.3%  from zinc deficiency.",Non-OADS,/arxiv_data1/oa_pdf/6f/6c/IJPVM-6-62.PMC4521300.pdf
"International Journal of Preventive Medicine 2015, 6:62 http://www.ijpvmjournal.net/content/6/1/62To obtain nutrient intakes of participants based on these  3‑day food diaries, we used Nutritionist IV software (First  Databank, San Bruno, CA, USA) modified for Iranian  foods.",Non-OADS,/arxiv_data1/oa_pdf/6f/6c/IJPVM-6-62.PMC4521300.pdf
"International Journal of Preventive Medicine 2015, 6:62 http://www.ijpvmjournal.net/content/6/1/62We did not find a significant difference in mean  changes of maternal serum iron levels comparing the  two groups.",Non-OADS,/arxiv_data1/oa_pdf/6f/6c/IJPVM-6-62.PMC4521300.pdf
"International Journal of Preventive Medicine 2015, 6:62 http://www.ijpvmjournal.net/content/6/1/62a significant increase in SBP and DBP (+6.08 mmHg;   P = 0.001, +3.05 mmHg;  P = 0.007, respectively).",Non-OADS,/arxiv_data1/oa_pdf/6f/6c/IJPVM-6-62.PMC4521300.pdf
"International Journal of Preventive Medicine 2015, 6:62 http://www.ijpvmjournal.net/content/6/1/62assess the effect of supplementation in the later life of  born babies.",Non-OADS,/arxiv_data1/oa_pdf/6f/6c/IJPVM-6-62.PMC4521300.pdf
"International Journal of Preventive Medicine 2015, 6:62 http://www.ijpvmjournal.net/content/6/1/6235.",Non-OADS,/arxiv_data1/oa_pdf/6f/6c/IJPVM-6-62.PMC4521300.pdf
"International Journal of Preventive Medicine 2015, 6:66 http://www.ijpvmjournal.net/content/6/1/66 of the drugs by physicians, many people directly refer  to pharmacies and prepare and consume various drugs  to prevent and treat diseases and possibly strengthen  themselves depending on their own diagnosis which is  often wrong.",Non-OADS,/arxiv_data1/oa_pdf/26/4e/IJPVM-6-66.PMC4521301.pdf
"International Journal of Preventive Medicine 2015, 6:66 http://www.ijpvmjournal.net/content/6/1/66 version of GHO, which originally consisted of 60 items with  four response categories in each item indicating the severity  of psychological distress experienced in past 4 weeks.",Non-OADS,/arxiv_data1/oa_pdf/26/4e/IJPVM-6-66.PMC4521301.pdf
"International Journal of Preventive Medicine 2015, 6:66 http://www.ijpvmjournal.net/content/6/1/66significantly (P < 0.001) higher and in contrast, good and  excellent self -rated mental health was significantly more   prevalent in no self-medication group.",Non-OADS,/arxiv_data1/oa_pdf/26/4e/IJPVM-6-66.PMC4521301.pdf
"International Journal of Preventive Medicine 2015, 6:66 http://www.ijpvmjournal.net/content/6/1/66et al.",Non-OADS,/arxiv_data1/oa_pdf/26/4e/IJPVM-6-66.PMC4521301.pdf
"International Journal of Preventive Medicine 2015, 6:66 http://www.ijpvmjournal.net/content/6/1/66for the practice of care for another, not only regarding  adverse events, medication interactions, or importance  of adherence to the therapeutic regimen, among others;  but also skills in the preparation and implementation  of educational nursing programs on responsible  self-medication.",Non-OADS,/arxiv_data1/oa_pdf/26/4e/IJPVM-6-66.PMC4521301.pdf
"International Journal of Preventive Medicine 2015, 6:66 http://www.ijpvmjournal.net/content/6/1/66Available from: http://www.webpoll.org/psych/ghq12.htm.",Non-OADS,/arxiv_data1/oa_pdf/26/4e/IJPVM-6-66.PMC4521301.pdf
Available from: http://www.iom.edu/CMS/3775/3827/19723.aspx.,Non-OADS,/arxiv_data1/oa_pdf/26/4e/IJPVM-6-66.PMC4521301.pdf
"International Journal of Preventive Medicine 2015, 6:63 http://www.ijpvmjournal.net/content/6/1/63be 39,607 Euros in Ireland.",Non-OADS,/arxiv_data1/oa_pdf/19/70/IJPVM-6-63.PMC4521302.pdf
"International Journal of Preventive Medicine 2015, 6:63 http://www.ijpvmjournal.net/content/6/1/63first‑line treatment of metastatic CRC are reported  in this study.",Non-OADS,/arxiv_data1/oa_pdf/19/70/IJPVM-6-63.PMC4521302.pdf
"International Journal of Preventive Medicine 2015, 6:63 http://www.ijpvmjournal.net/content/6/1/63The results of the extensive sensitivity analysis showed that,  although a %50 increase in OS would decrease the ICER  to $305408.7 per additional LYG, the results are still much higher than the WHO suggested threshold (24.9‑fold higher).",Non-OADS,/arxiv_data1/oa_pdf/19/70/IJPVM-6-63.PMC4521302.pdf
"International Journal of Preventive Medicine 2015, 6:63 http://www.ijpvmjournal.net/content/6/1/63DISCUSSION The aim of this study was to analyze the cost‑effectiveness  of different therapeutic regimens of cetuximab in the  first‑line treatment of metastatic CRC in Iran.",Non-OADS,/arxiv_data1/oa_pdf/19/70/IJPVM-6-63.PMC4521302.pdf
"International Journal of Preventive Medicine 2015, 6:63 http://www.ijpvmjournal.net/content/6/1/63repeated every three weeks and FOLFIRI and FOLFOX  regimens are iterated every 2 weeks.",Non-OADS,/arxiv_data1/oa_pdf/19/70/IJPVM-6-63.PMC4521302.pdf
Available from: http://www.Nccn.,Non-OADS,/arxiv_data1/oa_pdf/19/70/IJPVM-6-63.PMC4521302.pdf
Available  from: http://www.fdo.behdasht.gov.ir.,Non-OADS,/arxiv_data1/oa_pdf/19/70/IJPVM-6-63.PMC4521302.pdf
"International Journal of Preventive Medicine 2015, 6:63 http://www.ijpvmjournal.net/content/6/1/63Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer:  CECOG trial.",Non-OADS,/arxiv_data1/oa_pdf/19/70/IJPVM-6-63.PMC4521302.pdf
Available from:  http://www.cbi.ir/showitem/8918.aspx.,Non-OADS,/arxiv_data1/oa_pdf/19/70/IJPVM-6-63.PMC4521302.pdf
"International Journal of Preventive Medicine 2015, 6:60 http://www.ijpvmjournal.net/content/6/1/60Nitric oxide  (NO) is synthesized from its precursor  L‑arginine by NO synthase  (NOS).",Non-OADS,/arxiv_data1/oa_pdf/8b/83/IJPVM-6-60.PMC4521303.pdf
"International Journal of Preventive Medicine 2015, 6:60 http://www.ijpvmjournal.net/content/6/1/60RESULTS Serum levels of blood urea nitrogen, creatinine,  nitrite, malondialdehyde The serum levels of BUN and Cr were increased  significantly in all BUO groups (P<0.05), and the serum  level of MDA was decreased significantly in vehicle group  (P<0.05).",Non-OADS,/arxiv_data1/oa_pdf/8b/83/IJPVM-6-60.PMC4521303.pdf
"International Journal of Preventive Medicine 2015, 6:60 http://www.ijpvmjournal.net/content/6/1/60groups  (P < 0.05).",Non-OADS,/arxiv_data1/oa_pdf/8b/83/IJPVM-6-60.PMC4521303.pdf
"International Journal of Preventive Medicine 2015, 6:60 http://www.ijpvmjournal.net/content/6/1/60Received:  02 Dec 14 Accepted:  30 Apr 15   Published:  08 Jul 15 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/8b/83/IJPVM-6-60.PMC4521303.pdf
"International Journal of Preventive Medicine 2015, 6:59 http://www.ijpvmjournal.net/content/6/1/59to the full DASH questionnaire.",Non-OADS,/arxiv_data1/oa_pdf/5a/eb/IJPVM-6-59.PMC4521304.pdf
"International Journal of Preventive Medicine 2015, 6:59 http://www.ijpvmjournal.net/content/6/1/59relevant context to assess the correlation between the  two questionnaires.",Non-OADS,/arxiv_data1/oa_pdf/5a/eb/IJPVM-6-59.PMC4521304.pdf
"International Journal of Preventive Medicine 2015, 6:59 http://www.ijpvmjournal.net/content/6/1/59versions, Cronbach’s alpha was 0.89, 0.88 and 0.84,  respectively, showing good internal consistency.",Non-OADS,/arxiv_data1/oa_pdf/5a/eb/IJPVM-6-59.PMC4521304.pdf
"International Journal of Preventive Medicine 2015, 6:59 http://www.ijpvmjournal.net/content/6/1/5913.",Non-OADS,/arxiv_data1/oa_pdf/5a/eb/IJPVM-6-59.PMC4521304.pdf
"International Journal of Preventive Medicine 2015, 6:64 http://www.ijpvmjournal.net/content/6/1/64deaths from this of cancer are low, what is more  painful than the mortality rate of this type of cancer  is emotional and physical suffering from it.",Non-OADS,/arxiv_data1/oa_pdf/4f/33/IJPVM-6-64.PMC4521305.pdf
"International Journal of Preventive Medicine 2015, 6:64 http://www.ijpvmjournal.net/content/6/1/64incidence rate (9964 cases) was observed in 2008, but the  lowest rate (7320 cases) was recorded in 2004 [Table 1].",Non-OADS,/arxiv_data1/oa_pdf/4f/33/IJPVM-6-64.PMC4521305.pdf
"International Journal of Preventive Medicine 2015, 6:64 http://www.ijpvmjournal.net/content/6/1/64observed in Sistan and Baluchestan, and in female in  Hormozgan provinces the incidence of the disease was  more in all provinces in men than women.",Non-OADS,/arxiv_data1/oa_pdf/4f/33/IJPVM-6-64.PMC4521305.pdf
"International Journal of Preventive Medicine 2015, 6:64 http://www.ijpvmjournal.net/content/6/1/64skin cancer, especially in the older age, may be justifiable.",Non-OADS,/arxiv_data1/oa_pdf/4f/33/IJPVM-6-64.PMC4521305.pdf
"International Journal of Preventive Medicine 2015, 6:64 http://www.ijpvmjournal.net/content/6/1/64Daily activities in outdoor and sunny environments or  contact with the carcinogen can be main factors cause to  the high rate of the cancer in males.",Non-OADS,/arxiv_data1/oa_pdf/4f/33/IJPVM-6-64.PMC4521305.pdf
"International Journal of Preventive Medicine 2015, 6:64 http://www.ijpvmjournal.net/content/6/1/64Dermatol 2009;129:323‑8.",Non-OADS,/arxiv_data1/oa_pdf/4f/33/IJPVM-6-64.PMC4521305.pdf
"International Journal of Preventive Medicine 2015, 6:61 http://www.ijpvmjournal.net/content/6/1/61emphasize the excess risk associated with BP in this  range and to focus increased clinical and public health  attention on prevention.",Non-OADS,/arxiv_data1/oa_pdf/64/be/IJPVM-6-61.PMC4521306.pdf
"International Journal of Preventive Medicine 2015, 6:61 http://www.ijpvmjournal.net/content/6/1/61The BP was measured on the non‑dominant arm using a  mercury sphygmomanometer (Accoson, England) at heart  level using appropriate cuff size.",Non-OADS,/arxiv_data1/oa_pdf/64/be/IJPVM-6-61.PMC4521306.pdf
"International Journal of Preventive Medicine 2015, 6:61 http://www.ijpvmjournal.net/content/6/1/61while mean DBP was 80 ± 12.4 mmHg.",Non-OADS,/arxiv_data1/oa_pdf/64/be/IJPVM-6-61.PMC4521306.pdf
"International Journal of Preventive Medicine 2015, 6:61 http://www.ijpvmjournal.net/content/6/1/61corroborates this finding as majority of the participants  with prehypertension (61%) were <60 years.",Non-OADS,/arxiv_data1/oa_pdf/64/be/IJPVM-6-61.PMC4521306.pdf
"International Journal of Preventive Medicine 2015, 6:61 http://www.ijpvmjournal.net/content/6/1/6120.",Non-OADS,/arxiv_data1/oa_pdf/64/be/IJPVM-6-61.PMC4521306.pdf
"Surgical Neurology InternationalOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Pediatric Neurosurgery, a supplement to  Surgical Neurology International Editor: Sandi Lam, M.D.",Non-OADS,/arxiv_data1/oa_pdf/06/39/SNI-6-330.PMC4521309.pdf
http://surgicalneurologyint.com/surgicalint_articles/CSF-hydrothorax-without-intrathoracic-catheter-migration-in-children-with-ventriculoperitoneal-shunt/ Copyright: © 2015 Kim JH.,Non-OADS,/arxiv_data1/oa_pdf/06/39/SNI-6-330.PMC4521309.pdf
"Surgical Neurology InternationalOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Pediatric Neurosurgery, a supplement to  Surgical Neurology International Editor: Sandi Lam, M.D.",Non-OADS,/arxiv_data1/oa_pdf/d5/aa/SNI-6-327.PMC4521310.pdf
"http://surgicalneurologyint.com/surgicalint_articles/Trigeminal-neuralgia-associated-with-Chiari-1-malformation:-symptom-resolution-following-craniocervical-decompression- and-duroplasty:-Case-report-and-review-of-the-literature/ Copyright: © 2015 Loch-Wilkinson T.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,   distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d5/aa/SNI-6-327.PMC4521310.pdf
"Surgical Neurology InternationalOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Pediatric Neurosurgery, a supplement to  Surgical Neurology International Editor: Sandi Lam, M.D.",Non-OADS,/arxiv_data1/oa_pdf/b8/cb/SNI-6-346.PMC4521311.pdf
"http://surgicalneurologyint.com/surgicalint_articles/Management-of-hydrocephalus-in-children-with-posterior-fossa-tumors/ Copyright: © 2015 Lam S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/b8/cb/SNI-6-346.PMC4521311.pdf
"Surgical Neurology InternationalOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Pediatric Neurosurgery, a supplement to  Surgical Neurology International Editor: Sandi Lam, M.D.",Non-OADS,/arxiv_data1/oa_pdf/f4/c4/SNI-6-334.PMC4521312.pdf
"http://surgicalneurologyint.com/surgicalint_articles/“Countersinking”-of-reservoir-in-an-irradiated-patients-can-decrease-tension-on-scalp-closure/ Copyright: © 2015 Singh M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/f4/c4/SNI-6-334.PMC4521312.pdf
"Surgical Neurology InternationalOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Pediatric Neurosurgery, a supplement to  Surgical Neurology International Editor: Sandi Lam, M.D.",Non-OADS,/arxiv_data1/oa_pdf/3f/9e/SNI-6-337.PMC4521313.pdf
http://surgicalneurologyint.com/surgicalint_articles/How-I-Do-It:-Management-of-spina-bifida-in-a-hospital-in-The-People's-Republic-of-China/,Non-OADS,/arxiv_data1/oa_pdf/3f/9e/SNI-6-337.PMC4521313.pdf
"Surgical Neurology InternationalOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Pediatric Neurosurgery, a supplement to  Surgical Neurology International Editor: Sandi Lam, M.D.",Non-OADS,/arxiv_data1/oa_pdf/6f/bb/SNI-6-349.PMC4521314.pdf
http://surgicalneurologyint.com/surgicalint_articles/Huge-familial-colloid-cyst-of-the-third-ventricle:-An-extraordinary-presentation/ Copyright: © 2015 Niknejad HR.,Non-OADS,/arxiv_data1/oa_pdf/6f/bb/SNI-6-349.PMC4521314.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007248).,Non-OADS,/arxiv_data1/oa_pdf/d1/af/bmjopen-2014-007248.PMC4521509.pdf
Statistical analysis for this study was per- formed using the Stata statistics program (http://www.stata.org).,OADS,/arxiv_data1/oa_pdf/d1/af/bmjopen-2014-007248.PMC4521509.pdf
"Intrapartum care: care of healthy women and their babies during childbirth , 2007. http://www.nice.org.uk/guidance/cg55 16.",Non-OADS,/arxiv_data1/oa_pdf/d1/af/bmjopen-2014-007248.PMC4521509.pdf
2014. https://www.ranzcog.edu.au/intrapartum-fetal-surveillance-clinical-guidelines.html 19.,Non-OADS,/arxiv_data1/oa_pdf/d1/af/bmjopen-2014-007248.PMC4521509.pdf
Funding This study was funded and supported by the French National Institute of Cancer ( €206 000) (http://www.e-cancer.fr).,Non-OADS,/arxiv_data1/oa_pdf/1d/d5/bmjopen-2014-007471.PMC4521510.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1d/d5/bmjopen-2014-007471.PMC4521510.pdf
http://seer.cancer.gov/statfacts/html/ melan.html#survival (accessed 10 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/1d/d5/bmjopen-2014-007471.PMC4521510.pdf
2006. http://www.has-sante.fr/ 5.,Non-OADS,/arxiv_data1/oa_pdf/1d/d5/bmjopen-2014-007471.PMC4521510.pdf
http://demographie.medecin.fr/demographie(accessed 13 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/1d/d5/bmjopen-2014-007471.PMC4521510.pdf
"Evolution des taux de participation au programme national de dépistage organisé ducancer du sein par classe d ’âge, depuis 2005. http://www.invs.sante.",Non-OADS,/arxiv_data1/oa_pdf/1d/d5/bmjopen-2014-007471.PMC4521510.pdf
"Institut de Veille Sanitaire, 2008. http://opac.invs.sante.fr/doc_num.php?explnum_id=3243 47.",Non-OADS,/arxiv_data1/oa_pdf/1d/d5/bmjopen-2014-007471.PMC4521510.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-008366).,Non-OADS,/arxiv_data1/oa_pdf/56/76/bmjopen-2015-008366.PMC4521511.pdf
"○The QDScore 30(http://www.qdscore.org/) includes the following variables: ethnicity (9 ethni- cities: White, Indian, Pakistani, Bangladeshi, other Asian, Black Caribbean, Black African, Chinese,other ethnic group), age, BMI, smoking status (non smoker; ex-smoker; light smoker: <10; mod- erate smoker: 10 –19; heavy smoker: >19), history of diabetes in a ﬁrst degree relative, cardiovascular 4 Salinero-Fort Miguel Á, et al.BMJ Open 2015; 5:e007195.",Non-OADS,/arxiv_data1/oa_pdf/01/93/bmjopen-2014-007195.PMC4521512.pdf
"52 The score performance and predictive model will be presented in medical conferences, workshops, seminarsand round table discussions, and free copies for download will be made available on the website of the primary care administration (https://saluda.salud.madrid.org/ATENCIONPRIMARI A/Paginas/Default.aspx).",Non-OADS,/arxiv_data1/oa_pdf/01/93/bmjopen-2014-007195.PMC4521512.pdf
http://web.minsal.cl/ (accessed 25Aug 2014).,OADS,/arxiv_data1/oa_pdf/59/ba/bmjopen-2014-007037.PMC4521516.pdf
http://www.remediar.gov.ar/index.,OADS,/arxiv_data1/oa_pdf/59/ba/bmjopen-2014-007037.PMC4521516.pdf
http://www.who.int/ imci-mce/ (accessed 15 Oct 2014).,OADS,/arxiv_data1/oa_pdf/59/ba/bmjopen-2014-007037.PMC4521516.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 007684).,Non-OADS,/arxiv_data1/oa_pdf/4b/3d/bmjopen-2015-007684.PMC4521517.pdf
"Thus, we calculated consumption according to the conversion measures introduced in 2007 to the General Lifestyle Survey(GLS): ivone pint of a normal strength beer is equivalent to 2 units, a 175 mL glass of wine is equivalent to 2 units and a 250 mL glass of wine is equivalent to 3 units.Furthermore, we also applied the conversion tables in the drinkaware website (http://www.drinkaware.co.uk): 1 glass of wine, equivalent to 3 units, and 1 pint of beer,equal to 3 units.",Non-OADS,/arxiv_data1/oa_pdf/4b/3d/bmjopen-2015-007684.PMC4521517.pdf
"Self-reported health: categorised into Poor, Fair, Good, Very Good, Excellent iiiSee http://www.nhs.uk/Tools/Pages/Alcohol-unit-calculator.aspx.",Non-OADS,/arxiv_data1/oa_pdf/4b/3d/bmjopen-2015-007684.PMC4521517.pdf
Available at: http://www.ons.gov.uk/ons/rel/ghs/general-lifestyle-survey/2011/index.html 4 Iparraguirre J. BMJ Open 2015; 5:e007684.,Non-OADS,/arxiv_data1/oa_pdf/4b/3d/bmjopen-2015-007684.PMC4521517.pdf
ISRN Geriatr 2013:671218. http://dx.doi.org/10.1155/2013/671218 26.,OADS,/arxiv_data1/oa_pdf/4b/3d/bmjopen-2015-007684.PMC4521517.pdf
J Stat Software 2008;27. http://www.jstatsoft.org/v27/i05/ 77.,OADS,/arxiv_data1/oa_pdf/4b/3d/bmjopen-2015-007684.PMC4521517.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-008246).,Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
"Research highlights will also be shared with pol-icymakers and decision-makers and the public through 4-page reader-friendly summaries of research results ( Research InFOCUS On Research ), and by social media such as Facebook (http://www.facebook.com/cranhr) and Twitter (@CRaNHR, @NOSM and researchers ’ accounts).",Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
http://www.health.gov.on.ca/en/pro/programs/hhrsd/ physicians/increasing_supply.aspx (accessed 6 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
Hum Resour Health 2008;6:24. http://www.human-resources-health.com/ content/6/1/24 (accessed 6 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
"http://www.nosm.ca/uploadedFiles/About_Us/Vision,_Mission_and_Strategic_Plan/Strategic%20Plan%20-%20English%20-%20Full%20report%20-for%20web.pdf (accessed 6 Mar 2015).",Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
http://www12.statcan.ca/census-recensement/2011/dp-pd/ hlt-fst/pd-pl/Table-Tableau.cfm?LANG=Eng&T=1402&PR=35&SR= 1&S=9&O=D (accessed 6 Mar 2015).,OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
http://docs.files.ontario.ca/ documents/409/francophone-profile.pdf (accessed 6 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
"Ottawa, ON: Statistics Canada, 2011. http://www12.statcan.gc.ca/nhs-enm/2011/dp-pd/aprof/index.cfm?Lang=E (accessed 6 Mar 2015).",OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
"Ottawa, ON: Statistics Canada, 2013. http://www12.statcan.gc.ca/health-sante/82-228/index.cfm?Lang=E (accessed 6 Mar 2015).",OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
http://www12.statcan.gc.ca/health-sante/82-228/index.cfm?Lang=E (accessed 6 March 2015).,OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
"Ottawa, ON: Réseau de recherche appliquée sur la santé des Francophones de l ’Ontario, 2012. http://www.rrasfo.ca/images/docs/publications/2012/rapport_escc_ontario-final.pdf (accessed 6 Mar 2015).",Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
http://healthsocialaccountability.org (accessed6 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
https://www.afmc.ca/pdf/AdmissionRequirementsfor2015_en.pdf (accessed 6 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
http://www.nosm.ca/uploadedFiles/About_Us/Media_Room/ Publications_and_Reports/COMMUNITY%20REPORT%202014% 20%E2%80%94%20Web.pdf (accessed 6 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
http://www.nosm.ca/education/pgme/default.aspx?,Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
http://www.royalcollege.ca/ (accessed 6 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
http://www.nosm.ca/communities/aboriginal_affairs/general.aspx?id=4072 (accessed 6 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
http://www.nosm.ca/education/ume/general.aspx?id=1240 (accessed6 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
http://www.statcan.,OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
http://www.cranhr.ca/ workforce1.html (accessed 6 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
http://www.cranhr.ca/past10.,Non-OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
http://www.statcan.gc.ca/rdc-cdr/pdf/researcher-rechercheur-guide-eng.pdf (accessed 6 Mar 2015).,OADS,/arxiv_data1/oa_pdf/68/00/bmjopen-2015-008246.PMC4521518.pdf
http://www.hosonline.org/ 5.,Non-OADS,/arxiv_data1/oa_pdf/85/1e/bmjopen-2015-008325.PMC4521520.pdf
"UK, 2013. http://www.hscic.gov.uk/proms 14.",Non-OADS,/arxiv_data1/oa_pdf/85/1e/bmjopen-2015-008325.PMC4521520.pdf
Data sharing statement Data are freely available from the HSCIC: Cervical screening: http://www.hscic.gov.uk/catalogue/PUB10339/ bres-scre-prog-eng-2011 –12-tab.xls.,Non-OADS,/arxiv_data1/oa_pdf/7f/ec/bmjopen-2015-007735.PMC4521532.pdf
Breast screening: http://www.hscic.gov.,Non-OADS,/arxiv_data1/oa_pdf/7f/ec/bmjopen-2015-007735.PMC4521532.pdf
2014. http://www.hscic.,Non-OADS,/arxiv_data1/oa_pdf/7f/ec/bmjopen-2015-007735.PMC4521532.pdf
2011. https://www.gov.uk/government/publications/the-national-cancer-strategy (accessed 14 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/7f/ec/bmjopen-2015-007735.PMC4521532.pdf
2008 http://www.apho.org.uk/resource/item.aspx?,Non-OADS,/arxiv_data1/oa_pdf/7f/ec/bmjopen-2015-007735.PMC4521532.pdf
2008.http://www.apho.org.uk/resource/item.aspx?RID=53312 (accessed14 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/7f/ec/bmjopen-2015-007735.PMC4521532.pdf
2011. https://www.gov.uk/government/statistics/english-indices-of-deprivation-2010 (accessed02 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/7f/ec/bmjopen-2015-007735.PMC4521532.pdf
2011. http://www.nomisweb.co.uk/census/ 2011/qs501ew (Accessed 14 Nov 2014).,OADS,/arxiv_data1/oa_pdf/7f/ec/bmjopen-2015-007735.PMC4521532.pdf
2013. http://www.hscic.gov.uk/catalogue/PUB09536 (accessed 14 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/7f/ec/bmjopen-2015-007735.PMC4521532.pdf
http://r.birkdiedenhofen.de/pckg/cocor/ (accessed 14 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/7f/ec/bmjopen-2015-007735.PMC4521532.pdf
"Health Survey for England, 2014. http://www.dh.gov.uk/ prod_consum_dh/idcplg?IdcService=GET_FILE&dID=1084& Rendition=Web (accessed 14 Nov 2014).",OADS,/arxiv_data1/oa_pdf/7f/ec/bmjopen-2015-007735.PMC4521532.pdf
2014. http://www.alliescomputing.com/innovation/pct-ccg-mapping (accessed 14 Nov 2014).,OADS,/arxiv_data1/oa_pdf/7f/ec/bmjopen-2015-007735.PMC4521532.pdf
doi:10.1136/bmjopen-2015- 008921 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008921).,Non-OADS,/arxiv_data1/oa_pdf/e7/5c/bmjopen-2015-008921.PMC4521533.pdf
http://globocan.iarc.fr/ (accessed 2Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/e7/5c/bmjopen-2015-008921.PMC4521533.pdf
http://wiki.cancer.org.au/australia/COSA:Head_and_neck_cancer_nutrition_guidelines (accessed 10 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/e7/5c/bmjopen-2015-008921.PMC4521533.pdf
doi:10.1136/bmjopen-2015- 008369 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008369).,Non-OADS,/arxiv_data1/oa_pdf/7d/b0/bmjopen-2015-008369.PMC4521536.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 008468).,Non-OADS,/arxiv_data1/oa_pdf/b3/1a/bmjopen-2015-008468.PMC4521537.pdf
"John Wiley & Sons, Ltd, 1996. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004366.pub6/abstract (accessed 15 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/b3/1a/bmjopen-2015-008468.PMC4521537.pdf
"John Wiley & Sons, Ltd, 1996. http://onlinelibrary.wiley.com/doi/10.1002/14651858.",Non-OADS,/arxiv_data1/oa_pdf/b3/1a/bmjopen-2015-008468.PMC4521537.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006988).,Non-OADS,/arxiv_data1/oa_pdf/ba/28/bmjopen-2014-006988.PMC4521538.pdf
http://www.who.int/gho/ncd/risk_factors/blood_pressure_ prevalence_text/en/ (accessed 20 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/4a/b0/bmjopen-2015-008339.PMC4521539.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-007881).,Non-OADS,/arxiv_data1/oa_pdf/c5/03/bmjopen-2015-007881.PMC4521544.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-007819).,Non-OADS,/arxiv_data1/oa_pdf/d5/33/bmjopen-2015-007819.PMC4521547.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.v2j00.,OADS,/arxiv_data1/oa_pdf/d5/33/bmjopen-2015-007819.PMC4521547.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d5/33/bmjopen-2015-007819.PMC4521547.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-007765).,Non-OADS,/arxiv_data1/oa_pdf/55/45/bmjopen-2015-007765.PMC4521553.pdf
"Acknowledgements A copy of the OHS and OKS questionnaires and permission to use these measures can be acquired from Isis Innovation Ltd, the technology transfer company of the University of Oxford via website: http://www.isis-innovation.com/outcomes/index.html or email: healthoutcomes@isis.ox.ac.uk.",Non-OADS,/arxiv_data1/oa_pdf/55/45/bmjopen-2015-007765.PMC4521553.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-007947).,Non-OADS,/arxiv_data1/oa_pdf/6e/fd/bmjopen-2015-007947.PMC4521555.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/09/main.PMC4521643.pdf
"Up to 98% (88 – 98%) of all narcoleptic patients with de ﬁnite cataplexy share a speci ﬁc Human Leukocyte Antigen (HLA) allele, HLA DQB1 n0602 (mostly in combination with HLA DR2), compared with 12 –38% of the general population, as evaluated in http://dx.doi.org/10.1016/j.slsci.2014.01.001 1984-0063/ &2014 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/32/09/main.PMC4521643.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/09/main.PMC4521643.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/df/main.PMC4521644.pdf
http://dx.doi.org/10.1016/j.slsci.2014.09.006 1984-0063/ &2014 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/9d/df/main.PMC4521644.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/df/main.PMC4521644.pdf
"Hindawi Publishing Corporation, J Environ Public Health 2012;2012: AID: 518263, 8 pages, http://dx.doi.org/10.1155/2012/518263 .",Non-OADS,/arxiv_data1/oa_pdf/9d/df/main.PMC4521644.pdf
Available from: http://www.sleepfoundation.org/ ; 2014 February 7.,Non-OADS,/arxiv_data1/oa_pdf/9d/df/main.PMC4521644.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/5c/main.PMC4521645.pdf
http://dx.doi.org/10.1016/j.slsci.2014.07.018 1984-0063/ &2014 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/a8/5c/main.PMC4521645.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).☆Support: AFIP & FAPESP –CEPID 98/14303-3.,Non-OADS,/arxiv_data1/oa_pdf/a8/5c/main.PMC4521645.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/a9/main.PMC4521647.pdf
"The sleepdisorder of the type 1 myotonic dystrophy shows multifactorialetiology, maybe resulted from the muscle impairment, leadingto alveolar hypoventilation, sl eep obstructive respiratory dis- orders and effects upon the sleep regulatory circuits in the http://dx.doi.org/10.1016/j.slsci.2014.09.002 1984-0063/ &2014 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/71/a9/main.PMC4521647.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/a9/main.PMC4521647.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/3e/main.PMC4521648.pdf
"To date, these alterations remain a challenge to http://dx.doi.org/10.1016/j.slsci.2014.07.020 1984-0063/ &2014 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/3e/3e/main.PMC4521648.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/3e/main.PMC4521648.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/fa/main.PMC4521649.pdf
http://dx.doi.org/10.1016/j.slsci.2014.07.015 1984-0063/ &2014 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/bb/fa/main.PMC4521649.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).☆Support: AFIP & FAPESP –CEPID 98/14303-3.,Non-OADS,/arxiv_data1/oa_pdf/bb/fa/main.PMC4521649.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/2d/main.PMC4521650.pdf
The autoimmune destruction of hypothalamic http://dx.doi.org/10.1016/j.slsci.2014.07.022 1984-0063/ &2014 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/e9/2d/main.PMC4521650.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/2d/main.PMC4521650.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/84/main.PMC4521651.pdf
"When compared to normal popula tion, medical students show http://dx.doi.org/10.1016/j.slsci.2014.09.004 1984-0063/ &2014 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/38/84/main.PMC4521651.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/84/main.PMC4521651.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/6e/main.PMC4521652.pdf
"The audible potential of the brain stem (APBS)frequently show an elongation of the evoked potential wavesin this population with MS, indicating a dysfunction at the http://dx.doi.org/10.1016/j.slsci.2014.07.014 1984-0063/ &2014 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/3b/6e/main.PMC4521652.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).☆Support: AFIP & FAPESP –CEPID 98/14303-3.,Non-OADS,/arxiv_data1/oa_pdf/3b/6e/main.PMC4521652.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/1a/main.PMC4521653.pdf
...............................................3 2 http://dx.doi.org/10.1016/j.slsci.2014.07.023 1984-0063/ &2014 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/a1/1a/main.PMC4521653.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/1a/main.PMC4521653.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/85/main.PMC4521654.pdf
http://dx.doi.org/10.1016/j.slsci.2014.07.001 1984-0063/ &2014 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/b2/85/main.PMC4521654.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/85/main.PMC4521654.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/26/6e/main.PMC4521655.pdf
http://dx.doi.org/10.1016/j.slsci.2014.09.008 1984-0063/ &2014 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/26/6e/main.PMC4521655.pdf
"This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).☆Institution: The study was developed in Universidade Lusófona de Humanidades e Tecnologias and Universidad de Salamanca, and the Obstructive Sleep Apnea diagnosed subjects were assessed in Hospital Santa Marta (Lisbon), Hospital Amadora/Sintra (Amadora) and Hospital da Beira Interior (Covilhã), in Portugal.",Non-OADS,/arxiv_data1/oa_pdf/26/6e/main.PMC4521655.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/25/main.PMC4521656.pdf
"The end- points used in these investigations have included sleepquality scales [6,8,9,13,16], accelerometer-based measures of sleep ef ﬁciency [17] and the number of awakenings during http://dx.doi.org/10.1016/j.slsci.2014.09.009 1984-0063/ &2014 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/20/25/main.PMC4521656.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/25/main.PMC4521656.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/01/main.PMC4521657.pdf
http://dx.doi.org/10.1016/j.slsci.2014.11.004 Sleep Science 7 (2014) 73,Non-OADS,/arxiv_data1/oa_pdf/5e/01/main.PMC4521657.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/af/main.PMC4521658.pdf
http://dx.doi.org/10.1016/j.slsci.2014.07.019Editorial / Sleep Science 7 (2014) 1–2 2,Non-OADS,/arxiv_data1/oa_pdf/10/af/main.PMC4521658.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/99/main.PMC4521659.pdf
http://dx.doi.org/10.1016/j.slsci.2014.07.016 1984-0063/ &2014 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/03/99/main.PMC4521659.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).☆Support: AFIP and FAPESP –CEPID 98/14303-3.,Non-OADS,/arxiv_data1/oa_pdf/03/99/main.PMC4521659.pdf
"Thus, cataplexic narcolepsy becomes essentially de ﬁned as a hypocretin de ﬁ- ciency syndrome, which is re ﬂected in the need for objective http://dx.doi.org/10.1016/j.slsci.2014.07.025 1984-0063/ &2014 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/61/5b/main.PMC4521660.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/5b/main.PMC4521660.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/a5/main.PMC4521661.pdf
Studies of http://dx.doi.org/10.1016/j.slsci.2014.09.005 1984-0063/ &2014 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/96/a5/main.PMC4521661.pdf
"This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).☆Funding Sources: Associação Fundo de Incentivo à Pesquisa (AFIP), CNPq, and Fundação de Amparo à Pesquisa do Estado de São Paulo-FAPESP.",Non-OADS,/arxiv_data1/oa_pdf/96/a5/main.PMC4521661.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/1c/main.PMC4521662.pdf
The disorder is more frequent among teenagers of the male gender [1–5]and has an unpredictable course with http://dx.doi.org/10.1016/j.slsci.2014.09.001 1984-0063/ &2014 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/b0/1c/main.PMC4521662.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).☆Support: AFIP & FAPESP –CEPID 98/14303-3.,Non-OADS,/arxiv_data1/oa_pdf/b0/1c/main.PMC4521662.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/8c/main.PMC4521663.pdf
"Even though persistent and intermittent nocturnal desatura- tion had been related with the presence of some consequencesof OSA, such as pulmonary hypertension and atherosclerosis [4], the role that desaturation has on the pathogenesis, development http://dx.doi.org/10.1016/j.slsci.2014.09.003 1984-0063/ &2014 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/01/8c/main.PMC4521663.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).☆This study's cost were funded by the Fundación Neumológica Colombiana.,OADS,/arxiv_data1/oa_pdf/01/8c/main.PMC4521663.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/13/mder-8-317.PMC4521664.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 317–329Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  317REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S6636 0Everolimus-eluting stent platforms in  percutaneous coronary intervention:   comparative effectiveness and outcomes vasileios F Panoulas1 ioannis Mastoris2 Klio Konstantinou1 Maurizio T espili3 Alfonso ielasi3 1National Heart and Lung institute,   imperial College London, London,   UK; 2interventional Cardiovascular  Research and Clinical Trials, The Zena  and Michael A wiener Cardiovascular  institute, The icahn School of  Medicine at Mount Sinai, New Y ork  NY, USA;  3Cardiology Department,   Bolognini Hospital Seriate, Seriate  (BG), italy Correspondence: Alfonso ielasi   Cardiology Department, Bolognini  Hospital Seriate, via Paderno 21,    24068 Seriate (BG), italy   Tel +39 035 306 3628  Fax +39 035 306 3535  Email alielasi@hotmail.co mAbstract:  Despite the remarkable benefits obtained following the introduction of the  first-generation drug-eluting stent (DES), concerns were raised over its long-term safety, par - ticularly with regard to very late (beyond  1 year) stent thrombosis.",Non-OADS,/arxiv_data1/oa_pdf/fe/13/mder-8-317.PMC4521664.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2015:8submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 329Everolimus-eluting stent platforms in PCi  69.,Non-OADS,/arxiv_data1/oa_pdf/fe/13/mder-8-317.PMC4521664.pdf
Available from: http://www.pcronline.com/Lectures/2014/BVS- Expand-6-month-result s.  72.,Non-OADS,/arxiv_data1/oa_pdf/fe/13/mder-8-317.PMC4521664.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/7f/ott-8-1859.PMC4521665.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1859–1862OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1859Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8848 0Quantitative assessment of pre-mir-218  rs11134527 polymorphism and cancer risk in  chinese population hongyu Zhao1,* rui Wang2,* 1central laboratory, The second  affiliated hospital of southeast  University, nanjing, People’s republic  of china; 2nanjing Kingmed clinical  laboratory co., ltd, nanjing, People’s  republic of china *These authors contributed equally  to this workBackground:  Accumulated studies have evaluated the association of pre-miR-218  rs11134527 polymorphism with cancer risk in Chinese population.",Non-OADS,/arxiv_data1/oa_pdf/7b/7f/ott-8-1859.PMC4521665.pdf
"G) of the putative promoter region of  pre-miR-218 has been identified, and many studies from People’s Republic of China  have explored the association between rs11134527 polymorphism and susceptibility correspondence: hongyu Zhao  Central Laboratory, The Second Affiliated  hospital of southeast University,1-1  Zhongfu street, 210003 nanjing,   People’s republic of china email zhaohy1223@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhao and Wang Running head recto: Pre-miR-218 rs11134527 and cancer risk in Chinese populations DOI: http://dx.doi.org/10.2147/OTT.S8848 0",Non-OADS,/arxiv_data1/oa_pdf/7b/7f/ott-8-1859.PMC4521665.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7b/7f/ott-8-1859.PMC4521665.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/7f/ott-8-1859.PMC4521665.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1427–1442International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1427RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S8375 8Positioning new pharmacotherapies for COPD Igor Z Barjaktarevic1 Anthony F Arredondo1 Christopher B Cooper1,2 1Department of Medicine, 2Department  of Physiology, David Geffen School  of Medicine, University of California,  Los Angeles, Los Angeles, CA, USAAbstract:  COPD imposes considerable worldwide burden in terms of morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
"The most important aspect of preventative management is  avoidance of any potentially toxic exposures, especially smoking cessation, since this  alone has been shown to alter the progression of the disease, at least in terms of the rate  of decline in lung function.8 If we consider decline in functional capacity as an impor - tant aspect of disease progression, then it is important to acknowledge that exercise Correspondence: Igor Z Barjaktarevic Department of Medicine, David  Geffen School of Medicine, University  of California, Los Angeles, 10833  Le Conte Avenue, 37-131 CHS,  Los Angeles, CA 90095, USA email ibarjaktarevic@mednet.ucla.ed u Journal name: International Journal of COPD Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Barjaktarevic et al Running head recto: New pharmacotherapies for COPD DOI: http://dx.doi.org/10.2147/COPD.S83758",Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Available from: https://clinicaltrials.gov/ ct2/show/NCT0198533 4.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT00976144?term =NCT00976144&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01899638?ter m=NCT01899638&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Available from: https://clinicaltrials.gov/ ct2/show/NCT02257372?term =NCT02257372&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
"Available  from: http://www.fda.gov/newsevents/newsroom/pressannouncements/ ucm379057.ht m. Accessed June 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02343 458?term=NCT02343458&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02347 085?term=NCT02347085&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT02347072?term=NCT0234707 2&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Available  from: https://clinicaltrials.gov/ct2/show/NCT02347072?term=NCT02 347072&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
"Available  from: http://www.fda.gov/downloads/drugs/developmentapprovalpro - cess/druginnovation/ucm381803.pd f. Accessed June 17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT01543919.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02322775?ter m=NCT02322775&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT02138916?term=NCT02138916&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT02075255?term=NCT0207525 5&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT01928771?term=NCT01928771&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT02135692?term=NCT0213569 2&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT01463644?term=NCT0146364 4&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Avail - able from: https://clinicaltrials.gov/ct2/show/NCT02105961?term=NC T02105961&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Available from: https://clinicaltrials.gov/ ct2/show/NCT02105948?term=NCT02105948&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/58/copd-10-1427.PMC4521666.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fb/e6/ott-8-1871.PMC4521667.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1871–1876OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1871Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8523 6mir-20b overexpression is predictive of poor  prognosis in gastric cancer T ong-min Xue* li-de Tao* Miao Zhang* guang-cai Xu Jie Zhang Pei-Jian Zhang institute of general surgical research,   second affiliated hospital, Yangzhou  University, Yangzhou, Jiangsu, People’s  republic of china *These authors contributed equally  to this workBackground:  miR-20b has been shown to be aberrantly expressed in several tumor types.",Non-OADS,/arxiv_data1/oa_pdf/fb/e6/ott-8-1871.PMC4521667.pdf
"They function in either the repression of miRNA translation or the cleavage of target  miRNA and RNAs that are highly conserved among species.5–8 In recent years, an  increased number of studies have indicated that miRNAs have crucial functions in  specific cellular processes such as differentiation, morphogenesis, and tumorigenesis  and that miRNAs may also be considered oncogenes or tumor suppressors.9–13 Some studies have shown that miR-20b is deregulated in several types of cancers14–18  and that the upregulation of miR-20b correlates with a worse prognosis; all of these  studies indicated that miR-20b acts as a tumor promoter.17,19–23 Currently, the clinical  significance of miR-20b in the prognosis of patients with GC is poorly understood, and correspondence: Pei-Jian Zhang institute of general surgical research,  Second Affiliated Hospital, Yangzhou  University, Yangzhou, Jiangsu 225002,  People’s republic of china email yzu.edu.pjz@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Xue et al Running head recto: miR-20b overexpression is predictive of poor prognosis in gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S85236",Non-OADS,/arxiv_data1/oa_pdf/fb/e6/ott-8-1871.PMC4521667.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/fb/e6/ott-8-1871.PMC4521667.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/e6/ott-8-1871.PMC4521667.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/opth-9-1379.PMC4521668.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1379–1384Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1379Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8701 7a prospective study on postoperative discomfort  after 20-gauge pars plana vitrectomy Ji-guo Yu1,* Fang ni1,* Yi Xiang1 Yi-fan Feng2 Jue Wang1 Xun-an Fu1 1Department of Ophthalmology, the  Central hospital of Wuhan, Wuhan,   hubei Province, 2Department of  Ophthalmology, Zhongshan hospital,   Fudan University, shanghai, People’s  republic of China *These authors contributed equally  to this workPurpose:  To evaluate postoperative pain and other irritation symptoms after 20-gauge (20G)  pars plana vitrectomy.",Non-OADS,/arxiv_data1/oa_pdf/f1/e4/opth-9-1379.PMC4521668.pdf
"But other common Correspondence: Xun-an Fu Department of Ophthalmology, the  Central hospital of Wuhan, no 26  shengli street, Wuhan 430014, hubei  Province, People’s republic of China Tel +86 27 8220 1749 Fax +86 27 8220 1745 email fxayanke@163.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Yu et al Running head recto: Discomfort after 20-gauge pars plana vitrectomy DOI: http://dx.doi.org/10.2147/OPTH.S87017",Non-OADS,/arxiv_data1/oa_pdf/f1/e4/opth-9-1379.PMC4521668.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f1/e4/opth-9-1379.PMC4521668.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/opth-9-1379.PMC4521668.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5b/a2/ott-8-1849.PMC4521669.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1849–1858OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1849Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S6580 4Ganetespib: research and clinical development Komal Jhaveri Shanu Modi Breast Medicine Service, Department  of Medicine, Memorial Sloan Kettering  Cancer Center, New Y ork, NY, USAAbstract:  Under stressful conditions, the heat shock protein 90 (HSP90) molecular chaperone  protects cellular proteins (client proteins) from degradation via the ubiquitin-proteasome pathway.",Non-OADS,/arxiv_data1/oa_pdf/5b/a2/ott-8-1849.PMC4521669.pdf
"Keywords:  HSP90, lung cancer, breast cancer, colorectal cancer Introduction Heat shock protein 90 (HSP90), a 90 kDa ATP-dependent molecular chaperone, is  the most abundant intracellular protein in mammalian cells and is essential for protein  folding, assembly, and degradation processes.1,2 It is overexpressed in response to a  variety of physiological and environmental insults, allowing cells to survive poten - tially lethal conditions due to its cytoprotective functions.3–5 In this regard, HSP90  has recently received much attention due to its overexpression in certain types of  cancer,6–9 where it is associated with a poor prognosis and contributes to resistance to  chemotherapy and radiation.10 Unlike other molecular chaperones that are involved  in the primary folding of nascent polypeptides, HSP90 uses repeated cycles of client  protein binding, hydrolysis of ATP, and interaction with its co-chaperones such as  HSP70, Cdc37, HOP, p23, and Aha1 to control the stability and activity of hundreds  of client proteins.11,12 Importantly, the majority of these client proteins are involved in  critical signaling pathways necessary for cellular proliferation, cell cycle progression,  and apoptosis, including steroid hormone receptors, kinases, transcriptions factors,  human epidermal growth factor receptor 2 (HER2), Akt, mutant BRAF, and mutant p53  among others.12–16 Consistent with this, HSP90 inhibition results in the simultaneous  degradation of many of these clients (via the ubiquitin-proteasome pathway), leading Correspondence: Shanu Modi Breast Medicine Service, Department  of Medicine, Memorial Sloan Kettering  Cancer Center, New York, NY, USA Tel +1 646 888 4564 Fax +1 646 888 4555 email modis@mskcc.or gJournal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Jhaveri and Modi Running head recto: Current status of the development of ganetespib DOI: http://dx.doi.org/10.2147/OTT.S65804",Non-OADS,/arxiv_data1/oa_pdf/5b/a2/ott-8-1849.PMC4521669.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5b/a2/ott-8-1849.PMC4521669.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/a2/ott-8-1849.PMC4521669.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/ott-8-1823.PMC4521670.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1823–1830OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1823CASE SERIESopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8650 2Follicular dendritic cell sarcoma: two rare cases  and a brief review of the literature Yuan Ma1,* Jujie Sun2,* Cuicui Yang1 Dandan Yuan3 Jie Liu3 1Department of Oncology, Shandong  Cancer Hospital & Institute, School of  Medicine and Life Sciences, University  of Jinan-Shandong Academy of Medical  Sciences, Shandong Province, People’s  Republic of China; 2Department of  Pathology, 3Department of Oncology,   Shandong Cancer Hospital & Institute,   Jinan, Shandong Province, People’s  Republic of China *These authors contributed equally  to this workAbstract:  Follicular dendritic cell sarcoma (FDCS) is a rare malignant tumor recognized in  recent years.",Non-OADS,/arxiv_data1/oa_pdf/b8/e8/ott-8-1823.PMC4521670.pdf
"There was no significant past Correspondence: Jie Liu Department of Oncology, Shandong  Cancer Hospital, No 440 Jiyan Road,  Huaiyin District, Jinan, Shandong Province  250117, People’s Republic of China Tel +86 531 6762 6332 Fax +86 531 8798 4079 Email liujiesdch@126.co m Journal name: OncoTargets and Therapy Article Designation: CASE SERIES Y ear: 2015 Volume: 8 Running head verso: Ma et al Running head recto: Follicular dendritic cell sarcoma DOI: http://dx.doi.org/10.2147/OTT.S86502",Non-OADS,/arxiv_data1/oa_pdf/b8/e8/ott-8-1823.PMC4521670.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b8/e8/ott-8-1823.PMC4521670.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/e8/ott-8-1823.PMC4521670.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/68/8a/oajsm-6-229.PMC4521671.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2015:6 229–239Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  229OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S8315 9effects of vitamin D and quercetin, alone and in  combination, on cardiorespiratory fitness and  muscle function in physically active male adults Shane D Scholten1 igor n Sergeev2 Qingming Song3 chad B Birger4 1exercise and Sport Sciences,   Augustana college, Sioux Falls,   2Department of health and  nutritional Sciences, South Dakota  State University, Brookings, SD,   3gold green Farm corporation,   hammonton, nJ, 4center for health  Outcomes and Prevention research,   Sanford research, Sioux Falls, SD, USA correspondence: Shane D Scholten   exercise and Sport Sciences, Augustana  college, 2001 South Summit Avenue,  Sioux Falls, SD 57197, USA   Tel +1 605 274 5469   email shane.scholten@augie.ed uIntroduction:  Vitamin D and the antioxidant quercetin, are promising agents for improving  physical performance because of their possible beneficial effects on muscular strength and  cardiorespiratory fitness.",Non-OADS,/arxiv_data1/oa_pdf/68/8a/oajsm-6-229.PMC4521671.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/68/8a/oajsm-6-229.PMC4521671.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/8a/oajsm-6-229.PMC4521671.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/94/ott-8-1877.PMC4521672.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1877–1885OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1877Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7840 4investigation of brain tumors using 18F-fluorobutyl  ethacrynic amide and its metabolite with positron  emission tomography Ying-cheng huang1 ho-lien huang2 chun-n an Yeh3 Kun-Ju lin4 chung-shan Yu2,5 1Department of n eurosurgery, chang- gung Memorial hospital at linkou,   chang gung University, 2Department  of Biomedical engineering and  environmental sciences, national  Tsinghua University, 3Department  of surgery, 4Department of nuclear  Medicine, chang- gung Memorial  hospital at linkou, chang gung  University, 5institute of nuclear  engineering and science, national  Tsing-hua University, hsinchu, TaiwanAbstract:  To date, imaging of malignant glioma remains challenging.",Non-OADS,/arxiv_data1/oa_pdf/83/94/ott-8-1877.PMC4521672.pdf
"Fluorine-18-labeled compounds have been  extensively used in imaging of tumors4,5 and brain diseases.6 Fluorine atoms are often  used as hydrogen atom or hydroxyl group substitutes due to their similarity in van der  Waals radius and molecular size.7,8 For instance, the positron-emitting radioisotope  correspondence: chung-shan Yu Department of Biomedical engineering  and environmental sciences, national  Tsing-hua University, hsinchu 300,  Taiwan email csyu@mx.nthu.edu.t wJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Huang et al Running head recto: 18F-fluorobutyl ethacrynic amide for imaging brain tumors DOI: http://dx.doi.org/10.2147/OTT.S78404",Non-OADS,/arxiv_data1/oa_pdf/83/94/ott-8-1877.PMC4521672.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/83/94/ott-8-1877.PMC4521672.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/94/ott-8-1877.PMC4521672.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/62/03/ppa-9-1053.PMC4521673.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1053–1059Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1053OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8454 6Perspectives of patients on factors relating to  adherence to post-acute coronary syndrome  medical regimens Anne lambert-Kerzner1,2 edward P havranek2,3 Mary e Plomondon1,2 Katherine M Fagan1 Marina s Mccreight1 Kelty B Fehling1 David J Williams2 Alison B hamilton4 Karen Albright2 Patrick J Blatchford2 renee Mihalko-corbitt5 chris l Bryson6 hayden B Bosworth7 Miriam A Kirshner7 eric J Del giacco5 P Michael ho1,2 1Department of cardiology, Veterans  health Administration (VA) eastern  colorado health care system, Denver,  cO, 2school of Public health or school  of Medicine, University of colorado,  Anschutz Medical campus, Aurora, cO,  3cardiology, Denver health Medical  center, Denver, cO, 4health services  research, Veterans health Administration  (VA) greater los Angeles healthcare  system, los Angeles, cA, 5internal  Medicine, John l. Mcclellan Memorial  Veterans hospital, little rock, Ar,  6health services research, Veterans  health Administration (VA) Puget sound  health care system, seattle, WA, 7health  services research, Durham Veterans  Affairs Medical center, Durham, nc, UsAPurpose:  Poor adherence to cardioprotective medications after acute coronary syndrome (ACS)  hospitalization is associated with increased risk of rehospitalization and mortality.",Non-OADS,/arxiv_data1/oa_pdf/62/03/ppa-9-1053.PMC4521673.pdf
"Keywords:  cardiovascular disease, compliance, qualitative analysis, medications Introduction Acute coronary syndrome (ACS) is the leading cause of death and disability in the  United States.1 Nonadherence to proven cardiovascular medications is common follow - ing hospitalization for an ACS event and may result in serious complications, including  recurrent hospitalization and death.2–6 Multifaceted interventions targeting medication  adherence and health behaviors have demonstrated varying results.7,8 Understanding  patients’ perspectives on their experiences following an ACS event and their opinions  of the effectiveness of such interventions may support adherence behaviors.9correspondence: Anne lambert-Kerzner Veterans health Administration (VA)  eastern colorado health care system,  1055 clermont st, Denver, cO 80220,  UsA Tel +1 720 857 5129 email anne.lambert-kerzner@va.go v Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Lambert-Kerzner et al Running head recto: Patients’ perspectives on factors relating to adherence to post-ACS DOI: http://dx.doi.org/10.2147/PPA.S84546",Non-OADS,/arxiv_data1/oa_pdf/62/03/ppa-9-1053.PMC4521673.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/62/03/ppa-9-1053.PMC4521673.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a8/1e/ccid-8-397.PMC4521674.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 397–403Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  397RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S5398 5epidemiology and burden of alopecia areata:   a systematic review Alexandra C villasante Fricke Mariya Miteva Department of Dermatology and  Cutaneous Surgery, University of  Miami Miller School of Medicine,   Miami, FL, USA Correspondence: Mariya Miteva   Department of Dermatology and  Cutaneous Surgery, University of Miami  Miller School of Medicine, 1600 Nw   10th Avenue, Rosenstiel Medical   Science Building, Room 2023A,   33136 Miami, FL, USA   email mmiteva@med.maimi.ed uBackground:  Alopecia areata (AA) is an autoimmune disorder characterized by patches of  non-scarring alopecia affecting scalp and body hair that can be psychologically devastating.",Non-OADS,/arxiv_data1/oa_pdf/a8/1e/ccid-8-397.PMC4521674.pdf
"Avail - able from: http://www.healthdata.org/search-gbd-data?s=Alopecia%20 areat a. Accessed February 13, 2015.",OADS,/arxiv_data1/oa_pdf/a8/1e/ccid-8-397.PMC4521674.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/a8/1e/ccid-8-397.PMC4521674.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/1e/ccid-8-397.PMC4521674.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/d7/dddt-9-3885.PMC4521675.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3885–3898Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3885Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8790 6Ultrasound effects on brain-targeting mannosylated  liposomes: in vitro and blood–brain barrier  transport investigations ahmed s Zidan1,2 hibah aldawsari1 1Department of Pharmaceutics  and industrial Pharmacy, Faculty  of Pharmacy, King abdulaziz  University, Jeddah, Kingdom of saudi  arabia; 2Department of Pharmaceutics  and industrial Pharmacy, Faculty  of Pharmacy, Zagazig University,   Zagazig,  egyptAbstract:  Delivering drugs to intracerebral regions can be accomplished by improving the  capacity of transport through blood–brain barrier.",Non-OADS,/arxiv_data1/oa_pdf/bf/d7/dddt-9-3885.PMC4521675.pdf
"BBB would limit the  uptake of not only most ionized small molecules but also most large molecules.3,4  The specificity to achieve a sufficient concentration of the active medication at a  specific intracerebral region is also considered a major challenge.5 Therefore, drug  delivery systems that can transport BBB then deliver CNS-acting drugs to target  specific functional brain regions would propose an alternative therapy of many CNS correspondence: ahmed s Zidan Department of Pharmaceutics and  industrial Pharmacy, Faculty of Pharmacy,  King abdulaziz University, PO Box  80260, Jeddah 21589, Kingdom of  saudi arabia Tel +966 5 6426 6682 Fax +966 126 951 696 email aszidan@kau.edu.s a Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zidan and Aldawsari Running head recto: Ultrasound effects on brain-targeting mannosylated liposomes DOI: http://dx.doi.org/10.2147/DDDT.S87906",Non-OADS,/arxiv_data1/oa_pdf/bf/d7/dddt-9-3885.PMC4521675.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/bf/d7/dddt-9-3885.PMC4521675.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/d7/dddt-9-3885.PMC4521675.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/92/76/idr-8-231.PMC4521676.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2015:8 231–235Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  231ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IDR.S8705 2Profile and microbiological isolates of asymptomatic  bacteriuria among pregnant women in Abakaliki,  nigeria Fidelis agwu Onu1 Leonard Ogbonna Ajah1 Paul Olisaemeka Ezeonu1 Odidika Ugochukwu  Joannes Umeora1 Perpetus Chudi Ibekwe1 Monique Iheoma Ajah2 1Department of Obstetrics and  Gynaecology, Federal Teaching  Hospital, 2Department of  Microbiology, Ebonyi State University,   Abakaliki, Nigeria Correspondence: Leonard Ogbonna Ajah   Department of Obstetrics and  Gynaecology, Federal T eaching Hospital,  PMB 102, Abakaliki, Nigeria   Tel +234 803 392 0789   email leookpanku@yahoo.co mBackground:  Detecting and treating asymptomatic bacteriuria (ASB) prevents urinary tract  infection and its consequences.",Non-OADS,/arxiv_data1/oa_pdf/92/76/idr-8-231.PMC4521676.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/92/76/idr-8-231.PMC4521676.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/92/76/idr-8-231.PMC4521676.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/7f/jir-8-129.PMC4521677.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Inflammation Research 2015:8 129–135Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  129ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JIR.S8499 3effects of exendin-4, a glucagon like peptide-1  receptor agonist, on neutrophil count and  inflammatory cytokines in a rat model of  endotoxemia Ofer Yanay1,2 adam l Bailey3 Kelly Kernan1 Jerry J Zimmerman1,2 William R Osborne1 1Department of Pediatrics, University  of Washington,  2Division of Pediatric  critical care Medicine, seattle  children’s hospital, seattle, W a,  3Medical scientist Training Program,   University of Wisconsin, Madison, WI,   Usa correspondence: Ofer Yanay   Department of Pediatrics, University of  Washington, seattle children’s hospital,  Fa.2.112, 4800 sand Point Way ne,  seattle, Wa  98105, Usa   Tel +1 206 987 5391  Fax +1 206 987 3866  email ofer.yanay@seattlechildrens.or gBackground:  Sepsis remains a major cause of morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/65/7f/jir-8-129.PMC4521677.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/65/7f/jir-8-129.PMC4521677.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/7f/jir-8-129.PMC4521677.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3767–3777Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3767Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8802 3Albumin-bound paclitaxel in solid tumors: clinical  development and future directions Madappa N Kundranda1 Jiaxin Niu2 1Medical Oncology, Banner MD  Anderson Cancer Center, Gilbert,   2Department of Medical Oncology,   Cancer Treatment Centers of  America, Goodyear, AZ, USAAbstract:  Albumin-bound paclitaxel ( nab-paclitaxel) is a solvent-free formulation of paclitaxel  that was initially developed more than a decade ago to overcome toxicities associated with the  solvents used in the formulation of standard paclitaxel and to potentially improve efficacy.",Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
"comJournal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Kundranda and Niu Running head recto: Nab-paclitaxel in solid tumors DOI: http://dx.doi.org/10.2147/DDDT.S88023",Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Available from: http://www.sabcs.org /.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Available from: http://sabcs.org/programschedule/PosterSessions.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
"Available from: http://www.nccn.org/professionals/ physician_gls /pdf/breast.pd f. Accessed March 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT0178133 8.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0182231 4.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0169070 2.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Available from: https://clinicaltrials.gov/ ct2/show/NCT0201927 7.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Available from: https://www.clinicaltrials.gov/ ct2/show/NCT0215114 9.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
"Available from: http://www.nccn.org/profession - als/physician_gls/pdf/nscl.pd f. Accessed March 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
"Available  from: http://www.nccn.org/professionals/physician_gls/pdf/nscl.pd f.  Accessed July 9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT0202742 8.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
"Available from: http://www.nccn.org/ professionals /physician_gls/pdf/pancreatic.pd f. Accessed March  16,  2015.",Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
"Available from: http://www.nccn.org/professionals/ physician_gls / pdf/pancreatic.pd f. Accessed July 9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT0196443 0.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0183643 2.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
"Available from: http://www.nccn.org/professionals/physician_gls/pdf/ melanoma.pd f. Accessed March 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
"Available from: http://www.nccn.org/professionals/ physician_gls /pdf/ovarian.pd f. Accessed March 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT0215852 0.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT0182711 1.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0141222 9.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0198081 0.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Available from: https://clinicaltrials.gov/ ct2/show/NCT0173058 6.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/4e/c5/dddt-9-3767.PMC4521678.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/41/e7/ott-8-1863.PMC4521679.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1863–1869OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1863Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8586 6p27Kip1 and ser10-phosphorylated p27Kip1 in breast  cancer: clinical significance and expression Wei song1,* ruilian Xie2,* aiyu Zhu1 Yumei Xu1 Yaqin shi3 Yan shen3 Wenwen Zhang3 Fang Yang3 Xiaoxiang guan1,3 1Department of Medical Oncology,   Jinling hospital, southern Medical  University, guangzhou, 2Department  of Medical Oncology, The First  affiliated hospital of gannan Medical  college, ganzhou, 3Department of  Medical Oncology, Jinling hospital,   Medical school of n anjing University,   nanjing, People’s republic of china *These authors contributed equally   to this workBackground:  The protein p27 (p27Kip1) is a member of the cyclin-dependent kinase inhibitor  family, which negatively regulates cell cycle progression, and the phosphorylation of p27 has  been proven to affect its stability and nuclear export.",Non-OADS,/arxiv_data1/oa_pdf/41/e7/ott-8-1863.PMC4521679.pdf
"It has been proven that correspondence: Xiaoxiang guan Department of Medical Oncology, school  of Medicine, southern Medical University,  Jinling hospital, guangzhou 510282,  People’s republic of china Tel +86 25 8086 0434 Fax +86 25 8086 0220 email xguan@nju.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Song et al Running head recto: Expression of p27Kip1 and phosphorylated p27Kip1 in breast cancer DOI: http://dx.doi.org/10.2147/OTT.S85866",Non-OADS,/arxiv_data1/oa_pdf/41/e7/ott-8-1863.PMC4521679.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/41/e7/ott-8-1863.PMC4521679.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/e7/ott-8-1863.PMC4521679.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0b/af/idr-8-217.PMC4521680.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2015:8 217–230Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  217RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S5412 5vancomycin-resistant enterococcal infections:  epidemiology, clinical manifestations,   and optimal management Tristan O’Driscoll1 Christopher w Crank2 1Department of Pharmacy Practice,  Chicago College of Pharmacy,  Downers Grove, IL, USA; 2Pharmacy  Services, Rush-Copley Medical  Center, Aurora, IL, USA Correspondence: Christopher w Crank   Rush-Copley Medical Center,    2000 Ogden Avenue, Aurora,   IL 60504, USA   Tel +1 630 978 4853  email ccrank@rushcopley.co mAbstract:  Since its discovery in England and France in  1986, vancomycin-resistant   Enterococcus  has increasingly become a major nosocomial pathogen worldwide.",Non-OADS,/arxiv_data1/oa_pdf/0b/af/idr-8-217.PMC4521680.pdf
"EARS-Net Results ; 2015; Available from: http://www.ecdc.europa.eu/ en/ healthtopics/antimicrobial_resistance/database/Pages/database.asp x.  Accessed January  1, 2015.",OADS,/arxiv_data1/oa_pdf/0b/af/idr-8-217.PMC4521680.pdf
"Available from: http://www.bacterio.net/ enterococcus.htm l. Accessed February  17, 2015.",Non-OADS,/arxiv_data1/oa_pdf/0b/af/idr-8-217.PMC4521680.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/0b/af/idr-8-217.PMC4521680.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/0b/af/idr-8-217.PMC4521680.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/af/idr-8-217.PMC4521680.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/8e/main.PMC4521685.pdf
http://dx.doi.org/10.1016/j.slsci.2014.07.017 1984-0063/ &2014 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/95/8e/main.PMC4521685.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).☆Support: AFIP & FAPESP –CEPID 98/14303-3.,Non-OADS,/arxiv_data1/oa_pdf/95/8e/main.PMC4521685.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/bc/main.PMC4521686.pdf
Such http://dx.doi.org/10.1016/j.slsci.2014.07.024 1984-0063/ &2014 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/70/bc/main.PMC4521686.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/bc/main.PMC4521686.pdf
